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Nanomaterials are used in various applications, within consumer products (cosmetics, textiles, food) 
and for medical (tumor therapy, drug delivery) and technical (catalyst, batteries) purposes (Blasco & 
Pico 2011; Lewicka et al. 2011; Stark et al. 2015). Production and applications of engineered 
nanomaterials have increased during the last two decades.  
During production, handling and use of nanomaterials, a release into the air may occur. For airborne 
nanoparticles, inhalation exposure is the major route of concern. There has been raised the issue that 
nanomaterials yield new risks for human health. Therefore, possible toxic effects and underlying 
mechanisms after inhalation of engineered nanoparticles have to be studied in detail. So far, no 
“nano-specific toxicity”, the toxicity found with nanomaterials, but not seen with other materials, 
has been observed; there are rather different toxic effects of different nanoparticles. Nevertheless, 
nanoparticles can be grouped according to certain similarities (Arts et al. 2014). Several industrial 
nanomaterials of high production volume belong to the group of granular, poorly soluble low toxicity 
particles (PSLT); another group has been classified as biopersistent fibrous materials.  
Only little is known about long-term effects after inhalation of nanoparticles (Becker et al., 2011). From 
studies with micron-scale, non-nano PSLT, it is known, that high lung burdens can lead to impairment 
of macrophage mediated clearance (ECETOC 2013). Under these lung overload conditions, inhaled 
PSLT can cause chronic inflammation, increase in lung weights, epithelial cell proliferation, fibrosis, 
and possibly lung cancer in rats (Cullen et al. 1999; Cullen et al. 2000; Lee et al. 1986). So far, only 
two nanoparticles, nano-TiO2 and Carbon black, have been tested in long-term inhalation studies 
(Heinrich et al. 1995, Mauderly et al. 1994, Nikula et al. 1995). However, these studies were not 
conducted according to OECD test guidelines and only one single high aerosol concentration was 
tested. Therefore, a chronic and carcinogenicity inhalation study with two different nanoparticles was 
initiated in 2013. As a preparation work for the long-term study, two short-term studies with 1 and 4 
weeks of exposure were performed to select the aerosol concentrations. The tested materials were 
nano-CeO2 (NM-212) and -BaSO4 both assumed to be PSLT – based on their morphology,  
chemical water-solubility and previous short-term studies. The long-term study was performed 
according to OECD test guideline no. 453 (OECD 2009), under GLP (Good Laboratory Practice) and 
with aerosol concentrations range set according to the outcome of the short-term studies. The results 
of this long-term study will be used to set (occupational) exposure limit values for humans. 
Furthermore, these results will help to classify the carcinogenic potential of certain nanomaterials.  
This dissertation work contains the results of the short-term studies with 1 and 4 weeks of exposure as 
well as the interim results of the long-term study after 13 and 52 weeks of inhalation exposure to nano-
CeO2 (NM-212) and BaSO4. This work aims to investigate the lung deposition and clearance of inhaled 
nanomaterials and the resulting effects on the organism at different time points. The results will be the 
basis to understand and assess the results of the long-term study after two years of exposure.  
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Foreword
  Summary 2.
 
The aim of this work was to compare lung clearance and retention kinetics as well as biological effects 
of two poorly soluble, low toxicity nanoparticles (nano-PSLT) after 1, 4, 13 and 52 weeks of inhalation 
exposure. The two tested nano-PSLT may represent a range of biological responses within the group.  
Cerium dioxide (CeO2; NM-212) and barium sulfate (BaSO4) nanoparticles were tested for toxic effects 
and organ burden after inhalation exposure. Female Wistar rats inhaled nano-CeO2 or - BaSO4 by 
whole-body exposure, 6 hours per day, 5 days per week for a total of two years. Interim results after 
13 and 52 weeks of exposure including bronchoalveolar lavage fluid (BALF) analysis and 
determination of lung- and lymph node burdens are presented in this dissertation work. The tested 
aerosol concentrations were 0.1, 0.3, 1 and 3 mg/m³ CeO2 and 50 mg/m³ BaSO4. The aerosol 
concentrations were selected based on the results of short-term inhalation studies with 1 and 4 weeks 
of exposure to 0.5, 5 and 25 mg/m³ CeO2 and 50 mg/m³ BaSO4. Lung, lymph node and liver burdens 
(by inductively coupled plasma optical emission spectrometry), histopathology of lung and 
extrapulmonary organs and examination of BALF and blood were assessed after short-term exposure 
and post-exposure periods up to 129 days.  
In the short-term studies with 1 and 4 weeks of exposure, inhaled nano-CeO2 at low aerosol 
concentrations of 0.5 mg/m³ were cleared from the lung at physiological rates whereas higher aerosol 
concentrations above 5 mg/m³ retarded the lung clearance of the deposited particles and caused 
pulmonary inflammation already after one week of exposure. This pulmonary inflammation was still 
apparent by increased BALF neutrophils after long-term exposure.  
After inhalation of nano-CeO2, the first sign of a pulmonary inflammation was the increase of 
neutrophils in BALF. Neutrophils in the initial inflammation phase were later supplemented by 
macrophages, and the inflammation progressed towards a granulomatous type after 4 weeks plus 4 
weeks post-exposure. This effect was only observable by histopathology. Comparing inflammation 
upon sustained exposure and after post-exposure periods, it seems that the dose-rate drove the initial 
inflammation phase whereas the continuous presence of deposited particles in the lungs was driving 
the granulomatous inflammation. Nano-CeO2 seems to be a nano-PSLT with an inherent toxicity in the 
lung; lung inflammation and retarded particle clearance in the lung concurred. Its toxicity mechanism 
needs further investigations. 
In the short-term studies, inhaled nano-BaSO4 showed an unusually fast clearance. This may be 
explained by higher in vivo dissolution compared to cell-free in vitro solubility studies. The observed 
fast lung clearance and high systemic bioavailability of inhaled BaSO4 in vivo cannot be achieved by 
any known physiological process but dissolution of the particles. High BaSO4 aerosol concentrations 
of 50 mg/m³ achieved a lung burden of 0.8 mg/lung after 4 weeks of exposure. At these burdens, 
BaSO4 caused, however, no pulmonary inflammation and no morphological changes in the lung while 
similar lung burdens of nano-CeO2 (achieved, however, by lower aerosol concentrations) caused 





 increased indicating a change in the clearance rate and eventually, pulmonary inflammation indicated 
by increased BALF parameters occurred. There were no indications of barium-ion toxicity and the 
effects are regarded as being particle effects in the lung. The mechanisms of the fast lung clearance 
of BaSO4 and the basis of its low toxicity need further investigations.  
Cell proliferation rates in the lung examined by immunohistochemistry (BrdU stain of epithelial cells) 
were moderately increased after short-term exposure to nano-CeO2, but not after exposure to BaSO4. 
Cell proliferation rates in young, growing animals are, however, rather variable and the biological 
relevance of this moderate increase remains questionable.  
Systemic effects were evaluated by analysis of blood including hematology, clinical chemistry and 
acute phase proteins. Inhalation exposure to nano-CeO2 and -BaSO4 elicited no or only minimal 
systemic effects after short-term and long-term exposure, respectively.  
In summary, the two nanoparticles examined in this body of work differed in their particle kinetics and 
effects in the lung already after one week and up to 52 weeks of exposure. Within the group of nano-
PSLT, nano-CeO2 represents the biopersistent and higher toxicity end. Nano-BaSO4 could be 
regarded as not being a classical PSLT, but rather soluble in vivo albeit indicated to be insoluble by its 
chemical properties and behavior in vitro. The remarkably low toxicity of inhaled nano-BaSO4 could 
only partly be assigned to its fast lung clearance, but may also be the result of its low inherent toxicity.  
Whether the lung burdens and biological effects observed within the first 52 weeks of exposure will 
lead to lung tumour formation will be revealed by histopathology after 2 years of exposure in the 






  Zusammenfassung 3.
 
Das Ziel dieser Arbeit war der Vergleich zweier gering löslicher und gering toxischer Nanopartikel 
(Nano-PSLT) bezüglich ihrer Clearance- und Retentionskinetik in der Lunge und ihrer biologischen 
Effekte nach 1, 4, 13 und 52 Wochen Inhalationsexposition. Hiermit sollte die Bandbreite der 
Biopersistenz und Toxizität in der Gruppe der inhalierten PSLT-Nanopartikel untersucht werden. 
Die Inhalationstoxizität und die Organbeladung (Gehalt der Testmaterialien in verschiedenen 
Organen) von Ceriumdioxid- (CeO2) und Bariumsulfat- (BaSO4) Nanopartikeln wurden nach 
Langzeitexposition getestet. Weibliche Wistar-Ratten wurden in Ganzkörperinhalationskammern für 6 
Stunden pro Tag an fünf Tage pro Woche für insgesamt zwei Jahre exponiert. Die in dieser Arbeit 
präsentierten Zwischenergebnisse nach 13 und 52 Wochen Exposition beinhalten die Analyse der 
bronchoalveolären Lavageflüssigkeit (BALF) und die Untersuchung der Partikelbeladungen der Lunge 
und der assoziierten Lymphknoten. In der Langzeitstudie waren die getesteten 
Aerosolkonzentrationen 0.1, 0.3, 1 und 3 mg/m³ für CeO2 und 50 mg/m³ für BaSO4. Diese 
Konzentrationen wurden anhand der Ergebnisse der vorherigen Kurzzeitstudien mit 1 und 4 Wochen 
Exposition festgelegt. Die Aerosolkonzentrationen dieser Kurzzeitstudien waren 0.5, 5 und 25 mg/m³ 
für CeO2 und 50 mg/m³ für BaSO4. In den Kurzzeitstudien wurden die Tiere direkt nach der Exposition 
und nach einer Nachbeobachtungszeit von bis zu 129 Tagen untersucht. Die Partikelbeladungen der 
Lunge, Lymphknoten und Leber wurden mit Massenspektrometrie mit induktiv gekoppeltem Plasma 
gemessen. Die Histopathologie der Lunge und extrapulmonalen Organe sowie die bronchoalveoläre 
Lavageflüssigkeit und das Blut wurden weiterhin untersucht.  
Die Inhalation von niedrigen Aerosolkonzentrationen von 0.5 mg/m³ Nano-CeO2 in den 
Kurzzeitstudien führte zu Partikelbeladungen, die mit einer physiologischen Rate aus der Lunge 
gereinigt wurde. Aerosolkonzentrationen von 5 mg/m³ und höher verlangsamten die Partikelreinigung 
und verursachten bereits nach einwöchiger Exposition eine Entzündung in der Lunge. Dies war auch 
nach der Langzeitexposition anhand von erhöhten BALF-Neutrophilenzahlen erkennbar. Nano-CeO2 
repräsentiert innerhalb der Gruppe der Nano-PSLT Nanopartikel mit einer gewissen inhärenten 
Toxizität in der Lunge, die noch detaillierter untersucht werden muss. Nach der Inhalation der 
untersuchten CeO2-Nanopartikel war die Erhöhung der neutrophilen Granulozyten in der BALF das 
erste Anzeichen einer Entzündung in der Lunge. Dieser Entzündungsprozess wurde später durch 
Makrophagen ergänzt und entwickelte einen granulomatösen Charakter nach vierwöchiger Exposition 
und vierwöchiger Nachbeobachtungszeit ohne Exposition. Die spätere granulomatöse Entzündung 
war nur in der Histopathologie erkennbar. Wenn man den Verlauf der Entzündungen bei anhaltender 
Exposition und nach dem Ende der Exposition vergleicht, ergaben sich Unterschiede. Die Dosisrate 
(der Partikeleintrag in die Lunge pro Zeiteinheit) schien die initiale Entzündung zu bestimmten; dieser 
Prozess klang nach dem Ende der Exposition ab. Die Entwicklung der Entzündung zur 
granulomatösen Entzündung dagegen schien durch die andauernde Präsenz der Partikel in der Lunge 
verursacht zu sein; hohe Partikelbeladungen in der Lunge trugen auch nach dem Ende der Exposition 





 In der Kurzzeitstudie wurden die BaSO4-Nanopartikel ungewöhnlich schnell aus der Lunge entfernt. 
Dies kann möglicherweise durch eine höhere Löslichkeitsrate der BaSO4-Nanopartikel begründet 
werden, da die schnelle Clearance aus der Lunge und hohe systemische Bioverfügbarkeit nicht durch 
einen bekannten physiologischen Reinigungsprozess erklärt werden kann. Nach vierwöchiger 
Inhalation hoher Aerosolkonzentrationen von 50 mg/m³ BaSO4 wurden Lungengehalte von 0.8 mg pro 
Lunge gemessen, die keine Entzündung oder morphologische Veränderungen in der Lunge zur Folge 
hatten. Hingegen verursachten vergleichbare Lungengehalte von Nano-CeO2 bereits deutliche Effekte 
in der Lunge. Nach 52-wöchiger Exposition von Nano-BaSO4 stiegen die Lungengehalte jedoch 
deutlich an. Mit dieser verringerten Partikelreinigungskapazität der Lunge ging ein 
Entzündungsgeschehen in der Lunge einher, das durch eine Erhöhung der BALF-Parameter 
gekennzeichnet war. Dies sprach eher für Partikeleffekte in der Lunge. Zudem gab es keinen Hinweis 
auf toxische Effekte durch Barium-Ionen. Die schnelle Clearance und der ihr zugrundeliegende 
Mechanismus sowie die geringe Toxizität der BaSO4-Nanopartikel benötigen weitere und detailliertere 
Untersuchungen. 
Die Zellproliferationsraten in der Lunge wurden mittels einer immunhistochemischen Färbung von 
BrdU-markierten Epithelzellen erfasst. Sie zeigten einen moderaten Anstieg nach der 
Kurzzeitexposition mit Nano-CeO2, jedoch keinen Anstieg mit Nano-BaSO4. Jedoch können 
Zellproliferationsraten in jungen und wachsenden Tieren variieren. Die biologische Relevanz dieses 
Anstiegs ist daher fraglich.  
Neben lokalen Effekten in der Lunge wurden auch systemische Effekte anhand der Hämatologie und 
klinisch-chemischer Untersuchungen des Blutes, einschließlich der Messung von Akute-Phase-
Proteinen, untersucht. Nach Kurzzeit- und Langzeitinhalationsexpositionen zeigten Nano-CeO2 und –
BaSO4 keine oder nur geringgradige systemische Effekte.  
Die beiden hier untersuchten Nanopartikel unterschieden sich sowohl in ihrer Partikelkinetik als auch 
in ihren biologischen Effekten in der Lunge. Dies war bereits nach einer Woche und dann über die 
Expositionszeit von 52 Wochen zu beobachten. Innerhalb der Nano-PSLT repräsentiert CeO2 
Nanopartikel mit hoher Biopersistenz und inhärenter Toxizität. Nano-BaSO4 kann nicht als klassischer 
PSLT-Nanopartikel angesehen werden, obwohl es in abiotischen Systemen wasserunlöslich ist. Die 
bemerkenswert geringe Toxizität inhalierter BaSO4-Nanopartikel kann nur teilweise auf dessen 
schnellere Clearance zurückgeführt werden; Nano-BaSO4 hat daneben auch eine geringe inhärente 
Toxizität. 
Ob die Partikelbeladungen der Lunge und die biologischen Effekte, die innerhalb der ersten 52 
Wochen der Exposition beobachtet wurden, sich zu Lungentumoren weiterentwickeln, kann erst durch 





  Introduction 4.
 Engineered nanomaterials and their potential health concerns  4.1.
 
Nanomaterials are used in various applications, within consumer products (cosmetics, textiles, food) 
and for medical (tumor therapy, drug delivery) and technical (catalyst, batteries) purposes (Blasco & 
Pico 2011; Lewicka et al. 2011). Production and applications of engineered nanomaterials have 
accelerated in the last decades. By 2015, the European Commission predicts a global volume of € 2 
trillion for “nanotechnology involved products” (European Commission 2013b).  
An overview of major definitions of the term “nanomaterial” in Europe is presented in table 1. Common 
to all of these definitions is “nanoscale” but they differ in regard of mass or number size distribution, 
focusing on natural, engineered or intentionally manufactured nanoparticles, and unique nanospecific 
properties. Especially European Regulators ask for a harmonized definition to be used in the 
regulatory environment (Joint Research Centre of the European Commission 2010). The proposed 
definition of the European Commission (EC) includes number size distribution of 1 to 50 %, size of 
internal structural elements and surface area (European Commission 2011a; Liden 2011). However, 
these requirements also cover other materials which may otherwise not be considered to be 
nanomaterials. Conventional particulate materials (pigments, catalysts) of micron and submicron size 
have size distributions with a tail of primary particles below 100 nm; this nanoparticle fraction 
represents a small mass fraction but may account for a large number fraction (Brown et al. 2013). The 
European Commission aims to create a consistent definition and nomenclature of nanomaterials being 
the prerequisite for their regulation (Bleeker et al. 2013).  
The European chemical regulation REACH (Registration, Evaluation, Authorisation and Restriction of 
Chemicals) and CLP (Classification, Labelling and Packaging) addresses substances, on their own, in 
preparations or in articles, in whatever size, shape or physical state (European Commission 2013a). It 
further states: “The term ‘nanomaterial’ can be used as a synonym for a substance at the 
nanoscale/nanoform, on its own, in a preparation or in an article.” However, to date, there are no 
specific requirements for nanomaterials. Therefore, the European Commission plans to modify the 
REACH Annexes. A “Study for Impact Assessment of relevant regulatory options for nanomaterials” 
within REACH contains an assessment of future options to address nanomaterials under REACH with 
the aim “to ensure further clarity on how nanomaterials are addressed and safety demonstrated in 
registration dossiers” (Matrix Insigh Ltd 2014). Specific regulations (for food and cosmetics) demand 
nanomaterial ingredients to be labelled (European Commission 2011c). The information that products 
contain nanomaterials may, however, give no information on their human health hazards (Gebel et al. 
2014).  
Material properties of nanomaterials can be different from properties of the corresponding larger 
microscale materials. This difference is exploited in many technical applications of nanomaterials, and 
has raised the concern that they may have novel toxicological properties compared to larger materials 





 volumes and increased surface reactivity, particulate nanomaterials (nanoparticles) may have a higher 
biological activity on a mass basis and affect other compartments of the body compared to larger size 
particles with identical composition (Oberdörster et al. 2005). One option of this feature can be utilized 
to develop more effective and efficient formulations of therapeutic drugs (as discussed in chapter 4).  
With regard to toxicology, no “nano-specific-effect” could be detected. Effects observed with 
nanoparticles were also seen with other particles of the same or a different composition and size 
(Donaldson & Poland 2013; Gebel et al. 2013; Oomen et al. 2014). Hence, there is no general 
“nanotoxicity” exhibited by all nanoparticles, but rather different toxic effects of different nanoparticles. 
Not unlike the toxicity of different microscale particles, the same toxicological concerns are raised for 
nanoparticles and the type of effect in primary target organs seems to be similar to microscale 
particles. 
During production, handling and use of nanomaterials at the workplace, a release into the air may 
occur. For airborne nanoparticles, inhalation exposure is the major route of concern. Toxicological 
data for airborne particles can be derived from human studies (epidemiological studies, volunteers 
inhaling particles), animal studies and in vitro studies (Valberg et al. 2009). For broad application and 
prospective information, in vivo inhalation studies are the method of choice. In vivo instillation studies 
in rodents use bolus exposure conditions which are not reflecting the actual human exposure and are 
not applicable for long-term, repeated exposure studies. Likewise, in vitro systems most often do not 
adequately reflect the real-life concentration and form of nanoparticles and their read-out often 
interferes with the nanoparticles (Landsiedel et al. 2012b). Instillation and in vitro studies may be 
valuable tools to guide testing strategies and provide data to support grouping of nanomaterials (Arora 
et al. 2012; Arts et al. 2014; Kroll et al. 2012; Oomen et al. 2014; Stone et al. 2009).  
Extensive safety research within the last decade on nanomaterials improved the data base and 
knowledge on their effects after inhalation. But still, for many nanomaterials, the experimental 
toxicological database is not complete. Especially information on long-term effects, including 
carcinogenicity, is missing (Becker et al. 2011). Long-term inhalation studies are only available for 
titanium dioxide and carbon black nanoparticles (and diesel exhaust) (Heinrich et al. 1995, Mauderly 
et al. 1994, Nikula et al. 1995). Carbon black, however, is used since the early 20th century and an 
increased cancer risk from human exposure to these nanoparticles has not yet been observed 
(Anderson 2010). In terms of common particle toxicity, exposure to carbon-containing dusts (coal 
miners) can induce pneumoconiosis which is characterized by particle accumulation in the lungs, 
inflammation and macrophage involvement leading to granuloma formation (De Capitani et al. 2007; 
Wang & Christiani 2000; Szozda 1996). Silicosis and lung cancer induced by crystalline silica particles 
in the lungs occurred in humans working in coal- and metal-mining and building industries (IARC 
1997). The mechanism involved impaired particle lung clearance together with macrophage activation 
and persistent pulmonary inflammation leading to inflammation-driven secondary genotoxicity (Borm 
et al. 2011; IARC 1997). Respirable crystalline silica (quartz) particles are considered to be high-
toxicity particles and, inhaled from occupational sources, they are classified by the International 





mentioned dust materials have been studied in detail and are known to be able to cause lung tumors 
in both humans and animals. Transferring conventional particle toxicology to the nanoscale feature, 
inhaled nanoparticles may cause adverse health effects in the lung as well as in extra-pulmonary 
organs. The lung is the main portal of entry and primary target site for inhaled particles. However, 
inhaled nanoparticles have also shown to translocate via the blood system to extrapulmonary organs, 
such as spleen and liver, and to provoke systemic effects (Elder & Oberdörster 2006; Kreyling et al. 
2002). Neuronal translocation via the olfactory nerve to the brain and inflammatory changes in the 
olfactory bulb have also been reported following inhalation exposure to nanosized carbon and 
manganese oxide (Elder et al. 2006; Oberdörster et al. 2004). On the other hand, high concentrations 
of intravenously injected TiO2 nanoparticles did not cause toxicity in rats (Fabian et al. 2008).  
Nanomaterials differ in composition (core and shell chemistry and crystal structure) and geometry 
(shape and size). Moreover, exposure to nanoparticles usually involves the primary particles as well 
as aggregates and agglomerates of these particles. Their physico-chemical characteristics can 
influence their uptake and distribution in the body and the subsequent biological effects. Data on 
modes of action of nanoparticles, mechanisms leading to toxicity and related aspects of biokinetics are 
still required (European Commission 2004). To avoid extensive toxicological testing of each single 
nanomaterial, grouping or categorization strategies are needed (Arts et al. 2014). This will allow an 
efficient safety assessment of different nanomaterials and help to reduce animal testing according to 
the 3R-concept (Reduce, Refine, and Replace) (Russel & Burch 1959). Material properties are linked 
to biological effects and can be used for grouping (e.g. in classical QSAR approaches) (Burello & 
Worth 2011a; Burello & Worth 2011b). The biological pathway leading from material properties to the 
apical toxic effect may be complex and is often not yet fully understood. Rather than correlating 
material properties to adverse outcome, additional grouping criteria along the biological pathway can 
be applied.  
Arts et al. (2014) reviewed the available grouping strategies and recommended a “source-to-adverse-
outcome pathway” in which relevant physico-chemical properties, exposure, biokinetics and hazard 
endpoints are covered (Arts et al. 2014; Oomen et al. 2014). Grouping should include all aspects of 
the whole life-cycle of a nanomaterial. This comprehensive “multiple perspective framework” 
considered nanomaterial properties and biophysical interactions, their use, exposure and disposal, 
their uptake and kinetics, possible early and apical biological effects. These approaches aid to simplify 
a future hazard assessment because it is difficult to correlate nanomaterial induced effects to one 
special material property. Further proposals and concepts for grouping of nanomaterials are currently 
emerging.  
Many industrial relevant nanomaterials belong to the group of respirable granular biodurable particles 
without known significant specific toxicity (GBS) (as mentioned in chapter 4.2) (Gebel 2012; Roller & 
Pott 2006). For those dusts, a general threshold value at workplaces has been assigned by the 
Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area (DFG, 
German Research foundation) (DFG Deutsche Forschungsgemeinschaft 2013a). However, the 
recommendations apply to bulk-, not specifically to nano-dusts (also called “ultrafine”).  
8
Introduction
The German Maximum Workplace Concentration (MAK; “Maximale Arbeitsplatzkonzentration”) value 
is a threshold limit value (TVL) to which workers can be exposed daily for working-life time (8 
hours/day, average of 40 hours/week) without known adverse health effects. The MAK value is often 
derived from a no observed adverse effect level (NOAEL) of a 90-day inhalation study with animals 
(Deutsche Forschungsgesellschaft (DFG) 2014). In 2011, the Commission lowered the general 
threshold value for dust for the respirable fraction (dust particles reaches the alveoli, formerly called 
“fine dust” until 1996) from 1.5 mg/m³ to a new MAK value of 0.3 mg/m³ (respirable (R)-fraction) for a 
density of 1 g/cm³. The R-fraction of biopersistent granular dusts is categorized in Carcinogen 
Category 4 which includes substances with typically non-genotoxic mechanisms. At the international 
level, however, occupational exposure limits (OEL) of specific nanomaterials already exist. 
Recommended exposure limit values of titanium dioxide are 2.4 mg/m³ (fine (> 0.1 µm)) and 0.3 
mg/m³ (ultrafine, including “engineered nanoscale”) recommended by the US National Institute for 
Occupational Safety and Health (NIOSH) (National Institute for Occupational Safety and Health 
(NIOSH) 2011). The value covers up to 10 working hours per day during a 40-hour work week. 
However, generic OELs of nanomaterials are not yet available in Germany (DFG Deutsche 
Forschungsgemeinschaft 2013b; Packroff & Baron 2013). OELs for bulk materials applied to 
nanomaterials may provide no adequate protection for workers (Dankovic et al. 2007; Schulte et al. 
2010). Schulte et al. (2010) recommended that OELs should be developed for specific groups of 
nanomaterials rather than for individual nanomaterials (Schulte et al. 2010). For this, grouping 
approaches using mode of action and material properties can be applied together with concentration-





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 Poorly soluble, low toxicity particles (PSLT) 
Respirable granular biodurable particles (GBS) (Gebel 2012; Roller & Pott 2006) (as mentioned in 
chapter 4.1) are also known as poorly soluble, low toxicity particles (PSLT) (Dankovic et al. 2007; 
Maynard & Kuempel 2005), poorly soluble particles (PSP) (Oberdörster 2002a) or low-solubility low-
toxicity particles (LSLTP) (Monteiller et al. 2007). They are further termed as low toxicity (LT) dusts 
(Cherrie et al. 2013). PSLT include nano- and larger particles.  
Within the group of PSLT, there are high production volume and industrial relevant materials such as 
titanium dioxide, carbon black, coal dust, barium sulfate (BaSO4), zirconium oxide (ZrO2) and cerium 
dioxide (CeO2).  
PSLT are solid, granular, non-fibrous particles which are poorly soluble (“PS”) or insoluble in biological 
fluids and therefore biopersistent. Chemical dissolution is observed for biosoluble nanoparticles such 
as Zinc oxide with rapid clearance and release of toxic ions (Zn2+) (Xia et al. 2008).  
Due to their surface energy, dispersed nanoparticles tend to agglomerate. This was also shown for 
nano-PSLT. Aerosolized and inhaled TiO2 particles at the workplace comprise of a 20% fraction of 
particles <100 nm and 80 % larger agglomerates (Ma-Hock et al. 2007; Morfeld et al. 2012). However, 
only agglomerates >100 nm were found in the lungs and lymph nodes after 1 week (5 days) of 
inhalation. Therefore, deposition of inhaled nanoscaled particles in the lung seems to play a minor role 
and associated potential effects may be rather caused by agglomerated than by nanoscaled particles. 
On the other hand, disintegration of larger agglomerates to nanosized structures in the lung appears 
to be unlikely since agglomerated nanostructured TiO2 particles do not seem to disintegrate into 
smaller structures after exposure to biological fluids similar to lung surfactant (Maier et al. 2006; 
Morfeld et al. 2012). However, there are also other studies available which indicate a certain 
deagglomeration in the lung, e.g. with multi-walled carbon nanotubes (Mercer et al. 2013a, Mercer et 
al. 2013b; Oberdörster et al. 1992).  
In general, inhaled PSLT exhibit no or low cytotoxicity and no or low acute toxicity (“LT”). Compared to 
insoluble particles with known specific toxicity, such as the chemically active, cytotoxic crystalline silica 
(quartz), PSLT are rather non-reactive, without a known, specific toxicity. They exhibit no specific 
functional chemical surface groups and their toxicity is not based on specific substances present in the 
particles (Gebel et al. 2014). Furthermore, PSLT exhibit no primary genotoxicity which is defined as 
“genetic damage elicited by particles in the absence of pulmonary inflammation” (ILSI Risk Science 
Institute Workshop Participants 2000; Schins & Knaapen 2007).  
Prolonged exposure and high lung burdens of PSLT can lead to impairment of macrophage mediated 
clearance (as mentioned in chapter 4.2.1.) (ECETOC 2013). This overload condition is accompanied 
by increased particle transfer to the lymph nodes and accumulation of particles in the lung. Under 
overload conditions, inhaled PSLT can cause chronic inflammation, increases in lung weights, 
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epithelial cell proliferation, fibrosis, and possibly lung cancer in rats (Cullen et al. 1999; Cullen et al. 
2000; Lee et al. 1986).  
 
4.2.1. Particle deposition, clearance and overload 
 
Deposition of inhaled particles in the respiratory tract is determined by particle characteristics (size, 
shape, density, aerodynamic diameter and aggregation), the geometry of the airways and breathing 
pattern. Mechanisms of deposition are diffusion (Brownian motion), sedimentation, impaction and 
interception. The latter three are more relevant for larger particles while deposition of nanoparticles is 
mostly driven by diffusion (Oberdörster et al. 2005). 
Inhaled particle deposition in the lung is not uniformly distributed. In human and rats, more particles 
are deposited near the bifurcation and the entry of the alveolar ducts (Brain et al. 1976; Brody & Roe 
1983; Holma 1969; Snipes 1989). The mass median aerodynamic diameter (MMAD) of particles 
affects aerosol deposition in the lung. In humans, about 50% of the particles with an aerodynamic 
diameter of > 20 µm (inhalable fraction) can enter the respiratory system by the nose or mouth. With a 
50% probability, particles < 4 µm aerodynamic diameter can reach the alveoli (respirable fraction) (ISO 
2008; Maynard & Kuempel 2005). In the alveolar region, particles with a 20 nm size have the highest 
deposition rate whereas 1 nm particles have nearly no deposition (Oberdörster et al. 2005).  
Clearance of particles depends on the region where they are deposited (nasopharyngeal, 
tracheobronchial or pulmonary) (Snipes 1989). Particle removal can include dissolution-absorption 
processes or physical transport (e.g. uptake by phagocytic cells like alveolar macrophages). The latter 
is the most prevalent for PSLT in the lower respiratory tract.  
In the upper respiratory tract, coughing, sneezing and the mucociliary system are the first line of 
defense. The mucociliary escalator rapidly clears particles deposited in the tracheobronchial region 
with retention half-times from 24 to 48 hours (fast clearance) (IARC 1996). In the alveolar region, 
alveolar macrophages (AM) (and neutrophils) are attracted by chemotactic stimuli and migrate into the 
alveolar space with the aim to phagocytize, degrade or transport deposited particles. Via migration to 
terminal bronchioles, particles are transported to the mucociliary escalator and further to the larynx 
(Oberdörster 1988). These particles are swallowed and then excreted after passage through the 
gastro-intestinal tract. A smaller particle fraction may also be translocated to the lung-associated 
lymph nodes either by transepithelial migration of particle-containing alveolar macrophages or by 
translocation of free particles to the interstitium (IARC 2010; Ma-Hock et al. 2009; Ravenzwaay et al. 
2009). Furthermore, certain conditions, e.g. pulmonary inflammation, can influence mucociliary 






   
Phagocytosis of deposited particles by macrophages in the alveolar space starts within the first 6-12 
hours. After phagocytosis of the particles, the macrophages slowly move toward the mucociliary 
escalator. The subsequent migration of the laden macrophages is, however, rather slow. Retention 
half-times for rats and humans are around 70 and 700 days, respectively (Bailey et al. 1989; 
Landsiedel et al. 2012a ; Oberdörster et al. 2005).  
Retention is a “time-dependent distribution pattern” of deposited but not yet cleared particles, and is 
associated with potential lung effects (Morrow 1988; Snipes 1989). The particle content of the lung 
achieved by inhalation at given time is called lung burden. If the deposition rate is less or equal to the 
clearance rate at low inhaled concentrations, a steady-state lung burden develops (Oberdörster et al. 
1992).  The steady state of lung burdens can be reached after approximately 5 retention half-times 
have passed (Oberdörster 1995). High aerosol concentrations and/or prolonged, chronic exposure of 
PSLT can result in high lung burdens which overwhelm the mechanical macrophage-mediated 
clearance as observed by the decreased migration of macrophages to the mucociliary escalator. 
Clearance retardation with a constant exposure results in increasing retention half-times and 
consequently increasing lung burdens. This general condition was called dust overload and assigned 
to animals (e.g. rats, dogs) and possibly humans (Morrow 1988).  
Morrow (1988) estimated that volumetric overload starts when 6% of the average macrophage volume 
is filled with particles indicating a threshold above which macrophage clearance may decrease 
(Morrow 1988; Morrow et al. 1996). The 6% volume load of a macrophage can be expressed as a 
volumetric lung burden of 1 µL particles/ g lung of rats (Oberdörster 1995). Retardation of 
macrophage-mediated clearance and prolonged particle retention can lead to macrophage 
aggregates, higher access of particles to the interstitium and increased translocation rate to the lung 
associated lymph nodes (Tran et al. 2000). Overall, overload conditions have been related to 
pulmonary responses such as increased lung weights, pulmonary inflammation and increased cell 
proliferation with subsequent fibrosis and tumor formation in rats (ECETOC 2013; ILSI Risk Science 
Institute Workshop Participants 2000; Muhle et al. 1991).  
This concept was established in reference to larger PSLT; however, the overload concept may also 
applicable to inhaled nano-PSLT. Twelve weeks of inhalation of a 23.5 mg/m³ TiO2 aerosol (Degussa, 
anatase, 25 nm) and a burden of 5.22 mg/lung resulted in a retention half-time of 501 days, increased 
accumulation of nano-TiO2 in the regional lymph nodes and lung inflammation (based on analysis of 
bronchoalveolar lavage) (Oberdörster et al. 1994). Pulmonary inflammation was correlated with a large 
surface area and high interstitialization of nano-TiO2. In the same 12-week inhalation study, micron-
TiO2 (Degussa, 250 nm) with a similar concentration of 22.3 mg/m³ (burden of 6.62 mg/lung) was 
tested as a separate dose group and showed a lower potential for clearance retardation, particle 
translocation and inflammation.  
Volumetric macrophage loads of micron- and nano-TiO2 were 9% and 2.6%, respectively, with a 
clearance of the latter prolonged by a factor of 4 and no correlation to volumetric overload. The 





   
overload of macrophages but that particle surface correlated better with the prolongation of clearance. 
There may be additional factors which elicited responses similar to those observed with overload 
conditions (IARC 2010). Macrophages may also be affected by increased oxidative stress due to the 
large surface area of the nanoparticles or generation of ROS on the surface. In cases of inhaled nano-
PSLT, the retained concentration in the alveolar macrophages expressed as particle surface area may 
be more predictive for retarded clearance than the volume load formerly proposed by Morrow 
(Oberdörster et al. 1994, Tran et al., 2000) (as mentioned in chapter 4.2.5.).  
Furthermore, some nano-PSLT may escape macrophage clearance mechanisms and get access to 
the interstitium (Ferin et al. 1992). Twelve week inhalation of two TiO2 particles (around 21 nm and 
250 nm diameters) showed that, at equal masses, more nano-TiO2 than micron-TiO2 translocated to 
the interstitium resulting in prolonged lung retention of these nanoparticles. A neutrophil based 
inflammation was observed directly after exposure but decreased to control values after a post-
exposure period; however, the lung burdens were still elevated. 
 
4.2.2. Pulmonary cellular response to inhaled particles  
 
Inhaled particles are deposited on the alveolar epithelial surface which consists of type I and II alveolar 
cells. In close contact with alveolar epithelial cells, alveolar macrophages (and also other phagocytes) 
have the task to remove particles by phagocytosis, their degradation via released mediators and 
transport to the mucociliary escalator. Particle transport to the blood or lymph nodes by macrophages 
may also play a role, depending on size and concentration. 
Macrophages belong to the mononuclear phagocytic system (MPS). They originate from short-lived 
blood monocytes or have an embryonic origin without involving blood monocytes (Scott et al. 2014). 
Four different types of pulmonary macrophages are described: pleural, intravascular, interstitial and 
alveolar (Geiser 2010). Growth and differentiation from stem cells in the bone marrow to monocytes 
and later macrophages depends on cytokines like macrophage colony-stimulation factor (M-CSF) and 
granulocyte-macrophage colony-stimulation factor (GM-CSF) (Gordon 2003). Alveolar macrophages 
are long-lived, resident tissue cells scattered in the (healthy) lung with a turnover rate of 40% in one 
year (Janssen et al. 2011; Maus et al. 2006). Macrophages can be rapidly recruited from circulating 
monocytes and migrate along a chemoattractant gradient (chemotaxis) into the alveolar space. 
However, distinction between originally resident macrophages from recently recruited macrophages 
may be difficult since they adapt to their pulmonary environment (Gordon 2003). 
With their surface receptors (toll-like, G-protein coupled receptors, receptors for opsonins and 
cytokines), macrophages recognize endogenous and exogenous agents such as inhaled particles 
(Arredouani et al. 2004; Conner & Schmid 2003). Regulation, inhibition and activation of blood born 
macrophages include a cascade of events involving interactions between alveolar macrophages, 





cells with their CD200 receptor, their αvβ6 Integrin for transforming-growth factor β (TGF-β) 
attachment and secreted Interleukin-10 (IL-10) balance macrophage activation with inhibitory signals 
(Hussell & Bell 2014). Activation consists of the classical M1 and the alternative M2 macrophage 
pathways (Gordon 2003). The M1 is activated by microbes, toll-like receptor ligands or Interferon-ɣ 
(IFN-ɣ) which is produced by natural killer cells and activated T-lymphocytes.  
The synthesis and release of chemokines, cytokines (such as IL-1, IL-12, IL-23, tumor necrosis factor 
TNF), growth factors, and proteases by macrophages and other (epithelial) cells prolong inflammation 
(table 2). This results in an influx of other inflammatory cells, proliferation of fibroblasts and collagen 
deposition. TNFα as chemoattractant is mainly involved in inflammatory cell recruitment and activation 
after particle exposure (Driscoll 2000). Monocyte chemoattractant protein-1 (MCP-1) has shown to be 
chemoattractant for mononuclear phagocytes (e.g. macrophages), lead to their recruitment and 
stimulate their oxidant production (Driscoll et al. 1996; Rollins et al. 1991). Therefore, this pathway is 
responsible for triggering inflammation. The alternative modulators of macrophage activation (M2, 
alternative way) are IL-4 and IL-13. This way limits inflammation by release of IL-10 and Transforming 
Growth Factor (TGF-β). However, the M2 macrophage also contributes to repair and fibrosis by TGF-
β, the inflammatory resistin-like secreted protein FIZZ1 and chitinase-like secretory lectin YM1 
(Hussell & Bell 2014). In general, activated macrophages possess a higher phagocytic capacity, 
oxidative burst and proinflammatory cytokine production than inactivated (Lohmannmatthes et al. 
1994; Steinmuller et al. 2000). During chronic inflammation, macrophages may persist due to local 
proliferation and sustained recruitment from the blood (Gentek et al. 2014).  
Depending on the concentration, inhaled (nano)particles cause inflammation. They may directly 
interact with and affect alveolar macrophages. Particulate nano-TiO2 (size of 20 nm) was taken up by 
alveolar macrophages and stored as aggregates in lysosome-like vesicles (Liu et al. 2010b). After 
instillation of 5 and 50 mg/kg nano-TiO2 in rats, alveolar macrophages showed membrane damage, 
decreased phagocytic and chemotactic ability and an increase in nitric oxide (NO)- and TNFα-levels. 
These effects could be explained by the high exposure concentration of 50 mg/kg, surface area and 
crystal structure of nano-TiO2 (Liu et al. 2010a). Other nanoparticles, such as nano-SiO2, were shown 
to be M1-polarising proinflammatory stimuli by increasing the production of IL-1β and TNF-α, both 
major cytokines for acute inflammation (Lucarelli et al. 2004). 
The optimum size of particles which are effectively phagocytized is 1.5 - 3 µm. After particle 
engulfment, the alveolar macrophages exert to kill microorganisms or degrade particles in the 
phagolysosome by release of reactive oxygen species (ROS), NO and lysosomal enzymes. ROS can 
have intracellular impact on macrophages and other phagocytes, but they can also affect epithelial 
cells resulting in DNA damage, influencing signal transduction pathways and altering gene expression 
(Deutsche Forschungsgesellschaft (DFG) 2014; Driscoll et al. 1995a; Driscoll et al. 1995b; Driscoll et 
al. 1995c; Driscoll 2000).  
For example, ROS increase the synthesis and release of IL-1, IL-6 and TNF-α in alveolar 
macrophages and epithelial cells (Driscoll et al. 1995a). TNF-α, in turn, increases the synthesis of 
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prostaglandin E2 and prostacyclin and the synthesis of ROS and NO radicals in leukocytes (Deutsche 
Forschungsgesellschaft (DFG) 2014). ROS also activate transcription factor NF-κB which stimulates 
inflammatory and proliferative gene expression. For instance, the gene promotor of neutrophil 
chemoattractant macrophage inflammatory protein-2 (MIP-2α) has a NF-κB-binding site and activation 
of them by ROS leads to formation of MIP-2α. Increased lung mRNA expression of MIP-2 and 
increased neutrophil numbers in BAL were observed after 13 weeks of inhalation exposure to 7.1 and 
52.8 mg/m³ carbon black (Monarch 880, particle diameter of 0.016 µm) (Driscoll et al. 1996). MIP-2 
and also interleukin 8 (IL-8)/ cytokine-induced-neutrophil-chemoattractant (CINC-1; rat homologue of 
IL-8) further appeared to be proliferative and mitogenic stimuli for epithelial cells since IL-8 can 
increase mRNA synthesis in airway epithelial cells (Donaldson et al. 2008; Driscoll et al. 1995b; 
Standiford et al. 1990). The chemokine CINC-1 which is released by activated macrophages is also 
responsible for activation and chemotaxis of neutrophils (Driscoll et al. 1997; Grommes & Soehnlein 
2011) (table 2).  
Further recruitment of inflammatory cells includes the lymphocytes and polymorph nuclear neutrophils 
involved in acute and subchronic inflammatory processes. Since neutrophils respond faster to 
chemotaxis and inflammatory signals evoked by deposited particles in the lung, they appear earlier 
than recruited macrophages. Peak numbers of neutrophils are described within 6-48 hours after 
particle deposition and they are replaced by monocytes and lymphocytes thereafter (Alber et al. 2012). 
TNF-α from surveillance macrophages increases expression of E-selectin and vascular cell adhesion 
molecule (VCAM-1) on capillary endothelial cells which enable trapping of neutrophils and monocytes 
at the blood wall and migration through the endothelial pores (Hussell & Bell 2014). Depending on the 
degree of neutrophil activation, neutrophil recruitment into the interstitium and alveolar airspace of the 
lung can result in tissue injury (Grommes & Soehnlein 2011).  
However, mechanistic details of nanoparticle macrophage interaction leading to inflammation and 
secondary development of oxidative stress have not been sufficiently studied (Deutsche 
Forschungsgesellschaft (DFG) 2014).In cases of macrophage damage and death, the formerly 
phagocytized particles are re-released into the alveolar space. Free (non-phagocytized), persistent 
and small sized particles on the alveolar surface can be re-uptaken by other alveolar macrophages 
which can lead to particle redistribution among the alveolar macrophages of the lungs (Lehnert 1992). 
However, particles can also get in contact with epithelial cells and be taken up by alveolar epithelial 
cells, especially by type I cells (Ferin et al. 1992). Uptake by alveolar type II cells is not or rarely 
observed. Particle-epithelial contact can also result in the release of cytokines and chemokines (e.g. 
MCP-1, CINC-1) stimulating inflammatory cell infiltration. In case of damage (necrosis or apoptosis) of 
epithelial cells, type II cells divide and differentiate to replace type I cells. However, the process is not 
instantaneous and the epithelial surface can be left bare. Hyperplasia and compensatory cell 
proliferation of type II alveolar and bronchial epithelial cells follow (Barlow et al. 2005). Furthermore, 
epithelial cells (type II) are considered to be cell of origin for tumours related to PSLT exposure (IARC 





Under overload conditions (as mentioned in chapter 4.2.1.), the phagocytosis efficiency of 
macrophages, including their mobility and function, is decreased or even fails with increasing particle 
burdens (Morrow 1988). Increased numbers of particles reaching the interstitium (interstitialization) 
remain there and stimulate interstitial cells or transfer to the lymph nodes (Morrow 1988). Beyond the 
epithelium, interstitial macrophages (IM) represent around 40% of the total macrophages in total tissue 
and are able to phagocytize particles (below 1 µm diameter) (Crowell et al. 1992; Geiser 2002). They 
are close to matrix and connective-tissue cells (e.g. fibroblasts) which is important for effects elicited 
by their released mediators (Laskin et al. 2001). Their activation may result in a change of the 
chemotactic gradient from the alveoli towards the interstitium after which inflammatory cell infiltration 
follow (Oberdörster et al. 1992). Since interstitial macrophages may possess a higher proliferative 
capacity than alveolar macrophages, these particle-macrophage cell interaction can lead to release of 
fibrotic mediators (fibroblast growth factors, FGF; TNF-α) and initiation of fibrosis (Bowden et al. 1989; 
Laskin et al. 2001). Phagocytosis of deposited silica particles by interstitial macrophages was 
associated with increased fibroblastic proliferation and collagen deposition resulting in fibrosis and 
granuloma formation (Adamson et al. 1989).  
Dendritic cells (DC) in the lungs also have nanoparticle phagocytizing capabilities but their function 
here is rather unknown (Geiser 2002). Interstitial macrophages may be able to regulate and inhibit 
maturation and migration of pulmonary DCs (Bedoret et al. 2009). Monocyte-derived alveolar 
macrophages may re-enter the blood circulation and differentiate into DCs (Randolph 2001). DCs can 
further enter efferent lymphatics or the thoracic duct which may be important for particle clearance 
mechanisms (Gordon 2003). At increasing lung burdens, nanoparticles can be drained to a higher 
extent into the lung associated lymph nodes or in the blood circulation reaching extra-pulmonary 
organs (Semmler et al. 2004).  
Overall, inhaled PSLT may lead to activation and accumulation of particle loaded alveolar 
macrophages, infiltration of inflammatory cells such as neutrophils and lymphocytes, release of pro-
inflammatory mediators, oxidant generation, alveolar hypertrophy and cell proliferation of the 
epithelium. 
Biomarkers for initial inflammation (neutrophils, macrophages, cytokines and chemokines; see chapter 
8.2.3.) in the lungs can partly be assessed by bronchoalveolar lavage fluid (BALF) analysis, even after 
only 1 week of exposure (5-days, short-term inhalation test), depending on the inhaled concentration 
(Landsiedel et al. 2014). These markers indicate early morphological changes in the lung (Henderson 
et al. 1987). Morphological changes appear rather late after exposure to low toxicity nanoparticles. 
Sustained inflammation can be characterized by persistent elevation of the number of neutrophils (in 
BALF) and by an increased number of inflammatory cells (e.g. macrophages) in lung (detected by 
histopathology). Therefore, a combination of different methods (histopathology, BAL) enables an early 
detection as well as progression and regression of effects over time.  
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Table 2 Selected mediators relevant for macrophage function and inflammation 
 
 
Macrophage colony-stimulation factor (M-CSF)/granulocyte-macrophage colony-stimulation 
factor (GM-CSF):  
Differentiation from stem cells in the bone marrow to monocytes and later macrophages (Gordon 2003) 
 
Monocyte chemoattractant protein-1 (MCP-1):  
Chemoattractant; macrophage recruitment and stimulation of their oxidant production  
(Driscoll et al. 1996; Rollins et al. 1991). 
 
Tumor necrosis factor α (TNFα):  
Inflammatory cell recruitment and macrophage activation after particle exposure (Driscoll 2000) 
Increased expression of E-selectin and vascular cell adhesion molecules on capillary endothelial cells 
(relevant for monocyte migration into tissue) (Hussel & Bell 2014) 
 
Cytokine-induced-neutrophil-chemoattractant (CINC-1)/Interleukin IL-8 (rat homologue)  
Chemokine, released by activated macrophages, responsible for activation and chemotaxis of 
neutrophils (Grommes & Soehnlein 2011; Driscoll et al. 1997) 
Proliferative and mitogenic to epithelial cells (Standiford et al. 1990, Donaldson et al. 2008) 
 
Neutrophil chemoattractant macrophage inflammatory protein (MIP-2α): 
Proliferative and mitogenic to epithelial cells (Standiford et al. 1990, Donaldson et al. 2008) 
 
Fibroblast growth factor (FGF):  






4.2.3. Pulmonary effects of inhaled nano-PSLT 
Effects of inhaled PSLT in rats seem not to be fundamentally different from those observed for 
crystalline silica (quartz) besides the much higher potency of the latter (Roller & Pott 2006). 
Furthermore, the type of pulmonary effects of nano- and larger PSLT seem to be comparable. 
Therefore, this section will focus mainly on inhalation studies with nano-PSLT and their induced 
pulmonary effects. 
Multiple short-term rat inhalation studies of nano-PSLT are available. Nano-TiO2 and -carbon black 
were studied in short-term as well as subchronic studies (Driscoll et al. 1996; Johnston et al. 2000; 
Klein et al. 2012; Landsiedel et al. 2014; Ma-Hock et al. 2009; Noel et al. 2012). One week (5 days) of 
inhalation exposure of 10 mg/m³ nano-TiO2 (P25, Degussa, 25 nm, around 80% anastase, 20 % rutile) 
resulted in a lung burden of 1.6 mg/lung and caused an increase of inflammatory cells and mediators 
in BALF (e.g. elevated neutrophils, LDH) and alveolar infiltration with histiocytes (alveolar 
macrophages) (Landsiedel et al. 2014; Ma-Hock et al. 2009). Nano-ZrO2 (BASF, pyrolytic research 
product of NanoCare, 25-60 nm), on the other hand, caused no adverse effects at 0.5, 2.5 and 10 
mg/m³ (Kuhlbusch et al. 2009, Landsiedel et al. 2014, Wohlleben et al. 2013). After 13 weeks 
inhalation of 10 mg/m³ (resulting in burdens of about 11 mg/g lung), nano-TiO2 (P25, Degussa, 21 nm) 
induced increases in neutrophils, macrophages and lymphocytes in BALF and proliferation of type II 
alveolar cells, epithelial metaplasia and interstitial fibrosis in histopathology (Bermudez et al. 2004). 
The lung retention half-time was 395 days indicating overload conditions. Rats developed interstitial 
lung fibrosis after 13 weeks of inhalation exposure to 23 mg/m³ nano-TiO2 (P25, Degussa, 20 nm) and 
a post-exposure period of 6 months (Baggs et al. 1997). Thirteen week inhalation of 7 and 50 mg/m³ 
carbon black (Printex 90, 16 nm) in rats caused burdens of 0.97 and 4.87 mg/lung, respectively, and 
an increase in neutrophils in BAL indicating inflammation (Gallagher et al. 2003). Exposure to 50 
mg/m³ carbon black induced also an increase in 8-OH-2’-deoxyguanosine (8-oxo-dG) in pulmonary 
epithelial cells indicating oxidative stress and secondary genotoxicity. Oxidative stress in the lungs can 
be caused by retained particles provoking the influx of immune cells into the lung (as mentioned in 
chapter 4.2.2.). Overwhelmed antioxidant capacities and chronic inflammation in the lung can lead to 
subsequent oxidant-induced DNA damage as a secondary genotoxic effect (Driscoll 1997). 
However, the long-term effects of inhaled nano-PSLT are tentative since only two 
chronic/carcinogenicity inhalation studies on nanomaterials are currently available (Becker et al. 
2011). Epidemiological studies, e.g. on carbon black, provide no sufficient evidence of a carcinogenic 
potential in humans (Deutsche Forschungsgesellschaft (DFG) 2014). In the eighties and nineties of 
last century, inhalation studies were performed to investigate potential adverse effects after long-term 
exposure to particles. The main focus of these studies was diesel soot particles; nanoparticles were 
also simultaneously tested at a single high aerosol concentration. Female Wistar rats inhaled average 
aerosol concentrations of 10 mg/m³ nano-TiO2 (P25, Degussa, 80% anatase and 20% rutile, primary 
particle diameter 15-40 nm) and 11.6 mg/m³ carbon black (Printex 90, Degussa, primary particle 
20
Introduction
   
diameter 14 nm) (Heinrich et al. 1995). Lung burdens of nano-TiO2 and carbon black were around 40 
and 44 mg/lung after 24 months, respectively. Squamous cell carcinomas, bronchioalveolar adenomas 
and adenocarcinomas with tumor rates between 32 - 39% were observed in the rat lungs after 24 
months of inhalation exposure and a post-exposure period of 6 months. However, high aerosol 
concentrations, no dose-response-relationship and non-standardized study design with missing 
endpoints limit the use of these long-term inhalation studies for regulatory assessment (Becker et al. 
2011). Dose-response relations and long-term effects at low aerosol concentrations remain unknown.  
 
4.2.4. Systemic Effects of inhaled nano-PSLT 
 
Pulmonary exposure to ambient particulate matter seems to be associated with effects on 
cardiovascular function. Intratracheal instillation of 0.1 or 0.25 mg/rat micron-TiO2 to rats induced a 
dose-dependent impairment of endothelium-dependent arteriolar dilation in the systemic 
microcirculation, increased leukocyte rolling and adhesion in paired venules and local oxidative stress 
(Nurkiewicz et al. 2006).  
Besides local effects in the lung, systemic effects have also been studied after inhalation exposure to 
nanoparticles. Translocation of nanoparticles from the lung, across the air-blood barrier, to extra-
pulmonary organs has been observed (Elder & Oberdörster 2006, Kreyling et al. 2002). Increasing 
nanoparticle accumulation in extra-pulmonary organs and consequent effects have to be taken into 
account after long-term inhalation. However, the translocation rate of inhaled nano-PSLT to the blood 
and extrapulmonary organs is low. This was demonstrated after inhalation of insoluble nano-Iridium 
(15 nm and 80 nm) in rats (Kreyling et al. 2002; Kreyling et al. 2009). Biodistribution and uptake of 
nanoparticles was associated with mononuclear phagocyte system-organs like spleen and liver but 
also with the skeleton and soft tissues (Kreyling et al. 2009). Whole-body inhalation exposure of 180 
µg/m³ aerosolized nano-13C (count median diameter 20-29 nm) led to particle accumulation in liver 24 
hours post-exposure (5-times higher 13C liver burdens than lung) but not in any other extra-pulmonary 
organ (Oberdörster et al. 2002). Systemic toxicity seems to be less relevant for inhaled PSLT since 
they translocate to extrapulmonary organs less (<10 % by mass) and rarely induce toxic effects in 





   
 
 
4.2.5. Mechanism of action of inhaled PSLT 
 
PSLT are assumed to share a common mode of toxic action, but the overall mode of action is still 
under debate (Greim et al. 2001; Greim & Ziegler-Skylakakis 2007). A sequence of events describes 
the biological procedure starting with particle deposition in the lung and related cells and ending with 
potential lung tumour formation (IARC 2010). Most of the inhaled PSLT dusts commonly induce 
pulmonary inflammation which appears to be the main driver for further pathological changes. 
Activation of alveolar macrophages and neutrophils results in acute inflammation which, with 
increased particle accumulation, may progress to chronic inflammation and fibrosis (Oberdörster 
1995). 
ROS exceeding antioxidant defenses (oxidative stress) and secondary DNA damage seem to be also 
linked to PSLT exposure (Greim & Ziegler-Skylakakis 2007; Li et al. 2010). Oxidative stress can be 
mediated by persistent inflammation; ROS species are generated by alveolar macrophages and 
epithelial cells. This can lead to secondary genotoxicity and subsequent target-cell mutations (Driscoll 
1997; Madl et al. 2014). Epithelial cell metaplasia, proliferation and mutations seem to be the latest 
steps in lung tumour formation (such as adenocarcinomas, squamous cell carcinomas). 
For carbon black and crystalline silica particles, cell proliferation as well as inflammation, fibrosis, 
epithelial hyperplasia and squamous metaplasia may relate to tumor frequencies (Kolling et al. 2011; 
Kreyling et al. 2009; Oberdörster et al. 1992; Oberdörster et al. 1994; Rittinghausen et al. 2013). For 
other PSLT, such as TiO2, persistent inflammation, inflammatory cell derived ROS and increased cell 
proliferation rather than genotoxicity were associated with transformation of pulmonary epithelial and 
lung tumor formation (Deutsche Forschungsgesellschaft (DFG) 2013b; DFG Deutsche 
Forschungsgemeinschaft 2014; Driscoll 1997). It was proposed that additional or alternative pathways 
can be involved in PSLT-induced tumor formation although few data are available (IARC 2010): PSLT 
may also be able to translocate from the alveolar space to epithelial cells, enter them and interfere 
with the cytoskeleton during cell division inducing mutagenic effects.  
The mode of action of nano- and micron-PSLT is assumed to be the same (Gebel et al. 2014). 
Mechanisms, such as inflammation and oxidative stress, are also commonly known for larger particles 
(Gebel et al. 2013). The biological effects of nano- and larger PSLT, however, may differ in potency 
(Deutsche Forschungsgesellschaft (DFG) 2014). Correlated to the dose metric mass concentration, 
nano-PSLT showed a 2 to 3 times higher carcinogenic potency compared to larger PSLT (Gebel 
2012), but when adjusted to the dose-metric surface area, the potencies were comparable. This was 
explained by the higher surface area per mass of nano-PSLT. However, to date, no long-term 
inhalation study comparing nano- and micron-PSLT is available (Becker et al. 2011).  
Nano-PSLT are able to induce significantly greater inflammatory effects on a mass basis than their 
bulk materials with same chemical composition (Oberdörster et al. 2005). Differences in alveolar 
macrophage reaction were also observed: after phagocytosis of nano-PSLT, alveolar macrophages 
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initiate oxidative stress and inflammation at lower mass concentrations compared to larger PSLT 
(Donaldson et al. 2002; Gebel et al. 2014). The higher inflammatory potency of nano-PSLT might be 
explained by increased proinflammatory cytokine levels; carbon black induced TNF-α release by 
macrophage via increased intracellular Ca2+ levels (Donaldson et al. 2002). In a 3-month inhalation 
study, nano-TiO2 (20 nm) elicited higher fibrotic lung response than its bulk form (250 nm) at similar 
aerosol concentrations after 6 months of post-exposure (Baggs et al. 1997). 
Across the group of PSLT, there seem to be also a difference in potency to induce overload since 
nano-PSLT may impair macrophage clearance at mass doses that are much lower than those 
associated with micron-PSLT overload (Bellmann et al. 1991; ILSI Risk Science Institute Workshop 
Participants 2000). Here, adjustment of dose metrics is necessary since there seems to be different 
dose-response relationships between lung burdens and overload (Donaldson 2000). Lung burdens are 
usually expressed as mass burdens since this is the common dose metrics used for regulatory 
assessments. Particle surface area seems to be a good marker predicting pulmonary response (e.g. 
inflammation) (Driscoll et al. 1996; Oberdörster 2002a; Tran et al. 2000). A correlation was shown for 
pulmonary inflammation as well for tumor potential and incidences. Tran and others suggested particle 
surface area as better metric for overload, specifically inflammatory response per unit particle surface 
area (Oberdörster 2002b; Rushton et al., 2010; Tran et al. 2000).  
An increase in potency of overload effects was explained by higher “biologically-accessible surface” of 
these nanoparticles (Donaldson & Poland 2012). Possible cytotoxic effects due to generation of ROS 
on the large surface area, surface reactivity, coating and crystallinity of nano-PSLT may contribute to 
these differences since cytotoxic materials can also affect macrophage mediated particle clearance 
(Oberdörster 1995; Sager et al. 2008). Particle volume was the central focus of Morrow’s hypothesis 
for overload (Morrow 1988) but was also recognized as appropriate dose-metrics by others (Pauluhn 
2011a; Roller & Pott 2006). Lower agglomerate densities of nano-PSLT and higher void space of their 
agglomerates lead to a macrophage response by volumetric overload mediating inflammatory 
responses (Pauluhn 2011b).  
With an appropriate dose-metric representing lung burdens, similar pulmonary responses of PSLT 
may be expected (Cherrie et al. 2013). The relationship of (chronic) inflammation and overload is 
discussed to be strongly associated with tumour formation (as mentioned in chapter 4.2.1. and 4.2.2.) 
(ECETOC 2013). In concentrations below the overload range, no lung inflammation and also no 
tumours should occur (Gebel 2012). However, to date, other inhaled nano-PSLT, such as ZrO2 and 
BaSO4, showed only low or no inflammation and toxic effects, even at concentrations in the overload 
range (Cullen et al. 2000; Landsiedel et al. 2014; Tran et al. 2000). This may indicate a range with a 
lower and upper end across the group of PSLT. 
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4.2.6. Relevance of rat model to humans 
The relevance of a rat model to humans is questionable due differences in particle kinetics and 
pulmonary responses (Cherrie et al. 2013; ILSI Risk Science Institute Workshop Participants 2000). 
There is no overall agreement whether the rat overload phenomena is applicable to humans (ILSI Risk 
Science Institute Workshop Participants 2000), although accumulation of particles in lungs of humans 
comparable to the levels observed in rats can be seen, e.g. in coal miners after inhalation of coal dust 
(Gregoratto et al. 2011). Stöber et al. (1965) indicated prolonged lung clearance in coal workers 
(Stöber et al. 1965). In general, responses of humans comprise higher interstitialization of particles 
(Green 2000, Gregoratto et al. 2011).  
Human PSLT exposure may be linked to nonmalignant respiratory diseases rather than tumour 
formation since high particle lung burdens elicited chronic obstructive lung disease (COPD) and 
pneumoconiosis in exposed coal miners (Kuempel et al. 2001). In both, humans and rats, PSLT 
exposures lead to an alveolar macrophage response, accumulation of particles in the interstitium and 
mild interstitial fibrosis. Epithelial hyperplasia and fibrosis can be seen in humans, even without 
impaired macrophage-mediated clearance (Kuempel et al. 2014). In general, rats show a higher acute 
inflammatory and proliferative pulmonary response than humans (Green 2000).  
Lung tumours in humans differed from tumours found in rats after chronic dust inhalation (Deutsche 
Forschungsgesellschaft (DFG) 2014). Rat tumours observed in long-term studies (adenocarcinomas, 
squamous cell carcinoma) are mainly located in the peripheral (bronchiolo-alveolar) lung with high 
proliferation rates of type II alveolar cells whereas lung tumours found in humans are most frequently 
bronchial carcinomas. Thus, a direct comparison between coal-dust-exposed rats and coal miners 
may not be feasible. It was concluded that rats may be predictive for humans in case of non-neoplastic 
responses after inhalation to PSLT (Donaldson & Tran 2002; ILSI Risk Science Institute Workshop 
Participants 2000; ECETOC 2013).  
For neoplastic responses at overload conditions, rats seem to show a greater response in developing 
lung tumours than humans. However, epidemiological studies or sufficient human data are too sparse 
to rule out the risk in lung tumour formation for all inhaled PSLT appropriately, especially with respect 
to uncertainties related to nanostructures (Green 2000; Kuempel et al. 2014). 
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4.3. Inhalation toxicology of cerium dioxide (CeO2) and barium sulfate (BaSO4) 
  nanoparticles 
The Working Party on Manufactered Nanomaterials (WPMN) of the Organisation for Economic Co-
operation and Development (OECD) aims to assess the toxic potential of nanomaterials with a set of 
commercially relevant reference materials (OECD 2010). The following nanomaterials are on the list of 
the representative manufactured nanomaterials of the OECD sponsorship programme selected to be 
tested for human health and environmental safety: fullerenes (C60), single-walled carbon nanotubes 
(SWCNTs), multi-walled carbon nanotubes (MWCNTs), silver nanoparticles, iron nanoparticles, 
titanium dioxide, aluminium oxide, barium sulfate, cerium oxide, zinc oxide, silicon dioxide, 
dendrimers, nanoclays and gold nanoparticles (OECD 2010; OECD 2012; Singh et al. 2011). Data on 
measurement, toxicology and risk assessment of these nanomaterials may serve as international 
benchmarks. In 2011, the Institute for Health and Consumer Protection of the European Commission 
established a repository with samples of representative nanomaterials (European Commission 2011b). 
Samples of different nano-CeO2 and -BaSO4 are available within the repository (Singh et al. 2011). 
Each nanomaterial got a corresponding nanomaterial (NM) number: two CeO2 were coded as NM-
211and NM-212 and BaSO4 as NM-220 in the list of OECD WPMN Sponsorship Programme for the 
Testing of Manufactered Nanomaterials. In 2014, all nanomaterials in the JRC Repository were re-
numbered. Currently, CeO2 NM-211 and NM-212 are coded as JRCNM02101a and JRCNM02102a, 
respectively. However, in this body of work, the acronyms NM-211 and NM-212 were still used.  
As already mentioned in paper 2, nano-BaSO4 (NM-220) used in the intratracheal (IT) instillation, 
gavage and intravenous (IV) injection studies was a reference material for the Nanomaterial Testing 
Sponsorship Program of the OECD and its characterization of this original batch was described by 
Wohlleben et al. (2013) (Wohlleben et al. 2013). The long-term inhalation study required large 
amounts of the test material.Therefore, nano-BaSO4 was reproduced at a different production plant 
using the same synthesis protocol and characterized by the same methods. It was used for the studies 
with 4, 13 and 52 weeks of exposure. 
CeO2 is used in various commercial and industrial applications, e.g. as a diesel fuel combustion 
catalyst, as sun protection in UV resistant coatings or as polishing agent for silicon wafers (Antaria 
2014; Corma et al. 2004; Murray et al. 1999; Wakefield et al. 2008). Furthermore, CeO2 is also 
considered to be a versatile biocompatible material with promising use in therapeutics capturing ROS 
in vitro (Hirst et al. 2013). Nano-CeO2 has anti-oxidative and oxidative effects with the coexistence of 
tri- (Ce3+) and tetravalent (Ce4+) states resulting in both protective and toxic impacts (Xia et al. 2008; 
Kilbourn 2003). Representative test materials of commercially manufactured nano-CeO2 (NM-211 and 
NM-212; NM-213 is the bulk reference) were completely characterized by the European Commission's 
Joint Research Centre (JRC) (European Commission 2014). 
Associated with its industrial and commercial use, exposure of airborne nano-CeO2 has been identified 
since it was detected in diesel exhaust emissions (Cassee et al. 2011; PROSPEcT 2010). A male 
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patient with a history of 35 years in optical lens grinding (with exposure to CeO2 and other metal dusts) 
suffered from rare earth pneumoconiosis and pulmonary fibrosis (McDonald et al. 1995). SEM and 
EDX analysis of a lung biopsy showed mainly cerium particles (diameter range from <1 μm to 5 - 10 
μm) deposited in the lung associated with pulmonary interstitial fibrosis in this patient.  
Nano-CeO2 has been further studied in vitro and in vivo including animal studies with inhalation, 
instillation, oral and intravenous exposure (Aalapati et al. 2014; Babin et al. 2013; Environmental 
Protection Agency (EPA) 2009; Gosens et al. 2013; Kumari et al. 2014; Ma et al. 2014; Molina et al. 
2014; Yokel et al. 2008; Yokel et al. 2012). In vitro, human aortic endothelial cells exposed to 50 μg/ml 
nano-CeO2 (spray flame synthesized, median diameter 40 nm) did not exhibit significant inflammation 
measured as mRNA levels of inflammatory markers (IL-8, MCP-1, ICAM-1) (Gojova et al. 2009). 
Hepatotoxicity due to systemic bioavailability was observed after intratracheal instillation of 1.0, 3.5, or 
7.0 mg/kg b.w. of nano-CeO2 (Sigma-Aldrich, 10.14 nm) in male Sprague-Dawley rats (Nalabotu et al. 
2011). Nano-CeO2 may translocate via blood from lungs to liver and induced increase liver levels 
associated with decreases in liver weight and alterations in blood chemistry. Nano-CeO2 (Sigma-
Aldrich, 20 nm in water) caused significant lung inflammation (increase in AM, PMN, LDH) after 
instillation of 0.15, 0.5, 1.3, 5 and 7 mg/kg b.w. in male Sprague Dawley rats (Ma et al. 2011). It also 
increased IL-12 production and apoptosis of alveolar macrophages via caspase-3 and -9 activation. 
Male Sprague–Dawley rats were exposed to 0.15, 0.5, 1, 3.5 or 7 mg/kg b.w. nano-CeO2 (6.4 - 14.8 
nm) by a single intratracheal instillation (Ma et al. 2014). Nano-CeO2 exposure induced a sustained 
inflammatory response, macrophage secretion of proinflammatory cytokine IL-12 and phospholipidosis 
and fibrosis in histopathology 4 weeks post-exposure. The authors concluded that nano-CeO2 might 
be able to shift a proinflammatory to a fibrotic environment, ending up in pulmonary fibrosis (Ma et al. 
2012). 
In an acute inhalation study with rats, 4 hours of nose-only exposure to 641 mg/m³ nano-CeO2 
(primary particle size of 55 nm) resulted in pulmonary inflammation and formation of multifocal lung 
microgranulomas explained by impaired lung clearance (Srinivas et al. 2011). In short-term studies 
with one week (5 days) of inhalation to 2.5 and 10 mg/m³ of nano-CeO2 (BASF, laboratory batch for 
experimental uses, primary particle sizes of 10-200 nm, burdens of 166 and 417 µg/lung, respectively) 
caused increased levels of neutrophils, CINC-1, IFN-γ, IL-1α, MCP-1 and M-CSF in BAL and lung 
tissue as well as a mild histiocytosis in histopathology (Kuhlbusch et al. 2009; Landsiedel et al. 2014). 
Observed effects were not fully reversible after 3 weeks of post-exposure. Four weeks of inhalation 
exposure to dose-equivalent concentrations of 1.2 mg/m³ NM-211 and 2.5 mg/m³ NM-212 nano-CeO2 
(European Nanomaterial Repository, 5-10 and 40 nm, respectively) induced increases in either 
neutrophils and/ or lymphocytes in BAL and only mild morphological changes, such as particles within 
alveoli and macrophages, increased septal cellularity (Geraets et al. 2012; Gosens et al. 2013). 
Along with nano-TiO2, nano-CeO2 was ranked within substances causing lung effects in the STIS at 
aerosol concentrations of 0.5 mg/m³, and may be among the materials with higher biological activity 
(Landsiedel et al. 2014).  
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BaSO4 is a water-insoluble salt of barium. Hence, it is used for radiographic contrast media (Romero-
Ibarra et al. 2010; Zhang et al. 2011). Nano-BaSO4 particles are used as fillers in coatings (e.g. in 
motor vehicles) due to their mechanical, optical and chemical properties. Recently, nano-BaSO4 has 
been used in orthopedic medicine, diagnostic imaging and other applications, such as bone cement 
additive (Gillani et al. 2010). Incorporation of nano-BaSO4 into pellethane improved its antimicrobial 
activity and decreased biofilm formation and hospital-acquired infections (Aninwene et al. 2013).  
Human aspiration of radiographic contrast containing BaSO4 elicited thickened interlobular septa, 
subpleural cysts, and centrilobular micronodules along with barium particles in a subpleural distribution 
indicating clinical fibrosis (Voloudaki et al. 2003). Nine cases of baritosis (benign pneumoconiosis) in 
factory workers exposed to barium dusts were reported (Doig 1976). Two patients developed acute 
dyspnea after aspiration of the contrast agent BaSO4 into the lung (Tamm & Kortsik 1999).  
In a simulated physiological saline, BaSO4 showed negligible dissolution (Cullen et al. 2000; Tran et 
al. 2000).  
Nano-BaSO4 was found to have no or very low toxicity in short-term inhalation studies, in any case 
less toxic than nano-TiO2 and -CeO2 (Klein et al. 2012; Landsiedel et al. 2014). One week of exposure 
(5-days, STIS) to 50 mg/m³ nano-BaSO4 (Solvay, primary particle size of 25 nm, burden of 1.1 
mg/lung) elicited no effects in BAL and histopathology (besides a negligible, transient increase in IL-1α 
in tissue homogenates of the lavaged lungs). No other inhalation study with nano-BaSO4 has been 
performed until now. However, a subchronic rat inhalation study with 75 mg/m³ micron-BaSO4 (Aldrich, 
burden of 10 mg/lung) did not cause neutrophil response in BAL and showed no retarded clearance 
(Cullen et al. 2000; Tran et al. 2000). These studies showed that compared to other PSLT, nano-
BaSO4 is remarkable untoxic, even at high concentrations (Landsiedel et al. 2014). The effects 
observed with nano-BaSO4 and -CeO2 nanoparticles illustrate that the inhalation toxicity within the 






   
4.4. Nanotechnology in veterinary medicine 
 
Higher biological activity of nanomaterials can be desirable and intended, as for therapeutics, but can 
also be undesirable when humans are unintentionally exposed to airborne nanoparticles released from 
industrial products (see previous chapters). Nanoparticles can also be used as delivery systems, e.g. 
for pharmaceuticals or bioactive food ingredients (Oberdörster 2010). The delivered compound and 
the in vivo internal concentration determine the potential benefit or risk for this type of application. 
Nanotechnology will be a promising field in human and veterinary medicine and animal health 
(Etheridge et al. 2013). Nanomaterials used in human pharmaceutical applications can also be applied 
to veterinary medicine. Pharmaceutical applications are under development for drug delivery, disease 
diagnosis and treatment (Chakravarthi & Balaji 2010, Lobatto et al. 2011).  
For instance, synthetic polymers, e.g. dendrimers, can be used as pharmacological agents. Due to 
their small size, they are able to enter cells easily and deliver drugs directly to the target site, e.g. 
direct delivery into tumour microvasculature for tumour treatment and therapy. Polymeric nanoparticles 
are also used in pulmonary applications, mostly as drug delivery systems with all the benefits of 
modified surface properties, high drug encapsulation and degradation protection of the drug and 
prolonged drug delivery (Paranjpe & Muller-Goymann 2014). Loaded with an anti-cancer compound, 
polymeric micelles as pulmonary drug carriers were administered to animals via intratracheal 
instillation resulting in no toxicity and sustaining high target concentrations in lung over time (Gill et al. 
2014). 
Barium sulfate has been widely used as contrast agent for the visualization of abnormalities of the 
gastrointestinal tract. Mouse studies showed that it can also be used in angiography producing high-
contrast images using basic X-ray imaging (Givvimani et al. 2011). Here, various structural 
abnormalities in the vascular system of small animals, such as atherosclerotic coronary arteries, can 
be visualized. 
The advantages of nanomaterials in the field of diagnosis and treatment are many but at the same 
time the toxic potential of nanomaterials have to be studied to prevent harm to humans and animals 





   
 Aim of this work 5.
 
Long-term effects of inhaled engineered nanomaterials have been identified as a research priority 
(Becker et al., 2011). So far, for the group of PSLT, only nano-TiO2 and carbon black have been 
tested in long-term inhalation studies (Heinrich et al. 1995, Mauderly et al. 1994, Nikula et al. 1995). 
However, these studies were either not conducted according to OECD test guidelines or only one 
single high aerosol concentration was tested. There are no data on pulmonary or extrapulmonary 
effects after long-term exposure to low aerosol concentrations of nanomaterials.  
Nano-CeO2 and -BaSO4 are industrial relevant nanomaterials. They were further pointed out as high 
priority nanomaterials for toxicological testing by the Organisation for Economic Co-operation and 
Development (OECD) (OECD 2010; OECD 2012; Singh et al. 2011). Nano-CeO2 is known to possess 
a certain toxic potential since short-term inhalation studies showed high particle retention and slow 
pulmonary clearance (nearly no elimination from the lung within 48-72 hours), as well as 
corresponding biological effects in the lungs, such as pulmonary inflammation and granuloma 
formation (Geraets et al. 2012; Srinivas et al. 2011; see chapter 4.3). In the few published data 
available, nano-BaSO4 was found to have no or low toxicity with a remarkably fast pulmonary 
clearance in short-term inhalation studies, even at high aerosol concentrations (Klein et al. 2012; 
Landsiedel et al. 2014). Within this work, inhalation studies were carried out regarding the short-term 
(paper 1 and 2) and (sub)chronic effects of nano-CeO2 and BaSO4. 
The work addressed the following hypotheses: 
1. Inhaled nano-PLSTs are able to cause pulmonary inflammation and further biological effects 
after short-term exposure. Nano-CeO2 and -BaSO4 are both assumed to be PSLT – based on 
their morphology and chemical water-solubility – and may represent a range of biological 
responses. 
2. Repeated inhalation of nano-CeO2 and -BaSO4 exerts long-term effects by progression of 
these short-term effects. 
3. The long-term effects are driven by the particle (bio)kinetics and cellular effects in the lung,  
such as lung clearance and retention and inflammation. 
4. These effects are not observable below a certain aerosol concentration (no observed adverse 
effect concentration; NOAEC) depending on the kinetics and biological potency of the particles 
5. Translocation of inhaled nano-CeO2 and -BaSO4 to extra-pulmonary organs and systemic 
effects are less relevant at concentrations used in this work. 




Aim of this work
  
Phase 1 included two short-term inhalation studies with 1 and 4 weeks of exposure (paper 1 and 2). 
The specific objective was: 
1. To determine the lung and lymph node burdens as well as pulmonary and extrapulmonary 
effects after 1 week of exposure to two concentrations of CeO2 NM-211 and three 
concentrations of CeO2 NM-212;  
2. To examine the course of lung retention and clearance kinetics of CeO2 NM-212 and BaSO4 
after 4 weeks of exposure and a post-exposure period up to 129 days 
3. To examine particle burdens of extra-pulmonary organs (in this work based on liver) 
4. To assess the inflammatory response and morphological changes in the lung based on 
bronchoalveolar lavage and histopathology;  
5. To examine cell proliferation in the lung using a bromodeoxyuridine (BrdU) stain of pulmonary 
epithelial cells 
6. To assess systemic effects by hematology, clinical chemistry and acute phase proteins in 
serum, systemic genotoxicity (micronucleus test) in blood and histopathology in 
extrapulmonary organs 
For the short-term studies, 25 mg/m³ CeO2 were selected as highest test concentration, calculated to 
be in the overload range. In contrast, 5 mg/m³ were chosen as mid and 0.5 mg/m³ as low 
concentrations, expected not to be in the overload range and without significant biological effects. 
Aerosol concentrations of 50 mg/m³ were selected for BaSO4 based on the earlier published 1 week 
inhalation study and were expected to be in the overload range (Klein et al. 2012; Landsiedel et al. 
2014). The study with 4 weeks of exposure made reference to OECD Guidelines for Testing of 
Chemicals, Section 4: Health Effects, No. 412, with additional modifications to the study design 
(Organization for Economic Cooperation and Development (OECD) 2009). The two short-term studies 
were performed under GLP (Organisation for Economic Cooperation and Development (OECD) 1998). 
Part of the 1-week study contributed to the European project “NanoMILE” (“Engineered nanomaterial 
mechanisms of interactions with living systems and the environment”). 
Phase 2 
Based on the lung burdens and toxicological findings after short-term exposure, aerosol 
concentrations of 0.1, 0.3, 1 and 3 mg/m³ nano-CeO2 and 50 mg/m³ nano-BaSO4 were selected for a 
long-term inhalation study with up to two years of exposure. Results of the subchronic study on nano-
BaSO4 are presented in paper 2. The reported subchronic and chronic studies with 13 and 52 weeks 
of exposure were interim results of this long-term study which included 
1. Lung retention and clearance kinetics based on lung and associated lymph node burdens 
2. Pulmonary effects based on bronchoalveolar lavage fluid analysis 




Aim of this work
  
The long-term inhalation study with nano-CeO2 (NM-212) and -BaSO4 was initiated in 2013 and 
performed within the framework of the EU project “NanoREG” (Teunenbroek et al. 2013). The study 
was performed according to OECD test guideline No. 453, under GLP and with a relevant aerosol 
concentration range (OECD 2009). The results of this long-term study will be used to set exposure 
limit values for humans. The obtained NOAEC will be used as basis of future threshold limit values. 
Furthermore, these results will help to classify the carcinogenic potential of nanomaterials which will 
be based on mechanisms of tumour formation and incidences. Thus, the interim results after 13 and 
52 weeks of exposure have enabled early insights into lung retention, clearance and pulmonary 
effects within the course of the long-term study.  
Results of the short-term studies with exposure to nano-CeO2 and –BaSO4 are presented in the paper 
1 and 2 (chapter 6 and 7). Additional results of the short-term and (sub)chronic studies are presented 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Aim of this work
  Paper 1: Time course of lung retention and toxicity of inhaled particles: 6.





Paper 1: Time course of lung retention and toxicity of inhaled particles: 
short-term exposure to nano-Ceria
1  3
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T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
J a n a  K e l l e r  ·  W e n d e l  W o h l l e b e n  ·  L a n  M a - H o c k  ·  V o l k e r  S t r a u s s  ·  S i b y l l e  G r ö t e r s  ·  
K a r i n  K ü t t l e r  ·  K a r i n  W i e n c h  ·  C h r i s t i a n e  H e r d e n  ·  G ü n t e r  O b e r d ö r s t e r  ·  
B e n n a r d  v a n  R a v e n z w a a y  ·  R o b e r t  L a n d s i e d e l  
R e c e i v e d :  2 7  J u n e  2 0 1 4  /  A c c e p t e d :  2 5  A u g u s t  2 0 1 4  
©  T h e  A u t h o r ( s )  2 0 1 4 .  T h i s  a r t i c l e  i s  p u b l i s h e d  w i t h  o p e n  a c c e s s  a t  S p r i n g e r l i n k . c o m
t h e  e x p o s u r e  w a s  t e r m i n a t e d  ( d u r i n g  t h e  p o s t - e x p o s u r e  
p e r i o d ) .  T h e  n e u t r o p h i l  n u m b e r  o b s e r v e d  i n  b r o n c h o a l v e o -
l a r  l a v a g e  ﬂ u i d  ( B A L F )  w a s  d e c r e a s i n g  a n d  s u p p l e m e n t e d  
b y  m o n o n u c l e a r  c e l l s ,  e s p e c i a l l y  m a c r o p h a g e s  w h i c h  w e r e  
v i s i b l e  i n  h i s t o p a t h o l o g y  b u t  n o t  i n  B A L F .  F u r t h e r  p r o g r e s -
s i o n  t o  g r a n u l o m a t o u s  i n ﬂ a m m a t i o n  w a s  o b s e r v e d  4  w e e k s  
p o s t - e x p o s u r e .  T h e  s u r f a c e  a r e a  o f  t h e  p a r t i c l e s  p r o v i d e d  
a  d o s e  m e t r i c s  w i t h  t h e  b e s t  c o r r e l a t i o n  o f  t h e  t w o  C e r i a ’ s  
i n ﬂ a m m a t o r y  r e s p o n s e s ;  h e n c e ,  t h e  i n ﬂ a m m a t i o n  a p p e a r s  
t o  b e  d i r e c t e d  b y  t h e  p a r t i c l e  s u r f a c e  r a t h e r  t h a n  m a s s  o r  
v o l u m e  i n  t h e  l u n g .  O b s e r v i n g  t h e  t i m e  c o u r s e  o f  l u n g  
b u r d e n  a n d  i n ﬂ a m m a t i o n ,  i t  a p p e a r s  t h a t  t h e  d o s e  r a t e  o f  
p a r t i c l e  d e p o s i t i o n  d r o v e  a n  i n i t i a l  i n ﬂ a m m a t o r y  r e a c t i o n  
b y  n e u t r o p h i l s .  T h e  l a t e r  p h a s e  ( a f t e r  4  w e e k s )  w a s  d o m i -
n a t e d  b y  m o n o n u c l e a r  c e l l s ,  e s p e c i a l l y  m a c r o p h a g e s .  T h e  
p r o g r e s s i o n  t o w a r d  t h e  s u b s e q u e n t  g r a n u l o m a t o u s  r e a c t i o n  
w a s  d r i v e n  b y  t h e  d u r a t i o n  a n d  a m o u n t  o f  t h e  p a r t i c l e s  i n  
t h e  l u n g .  T h e  f u r t h e r  p r o g r e s s i o n  o f  t h e  b i o l o g i c a l  r e s p o n s e  
w i l l  b e  d e t e r m i n e d  i n  t h e  o n g o i n g  l o n g - t e r m  s t u d y .
K e y w o r d s  N a n o m a t e r i a l  ( N M )  ·  I n h a l a t i o n  ·  C e r i a  ·  
R e s p i r a t o r y  t r a c t  ·  B r o n c h o a l v e o l a r  l a v a g e
A b b r e v i a t i o n s
A A A L A C   A s s o c i a t i o n  f o r  A s s e s s m e n t  a n d  A c c r e d i t a t i o n  
o f  L a b o r a t o r y  A n i m a l  C a r e  I n t e r n a t i o n a l
A A N   A v e r a g e  a g g l o m e r a t i o n  n u m b e r s
A L P   A l k a l i n e  p h o s p h a t a s e
A U C   A r e a  u n d e r  t h e  c u r v e
B A L F   B r o n c h o a l v e o l a r  l a v a g e  ﬂ u i d
B A L T   B r o n c h u s - a s s o c i a t e d  l y m p h o i d  t i s s u e
B E T   B r u n a u e r – E m m e t – T e l l e r
C e r i a   C e r i u m  d i o x i d e
C I N C   C y t o k i n e - i n d u c e d  n e u t r o p h i l  c h e m o a t t r a c t a n t
F a S S I F   F a s t e d  s t a t e  s i m u l a t e d  i n t e s t i n a l  ﬂ u i d
A b s t r a c t  T w o  C e r i a  n a n o m a t e r i a l s  ( N M - 2 1 1  a n d  
N M - 2 1 2 )  w e r e  t e s t e d  f o r  i n h a l a t i o n  t o x i c i t y  a n d  o r g a n  
b u r d e n s  i n  o r d e r  t o  d e s i g n  a  c h r o n i c  a n d  c a r c i n o g e n i c i t y  
i n h a l a t i o n  s t u d y  ( O E C D  T G  N o .  4 5 3 ) .  R a t s  i n h a l e d  a e r o -
s o l  c o n c e n t r a t i o n s  o f  0 . 5 ,  5 ,  a n d  2 5  m g / m
3
 b y  w h o l e - b o d y  
e x p o s u r e  f o r  6  h / d a y  o n  5  c o n s e c u t i v e  d a y s  f o r  1  o r  4  w e e k s  
w i t h  a  p o s t - e x p o s u r e  p e r i o d  o f  2 4  o r  1 2 9  d a y s ,  r e s p e c t i v e l y .  
L u n g s  w e r e  e x a m i n e d  b y  b r o n c h o a l v e o l a r  l a v a g e  a n d  h i s -
t o p a t h o l o g y .  I n h a l e d  C e r i a  i s  d e p o s i t e d  i n  t h e  l u n g  a n d  
c l e a r e d  w i t h  a  h a l f - t i m e  o f  4 0  d a y s ;  a t  a e r o s o l  c o n c e n t r a -
t i o n s  h i g h e r  t h a n  0 . 5  m g / m
3
,  t h i s  c l e a r a n c e  w a s  i m p a i r e d  
r e s u l t i n g  i n  a  h a l f - t i m e  a b o v e  2 0 0  d a y s  ( 2 5  m g / m
3
) .  A f t e r  
5  d a y s ,  C e r i a  ( > 0 . 5  m g / m
3
)  i n d u c e d  a n  e a r l y  i n ﬂ a m m a -
t o r y  r e a c t i o n  b y  i n c r e a s e s  o f  n e u t r o p h i l s  i n  t h e  l u n g  w h i c h  
d e c r e a s e d  w i t h  t i m e ,  w i t h  s u s t a i n e d  e x p o s u r e ,  a n d  a l s o  a f t e r  
E l e c t r o n i c  s u p p l e m e n t a r y  m a t e r i a l  T h e  o n l i n e  v e r s i o n  o f  t h i s  
a r t i c l e  ( d o i : 1 0 . 1 0 0 7 / s 0 0 2 0 4 - 0 1 4 - 1 3 4 9 - 9 )  c o n t a i n s  s u p p l e m e n t a r y  
m a t e r i a l ,  w h i c h  i s  a v a i l a b l e  t o  a u t h o r i z e d  u s e r s .
J .  K e l l e r  ·  W .  W o h l l e b e n  ·  L .  M a - H o c k  ·  V.  S t r a u s s  ·  S .  G r ö t e r s  ·  
K .  K ü t t l e r  ·  B .  v a n  R a v e n z w a a y  ·  R .  L a n d s i e d e l  ( * )  
E x p e r i m e n t a l  T o x i c o l o g y  a n d  E c o l o g y ,  B A S F  S E ,  
6 7 0 5 6  L u d w i g s h a f e n  a m  R h e i n ,  G e r m a n y
e - m a i l :  r o b e r t . l a n d s i e d e l @ b a s f . c o m
W .  W o h l l e b e n  
M a t e r i a l  P h y s i c s ,  B A S F  S E ,  L u d w i g s h a f e n  a m  R h e i n ,  G e r m a n y
K .  W i e n c h  
P r o d u c t  S a f e t y ,  B A S F  S E ,  L u d w i g s h a f e n  a m  R h e i n ,  G e r m a n y
C .  H e r d e n  
I n s t i t u t e  o f  V e t e r i n a r y  P a t h o l o g y ,  J u s t u s - L i e b i g - U n i v e r s i t y ,  
G i e s s e n ,  G e r m a n y
G .  O b e r d ö r s t e r  
D e p a r t m e n t  o f  E n v i r o n m e n t a l  M e d i c i n e ,  U n i v e r s i t y  o f  R o c h e s t e r ,  
R o c h e s t e r ,  N Y,  U S A
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G G T   γ - G l u t a m y l t r a n s f e r a s e
G S D   G e o m e t r i c  s t a n d a r d  d e v i a t i o n
I C P - A E S   I n d u c t i v e l y  c o u p l e d  p l a s m a  a t o m i c  e m i s s i o n  
s p e c t r o m e t r y
I C P - M S   I n d u c t i v e l y  c o u p l e d  p l a s m a  o p t i c a l  e m i s s i o n  
s p e c t r o m e t r y
I L   I n t e r l e u k i n
L D H   L a c t a t e  d e h y d r o g e n a s e
M - C S F   M a c r o p h a g e  c o l o n y - s t i m u l a t i n g  f a c t o r
M C P   M o n o c y t e  c h e m o a t t r a c t a n t  p r o t e i n
M M A D   M a s s  m e d i a n  a e r o d y n a m i c  d i a m e t e r
M P P D   M u l t i p l e - p a t h  p a r t i c l e  d o s i m e t r y  m o d e l
N A G   N - a c e t y l - β - g l u c o s a m i n i d a s e
N O A E C   N o  o b s e r v e d  a d v e r s e  e f f e c t  c o n c e n t r a t i o n
O P N   O s t e o p o n t i n
P M N   P o l y m o r p h n u c l e a r  n e u t r o p h i l
P S F   P h a g o l y s o s o m a l  s i m u l a n t  ﬂ u i d
P S P   P o o r l y  s o l u b l e  p a r t i c l e s  w i t h  l o w  t o x i c i t y
S A D   S e l e c t e d  a r e a  e l e c t r o n  d i f f r a c t i o n
S E M   S c a n n i n g  e l e c t r o n  m i c r o s c o p y
S I M S   S e c o n d a r y  i o n  m a s s  s p e c t r o m e t r y
S M P S   S c a n n i n g  m o b i l i t y  p a r t i c l e  s i z e r
S T I S   S h o r t - t e r m  i n h a l a t i o n  s t u d y  p r o t o c o l
T E M   T r a n s m i s s i o n  e l e c t r o n  m i c r o s c o p y
T G A   T h e r m o g r a v i m e t r i c  a n a l y s i s
T i O
2
  T i t a n i u m  d i o x i d e
X P S   X - r a y  p h o t o e l e c t r o n  s p e c t r o s c o p y
I n t r o d u c t i o n
D u r i n g  t h e  p r o d u c t i o n  a n d  p r o c e s s i n g  o f  n a n o m a t e r i a l s  i n  
t h e  w o r k p l a c e ,  r e l e a s e s  i n t o  t h e  a i r  m a y  o c c u r  ( K u h l b u s c h  
e t  a l .  2 0 1 1 ) .  T h e r e f o r e ,  i n h a l a t i o n  i s  c o n s i d e r e d  t o  b e  t h e  
m a j o r  r o u t e  o f  c o n c e r n .  F u r t h e r m o r e ,  p u l m o n a r y  i n ﬂ a m m a -
t i o n ,  ﬁ b r o s i s ,  a n d  l u n g  c a n c e r  a r e  m o s t  i m p o r t a n t  a d v e r s e  
e f f e c t s  a f t e r  c h r o n i c  i n h a l a t i o n  e x p o s u r e  o f  r a t s  t o  p o o r l y  
s o l u b l e ,  n o n - ﬁ b r o u s  ( n a n o ) p a r t i c l e s  o f  l o w  t o x i c i t y  ( P S P )  
( O b e r d o r s t e r  2 0 0 2 ) .  T u m o r  f o r m a t i o n  i n  r a t  l u n g s  a f t e r  
l o n g - t e r m  P S P  e x p o s u r e  i s  t h o u g h t  t o  b e  c a u s e d  b y  a l t e r e d  
p a r t i c l e  c l e a r a n c e  k i n e t i c s  i n v o l v i n g  c h r o n i c  i n ﬂ a m m a t i o n  
a s s o c i a t e d  w i t h  o x i d a t i v e  s t r e s s ,  s e c o n d a r y  g e n o t o x i c i t y ,  
a n d  c e l l  p r o l i f e r a t i o n  ( G r e i m  a n d  Z i e g l e r - S k y l a k a k i s  2 0 0 7 ;  
I L S I  R i s k  S c i e n c e  I n s t i t u t e  W o r k s h o p  P a r t i c i p a n t s  2 0 0 0 ) .  
A  p r e v i o u s  s t u d y  o b s e r v e d  t h a t  e x c e s s i v e  a m o u n t s  o f  t h e  
m i c r o s c a l e  T i t a n i a  i n d u c e d  l u n g  t u m o r s  i n  r a t s  a f t e r  2 - y e a r  
i n h a l a t i o n  e x p o s u r e  t o  a  h i g h  c o n c e n t r a t i o n  o f  2 5 0  m g / m
3
 
( L e e  e t  a l .  1 9 8 5 ) .  A l s o ,  n a n o s c a l e  m a t e r i a l s ,  T i t a n i a  ( P 2 5 )  
a n d  c a r b o n  b l a c k  ( P r i n t e x  9 0 ) ,  c a u s e d  l u n g  t u m o r s  i n  r a t s  
a f t e r  2  y e a r s  o f  i n h a l a t i o n  t o  1 0  a n d  1 1 . 7  m g / m
3
,  r e s p e c -
t i v e l y  ( H e i n r i c h  e t  a l .  1 9 9 5 ;  N i k u l a  e t  a l .  1 9 9 5 ) .  T h e  t u m o r  
i n c i d e n c e  o b s e r v e d  i n  t h e s e  s t u d i e s  w a s  h i g h  ( 3 2 – 2 9  % ) .  
O n l y  h i g h  c o n c e n t r a t i o n s  w e r e  t e s t e d  i n  t h e s e  s t u d i e s ,  a n d  
n o  i n f o r m a t i o n  a b o u t  d e t a i l e d  d e p o s i t i o n ,  c l e a r a n c e ,  a n d  
r e t e n t i o n  w a s  p r o v i d e d .  T h u s ,  t h e  e x i s t i n g  s t u d i e s  c o n t r i b -
u t e  l i t t l e  t o  t h e  u n d e r s t a n d i n g  o f  t h e  m e c h a n i s m s  o f  n a n -
o p a r t i c l e - i n d u c e d  t u m o r  f o r m a t i o n  b y  l o n g - t e r m  i n h a l a -
t i o n  ( B e c k e r  e t  a l .  2 0 1 1 ) .  S t a n d a r d i z e d  l o n g - t e r m  s t u d i e s  
a c c o r d i n g  t o  t h e  t e s t  g u i d e l i n e s  w i t h  a  d i s t i n c t  s t u d y  d e s i g n  
a n d  c o n c e n t r a t i o n  s e l e c t i o n  f o c u s i n g  o n  e x p o s u r e  d o s e –
r e s p o n s e  r e l a t i o n s h i p s  a r e  c r u c i a l  f o r  r i s k  a s s e s s m e n t  a n d  
d e r i v a t i o n  o f  o c c u p a t i o n a l  s a f e t y  v a l u e s ,  a s  w e l l  a s  f o r  c l a s -
s i ﬁ c a t i o n  a n d  l a b e l i n g  u n d e r  R E A C H  ( B e c k e r  e t  a l .  2 0 1 1 ;  
E u r o p e a n  C o m m i s s i o n  2 0 1 3 ) .
T h e r e f o r e ,  a n  a p p r o p r i a t e  l o n g - t e r m  i n h a l a t i o n  s t u d y  h a s  
b e e n  i n i t i a t e d  a s  a  c o l l a b o r a t i o n  o f  t h e  G e r m a n  g o v e r n m e n t  
w i t h  B A S F  w i t h i n  t h e  O E C D  s p o n s o r s h i p  p r o g r a m m e  a n d  
t h e  E U - p r o j e c t  N a n o R E G  ( T e u n e n b r o e k  e t  a l .  2 0 1 3 ;  F e d -
e r a l  M i n i s t r y  f o r  t h e  E n v i r o n m e n t  2 0 1 2 ) .  T h i s  s t u d y  i s  p e r -
f o r m e d  a c c o r d i n g  t o  O E C D  t e s t  g u i d e l i n e  N o .  4 5 3  ( O E C D  
2 0 0 9 a ) .  N a n o - C e r i a  w a s  s e l e c t e d  a s  a  t e s t  m a t e r i a l  r e p r e -
s e n t i n g  a  p o o r l y  s o l u b l e  p a r t i c l e  b e c a u s e  o f  i t s  i m p o r t a n c e  
f o r  i n d u s t r i a l  a p p l i c a t i o n s .  N a n o - C e r i a  i s  u s e d  a s  a n  U V -
a b s o r b e n t ,  a  p o l i s h i n g  a g e n t  f o r  s i l i c o n  w a f e r s ,  a n d  a  f u e l  
a d d i t i v e  t o  d e c r e a s e  d i e s e l  p a r t i c l e  e m i s s i o n  ( C a r g n e l l o  e t  a l .  
2 0 1 3 ) .  T h e  O E C D  h a s  a d d e d  C e r i a  t o  t h e  l i s t  o f  r e p r e s e n t a -
t i v e  m a n u f a c t u r e d  n a n o m a t e r i a l s  f o r  t o x i c o l o g i c a l  e v a l u -
a t i o n s  ( N M - 2 1 1 ,  N M - 2 1 2 ,  N M - 2 1 3 )  ( D e m o k r i t o u  e t  a l .  
2 0 1 2 ;  O E C D  2 0 1 0 ) .  T h e  s h o r t - t e r m  s t u d i e s  w i t h  5  d a y s  
a n d  4  w e e k s  o f  e x p o s u r e  p r e s e n t e d  i n  t h i s  m a n u s c r i p t  p r o -
v i d e  i n f o r m a t i o n  o n  b i o k i n e t i c s  a n d  e f f e c t s  o f  n a n o - C e r i a  
r e q u i r e d  f o r  t h e  d e s i g n  o f  a  l o n g - t e r m  i n h a l a t i o n  s t u d y .
T i l l  n o w ,  t h e  a v a i l a b l e  k n o w l e d g e  c o n c e r n i n g  i n h a l a t i o n  
t o x i c i t y  o f  C e r i a  i s  l i m i t e d .  I n  a n  a c u t e  s t u d y ,  4 - h  n o s e -
o n l y  e x p o s u r e  t o  6 4 1  m g / m
3
 n a n o - C e r i a  i n  r a t s  r e s u l t e d  i n  
p u l m o n a r y  i n ﬂ a m m a t i o n  a n d  t h e  f o r m a t i o n  o f  m u l t i f o c a l  
m i c r o g r a n u l o m a s  i n  l u n g  a f t e r  1 4  d a y s  o f  p o s t - e x p o s u r e .  
T h i s  w a s  e x p l a i n e d  b y  t h e  i m p a i r e d  c l e a r a n c e  o f  t h e  p a r -
t i c l e s  f r o m  t h e  l u n g  ( S r i n i v a s  e t  a l .  2 0 1 1 ) .  I n  a  w h o l e - b o d y  
4 - d a y  i n h a l a t i o n  s t u d y ,  e x p o s i n g  r a t s  t o  2 . 7  m g / m
3
 n a n o -
C e r i a  2  h / d a y ,  l u n g  i n j u r y ,  a n d  i n ﬂ a m m a t i o n  w e r e  o b s e r v e d  
a f t e r  1  d a y  p o s t - e x p o s u r e  ( D e m o k r i t o u  e t  a l .  2 0 1 2 ) .  
I n  a  2 8 - d a y  i n h a l a t i o n  s t u d y  o f  m i c r o -  a n d  n a n o - C e r i a  
( 1 0 . 7 9  m g / m
3
 N M - 2 1 1 ,  1 9 . 9 5  m g / m
3
 N M - 2 1 2 ,  5 5 . 0  m g /
m
3
 N M - 2 1 3 )  i n  r a t s ,  h i g h  l u n g  b u r d e n s ,  d i s t r i b u t i o n  o f  
i n h a l e d  C e r i a  t o  v a r i o u s  e x t r a p u l m o n a r y  o r g a n s ,  a n d  s l o w  
t i s s u e  c l e a r a n c e  f r o m  t h e  l u n g  w e r e  o b s e r v e d  ( G e r a e t s  e t  a l .  
2 0 1 2 ) .  F u r t h e r m o r e ,  2 8 - d a y  n o s e - o n l y  i n h a l a t i o n  o f  2  m g /
m
3
 n a n o - C e r i a  i n  m i c e  i n d u c e d  s e v e r e  a n d  c h r o n i c  i n ﬂ a m -
m a t i o n  i n c l u d i n g  n e c r o s i s ;  p r o t e i n o s i s ;  ﬁ b r o s i s  a n d  g r a n u -
l o m a s  i n  t h e  l u n g s ;  a n d  s e v e r e  c h a n g e s  i n  k i d n e y ,  l i v e r ,  a n d  
h e a r t  ( A a l a p a t i  e t  a l .  2 0 1 4 ) .  T h e s e  s t r o n g  e f f e c t s  w e r e  a s s o -
c i a t e d  w i t h  s i g n i ﬁ c a n t  a c c u m u l a t i o n  o f  t h e  n a n o p a r t i c l e s  i n  
t h e  ( e x t r a ) p u l m o n a r y  t i s s u e s  a n d  i n d i c a t e d  t h a t  i n h a l a t i o n  
o f  C e r i a  c a n  l e a d  t o  p u l m o n a r y  a n d  e x t r a p u l m o n a r y  t o x -
i c i t y .  T h e r e  w e r e  a l s o  a  f e w  i n s t i l l a t i o n  s t u d i e s  a s s e s s i n g  
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t o x i c i t y  o f  n a n o - C e r i a  ( H e  e t  a l .  2 0 1 0 ;  N a l a b o t u  e t  a l .  
2 0 1 1 ;  M a  e t  a l .  2 0 1 1 ,  2 0 1 4 ;  M o l i n a  e t  a l .  2 0 1 4 ) .  A f t e r  s i n -
g l e  i n t r a t r a c h e a l  i n s t i l l a t i o n  o f  0 . 1 5 ,  0 . 5 ,  1 . 3 ,  5 ,  a n d  7  m g /
k g  i n  m a l e  S p r a g u e – D a w l e y  r a t s ,  C e r i a  c a u s e d  c o n c e n t r a -
t i o n - d e p e n d e n t  a l v e o l a r  m a c r o p h a g e  f u n c t i o n a l  c h a n g e ,  
s i g n i ﬁ c a n t  l u n g  i n ﬂ a m m a t i o n ,  a n d  c y t o t o x i c i t y ,  i n d i c a t i n g  a  
p o t e n t i a l  s h i f t  f r o m  a  p r o i n ﬂ a m m a t o r y  e n v i r o n m e n t  t o  ﬁ n a l  
p u l m o n a r y  ﬁ b r o s i s  ( M a  e t  a l .  2 0 1 1 ) .  H o w e v e r ,  i n s t i l l a t i o n  
s t u d i e s  u s u a l l y  h a v e  a  b o l u s  o f  h i g h  d o s e  a n d  h i g h  d o s e  r a t e  
i n  t h e  l u n g  a n d  a r e  t h e r e f o r e  l e s s  s u i t a b l e  t o  d e t e r m i n e  t h e  
e x p o s u r e  c o n c e n t r a t i o n s ,  b i o k i n e t i c s ,  a n d  b i o l o g i c a l  e f f e c t s  
t o w a r d  t h e  d e s i g n  o f  a  l o n g - t e r m  i n h a l a t i o n  s t u d y  ( B a i s c h  
e t  a l .  2 0 1 4 ) .  T h e  m a j o r i t y  o f  t h e  p u b l i s h e d  s t u d i e s  i n d i -
c a t e  a n  i n ﬂ a m m a t o r y  p o t e n t i a l  o f  C e r i a  b u t  l a c k  a p p r o p r i -
a t e  d o s e  m e t r i c s  a n d  b i o k i n e t i c  i n f o r m a t i o n  ( C a s s e e  e t  a l .  
2 0 1 1 ;  B e c k e r  e t  a l .  2 0 1 1 ) .
T h e  s h o r t - t e r m  s t u d i e s  w i t h  5  d a y s  a n d  4  w e e k s  o f  e x p o -
s u r e  d e s c r i b e d  i n  t h i s  m a n u s c r i p t  p r o v i d e  d a t a  o n  b i o k i -
n e t i c s  a s  w e l l  a s  p u l m o n a r y  a n d  p o t e n t i a l  e x t r a p u l m o n a r y  
e f f e c t s  o f  t w o  n a n o - C e r i a  ( N M - 2 1 1  a n d  N M - 2 1 2 )  u s i n g  
e s t a b l i s h e d  a n d  s t a n d a r d i z e d  s t u d y  p r o t o c o l s .  W h o l e - b o d y  
e x p o s u r e  i s  t h e  o n l y  o p t i o n  f o r  e x p o s u r e  r o u t e s  i n  l o n g -
t e r m  s t u d i e s  f o r  a n i m a l  w e l f a r e  r e a s o n s  b e c a u s e  t h e  a n i -
m a l s  a r e  n o t  r e s t r a i n e d  d u r i n g  t h e  e x p o s u r e .  F u r t h e r m o r e ,  
o r a l  a n d  d e r m a l  u p t a k e  o f  d i f f e r e n t  m i c r o -  a n d  n a n o - s i z e d  
t e s t  m a t e r i a l s  h a s  b e e n  p r o v e n  t o  b e  n e g l i g i b l e  ( L a n d s i e d e l  
e t  a l .  2 0 1 2 ;  G a m e r  e t  a l .  2 0 0 6 ;  P ﬂ u c k e r  e t  a l .  2 0 0 1 ;  M o l i n a  
e t  a l .  2 0 1 4 ) .
P h y s i c o c h e m i c a l  p r o p e r t i e s  o f  n a n o p a r t i c l e s  c a n  h a v e  
a  s i g n i ﬁ c a n t  i n ﬂ u e n c e  o n  t h e i r  f a t e  a n d  b i o l o g i c a l  e f f e c t s  
( O b e r d o r s t e r  e t  a l .  1 9 9 4 a ;  A n j i l v e l  a n d  A s g h a r i a n  1 9 9 5 ) .  
T h e r e f o r e ,  t h e  t w o  n a n o p a r t i c l e s  w e r e  c h a r a c t e r i z e d  i n  
a c c o r d a n c e  w i t h  t h e  n a n o - s p e c i ﬁ c  g u i d a n c e  i n  R E A C H ,  a s  
v a l i d a t e d  e a r l i e r  w i t h  o t h e r  m a t e r i a l s  f r o m  t h e  O E C D  s p o n -
s o r s h i p  p r o g r a m m e  ( W o h l l e b e n  e t  a l .  2 0 1 3 ) .  P e r s i s t e n c e  
a n d  s o l u b i l i t y  i n  d i f f e r e n t  m e d i a  w e r e  i n v e s t i g a t e d  t o  s t u d y  
t h e  b i o a v a i l a b i l i t y  o f  t h e  t e s t e d  C e r i a .  C o m p r e h e n s i v e  
c h a r a c t e r i z a t i o n s  o f  t h e  t e s t  a t m o s p h e r e s  w e r e  p e r f o r m e d  
a c c o r d i n g  t o  t h e  r e s p e c t i v e  g u i d e l i n e s  a n d  O E C D  g u i d a n c e  
d o c u m e n t s  ( E C H A  2 0 1 2 ;  H u s s a i n  e t  a l .  2 0 0 9 ) .
M a t e r i a l s  a n d  m e t h o d s
G e n e r a l
T w o  s h o r t - t e r m  s t u d i e s  ( 5  d a y s  a n d  4  w e e k s  o f  e x p o s u r e )  
w e r e  d e s i g n e d  u s i n g  t w o  d i f f e r e n t  n a n o - C e r i a .  I n  t h e  s h o r t -
t e r m  s t u d y  w i t h  5  d a y s  o f  e x p o s u r e ,  w e  c o m p a r e d  t w o  
C e r i a  ( N M - 2 1 2  a n d  N M - 2 1 1 )  w i t h  r e g a r d  t o  t h e i r  i n h a -
l a t i o n  t o x i c i t y ,  d e p o s i t i o n ,  a n d  c l e a r a n c e  k i n e t i c s .  C e r i a  
( N M - 2 1 2 )  w a s  t e s t e d  f u r t h e r  a f t e r  4  w e e k s  o f  e x p o s u r e .  
I n  o r d e r  t o  c o m p a r e  t h e  e f f e c t s  a f t e r  d i f f e r e n t  e x p o s u r e  
d u r a t i o n s ,  s a m e  t a r g e t  c o n c e n t r a t i o n s  w e r e  s e l e c t e d  f o r  t h e  
t w o  s t u d i e s .  B i o l o g i c a l  e f f e c t s  o f  C e r i a  w e r e  s t u d i e d  b y  
t h e  a n a l y s i s  o f  b r o n c h o a l v e o l a r  l a v a g e  ﬂ u i d  ( B A L F )  a n d  
b l o o d  a n d  h i s t o p a t h o l o g y  o f  t h e  r e s p i r a t o r y  t r a c t .  B i o k i n e t -
i c s  w e r e  a s s e s s e d  b y  t h e  d e t e r m i n a t i o n  o f  l u n g  a n d  l u n g -
a s s o c i a t e d  l y m p h  n o d e  b u r d e n s  a t  d i f f e r e n t  t i m e  p o i n t s .  T h e  
s h o r t - t e r m  i n h a l a t i o n  s t u d i e s  w e r e  p e r f o r m e d  a c c o r d i n g  t o  
t h e  O E C D  P r i n c i p l e s  o f  G o o d  L a b o r a t o r y  P r a c t i c e  ( G L P )  
[ O r g a n i z a t i o n  f o r  E c o n o m i c  C o o p e r a t i o n  a n d  D e v e l o p m e n t  
( O E C D )  1 9 9 8 ] .  T h e  s t u d y  d e s i g n  o f  t h e  s t u d y  w i t h  4  w e e k s  
o f  e x p o s u r e  w a s  c a r r i e d  o u t  a c c o r d i n g  t o  t h e  O E C D  g u i d e -
l i n e s  f o r  t e s t i n g  o f  c h e m i c a l s ,  S e c t i o n  4 :  H e a l t h  E f f e c t s ,  
N o .  4 1 2 ,  w i t h  a d d i t i o n a l  m o d i ﬁ c a t i o n s  [ O r g a n i z a t i o n  f o r  
E c o n o m i c  C o o p e r a t i o n  a n d  D e v e l o p m e n t  ( O E C D )  2 0 0 9 b ] .  
T o  i n c r e a s e  t h e  c o m p a r a b i l i t y ,  t h e  s h o r t - t e r m  s t u d i e s  w e r e  
p e r f o r m e d  i n  t h e  s a m e  i n h a l a t i o n  l a b o r a t o r y  u n d e r  t h e  s a m e  
t e s t  c o n d i t i o n s ,  d e t e r m i n i n g  s a m e  e n d  p o i n t s  f o r  a s s e s s i n g  
b i o l o g i c a l  e f f e c t s  a n d  d e p o s i t i o n  a n d  c l e a r a n c e  k i n e t i c s .  
T h i s  f a c i l i t a t e d  a  d i r e c t  c o m p a r i s o n  b e t w e e n  t h e  m e a s u r e d  
p a r a m e t e r s .
T e s t  m a t e r i a l s  a n d  c h a r a c t e r i z a t i o n
T h e  t w o  C e r i a  t e s t  m a t e r i a l s  i n  t h i s  w o r k  a r e  N M - 2 1 1  a n d  
N M - 2 1 2  r e c e i v e d  f r o m  t h e  O E C D  s p o n s o r s h i p  p r o g r a m m e  
f o r  s a f e t y  t e s t i n g  o f  m a n u f a c t u r e d  n a n o m a t e r i a l s  ( H u s s a i n  
e t  a l .  2 0 0 9 ) .  V e r y  r e c e n t l y ,  t h e  E u r o p e a n  C h e m i c a l s  A g e n c y  
( E C H A )  d r a f t e d  a  n a n o - s p e c i ﬁ c  g u i d a n c e  d o c u m e n t ,  d e s -
i g n a t e d  a s  A p p e n d i x  R 7 - 1  ( H e r m a n s  1 9 6 3 ) .  T h e  f o l l o w i n g  
e n d  p o i n t s  f o r  t h e  c h a r a c t e r i z a t i o n  o f  t h e  a e r o s o l  m a t e r i a l s  
w e r e  c o n s i d e r e d  a s  f o l l o w s :  a g g l o m e r a t i o n / a g g r e g a t i o n ,  
p a r t i c l e  s i z e  d i s t r i b u t i o n ,  w a t e r  s o l u b i l i t y / d i s p e r s a b i l i t y ,  
c r y s t a l l i n e  p h a s e  a n d  s i z e ,  r e p r e s e n t a t i v e  e l e c t r o n  m i c r o s -
c o p y  ( T E M )  f o r  m o r p h o l o g y ,  s p e c i ﬁ c  s u r f a c e  a r e a ,  z e t a -
p o t e n t i a l  ( s u r f a c e  c h a r g e ) ,  s u r f a c e  c h e m i s t r y ,  p h o t o c a t a l y t i c  
a c t i v i t y ,  p u r i t y  a n d  i m p u r i t i e s ,  a n d  p o r o s i t y .  T h e  m e t h o d s  
t o  c h a r a c t e r i z e  t h e s e  p r o p e r t i e s  a r e  d e s c r i b e d  i n  d e t a i l  i n  
a  p r e v i o u s  w o r k  ( W o h l l e b e n  e t  a l .  2 0 1 3 ) .  T h e  a g g l o m e r -
a t e  d e n s i t y  o f  C e r i a  N M - 2 1 2  w a s  d e r i v e d  f r o m  m e r c u r y  
p o r o s i m e t r y  ( s e e  F i g .  S 1 ) .  B y  i n t e g r a t i n g  a l l  v o i d  v o l u m e s  
u p  t o  t h e  a g g l o m e r a t e  o u t e r  d i m e n s i o n s  o f  1 . 1  μ m ,  t h e  
a g g l o m e r a t e  d e n s i t y  o f  N M - 2 1 2  w o u l d  b e  2 . 0  g / m
3
 b a s e d  
o n  t h e  m e r c u r y  p o r o s i m e t r y  m e a s u r e m e n t .  T h e  d e n s i t y  o f  
N M - 2 1 1  w a s  d e t e r m i n e d  c o n s i s t e n t l y .  T h e  a g g l o m e r a t e  
d e n s i t y  w a s  u s e d  i n  t h e  c a l c u l a t i o n  o f  e x p e c t e d  l u n g  b u r d e n  
b y  m u l t i p l e - p a t h  p a r t i c l e  d o s i m e t r y  ( M P P D )  m o d e l  ( A n j i l -
v e l  a n d  A s g h a r i a n  1 9 9 5 ) .
A n i m a l s
T h i s  s t u d y  w a s  a p p r o v e d  b y  t h e  l o c a l  a u t h o r i z i n g  a g e n c y  
f o r  a n i m a l  e x p e r i m e n t s  ( L a n d e s u n t e r s u c h u n g s a m t  K o b -
l e n z ,  G e r m a n y )  a s  r e f e r e n c e d  b y  t h e  a p p r o v a l  n u m b e r  G  
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1  3
1 2 - 3 - 0 2 8 .  A n i m a l s  w e r e  h o u s e d  i n  a n  A A A L A C - a c c r e d i t e d  
f a c i l i t y  i n  a c c o r d a n c e  w i t h  t h e  G e r m a n  A n i m a l  W e l f a r e  
A c t  a n d  t h e  e f f e c t i v e  E u r o p e a n  C o u n c i l  D i r e c t i v e .  F e m a l e  
W i s t a r  r a t s  [ s t r a i n :  C r l : W I ( H a n ) ]  w e r e  o b t a i n e d  a t  a n  a g e  
o f  7  w e e k s  f r o m  C h a r l e s  R i v e r  L a b o r a t o r i e s  ( S u l z f e l d ,  G e r -
m a n y ) .  T h e  a n i m a l s  w e r e  m a i n t a i n e d  i n  g r o u p s  u p  t o  ﬁ v e  
a n i m a l s  i n  a  p o l y s u l f o n e  c a g e  [ H - T e m p  ( P S U ) ] ,  T E C N I -
P L A S T ,  G e r m a n y )  w i t h  a  ﬂ o o r  a r e a  o f  a b o u t  2 , 0 6 5  c m
2
 
( 6 1 0  ×  4 3 5  ×  2 1 5  m m )  w i t h  a c c e s s  t o  w o o d e n  g n a w i n g  
b l o c k s ,  G L P - c e r t i ﬁ e d  f e e d  ( K l i b a  l a b o r a t o r y  d i e t ,  P r o v i m i  
K l i b a  S A ,  K a i s e r a u g s t ,  B a s e l  S w i t z e r l a n d ) ,  a n d  w a t e r  a d  
l i b i t u m .  A n i m a l  r o o m  w a s  k e p t  a t  2 0 – 2 4  ° C  a n d  r e l a t i v e  
h u m i d i t y  3 0 – 7 0  %  w i t h  1 5  a i r  c h a n g e s / h .  A  l i g h t / d a r k  c y c l e  
o f  1 2  h  e a c h  w a s  k e p t  t h r o u g h o u t  t h e  s t u d y  p e r i o d s .  T o  
a d a p t  t o  t h e  e x p o s u r e  c o n d i t i o n s ,  t h e  a n i m a l s  w e r e  a c c l i m a -
t i z e d  t o  f r e s h  a i r  u n d e r  t h e  s t u d y  ﬂ o w  c o n d i t i o n s  i n  w h o l e -
b o d y  i n h a l a t i o n  c h a m b e r s  f o r  2  d a y s  b e f o r e  t h e  s t a r t  o f  t h e  
e x p o s u r e  p e r i o d .  U p  t o  2  a n i m a l s / c a g e  w e r e  e x p o s e d  i n  
w i r e  c a g e s ,  t y p e  D K I I I  ( B E C K E R  &  C o . ,  C a s t r o p - R a u x e l ,  
G e r m a n y )  i n  a  w h o l e - b o d y  c h a m b e r .  D u r i n g  t h e  e x p o s u r e ,  
f e e d  a n d  d r i n k i n g  w a t e r  w e r e  w i t h d r a w n  f r o m  t h e  a n i m a l s .
I n h a l a t i o n  s y s t e m
T h e  a n i m a l s  w e r e  e x p o s e d  i n  w i r e  c a g e s  t h a t  w e r e  l o c a t e d  
i n  a  s t a i n l e s s  s t e e l  w h o l e - b o d y  i n h a l a t i o n  c h a m b e r  
( V  =  2 . 8  m
3
 o r  V  =  1 . 4  m
3
) .  T h e  i n h a l a t i o n  a t m o s p h e r e s  
w e r e  p a s s e d  i n t o  t h e  i n h a l a t i o n  c h a m b e r s  w i t h  t h e  s u p p l y  
a i r  a n d  w e r e  r e m o v e d  b y  a n  e x h a u s t  a i r  s y s t e m  w i t h  2 0  a i r  
c h a n g e s / h .  F o r  t h e  c o n t r o l  a n i m a l s ,  t h e  e x h a u s t  a i r  s y s t e m  
w a s  a d j u s t e d  i n  s u c h  a  w a y  t h a t  t h e  a m o u n t  o f  e x h a u s t  a i r  
w a s  l o w e r  t h a n  t h e  ﬁ l t e r e d  c l e a n ,  s u p p l y  a i r  ( p o s i t i v e  p r e s -
s u r e )  t o  e n s u r e  t h a t  n o  l a b o r a t o r y  r o o m  a i r  r e a c h e s  t h e  c o n -
t r o l  a n i m a l s .  F o r  t h e  t r e a t e d  a n i m a l s ,  t h e  a m o u n t  o f  e x h a u s t  
a i r  w a s  h i g h e r  t h a n  t h e  s u p p l y  a i r  ( n e g a t i v e  p r e s s u r e )  t o  
p r e v e n t  t h e  c o n t a m i n a t i o n  o f  t h e  l a b o r a t o r y  a s  a  r e s u l t  o f  
p o t e n t i a l  l e a k a g e s  f r o m  t h e  i n h a l a t i o n  c h a m b e r s .
A e r o s o l  g e n e r a t i o n  a n d  m o n i t o r i n g
C e r i a  a e r o s o l s  w e r e  p r o d u c e d  b y  d r y  d i s p e r s i o n  o f  p o w d e r  
p e l l e t s  w i t h  a  b r u s h  d u s t  g e n e r a t o r  ( d e v e l o p e d  b y  t h e  T e c h -
n i c a l  U n i v e r s i t y  o f  K a r l s r u h e  i n  c o o p e r a t i o n  w i t h  B A S F ,  
G e r m a n y )  u s i n g  c o m p r e s s e d  a i r  ( 1 . 5  m
3
/ h ) .  T h e  s o  g e n e r -
a t e d  d u s t  a e r o s o l  w a s  d i l u t e d  b y  c o n d i t i o n e d  a i r  ( 5 4 . 5  m
3
/ h )  
p a s s e d  i n t o  w h o l e - b o d y  i n h a l a t i o n  c h a m b e r s .  T h e  c o n t r o l  
g r o u p  w a s  e x p o s e d  t o  c o n d i t i o n e d ,  c l e a n  a i r .  T h e  d e s i r e d  
c o n c e n t r a t i o n s  w e r e  a c h i e v e d  b y  v a r y i n g  t h e  f e e d i n g  s p e e d  
o f  t h e  s u b s t a n c e  p e l l e t  a n d  b y  v a r y i n g  t h e  r o t a t i n g  s p e e d  o f  
t h e  b r u s h .  B a s e d  o n  t h e  d a t a  o f  a  c o m p r e h e n s i v e  t e c h n i c a l  
t r i a l ,  t h e  a e r o s o l  c o n c e n t r a t i o n s  w i t h i n  t h e  c h a m b e r s  w e r e  
c o n s i d e r e d  t o  b e  h o m o g e n o u s  ( d a t a  n o t  s h o w n ) .  N e v e r t h e -
l e s s ,  t h e  p o s i t i o n s  o f  t h e  e x p o s u r e  c a g e s  w e r e  r o t a t e d  w i t h i n  
e a c h  c h a m b e r .  G e n e r a t e d  a e r o s o l s  w e r e  c o n t i n u o u s l y  m o n i -
t o r e d  b y  s c a t t e r e d  l i g h t  p h o t o m e t e r s  ( V i s G u a r d ,  S i g r i s t ) .  
P a r t i c l e  c o n c e n t r a t i o n s  i n  t h e  i n h a l a t i o n  a t m o s p h e r e s  w e r e  
a n a l y z e d  b y  g r a v i m e t r i c  m e a s u r e m e n t  o f  a i r  ﬁ l t e r  s a m p l e s .  
P a r t i c l e  s i z e  d i s t r i b u t i o n  w a s  d e t e r m i n e d  g r a v i m e t r i c a l l y  b y  
c a s c a d e  i m p a c t o r  a n a l y s i s  u s i n g  e i g h t  s t a g e s  M a r p l e  p e r -
s o n a l  c a s c a d e  i m p a c t o r  ( S i e r r a  A n d e r s o n ,  U S A ) .  I n  a d d i -
t i o n ,  l i g h t - s c a t t e r i n g  a e r o s o l  s p e c t r o m e t e r  ( W E L A S
®
 2 0 0 0 ,  
P a l a s ,  K a r l s r u h e ,  G e r m a n y )  w a s  u s e d  t o  m e a s u r e  p a r t i c l e s  
f r o m  0 . 2 4  t o  1 0  μ m .  T o  m e a s u r e  p a r t i c l e s  i n  t h e  s u b m i -
c r o m e t e r  r a n g e ,  s c a n n i n g  m o b i l i t y  p a r t i c l e  s i z e r  ( S M P S  
5 . 4 0 0 ,  G r i m m  A e r o s o l t e c h n i k ,  A i n r i n g ,  G e r m a n y )  w a s  
u s e d .  T h e  s a m p l i n g  p r o c e d u r e s  a n d  m e a s u r e m e n t s  t o  c h a r -
a c t e r i z e  t h e  g e n e r a t e d  a e r o s o l s  w e r e  d e s c r i b e d  i n  d e t a i l  i n  a  
p r e v i o u s  w o r k  ( M a - H o c k  e t  a l .  2 0 0 7 ) .
S t u d y  d e s i g n  o f  s h o r t - t e r m  s t u d i e s  ( 5  d a y s  a n d  4  w e e k s  
o f  e x p o s u r e )
I n  g e n e r a l ,  t h e  a n i m a l s  w e r e  w h o l e - b o d y  e x p o s e d  t o  d u s t  
a e r o s o l s  f o r  6  h / d a y  o n  5  c o n s e c u t i v e  d a y s / w e e k  w i t h  a  
r e s p e c t i v e  p o s t - e x p o s u r e  p e r i o d  ( s e e  F i g .  1 ) .  T h e  h i g h e s t  
a e r o s o l  c o n c e n t r a t i o n  w a s  2 5  m g / m
3
,  w h i c h  w a s  e x p e c t e d  
t o  c a u s e  b i o l o g i c a l  e f f e c t s  a n d  s h o u l d  l e a d  t o  l u n g  o v e r -
l o a d  a t  l e a s t  f o r  2 0  e x p o s u r e s .  T h e  m i d  a n d  l o w  a e r o s o l  
c o n c e n t r a t i o n s  w e r e  5  a n d  0 . 5  m g / m
3
.  T h e  l o w  a e r o s o l  
c o n c e n t r a t i o n  w i t h  a n  e x p e c t e d  l u n g  b u r d e n  f a r  b e l o w  t h e  
o v e r l o a d  c o n d i t i o n  s h o u l d  n o t  l e a d  t o  a n y  a d v e r s e  e f f e c t s .  
T h e  m i d  a e r o s o l  c o n c e n t r a t i o n ,  w h i c h  w a s  s p a c e d  t e n f o l d  
h i g h e r  t h a n  t h e  l o w  c o n c e n t r a t i o n ,  w a s  e x p e c t e d  t o  c a u s e  
s o m e  b i o l o g i c a l  e f f e c t s .  T h e  p o s t - e x p o s u r e  p e r i o d  a n d  
t h e  e x a m i n a t i o n  t i m e  p o i n t s  w e r e  s c h e d u l e d  t o  a d d r e s s  
t h e  p r o g r e s s i o n  o r  r e g r e s s i o n  o f  t h e  b i o l o g i c a l  e f f e c t s ,  
w i t h  t h e i r  c o r r e l a t i o n  t o  l u n g  b u r d e n  a n d  l u n g  c l e a r a n c e  
k i n e t i c s .
C l i n i c a l  e x a m i n a t i o n s
C l i n i c a l  o b s e r v a t i o n s  o f  t h e  a n i m a l s  w e r e  r e c o r d e d  f o r  
e a c h  a n i m a l  a t  l e a s t  t h r e e  t i m e s  p e r  d a y  o n  e x p o s u r e  d a y s  
a n d  o n c e  a  d a y  d u r i n g  t h e  p r e - e x p o s u r e  a n d  p o s t - e x p o s u r e  
p e r i o d s .  S i g n s  a n d  ﬁ n d i n g s  w e r e  r e c o r d e d  f o r  e a c h  a n i -
m a l .  D u r i n g  e x p o s u r e ,  e x a m i n a t i o n  w a s  p o s s i b l e  o n l y  o n  
a  g r o u p  b a s i s .  T h e  a n i m a l s  w e r e  w e i g h e d  p r i o r  t o  t h e  p r e -
e x p o s u r e  p e r i o d ,  a t  t h e  s t a r t  o f  t h e  e x p o s u r e  p e r i o d  ( d a y  0 ) ,  
a n d  t w i c e  w e e k l y  u n t i l  k i l l i n g  o r  t w i c e  w i t h i n  t h e  5  e x p o -
s u r e  d a y s .
H e m a t o l o g y  a n d  c l i n i c a l  c h e m i s t r y
B l o o d  s a m p l i n g  o f  ﬁ v e  f a s t e d  r a t s  p e r  t e s t  g r o u p  w a s  p e r -
f o r m e d  i n  t h e  m o r n i n g  b y  r e t r o - o r b i t a l  v e n o u s  p l e x u s  p u n c -
t u r e  u n d e r  i s o ﬂ u r a n e  a n e s t h e s i a  ( I s o b a
®
,  E s s e x  G m b H  
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M u n i c h ,  G e r m a n y ) .  T h e  e x t e n t  o f  t h e  e x a m i n a t i o n  w a s  
a c c o r d i n g  t o  t h e  d a t a  r e q u i r e m e n t s  o f  O E C D  t e s t  g u i d e l i n e  
4 1 2 .  T h e  p a r a m e t e r s  s u c h  a s  r e d  b l o o d  c e l l  c o u n t s ,  h e m o -
g l o b i n ,  h e m a t o c r i t ,  m e a n  c o r p u s c u l a r  v o l u m e  ( M C V ) ,  
m e a n  c o r p u s c u l a r  h e m o g l o b i n  c o n t e n t  ( M C H ) ,  m e a n  c o r -
p u s c u l a r  h e m o g l o b i n  c o n c e n t r a t i o n  ( M C H C ) ,  p l a t e l e t  
c o u n t s ,  t o t a l  w h i t e  b l o o d  c e l l  a s  w e l l  a s  d i f f e r e n t i a l  b l o o d  
c e l l  c o u n t s  w e r e  d e t e r m i n e d  i n  t h e  E D T A - s t a b i l i z e d  b l o o d  
w i t h  a  h e m a t o l o g y  a n a l y z e r  ( A D V I A
®
 1 2 0 ,  S i e m e n s  D i a g -
n o s t i c s ,  F e r n w a l d ,  G e r m a n y ) .  A d d i t i o n a l l y ,  a c u t e - p h a s e  
p r o t e i n s  w e r e  d e t e r m i n e d  i n  s e r u m :  r a t  h a p t o g l o b i n  a n d  
r a t  γ 2 - m a c r o g l o b u l i n  ( E L I S A  b y  I m m u n o l o g y  C o n s u l t a n t s  
L a b o r a t o r y  I n c . ,  N e w b e r g ,  O R ,  U S A )  w e r e  m e a s u r e d  w i t h  
a  S u n r i s e  M T P  R e a d e r  ( T e c a n  A G ,  S w i t z e r l a n d )  b y  u s i n g  
t h e  M a g e l l a n  S o f t w a r e  p r o v i d e d  b y  t h e  i n s t r u m e n t  p r o -
d u c e r .  T h e  e n z y m e  l e v e l s  [ a l a n i n e  a m i n o t r a n s f e r a s e  ( A L T ) ,  
a s p a r t a t e  a m i n o t r a n s f e r a s e  ( A S T ) ,  a l k a l i n e  p h o s p h a t a s e  
( A L P ) ,  γ - g l u t a m y l t r a n s f e r a s e  ( G G T ) ]  a n d  d i f f e r e n t  b l o o d  
p a r a m e t e r s  o f  c l i n i c a l  c h e m i s t r y  w e r e  e v a l u a t e d  b y  u s i n g  
a n  a u t o m a t i c  a n a l y z e r  ( H i t a c h i  9 1 7 ;  R o c h e ,  M a n n h e i m ,  
G e r m a n y ) .
S y s t e m i c  g e n o t o x i c i t y  ( m i c r o n u c l e u s  t e s t )
S y s t e m i c  g e n o t o x i c i t y  ( m i c r o n u c l e u s  t e s t )  w a s  p e r f o r m e d  
i n  t h e  s h o r t - t e r m  s t u d i e s  w i t h  5  d a y s  a n d  4  w e e k s  o f  e x p o -
s u r e  ( 3  a n d  2  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e ,  r e s p e c t i v e l y ) .  
M i c r o n u c l e u s  a n a l y s i s  i n  e r y t h r o c y t e s  o f  r a t  p e r i p h e r a l  
b l o o d  w a s  p e r f o r m e d  w i t h  t h e  M i c r o F l o w
®
 p l u s  ( R a t  
B l o o d )  k i t  f r o m  L i t r o n  L a b o r a t o r i e s ,  R o c h e s t e r ,  N Y,  U S A .  
T h e  ﬂ o w  c y t o m e t r i c  d i f f e r e n t i a t i o n  o f  r e t i c u l o c y t e s  a s  w e l l  
a s  n o r m o c h r o m i c  e r y t h r o c y t e s  w i t h  a n d  w i t h o u t  m i c r o n u -
c l e i  w a s  d o n e  o n  t h e  F a c s C a l i b u r  i n s t r u m e n t  ( B e c t o n D i c k -
i n s o n ,  H e i d e l b e r g ,  G e r m a n y )  a f t e r  s t a i n i n g  o f  t h e  c e l l s  w i t h  
C D 7 1  a n d  p r o p i d i u m  i o d i d e .
B r o n c h o a l v e o l a r  l a v a g e
F i v e  a n i m a l s  p e r  t e s t  g r o u p  w e r e  k i l l e d  b y  e x s a n g u i n a -
t i o n  f r o m  t h e  a o r t a  a b d o m i n a l s  a n d  v e n a  c a v a  u n d e r  
p e n t o b a r b i t a l  ( N a r c o r e n
®
)  a n e s t h e s i a .  T h e  l u n g s  o f  t h e  
a n i m a l s  w e r e  l a v a g e d  i n  s i t u  t w i c e  w i t h  6  m L  ( 2 2  m L /
k g  b o d y  w e i g h t )  o f  9  %  ( w / v )  s a l i n e  s o l u t i o n .  A  t o t a l  o f  
1 1  m L  B A L F  w a s  o b t a i n e d  p e r  a n i m a l  f o r  a n a l y s i s .  A l i -
q u o t s  o f  t h e  B A L F  w e r e  u s e d  f o r  t h e  d e t e r m i n a t i o n s  o f  
t o t a l  p r o t e i n  c o n c e n t r a t i o n ,  t o t a l  c e l l  c o u n t ,  d i f f e r e n -
t i a l  c e l l  c o u n t ,  a n d  a c t i v i t y  o f  t h e  e n z y m e s .  I n  t h e  s h o r t -
t e r m  s t u d y  w i t h  5  d a y s  o f  e x p o s u r e ,  B A L F  w a s  a n a l y z e d  
3  a n d  2 4  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e .  A f t e r  4  w e e k s  
o f  e x p o s u r e ,  l a v a g e d  l u n g s  a n d  a l i q u o t s  o f  t h e  B A L F  
( 1  m L )  w e r e  s t o r e d  a t  − 8 0  ° C  a n d  u s e d  f o r  t h e  d e t e r -
m i n a t i o n  o f  t h e  C e r  c o n t e n t  i n  t h e  l u n g  ( l u n g  b u r d e n )  1  
a n d  3 5  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e .  T o t a l  B A L F  c e l l  
c o u n t s  w e r e  d e t e r m i n e d  w i t h  a n  A D V I A
®
 1 2 0  ( S i e m e n s  
D i a g n o s t i c s ,  F e r n w a l d ,  G e r m a n y )  h e m a t o l o g y  a n a l y z e r .  
C o u n t s  o f  m a c r o p h a g e s ,  p o l y m o r p h o n u c l e a r  n e u t r o p h i l s  
( P M N ) ,  l y m p h o c y t e s ,  e o s i n o p h i l s ,  m o n o c y t e s ,  a n d  a t y p i -
c a l  c e l l s  w e r e  p e r f o r m e d  o n  W r i g h t - s t a i n e d  c y t o c e n t r i -
f u g e  s l i d e  p r e p a r a t i o n s  ( W a r h e i t  a n d  H a r t s k y  1 9 9 3 ) .  T h e  
d i f f e r e n t i a l  c e l l  c o u n t  w a s  e v a l u a t e d  m a n u a l l y  b y  c o u n t -
i n g  a t  l e a s t  4 0 0  B A L F  c e l l s  p e r  s a m p l e .  U s i n g  a  H i t a c h i  
9 1 7  ( R o c h e  D i a g n o s t i c s ,  M a n n h e i m ,  G e r m a n y )  r e a c t i o n  
r a t e  a n a l y z e r ,  l e v e l s  o f  B A L F  t o t a l  p r o t e i n  a n d  a c t i v i t i e s  
o f  l a c t a t e  d e h y d r o g e n a s e  ( L D H ) ,  a l k a l i n e  p h o s p h a t a s e  
( A L P ) ,  γ - g l u t a m y l t r a n s f e r a s e  ( G G T ) ,  a n d  N - a c e t y l - β -
g l u c o s a m i n i d a s e  ( N A G )  w e r e  m e a s u r e d .
C y t o k i n e s  a n d  c h e m o k i n e s  ( i n  B A L F  a n d  s e r u m )
C y t o k i n e s  a n d  c h e m o k i n e s  i n  B A L F  a n d  s e r u m  w e r e  m e a s -
u r e d  a t  R u l e s - b a s e d  M e d i c i n e  I n c . ,  A u s t i n ,  T X ,  U S A ,  w i t h  
x M A P  t e c h n o l o g y  ( L u m i n e x  C o r p . ,  A u s t i n ,  T X ,  U S A ) .  
T h e  m e a s u r e d  p a r a m e t e r s  c o m p r i s e d  v a r i o u s  c y t o k i n e s ,  
c h e m o k i n e s ,  a d h e s i o n  m o l e c u l e s ,  m a t r i x  m e t a l l o p r o t e i n -
a s e s ,  a c u t e - p h a s e  p r o t e i n s ,  s i g n a l  p r o t e i n s  o f  a p o p t o s i s ,  o r  
c e l l  p r o l i f e r a t i o n .  B r i e ﬂ y ,  a  l i s t  o f  p a r a m e t e r s  w a s  d e s c r i b e d  
p r e v i o u s l y  ( M a - H o c k  e t  a l .  2 0 0 9 ) .  A f t e r  e v a l u a t i o n  o f  t h e  
m o s t  s e n s i t i v e  p a r a m e t e r s  o r  r e a c t i o n  p a t t e r n s  i n  p r e v i o u s  
s t u d i e s ,  t h e  f o l l o w i n g  s t a n d a r d  p a r a m e t e r s  w e r e  c h o s e n  f o r  
c h a r a c t e r i z i n g  t h e  l u n g  i n ﬂ a m m a t i o n  i n  B A L F :
F i g .  1   S t u d y  d e s i g n  o f  s h o r t -
t e r m  s t u d i e s  w i t h  5  d a y s  a n d  
4  w e e k s  o f  e x p o s u r e
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•  R a t  m o n o c y t e  c h e m o a t t r a c t a n t  p r o t e i n - 1  l e v e l  ( r a t  
M C P - 1 ;  I n s t a n t  E L I S A ,  B e n d e r  M e d S y s t e m s ,  V i e n n a ,  
A u s t r i a  ( c a t .  n o  B M S 6 3 1 I N S T ) ;
•  R a t  c y t o k i n e - i n d u c e d  p o l y m o r p h o n u c l e a r  n e u t r o p h i l  
c h e m o a t t r a c t a n t - 1  l e v e l  ( r a t  C I N C - 1 / I L - 8 ;  E L I S A ,  R & D  
S y s t e m s  I n c . ,  M i n n e a p o l i s ,  U S A  ( Q u a n t i k i n e  r a t  C I N C -
1 ,  c a t .  n o .  R C N 1 0 0 ) ;
•  M a c r o p h a g e  c o l o n y - s t i m u l a t i n g  f a c t o r  ( M - C S F ;  Q u a n -
t i k i n e  M o u s e  M - C S F  E L I S A ,  R & D  S y s t e m s  I n c . ,  M i n -
n e a p o l i s ,  U S A  ( c a t  n o .  M M C 0 0 ) ;
•  R o d e n t  o s t e o p o n t i n ;  E L I S A ,  R & D  S y s t e m s ,  I n c . ,  M i n -
n e a p o l i s ,  U S  ( Q u a n t i k i n e  m o u s e  o s t e o p o n t i n ,  c a t .  n o .  
M O S T 0 0 ) .
•  T h e  c e l l  m e d i a t o r s  w e r e  m e a s u r e d  a t  a  s u n r i s e  M T P  
r e a d e r  ( T e c a n  A G ,  S w i t z e r l a n d )  b y  u s i n g  t h e  M a g e l l a n  
S o f t w a r e  p r o v i d e d  b y  t h e  i n s t r u m e n t  p r o d u c e r .  F o u r  
c h e m o k i n e s  a n d  c y t o k i n e s  w e r e  m e a s u r e d  u s i n g  E L I S A  
t e s t  k i t s :  M C P - 1 ,  I L - 8 / C I N C - 1 ,  M - C S F ,  a n d  o s t e o p o n -
t i n .  T h e  d e t a i l e d  p r o c e d u r e  w a s  d e s c r i b e d  p r e v i o u s l y  
( M a - H o c k  e t  a l .  2 0 0 9 ) .
P a t h o l o g y
I n  t h e  s h o r t - t e r m  s t u d i e s ,  n e c r o p s y  a n d  h i s t o p a t h o l o g y  
w e r e  p e r f o r m e d  a f t e r  5  d a y s  o f  e x p o s u r e  a n d  2 1  d a y s  a f t e r  
t h e  e n d  o f  e x p o s u r e  ( 5  d a y s  o f  e x p o s u r e )  a n d  2  a n d  3 4  d a y s  
a f t e r  t h e  e n d  o f  e x p o s u r e  ( 4  w e e k s  o f  e x p o s u r e ) .  I n  g e n e r a l ,  
ﬁ v e  a n i m a l s  p e r  t e s t  g r o u p  w e r e  i n v e s t i g a t e d  f o r  p a t h o l o g i -
c a l  e x a m i n a t i o n  i n  b o t h  s h o r t - t e r m  s t u d i e s .  F o r  t h e  s h o r t -
t e r m  s t u d y  w i t h  4  w e e k s  o f  e x p o s u r e ,  h o w e v e r ,  t e n  a n i m a l s  
w e r e  e x a m i n e d  f o r  p a t h o l o g i c a l  e x a m i n a t i o n  o f  t h e  r e s p i r a -
t o r y  t r a c t  a n d  a l l  g r o s s  l e s i o n s .  A t  n e c r o p s y ,  a n i m a l s  w e r e  
e x s a n g u i n a t e d  b y  o p e n i n g  o f  t h e  a b d o m i n a l  g r e a t  v e s s e l s  
u n d e r  d e e p  p e n t o b a r b i t a l  a n e s t h e s i a .  A l l  o r g a n s  w e r e  p r e -
s e r v e d  a c c o r d i n g  t o  O E C D  T G  N o .  4 1 2 .  F o l l o w i n g  o r g a n s  
w e r e  w e i g h e d :  a d r e n a l  g l a n d s ,  b r a i n ,  h e a r t ,  o v a r i e s ,  u t e r u s  
w i t h  c e r v i x ,  k i d n e y ,  l i v e r ,  l u n g s ,  s p l e e n ,  t h y m u s ,  a n d  t h y -
r o i d  g l a n d s .  T h e  l u n g s  w e r e  i n s t i l l e d  ( 3 0  c m  w a t e r  c o l u m n )  
w i t h  a n d  ﬁ x e d  i n  1 0  %  n e u t r a l - b u f f e r e d  f o r m a l i n  ( N B F ) .  
A f t e r  2 4 -  t o  4 8 - h  ﬁ x a t i o n  i n  1 0  %  N B F ,  t h e  l u n g s  w e r e  
t r a n s f e r r e d  t o  7 0  %  e t h a n o l .  A l l  o t h e r  o r g a n s  w e r e  ﬁ x e d  
i n  1 0  %  N B F .  A l l  t h e  o r g a n s  a n d  t i s s u e s  d e s c r i b e d  i n  t h e  
O E C D  T G  N o .  4 1 2  w e r e  t r i m m e d  a c c o r d i n g  t o  t h e  R I T A  
t r i m m i n g  g u i d e s  f o r  i n h a l a t i o n  s t u d i e s  ( K i t t e l  e t  a l .  2 0 0 4 ;  
R u e h l - F e h l e r t  e t  a l .  2 0 0 3 ) .  A f t e r  p a r a p l a s t - e m b e d d i n g ,  t h e  
b l o c k s  w e r e  c u t  a t  2 -  t o  3 - μ m  t h i c k n e s s ,  m o u n t e d  o n  g l a s s  
s l i d e s  a n d  s t a i n e d  w i t h  h e m a t o x y l i n  a n d  e o s i n .  E x t r a p u l -
m o n a r y  o r g a n s  a n d  t h e  r e s p i r a t o r y  t r a c t  c o m p r o m i s i n g  
n a s a l  c a v i t y  ( f o u r  l e v e l s ) ,  l a r y n x  ( t h r e e  l e v e l s ) ,  t r a c h e a  
( t r a n s v e r s e  a n d  l o n g i t u d i n a l  w i t h  c a r i n a ) ,  l u n g  ( ﬁ v e  l o b e s ) ,  
a n d  m e d i a s t i n a l  a n d  t r a c h e o b r o n c h i a l  l y m p h  n o d e s  w e r e  
a s s e s s e d  b y  l i g h t  m i c r o s c o p y .  F o r  t h e  l u n g s ,  w h o l e  h i s t o -
p a t h o l o g i c a l  e x a m i n a t i o n  w a s  p e r f o r m e d  i n  a n i m a l s  o f  a l l  
t e s t  g r o u p s .  F o r  a l l  o t h e r  t i s s u e s ,  o n l y  t h e  a n i m a l s  o f  t h e  
c o n t r o l  a n d  h i g h  c o n c e n t r a t i o n  g r o u p  o f  C e r i a  w e r e  i n i -
t i a l l y  e x a m i n e d .  W h e n  c h a n g e s  w e r e  o b s e r v e d  i n  t h e  h i g h  
c o n c e n t r a t i o n  g r o u p ,  r e s p e c t i v e  o r g a n s  a n d  t i s s u e s  o f  t h e  
a n i m a l s  e x p o s e d  t o  l o w  a n d  i n t e r m e d i a t e  a e r o s o l  c o n c e n -
t r a t i o n s  w e r e  a l s o  e x a m i n e d  b y  l i g h t  m i c r o s c o p y .  A l l  h i s -
t o p a t h o l o g i c a l  e x a m i n a t i o n s  w e r e  p e r f o r m e d  b y  a  w e l l -
e x p e r i e n c e d  b o a r d - c e r t i ﬁ e d  v e t e r i n a r i a n  t o x i c o p a t h o l o g i s t  
f o l l o w e d  b y  a n  i n t e r n a l  p a t h o l o g y  p e e r  r e v i e w .
O r g a n  b u r d e n  a n a l y s i s
L u n g  b u r d e n  o f  t h e  t w o  d i f f e r e n t  C e r i a  w a s  e v a l u a t e d  
t w i c e ,  i m m e d i a t e l y  a f t e r  5  d a y s  o f  e x p o s u r e  a n d  a f t e r  
2 1  d a y s  a f t e r  t h e  e x p o s u r e  e n d .  I n  t h e  s h o r t - t e r m  s t u d y  w i t h  
4  w e e k s  o f  e x p o s u r e ,  C e r i u m  c o n t e n t  w a s  d e t e r m i n e d  a t  
s e v e n  t i m e  p o i n t s  o v e r  1 2 9  d a y s  o f  p o s t - e x p o s u r e  p e r i o d .  
C e r i u m  c o n t e n t  i n  t h e  l u n g s ,  l u n g - a s s o c i a t e d  l y m p h  n o d e s ,  
a n d  l i v e r  o f  e i t h e r  t h r e e  o r  ﬁ v e  a n i m a l s  p e r  t e s t  g r o u p  w e r e  
e x a m i n e d .  1  a n d  3 5  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e  ( 4  w e e k s  
o f  e x p o s u r e ) ,  t h e  l a v a g e d  l u n g s  a n d  a l i q u o t s  o f  B A L F  o f  
ﬁ v e  a n i m a l s  p e r  g r o u p  w e r e  u s e d  f o r  t h e  d e t e r m i n a t i o n  o f  
l u n g  b u r d e n .  T h i s  e x a m i n a t i o n  m e t h o d  h a s  l i k e l y  c a u s e d  a  
l o s s  o f  t h e  t e s t  m a t e r i a l  d u r i n g  p r e p a r a t i o n  a n d  h a n d l i n g  o f  
t h e  l u n g s .  F u r t h e r m o r e ,  l u n g  b u r d e n s  w e r e  m e a s u r e d  2  d a y s  
a f t e r  t h e  e n d  o f  e x p o s u r e  u s i n g  t h e  l e f t  h a l f  l u n g s  o f  ﬁ v e  
a n i m a l s / t e s t  g r o u p ,  o n l y .  O n  t h e  b a s i s  o f  t h e  a v a i l a b i l i t y  o f  
t o t a l  l u n g  w e i g h t s ,  l u n g  b u r d e n s  w e r e  c a l c u l a t e d  u p  f r o m  
t h e  h a l f  l u n g  b u r d e n  v a l u e s  w i t h  t h e  c o r r e s p o n d i n g  w e i g h t  
o f  t h e  h a l f  l u n g s .  L u n g  b u r d e n  o f  t h e  r e m a i n i n g  t i m e  p o i n t s  
w a s  d e t e r m i n e d  u s i n g  t h e  w h o l e  ( n o t  l a v a g e d )  l u n g .  A f t e r  
d i g e s t i o n  w i t h  m i x e d  a c i d ,  s a m p l e s  o f  e a c h  l u n g  o r  l y m p h  
n o d e  w e r e  d i s s o l v e d  i n  s u l f u r i c  a c i d  a n d  a m m o n i u m  s u l -
f a t e .  
1 4 0
C e r  c o n t e n t  i n  t h e  o b t a i n e d  s o l u t i o n  w a s  a n a l y z e d  
b y  i n d u c t i v e l y  c o u p l e d  p l a s m a  m a s s  s p e c t r o m e t r y  ( I C P -
M S ,  A g i l e n t  7 5 0 0  C )  o r  b y  i n d u c t i v e l y  c o u p l e d  p l a s m a  
o p t i c a l  e m i s s i o n  s p e c t r o m e t r y  ( I C P - O E S ,  V a r i a n  7 2 0 - E S )  
w i t h  a  w a v e l e n g t h  o f  4 1 9  n m .  W i t h  t h i s  m e t h o d ,  l i m i t  o f  
d e t e c t i o n  f o r  C e r  i s  0 . 3  μ g .  T h e  a m o u n t s  o f  C e r i a  i n  t h e  
r e s p e c t i v e  t i s s u e s  w e r e  c a l c u l a t e d  b y  m e a s u r i n g  e l e m e n t a l  
C e r i u m  w i t h  I C P - M S .
S t a t i s t i c a l  a n a l y s i s
F o r  b o d y  w e i g h t  c h a n g e s ,  D u n n e t t ’ s  t e s t  w a s  u s e d  f o r  a  
c o m p a r i s o n  o f  e a c h  t e s t  g r o u p  w i t h  t h e  c o n t r o l  g r o u p  t e s t  
( D u n n e t t  1 9 5 5 ;  D u d e w i c z  e t  a l .  1 9 7 5 ) .  C l i n i c a l  p a t h o l o g y  
p a r a m e t e r s  ( B A L F  c y t o l o g y ,  e n z y m e  d a t a ,  a n d  B A L F  a n d  
s e r u m  c e l l  m e d i a t o r  d a t a )  w e r e  a n a l y z e d  b y  n o n p a r a m e t -
r i c  o n e - w a y  a n a l y s i s  u s i n g  t h e  K r u s k a l – W a l l i s  t e s t  ( t w o -
s i d e d ) .  I f  t h e  r e s u l t i n g  p  v a l u e  w a s  ≤ 0 . 0 5 ,  a  p a i r - w i s e  
c o m p a r i s o n  o f  e a c h  t e s t  g r o u p  w i t h  t h e  c o n t r o l  g r o u p  w a s  
p e r f o r m e d  u s i n g  t h e  W i l c o x o n  t e s t  o r  t h e  M a n n – W h i t n e y  U  
4 0
P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
A r c h  T o x i c o l  
1  3
t e s t  ( b o t h  t w o - s i d e d )  ( p  ≤  0 . 0 5  f o r  s t a t i s t i c a l  s i g n i ﬁ c a n c e ) .  
C o m p a r i s o n  o f  o r g a n  w e i g h t s  a m o n g  t e s t  g r o u p s  w a s  p e r -
f o r m e d  b y  n o n p a r a m e t r i c  o n e - w a y  a n a l y s i s  u s i n g  t h e  t w o -
s i d e d  K r u s k a l – W a l l i s  t e s t ,  f o l l o w e d  b y  a  t w o - s i d e d  W i l -
c o x o n  t e s t  f o r  t h e  h y p o t h e s i s  o f  e q u a l  m e d i a n s  i n  c a s e  o f  
p  ≤  0 . 0 5 .
R e s u l t s
C h a r a c t e r i z a t i o n  o f  t e s t  m a t e r i a l
B o t h  C e r i a  w e r e  y e l l o w i s h  w h i t e  p o w d e r s  t h a t  w e r e  p r o -
d u c e d  b y  p r e c i p i t a t i o n  a n d  w e r e  n o m i n a l l y  u n c o a t e d .  
W e  c o m p l e t e l y  r e - c h a r a c t e r i z e d  t h e  C e r i a  N M - 2 1 1  a n d  
N M - 2 1 2  b a s e d  o n  t h e  n a n o - s p e c i ﬁ c  g u i d a n c e  o n  p h y s i c a l –
c h e m i c a l  p r o p e r t i e s  ( W o h l l e b e n  e t  a l .  2 0 1 3 ) .  T a b l e  1  i n d i -
c a t e s  t h e  t e c h n i q u e s  c h o s e n  f o r  e a c h  e n d  p o i n t  ( s e e  “ M a t e -
r i a l s  a n d  m e t h o d s ”  s e c t i o n )  a n d  s u m m a r i z e s  t h e  r e s u l t s .  
T h e  C e r i a  N M - 2 1 2  m a t e r i a l  h a d  a n  a v e r a g e  p r i m a r y  p a r t i -
c l e  d i a m e t e r  o f  4 0  n m ,  i n  e x c e l l e n t  a c c o r d a n c e  o f  e l e c t r o n  
m i c r o s c o p y  w i t h  t h e  c r y s t a l l i t e  s i z e  d e r i v e d  f r o m  t h e  d i f -
f r a c t i o n  p e a k  w i d t h  a n d  w i t h  t h e  s p h e r e - e q u i v a l e n t  d i a m -
e t e r  d e r i v e d  f r o m  t h e  B E T - s p e c i ﬁ c  s u r f a c e  a r e a  o f  2 7  m
2
/ g  
( s e e  F i g .  2 ) .  T h e  C e r i a  N M - 2 1 1  m a t e r i a l  c o n s i s t e d  o f  c o n -
s i d e r a b l y  s m a l l e r  p r i m a r y  p a r t i c l e s  w i t h  n u m b e r - b a s e d  
m e d i a n  d i a m e t e r  o f  8 . 2  n m  ( f r o m  T E M )  a n d  c o r r e s p o n d -
i n g l y  l a r g e r  s p e c i ﬁ c  s u r f a c e  ( 5 3  m
2
/ g ,  f r o m  B E T ) .  P r i m a r y  
p a r t i c l e s  o f  b o t h  m a t e r i a l s  w e r e  c r y s t a l l i n e  w i t h  c u b i c  l a t -
t i c e  a s  i t  i s  t h e  c h a r a c t e r i s t i c  f o r  c e r i a n i t e  a n d  h a d  i r r e g u l a r ,  
b u t  r o u g h l y  g l o b u l a r  s h a p e s .  I n  t h e  a s - p r o d u c e d  p o w d e r ,  
p o r o s i m e t r y  b y  H g  i n t r u s i o n  i n d i c a t e d  t h a t  t h e s e  p a r t i c l e s  
w e r e  a g g r e g a t e d  a n d  a g g l o m e r a t e d  t o  s i z e s  t h a t  r a n g e  f r o m  
a  f e w  h u n d r e d  n m  t o  t e n s  o f  μ m .
T h e  s u r f a c e  o f  C e r i a  N M - 2 1 2  b e a r e d  o r g a n i c  c o n t a m i -
n a t i o n s .  A n  a s s e s s m e n t  b y  t h e r m o g r a v i m e t r y  ( T G A )  c o n -
ﬁ r m e d  t h a t  t h e  t o t a l  o r g a n i c  c o n t e n t  r e m a i n e d  b e l o w  0 . 7  % ,  
b u t  t h e  p h o t o e l e c t r o n  s i g n a l  o f  X P S ,  w h i c h  h a d  a n  i n f o r -
m a t i o n  d e p t h  b e t w e e n  3  a n d  1 0  n m ,  i n d i c a t e d  8 0  %  c a r b o n  
a t o m s  o n  t h e  s u r f a c e .  T h e  c o n t a m i n a t i o n  w a s  h e n c e  a  v e r y  
t h i n  a n d  h o m o g e n e o u s  l a y e r  a r o u n d  t h e  p u r e l y  i n o r g a n i c  
p a r t i c l e s .  A c c o r d i n g  t o  t h e  ﬁ t  o f  p h o t o e l e c t r o n  e n e r g i e s  
f r o m  C ( 1 s )  l e v e l  a n d  f r o m  O ( 1 s )  l e v e l ,  t h e  c o n t a m i n a t i o n  
c o u l d  b e  a n  e s t e r  w i t h  a  l o n g  a l k y l  c h a i n .  I n  c o n t r a s t ,  t h e  
C e r i a  N M - 2 1 1  h a d  o n l y  1 4  %  c a r b o n  a t o m s  o n  t h e  s u r f a c e  
( b y  X P S ) ,  a n d  t h e  e v e n  m o r e  s e n s i t i v e  S I M S  t e c h n i q u e s  
c o n ﬁ r m e d  t h a t  C e r i a  d o m i n a t e d  t h e  s u r f a c e ,  w i t h  v a n i s h -
i n g  a m o u n t s  o f  n i t r a t e s  a n d  a l k y l s .  T h e  C e r i u m  a t o m s  a t  
c r y s t a l l i n e  e d g e s  w e r e  k n o w n  t o  b e  r e d o x - a c t i v e ,  w h i c h  
w a s  c o n ﬁ r m e d  b y  t h e  d e t e c t i o n  o f  1 4  %  o f  t h e  C e r i u m  a s  
C e ( I I I )  ( w i t h i n  t h e  X P S - a c c e s s i b l e  s u r f a c e  l a y e r )  i n  C e r i a  
N M - 2 1 2 ,  r e s p e c t i v e l y ,  2 2  %  f o r  t h e  C e r i a  N M - 2 1 1  w i t h  i t s  
d e c r e a s e d  r a d i u s  o f  c u r v a t u r e .
I f  d i s p e r s e d  i n  c l e a n  w a t e r ,  t h e  C e r i a  N M - 2 1 2  s u r f a c e  
w a s  p o s i t i v e l y  c h a r g e d  a c r o s s  t h e  e n t i r e  p h y s i o l o g i c a l  p H  
r a n g e ,  w i t h  a  z e t a - p o t e n t i a l  o f  + 4 2  m V  a t  p H  7 .  T h e  s u r -
f a c e  o f  C e r i a  N M - 2 1 2  w a s  r a t h e r  r e a c t i v e  i n  a  p h o t o c a t a -
l y t i c  a s s a y  w i t h  a  p h o t o n  e f ﬁ c i e n c y  o f  1 . 3  ×  1 0
− 2
,  w h i c h  
w a s  5  t i m e s  h i g h e r  t h a n  t h e  w e l l - k n o w n  T i t a n i a  P 2 5  ( N M -
1 0 5 )  a n d  a n  o r d e r  o f  m a g n i t u d e  h i g h e r  t h a n  f o r  t h e  C e r i a  
N M - 2 1 1 ,  l e a v i n g  t h e  p o s s i b i l i t y  o f  t h e  o r g a n i c  c o n t a m i n a -
t i o n s  b e i n g  r e s p o n s i b l e  f o r  t h a t  c a t a l y t i c  a c t i v i t y ,  o b s e r v e d  
o n l y  u n d e r  U V  i r r a d i a t i o n  ( W o h l l e b e n  e t  a l .  2 0 1 3 ;  M o l i n a  
e t  a l .  2 0 1 4 ) .  A f t e r  d i s p e r s i o n  i n  w a t e r  b y  s t i r r i n g  o n l y ,  t h e  
d i s p e r s a b i l i t y  w a s  l i m i t e d  w i t h  a v e r a g e  a g g l o m e r a t i o n  
n u m b e r s  ( A A N  =  t h e  r a t i o  o f  a g g l o m e r a t e  d i a m e t e r  t o  p r i -
m a r y  p a r t i c l e  d i a m e t e r )  a b o v e  1 0 ,  b a s e d  o n  t h e  m e a s u r e -
m e n t  o f  t h e  r e s u l t i n g  a g g l o m e r a t e s  t h a t  w e r e  j u s t  b e l o w  t h e  
m i c r o n  r a n g e  ( b y  a n a l y t i c a l  u l t r a c e n t r i f u g a t i o n ) ,  a n d  t e n d e d  
t o  b e  l a r g e r  f o r  t h e  C e r i a  N M - 2 1 1  t h a n  f o r  N M - 2 1 2 ,  c o n -
ﬁ r m i n g  e a r l i e r  ﬁ n d i n g s  o f  t h e  P R O S P E C T  c o n s o r t i u m  a n d  
t h e  E u r o p e a n  C o m m i s s i o n ’ s  J R C  r e p o r t  ( H e r m a n s  1 9 6 3 ;  
P R O S P E c T :  E c o t o x i c o l o g y  T e s t  P r o t o c o l s  f o r  R e p r e s e n t a -
t i v e  N a n o m a t e r i a l s  i n  S u p p o r t  o f  t h e  O E C D S p o n s o r s h i p  
P r o g r a m m e  1 0  A . D . ;  E u r o p e a n  C o m m i s s i o n  2 0 1 4 ) .
T h e  s o l u b i l i t y  i n  p h y s i o l o g i c a l  m e d i a  w a s  i n v e s t i g a t e d  
b y  2 8 - d a y  a b i o t i c  i n c u b a t i o n  i n  d i f f e r e n t  ﬂ u i d s  a n d  d e t e c -
t i o n  o f  b o t h  t h e  r e m a i n i n g  p a r t i c u l a t e  f r a c t i o n  ( b y  S E M ,  
c e n t r i f u g a t i o n ,  L D ,  z e t a - p o t e n t i a l )  a n d  o f  t h e  r e l e a s e d  
m e t a l  i o n s  ( b y  I C P - M S ) .  B o t h  C e r i a  w e r e  i n s o l u b l e  e x c e p t  
f o r  m a r g i n a l  s o l u b i l i t y  i n  0 . 1  N  H C l  ( s i m u l a t e  o r a l  i n g e s -
t i o n ) ,  w h e r e a s  a  n a n o s c a l e  p r e c i p i t a t e d  S i l i c a  a s  p o s i t i v e  
c o n t r o l  d i s s o l v e d  r e a d i l y  a n d  T i t a n i a  ( N M - 1 0 5 )  s h o w e d  
m a r g i n a l  s o l u b i l i t y  i n  p h a g o l y s o s o m a l  s i m u l a n t  ﬂ u i d  ( P S F ,  
s i m u l a t e  u p t a k e  a n d  d i g e s t i o n  i n  m a c r o p h a g e s )  ( W o h l l e -
b e n  e t  a l .  2 0 1 3 ) .  I n  b u f f e r s  w i t h  o r g a n i c  c o n s t i t u e n t s  ( P S F ,  
f a s t e d  s t a t e  s i m u l a t e d  i n t e s t i n a l  ﬂ u i d  =  F a S S I F ) ,  t h e  s u r -
f a c e  c h a r g e  r e v e r s e d  t o  n e g a t i v e  z e t a - p o t e n t i a l s ,  w h i c h  
w a s  i d e n t i ﬁ e d  e a r l i e r  a s  i n d i c a t o r  f o r  t h e  a d s o r p t i o n  o f  
c o n s t i t u e n t s  o f  t h e  b u f f e r  f o r  a  r a n g e  o f  t h e  n a n o - C e r i a  
( W o h l l e b e n  e t  a l .  2 0 1 3 ) .  U n d e r  a l l  c o n d i t i o n s ,  p r i m a r y  p a r -
t i c l e s  r e m a i n e d  r e c o g n i z a b l e  i n  T E M  s c a n s ,  b u t  b o t h  C e r i a  
N M - 2 1 1  a n d  N M - 2 1 2  f o r m e d  l a r g e  s t r u c t u r e s  a f t e r  2 8 - d a y  
i n c u b a t i o n  i n  t h e  a c i d i c  P S F  m e d i u m  t h a t  s i m u l a t e s  t h e  l y s -
o s o m e  o f  m a c r o p h a g e s  ( s e e  F i g .  3 ) .  W e  f o u n d  b y  s e l e c t e d  
a r e a  e l e c t r o n  d i f f r a c t i o n  ( S A D )  t h a t  t h e s e  a g e d  s t r u c t u r e s  
r e t a i n e d  t h e  s a m e  c u b i c  c e r i a n i t e  c r y s t a l l i n e  p h a s e  o f  t h e  
a s - p r o d u c e d  p o w d e r  f o r  b o t h  C e r i a  N M - 2 1 1  a n d  N M - 2 1 2 .  
U n d e r  i d e n t i c a l  c o n d i t i o n s ,  a l s o  o t h e r  n a n o m a t e r i a l s ,  e . g . ,  
t h e  T i t a n i a  ( N M - 1 0 5 ) ,  a g e d  i n t o  s i m i l a r  s t r u c t u r e s ,  a n d  
w e  a d d e d  t h e  r e s p e c t i v e  T E M  a n d  S A D  f o r  c o m p a r i s o n  
( W o h l l e b e n  e t  a l .  2 0 1 3 ) .
T o  s u m m a r i z e  t h e  c o m p a r a t i v e  p h y s i c a l – c h e m i c a l  
c h a r a c t e r i z a t i o n ,  C e r i a  N M - 2 1 1  a n d  N M - 2 1 2  h a d  i d e n t i -
c a l  c o m p o s i t i o n ,  a g g l o m e r a t i o n  s t a t e ,  c r y s t a l l i n i t y ,  a n d  
i n s o l u b i l i t y .  C o m p a r e d  t o  N M - 2 1 2 ,  t h e  C e r i a  N M - 2 1 1  
4 1
P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a








































































































































































































































































































































































































































































































































































































































































































































































P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
A r c h  T o x i c o l  
1  3
h a d  c o n s i d e r a b l y  s m a l l e r  p r i m a r y  p a r t i c l e s ,  l a r g e r  s p e c i ﬁ c  
s u r f a c e ,  s i g n i ﬁ c a n t l y  f e w e r  o r g a n i c  c o n t a m i n a t i o n s  o n  t h e  
s u r f a c e ,  a n d  m u c h  r e d u c e d  p h o t o c a t a l y t i c  a c t i v i t y .  D e s p i t e  
t h e s e  d i f f e r e n c e s ,  C e r i a  N M - 2 1 1  a n d  N M - 2 1 2  s h a r e d  t h e  
s a m e  t e n d e n c y  t o  r e c r y s t a l l i z e  i n  P S F .
C h a r a c t e r i z a t i o n  o f  t e s t  a t m o s p h e r e
T h e  t a r g e t  c o n c e n t r a t i o n s  w e r e  0 . 5 ,  5 ,  a n d  2 5  m g / m
3
 i n  t h e  
s h o r t - t e r m  s t u d i e s  ( 5  d a y s  a n d  4  w e e k s  o f  e x p o s u r e )  w i t h  
n a n o - C e r i a  N M - 2 1 2 .  I n  t h e  s t u d y  w i t h  5  d a y s  o f  e x p o s u r e ,  
F i g .  2   S t r u c t u r e  o f  C e r i a .  
E l e c t r o n  m i c r o s c o p y  i m a g e s  
o f  a  r e p r e s e n t a t i v e  e n s e m b l e  o f  
p a r t i c l e s  o f  C e r i a  N M - 2 1 1  ( a )  
a n d  N M - 2 1 2  ( b )  ( s e e  T a b l e  1  
f o r  s i z e  c h a r a c t e r i z a t i o n  b y  
c o m p l e m e n t a r y  m e t h o d s )
F i g .  3   P e r s i s t e n c e  o f  C e r i a  N M - 2 1 1  ( a ) ,  N M - 2 1 2  ( b ) ,  a n d  T i t a n i a  
N M - 1 0 5  ( c )  a s  b e n c h m a r k .  T r a n s m i s s i o n  e l e c t r o n  m i c r o s c o p y  ( T E M )  
a n d  s e l e c t e d  a r e a  d i f f r a c t i o n  ( S A D )  a f t e r  2 8 - d a y  i n c u b a t i o n  i n  p h a g o -
l y s o s o m a l  s i m u l a n t  ﬂ u i d  ( P S F )  [ s e e  T a b l e  1  f o r  d i s s o l u t i o n  d e t e c t e d  
b y  i o n s  i n  t h e  s u p e r n a t a n t  ( I C P - M S ) ] .  T h e  l a r g e  a l m o s t  s p h e r i c a l  
s t r u c t u r e s  a r e  n o  c o n t a m i n a t i o n s ,  b u t  a r e  c o n ﬁ r m e d  a s  C e r i a  i n  t h e  
s a m e  c r y s t a l l i n e  p h a s e
4 3
P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
 A r c h  T o x i c o l
1  3
0 . 5  a n d  2 5  m g / m
3
 w e r e  s e l e c t e d  f o r  n a n o - C e r i a  N M - 2 1 1 .  
A n a l y z e d  c o n c e n t r a t i o n s  a n d  p a r t i c l e  s i z e  d i s t r i b u t i o n s  a r e  
s u m m a r i z e d  i n  T a b l e  2 .  T h e  t a r g e t  c o n c e n t r a t i o n s  w e r e  m e t  
a n d  m a i n t a i n e d  w e l l  t h r o u g h o u t  t h e  s t u d i e s .  P a r t i c l e  s i z e  
d i s t r i b u t i o n  d e m o n s t r a t e d  t h a t  C e r i a  p a r t i c l e s  w e r e  i n  t h e  
r e s p i r a b l e  r a n g e  f o r  r a t s .
C l i n i c a l  e x a m i n a t i o n
F i v e  d a y s  a n d  4  w e e k s  o f  i n h a l a t i o n  e x p o s u r e  t o  C e r i a  
N M - 2 1 2  a n d  N M - 2 1 1  d i d  n o t  a f f e c t  t h e  b o d y  w e i g h t  d e v e l -
o p m e n t  o f  t h e  a n i m a l s  ( d a t a  n o t  s h o w n ) .  T h e  a n i m a l s  e x p o s e d  
t o  C e r i a  N M - 2 1 1  a n d  N M - 2 1 2  s h o w e d  n o  c l i n i c a l  s i g n s  o r  
ﬁ n d i n g s  c o m p a r e d  t o  t h e  c o n t r o l  a n i m a l s  ( d a t a  n o t  s h o w n ) .
H e m a t o l o g y ,  c l i n i c a l  c h e m i s t r y ,  c y t o k i n e s ,  a n d  c h e m o k i n e s  
i n  s e r u m
F i v e  d a y s  o f  e x p o s u r e
A b s o l u t e  a n d  r e l a t i v e  n e u t r o p h i l  c o u n t s  i n  b l o o d  w e r e  
i n c r e a s e d  3  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e  t o  2 5  m g / m
3
 
C e r i a  N M - 2 1 2  a n d  N M - 2 1 1 ,  w h e r e a s  r e l a t i v e  l y m p h o c y t e  
c o u n t s  w e r e  d e c r e a s e d  ( s e e  T a b l e  S 2 ) .  T h e  c h a n g e s  w e r e  
i n  a  c o n c e n t r a t i o n - r e l a t e d  m a n n e r .  2 4  d a y s  a f t e r  t h e  e n d  o f  
e x p o s u r e ,  a l l  p a r a m e t e r s  h a d  r e t u r n e d  t o  n e a r  c o n t r o l  v a l -
u e s .  N o  o t h e r  b l o o d  p a r a m e t e r s  w e r e  a f f e c t e d .
F o u r  w e e k s  o f  e x p o s u r e
H e m a t o l o g i c a l ,  c l i n i c a l  c h e m i s t r y  p a r a m e t e r s ,  a n d  a c u t e -
p h a s e  p r o t e i n  l e v e l s  w e r e  n o t  a f f e c t e d  i n  r a t s  e x p o s e d  t o  
C e r i a  N M - 2 1 2  ( s e e  T a b l e  S 2 ;  t h e  o t h e r  d a t a  a r e  n o t  s h o w n ) .
S y s t e m i c  g e n o t o x i c i t y  ( m i c r o n u c l e u s  t e s t )
M i c r o n u c l e i  i n  t h e  e r y t h r o c y t e s  o f  p e r i p h e r a l  b l o o d  c e l l s  
w e r e  c o u n t e d  t o  a s s e s s  c h r o m o s o m a l  a b e r r a t i o n s  o f  
h e m a t o p o i e t i c  c e l l s  i n  t h e  b o n e  m a r r o w .  P e r i p h e r a l  b l o o d  
c e l l s  w e r e  e x a m i n e d  i n  t h e  s h o r t - t e r m  s t u d i e s  w i t h  5  d a y s  
a n d  4  w e e k s  o f  e x p o s u r e  ( 3  a n d  2  d a y s  a f t e r  t h e  e n d  o f  
e x p o s u r e ,  r e s p e c t i v e l y ) .  A l l  e x a m i n e d  p a r a m e t e r s  w e r e  i n  
t h e  r a n g e  o f  c o n t r o l  v a l u e s  ( s e e  T a b l e  S 3 ) .
B r o n c h o a l v e o l a r  l a v a g e  ( B A L )
I n  t h e  s h o r t - t e r m  s t u d i e s  w i t h  5  d a y s  a n d  4  w e e k s  o f  e x p o -
s u r e ,  B A L F  a n a l y s i s  o f  ﬁ v e  a n i m a l s  p e r  t e s t  g r o u p  w a s  
o b t a i n e d  3  d a y s  o r  1  d a y  a f t e r  t h e  e n d  o f  e x p o s u r e  a n d  2 4  o r  
3 5  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e ,  r e s p e c t i v e l y  ( s e e  F i g .  1 ) .  
T h e  r e s u l t i n g  B A L F  p a r a m e t e r s  a r e  p r e s e n t e d  i n  T a b l e  3 .
F i v e  d a y s  o f  e x p o s u r e
I n  a n i m a l s  e x p o s e d  t o  C e r i a  N M - 2 1 2 ,  t h e  m a j o r i t y  o f  
B A L F  p a r a m e t e r s  w e r e  i n c r e a s e d  a t  a e r o s o l  c o n c e n t r a -
t i o n s  o f  5  m g / m
3
.  A t  0 . 5  m g / m
3
,  t h e  n e u t r o p h i l  c o u n t s  a n d  
c y t o k i n e - i n d u c e d  n e u t r o p h i l  c h e m o a t t r a c t a n t - 1  ( C I N C - 1 )  
w e r e  b o t h  s t a t i s t i c a l l y  i n c r e a s e d  a n d  w e r e  s l i g h t l y  a b o v e  
t h e  h i s t o r i c a l  c o n t r o l  r a n g e  ( s e e  T a b l e  S 4 ) .  W i t h  C e r i a  
N M - 2 1 1 ,  b u t  n o t  N M - 2 1 2 ,  m o n o c y t e  c h e m o a t t r a c t a n t  p r o -
t e i n - 1  ( M C P - 1 )  a n d  m a c r o p h a g e  c o l o n y - s t i m u l a t i n g  f a c -
t o r  ( M - C S F )  w e r e  i n c r e a s e d  a t  a e r o s o l  c o n c e n t r a t i o n s  o f  
0 . 5  m g / m
3
 a n d  a b o v e .  2 4  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e ,  
a  f u l l  r e c o v e r y  w a s  o b s e r v e d  a t  a e r o s o l  c o n c e n t r a t i o n s  o f  
0 . 5  m g / m
3
 a n d  a  p a r t i a l  r e c o v e r y  a t  a e r o s o l  c o n c e n t r a t i o n s  
o f  5  a n d  2 5  m g / m
3
.  T h e  r e c o v e r y  o f  a n i m a l s  e x p o s e d  t o  
2 5  m g / m
3
 C e r i a  N M - 2 1 1  s e e m s  t o  b e  s l o w e r  t h a n  t h o s e  
e x p o s e d  t o  N M - 2 1 2 .
4  w e e k s  o f  e x p o s u r e
F o u r  w e e k s  o f  i n h a l a t i o n  e x p o s u r e  t o  5  a n d  2 5  m g / m
3
 C e r i a  
N M - 2 1 2  r e s u l t e d  i n  a n  i n c r e a s e  i n  t o t a l  c e l l s  i n  B A L F  d u e  
t o  i n c r e a s e s  i n  p o l y m o r p h  n u c l e a r  n e u t r o p h i l s ,  l y m p h o -
c y t e s ,  a n d  m o n o c y t e s  i n  B A L F  ( s e e  T a b l e  3 ) .  C o n s i s t e n t  
T a b l e  2   M e a s u r e d  c o n c e n t r a t i o n s  a n d  p a r t i c l e  s i z e  d i s t r i b u t i o n s  o f  C e r i a
S t u d y T e s t   
s u b s t a n c e
T a r g e t e d   
c o n c e n t r a t i o n s  
( m g / m
3
)
M e a s u r e d   
c o n c e n t r a t i o n s  
m e a n  ±  S D  ( m g / m
3
)
M M A D  ( μ m ) /  
G S D  m e a n
P a r t i c l e  c o u n t   
c o n c e n t r a t i o n  m e a s u r e d   
b y  S M P S  ( p a r t i c l e / c m
3
)
P a r t i c l e  c o u n t  
m e d i a n  ( n m )
5  d a y s  o f  
e x p o s u r e
C e r i a  N M - 2 1 2 0 . 5 0 . 5  ±  0 . 2 1 . 4 / 2 . 3 2 , 5 8 3 2 8 3
5 5 . 3  ±  0 . 9 1 . 2 / 2 . 1 1 3 7 , 0 9 6 2 0 6
2 5 2 5 . 9  ±  6 . 0 1 . 0 / 2 . 5 5 3 7 , 5 4 8 1 7 1
C e r i a  N M - 2 1 1 0 . 5 0 . 4 8  ±  0 . 0 1 . 6 / 2 . 1 5 , 6 8 9 2 5 6
2 5 5 . 2  ±  1 . 1 1 . 3 / 2 . 1 8 4 , 6 5 5 1 6 7
4  w e e k s  o f  
e x p o s u r e
C e r i a  N M - 2 1 2 0 . 5 2 5 . 6  ±  6 . 0 0 . 9 / 2 . 5 5 1 4 , 1 9 3 2 0 3
5 0 . 4 5  ±  0 . 1 1 . 9 / 2 . 9 1 , 5 0 3 2 4 2
2 5 2 5 . 8  ±  1 . 7 2 . 2 / 2 . 4 1 6 0 , 1 6 2 1 8 8
4 4
P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
A r c h  T o x i c o l  
1  3
w i t h  t h e s e  ﬁ n d i n g s ,  s e v e r a l  o t h e r  p a r a m e t e r s  i n c l u d i n g  t h e  
e x a m i n e d  c e l l  m e d i a t o r s  w e r e  i n c r e a s e d .  3 5  d a y s  a f t e r  t h e  
e n d  o f  e x p o s u r e ,  s o m e  o f  t h e  B A L F  p a r a m e t e r s  r e t u r n e d  t o  
c o n t r o l  l e v e l s ,  w h e r e a s  s e v e r a l  o f  t h e m  w e r e  s t i l l  s i g n i ﬁ -
c a n t l y  i n c r e a s e d  a t  5  a n d  2 5  m g / m
3
 ( e . g . ,  t o t a l  c e l l s ,  l y m -
p h o c y t e s ,  n e u t r o p h i l s ;  G G T ,  L D H ,  A L P ;  M C P - 1 ,  C I N C - 1 ) .
F i v e  d a y s  o f  e x p o s u r e  c a u s e d  s l i g h t l y  h i g h e r  n e u t r o p h i l  
a n d  l y m p h o c y t e  c o u n t s  a t  a e r o s o l  c o n c e n t r a t i o n s  o f  2 5  m g /
m
3
 C e r i a  N M - 2 1 2  c o m p a r e d  t o  4  w e e k s  o f  e x p o s u r e  ( s e e  
F i g .  4 ) .  C I N C - 1  w a s  a l r e a d y  i n c r e a s e d  a t  0 . 5  m g / m
3
 a f t e r  
5  d a y s  b u t  n o t  a f t e r  4  w e e k s  o f  e x p o s u r e .  T h e  r e g r e s s i o n  
o f  t h e  B A L F  p a r a m e t e r s  w a s  f a s t e r  a f t e r  5  d a y s  t h a n  a f t e r  
4  w e e k s  o f  i n h a l a t i o n  e x p o s u r e .  C e l l  m e d i a t o r s ,  e s p e c i a l l y  
M C P - 1 ,  w e r e  h i g h e r  e l e v a t e d  a t  c o n c e n t r a t i o n s  o f  5  a n d  
2 5  m g / m
3
 a f t e r  4  w e e k s  t h a n  a f t e r  5  d a y s  o f  e x p o s u r e .
P a t h o l o g y
O r g a n  w e i g h t s  a n d  m a c r o s c o p i c  ﬁ n d i n g s
F i v e  d a y s  o f  e x p o s u r e  A f t e r  5  d a y s  o f  e x p o s u r e ,  n o  
i n c r e a s e  i n  l u n g  w e i g h t s  w a s  o b s e r v e d  a f t e r  e x p o s u r e  t o  
C e r i a  N M - 2 1 2  ( s e e  T a b l e  S 5 ) .  A n  a e r o s o l  c o n c e n t r a t i o n  o f  
2 5  m g / m
3
 C e r i a  N M - 2 1 1 ,  h o w e v e r ,  r e s u l t e d  i n  s i g n i ﬁ c a n t  
i n c r e a s e s  i n  a b s o l u t e  a n d  r e l a t i v e  l u n g  w e i g h t s  ( + 2 0  a n d  
2 4  % ,  r e s p e c t i v e l y ,  p  <  0 . 0 1 ) .  T h e  i n c r e a s e  i n  l u n g  w e i g h t  
w a s  n o  l o n g e r  p r e s e n t  2 1  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e .  
A f t e r  5  d a y s  o f  e x p o s u r e ,  t h e  m a c r o s c o p i c  ﬁ n d i n g  e n l a r g e d  
m e d i a s t i n a l  l y m p h  n o d e s  w e r e  f o u n d  i n  i n d i v i d u a l  a n i m a l s  
o f  a l l  t e s t  g r o u p s  ( s e e  T a b l e  S 5 ) .  2 1  d a y s  a f t e r  t h e  e n d  
o f  t h e  e x p o s u r e ,  e n l a r g e d  m e d i a s t i n a l  l y m p h  n o d e s  w e r e  
o b s e r v e d  i n  a l m o s t  a l l  a n i m a l s  e x p o s e d  t o  C e r i a  N M - 2 1 1  
o r  N M - 2 1 2 .  T h e  t r a c h e o b r o n c h i a l  l y m p h  n o d e s  a n d  a l l  
o t h e r  e x a m i n e d  o r g a n s  d i d  n o t  s h o w  a n y  m a c r o s c o p i c  
ﬁ n d i n g s .
F o u r  w e e k s  o f  e x p o s u r e  A b s o l u t e  a n d  r e l a t i v e  l u n g  
w e i g h t s  w e r e  s i g n i ﬁ c a n t l y  i n c r e a s e d  a t  a e r o s o l  c o n c e n t r a -
t i o n s  o f  2 5  m g / m
3
 C e r i a  N M - 2 1 2  ( + 3 0  a n d  2 9  % ,  r e s p e c -
t i v e l y )  2  d a y s  a f t e r  t h e  e n d  o f  t h e  e x p o s u r e  a n d  w e r e  s t i l l  
s i g n i ﬁ c a n t l y  e l e v a t e d  ( + 1 6  a n d  2 0  % )  3 4  d a y s  a f t e r  t h e  
e n d  o f  t h e  e x p o s u r e  ( s e e  S I ,  S 5 ) .  2  d a y s  a f t e r  t h e  e n d  o f  
t h e  e x p o s u r e ,  a b s o l u t e  a n d  r e l a t i v e  l u n g  w e i g h t s  o f  a n i -
m a l s  e x p o s e d  t o  5  m g / m
3
 w e r e  i n c r e a s e d  s i g n i ﬁ c a n t l y  b y  
+ 1 3  a n d  1 0  % ,  r e s p e c t i v e l y .  T h e y  r e t u r n e d  t o  c o n t r o l  l e v e l s  
w i t h i n  t h e  f o l l o w i n g  3 4  d a y s .  N o  e f f e c t s  o n  o r g a n  w e i g h t s  
w e r e  o b s e r v e d  a f t e r  i n h a l a t i o n  o f  0 . 5  m g / m
3
.  2  d a y s  a f t e r  
t h e  e n d  o f  e x p o s u r e ,  m e d i a s t i n a l  l y m p h  n o d e s  o f  t w o  a n i -
m a l s  ( o u t  o f  t e n )  w e r e  e n l a r g e d  a t  a e r o s o l  c o n c e n t r a t i o n s  
o f  2 5  m g / m
3
 C e r i a  N M - 2 1 2 .  3 4  d a y s  a f t e r  t h e  e n d  o f  
e x p o s u r e ,  t h e  i n c i d e n c e  o f  a n i m a l s  w i t h  e n l a r g e d ,  y e l l o w  
w h i t e - c o l o r e d  m e d i a s t i n a l  l y m p h  n o d e s  i n c r e a s e d  c o n s i d -
e r a b l y  f r o m  t w o  t o  e i g h t  ( o u t  o f  t e n )  p e r  g r o u p  a t  a e r o s o l  
c o n c e n t r a t i o n s  o f  2 5  m g / m
3
 C e r i a  N M - 2 1 2 ,  r e s p e c t i v e l y .  
M e d i a s t i n a l  l y m p h  n o d e s  o f  a n i m a l s  e x p o s e d  t o  5  m g / m
3
 
w e r e  ﬁ r s t l y  e n l a r g e d  3 4  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e .
A l l  o t h e r  e x t r a p u l m o n a r y  o r g a n s  i n c l u d i n g  t h e  t r a c h e o -
b r o n c h i a l  l y m p h  n o d e s  r e v e a l e d  n o  m a c r o s c o p i c a l  ﬁ n d i n g s  
a f t e r  i n h a l a t i o n  e x p o s u r e  t o  C e r i a .
H i s t o p a t h o l o g y
O v e r a l l ,  h i s t o p a t h o l o g i c a l  e v a l u a t i o n s  w e r e  c o n s i s t e n t  i n  
t h e  s h o r t - t e r m  s t u d i e s  w i t h  5  d a y s  a n d  4  w e e k s  o f  e x p o s u r e .  
T h e  ﬁ n d i n g s  a s s e s s e d  i n  t h e  s h o r t - t e r m  s t u d y  w i t h  5  d a y s  
s h o w e d  l o w e r  s e v e r i t i e s  ( s e e  T a b l e  4 ;  F i g .  5 a – c ) .  
L u n g s
F i v e  d a y s  o f  e x p o s u r e
A f t e r  5  d a y s  o f  e x p o s u r e ,  s i n g l e  o r  a c c u m u l a t e d  m a c -
r o p h a g e s  w e r e  l o c a t e d  i n  t h e  l u m e n  o f  t h e  a l v e o l i  a n d  a  
f e w  m a c r o p h a g e s  o c c u r r e d  a l s o  i n  t h e  a l v e o l a r  w a l l  a n d  
d u c t s .  T h e y  w e r e  d i s t r i b u t e d  m u l t i f o c a l l y  i n  a l l  l o b e s  o v e r  
t h e  w h o l e  l u n g .  M o s t  o f  t h e m  w e r e  l o a d e d  w i t h  a m b e r - l i k e  
c o l o r e d  p a r t i c l e s  o f  d i f f e r e n t  s i z e s  ( b e l o w  1  μ m  d i a m e t e r ) .  
T h e s e  p a r t i c l e s  w e r e  c o n s i d e r e d  t o  r e p r e s e n t  a g g l o m e r -
a t e d  o r  a g g r e g a t e d  C e r i a  p a r t i c l e s  ( “ a l v e o l a r  h i s t i o c y t o s i s  
w i t h  p a r t i c l e s ” ) .  A l v e o l a r  h i s t i o c y t o s i s  a n d  f r e e  e o s i n o -
p h i l i c  g r a n u l a r  m a t e r i a l  w i t h  p a r t i c l e s ,  i n t e r p r e t e d  a s  r e m -
n a n t s  o f  d e s t r o y e d  m a c r o p h a g e s ,  w e r e  f o u n d  i n  t h e  l u n g  
o f  a l m o s t  a l l  a n i m a l s  e x p o s e d  t o  2 5  m g / m
3
 C e r i a  N M - 2 1 1  
a n d  N M - 2 1 2 .  A t  a e r o s o l  c o n c e n t r a t i o n s  o f  0 . 5  m g / m
3
 C e r i a  
N M - 2 1 1 ,  0 . 5  a n d  5  m g / m
3
 C e r i a  N M - 2 1 2 ,  a m b e r - c o l o r e d  
p a r t i c l e s  w e r e  n o t e d  w i t h i n  s i n g l e  h i s t i o c y t e  i n  t h e  a l v e o l i .  
I n  t h e  b r o n c h u s - a s s o c i a t e d  l y m p h o i d  t i s s u e  ( B A L T ) ,  p a r t i -
c l e s  w e r e  d e t e c t e d  f r e e  o r  i n  s i n g l e  m a c r o p h a g e s ,  m o s t l y  
a t  5  m g / m
3
 C e r i a  a n d  a b o v e .  F i n d i n g s  r e g r e s s e d  b u t  w e r e  
s t i l l  p r e s e n t  2 1  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e .  T h e  ﬁ n d -
i n g  “ e o s i n o p h i l i c  g r a n u l a r  m a t e r i a l  w i t h  p a r t i c l e s ”  w a s  n o  
l o n g e r  v i s i b l e  a f t e r  t h e  p o s t - e x p o s u r e  p e r i o d .  P a r t i c l e s  w e r e  
d e t e c t e d  f r e e  o r  i n  s i n g l e  m a c r o p h a g e s  i n  B A L T ,  e v e n  a t  t h e  
l o w e s t  c o n c e n t r a t i o n  o f  0 . 5  m g / m
3
 C e r i a  N M - 2 1 1 .  O n l y  
o n e  a n i m a l  e x p o s e d  t o  2 5  m g / m
3
 C e r i a  N M - 2 1 1  s h o w e d  
m a c r o p h a g e  a g g r e g a t e s  i n  B A L T  2 1  d a y s  a f t e r  t h e  e n d  o f  
e x p o s u r e .
F o u r  w e e k s  o f  e x p o s u r e
T w o  d a y s  a f t e r  t h e  e n d  o f  t h e  e x p o s u r e ,  a  c o n c e n t r a t i o n -
r e l a t e d  i n c r e a s e  i n  a l v e o l a r  m a c r o p h a g e s  w a s  o b s e r v e d  i n  
t h e  l u n g s  i n  a l l  C e r i a  N M - 2 1 2 - e x p o s e d  a n i m a l s  ( T a b l e  4 ;  
F i g .  5 a ) .  E o s i n o p h i l i c  g r a n u l a r  m a t e r i a l  a n d  s m a l l  p a r t i -
c l e s  w e r e  d i s t r i b u t e d  i n  t h e  a l v e o l i  o f  a n i m a l s  e x p o s e d  t o  
5  a n d  2 5  m g / m
3
 C e r i a  N M - 2 1 2 .  T h e  o c c u r r e n c e  o f  a l v e o -
l a r  h i s t i o c y t o s i s  a n d  o f  e o s i n o p h i l i c  g r a n u l a r  m a t e r i a l  w a s  
4 7
P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
 A r c h  T o x i c o l
1  3
c o r r e l a t e d  w i t h  i n c r e a s e d  l u n g  w e i g h t s  i n  a n i m a l s  e x p o s e d  
t o  5  a n d  2 5  m g / m
3
 C e r i a  N M - 2 1 2 .  I n  B A L T ,  s i n g l e ,  s m a l l  
m a c r o p h a g e  a g g r e g a t e s  w i t h  p a r t i c l e s  o c c u r r e d  i n  a n i -
m a l s  e x p o s e d  t o  2 5  m g / m
3
 ( s e e  F i g .  5 b ) .  I n  a d d i t i o n ,  s i n -
g l e  o r  a  f e w  a m b e r - l i k e  c o l o r e d  p a r t i c l e s  o c c u r r e d  e x t r a -
c e l l u l a r l y  i n  B A L T  w i t h o u t  a n y  m a c r o p h a g e  a c t i v a t i o n  a t  
a e r o s o l  c o n c e n t r a t i o n s  o f  5  a n d  2 5  m g / m
3
.  3 4  d a y s  a f t e r  
t h e  e n d  o f  e x p o s u r e ,  a l v e o l a r  h i s t i o c y t o s i s  a n d  e o s i n o -
p h i l i c  g r a n u l a r  m a t e r i a l  w i t h  p a r t i c l e s  w e r e  s t i l l  o b s e r v e d  
a t  c o n c e n t r a t i o n s  o f  5  a n d  2 5  m g / m
3
 C e r i a  N M - 2 1 2 .  A t  
0 . 5  m g / m
3
,  i n  c o n t r a s t ,  a m b e r - l i k e  c o l o r e d  p a r t i c l e s  c o u l d  
o n l y  b e  n o t e d  w i t h i n  s i n g l e  h i s t i o c y t e .  I n  o n e  a n i m a l  o f  
5  m g / m
3
 a n d  i n  ﬁ v e  o u t  o f  t e n  a n i m a l s  e x p o s e d  t o  2 5  m g /
m
3
 C e r i a  N M - 2 1 2 ,  a  m u l t i f o c a l  g r a n u l o m a t o u s  i n ﬂ a m m a -
t i o n  a p p e a r e d  ﬁ r s t .  I n  B A L T ,  s i n g l e  o r  f e w  a m b e r - c o l o r e d  
p a r t i c l e s  a t  0 . 5 ,  5 ,  a n d  2 5  m g / m
3
 C e r i a  N M - 2 1 2  a s  w e l l  a s  
a n  i n c r e a s i n g  n u m b e r  o f  a n i m a l s  w i t h  m a c r o p h a g e  a g g r e -
g a t e s  w i t h  p a r t i c l e s  a t  5  a n d  2 5  m g / m
3
 w e r e  s t i l l  o b s e r v e d  
F i g .  4   C o m p a r i s o n  o f  c h a n g e s  i n  B A L F  p a r a m e t e r s  a f t e r  5  d a y s  ( a ,  
b )  a n d  4  w e e k s  ( c ,  d )  o f  e x p o s u r e  t o  C e r i a  N M - 2 1 1  a n d  N M - 2 1 2 :  
s h o r t - t e r m  s t u d y  w i t h  5  d a y s  o f  e x p o s u r e :  a  3  d a y s  a f t e r  t h e  e n d  o f  
e x p o s u r e ,  b  2 4  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e ;  s h o r t - t e r m  s t u d y  w i t h  
4  w e e k s  o f  e x p o s u r e ,  c  1  d a y  a f t e r  t h e  e n d  o f  e x p o s u r e ,  d  3 5  d a y s  
a f t e r  t h e  e n d  o f  e x p o s u r e .  C h a n g e s  a r e  s h o w n  a s  x - f o l d  d i f f e r e n c e s  
c o m p a r e d  t o  c o n t r o l s  u s i n g  a  l o g a r i t h m i c  s c a l i n g
4 8
P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
A r c h  T o x i c o l  
1  3
T a b l e  4   H i s t o p a t h o l o g y  o f  s h o r t - t e r m  s t u d i e s  w i t h  5  d a y s  a n d  4  w e e k s  o f  e x p o s u r e
T a r g e t  c o n c .  ( m g / m
3
) 5  d a y s  o f  e x p o s u r e  t o  C e r i a  N M - 2 1 2 5  d a y s  o f  e x p o s u r e  t o  
C e r i a  N M - 2 1 1
4  w e e k s  o f  e x p o s u r e  t o  C e r i a  
N M - 2 1 2
T i m e  p o i n t  1
a
T i m e  p o i n t  2
b
T i m e  p o i n t  
1
a
T i m e  p o i n t  
2
b
T i m e  p o i n t  1
a
T i m e  p o i n t  2
b
0 . 5 5 2 5 0 . 5 5 2 5 0 . 5 2 5 0 . 5 2 5 0 . 5 5 2 5 0 . 5 5 2 5
H i s t o p a t h o l o g y
L u n g s
A l v e o l a r  h i s t i o c y t o s i s  w i t h  p a r t i c l e s – – 5 – 3 5 – 5 – 4 1 0 1 0 1 0 – 1 0 1 0
 G r a d e  1 1 3 5 3 4 1 0 4 3
 G r a d e  2 4 2 6 5 7
 G r a d e  3 5 1 0
E o s i n o p h i l i c  g r a n u l a r  m a t e r i a l / p a r t i c l e s – – 5 – – – – 5 – – – 1 0 1 0 – 2 1 0
 G r a d e  1 2 5 1 0 2 5
 G r a d e  2 3 6 4
 G r a d e  3 4 1
B A L T :  m a c r o p h a g e  a g g r e g a t e s  p a r t i c l e s – – – – – – – – – 1 – – 5 – 1 8
 G r a d e  1 1 5 3
 G r a d e  2 1 2
 G r a d e  3 3
B A L T :  o c c u r r e n c e  o f  p a r t i c l e s – 2 5 – 3 5 – 5 2 4 – 8 5 3 8 2
I n ﬂ a m m a t i o n ,  g r a n u l o m a t o u s – – – – – – – – – – – – – – 1 5
 G r a d e  1 1
 G r a d e  2 5
P a r t i c l e s  w i t h i n  h i s t i o c y t e s 5 5 – 5 2 – 5 – 5 – – – – 1 0 – –
M e d i a s t i n a l  l y m p h  n o d e s
M a c r o p h a g e  a g g r e g a t e s  p a r t i c l e . – – – – – 4 – – – 2 – – 4 – 9 9
 G r a d e  1 2 1 2
 G r a d e  2 1 2
 G r a d e  3 1 2 6 2
 G r a d e  4 1 1 7
O c c u r r e n c e  o f  p a r t i c l e s – – 2 – 1 1 – 3 – 2 – 6 6 1 – 1
H y p e r p l a s i a ,  l y m p h o - r e t i c u l o c e l l u l a r 1 – 3 – – 3 3 3 – 1 1 1 4 – 2 7
 G r a d e  1 1 3 2 3 1 1
 G r a d e  2 1 1 1 1 1 3 2 6
 G r a d e  3 1 1
T r a c h e o b r o n c h i a l  l y m p h  n o d e s
M a c r o p h a g e  a g g r e g a t e s  p a r t i c l e . – – – – – 4 – – – 3 – 1 8 – 1 0 1 0
 G r a d e  1 1 1 3 1 1
 G r a d e  2 2 1 5 1 1
 G r a d e  3 2 5 2
 G r a d e  4 1 3 6
O c c u r r e n c e  o f  p a r t i c l e s – – 5 – 3 1 – 4 – 2 – 7 2 1 – –
4 9
P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
 A r c h  T o x i c o l
1  3
( s e e  F i g .  5 b ) .  A l l  c o m p o u n d - r e l a t e d  ﬁ n d i n g s  a f t e r  e x p o s u r e  
o f  5  a n d  2 5  m g / m
3
 C e r i a  N M - 2 1 2  w e r e  c o r r e l a t e d  w i t h  
i n c r e a s e d  l u n g  w e i g h t s  i n  t h e s e  t e s t  g r o u p s .
L u n g - a s s o c i a t e d  l y m p h  n o d e s  ( m e d i a s t i n a l  
a n d  t r a c h e o b r o n c h i a l  l y m p h  n o d e s )
F i v e  d a y s  o f  e x p o s u r e
A f t e r  5  d a y s  o f  e x p o s u r e  t o  2 5  m g / m
3
 C e r i a  N M - 2 1 1  a n d  
N M - 2 1 2 ,  c o m p a r a b l e  t o  t h e  ﬁ n d i n g  o f  p a r t i c l e s  i n  B A L T  
o f  t h e  l u n g ,  a m b e r - l i k e  c o l o r e d  p a r t i c l e s  w e r e  s e e n  p a r t l y  
w i t h i n  m a c r o p h a g e s  o r  e x t r a c e l l u l a r l y  i n  t h e  l y m p h o i d  
t i s s u e ,  w i t h o u t  a n y  m a c r o p h a g e  a c t i v a t i o n  o r  a g g r e g a -
t i o n .  2 1  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e  t o  2 5  m g / m
3
 C e r i a  
N M - 2 1 1 ,  ﬁ n d i n g s  i n  b o t h  l y m p h  n o d e s  p r o g r e s s e d .  I n  t h e  
m e d i a s t i n a l  a n d  t h e  t r a c h e o b r o n c h i a l  l y m p h  n o d e s ,  m u l -
t i f o c a l  m a c r o p h a g e  a g g r e g a t e s  w i t h  a m b e r - l i k e  c o l o r e d  
p a r t i c l e s  w e r e  n o t e d  i n  a n i m a l s  e x p o s e d  t o  C e r i a  N M - 2 1 1  
a n d  N M - 2 1 2  ( s e e  T a b l e  4 ) .  I n  b o t h  l y m p h  n o d e s ,  l y m p h o -
r e t i c u l o c e l l u l a r  h y p e r p l a s i a  w a s  o b s e r v e d  a f t e r  5  d a y s  o f  
e x p o s u r e  a n d  2 1  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e  t o  C e r i a  
N M - 2 1 1  a n d  N M - 2 1 2 .
F o u r  w e e k s  o f  e x p o s u r e
T w o  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e  t o  5  a n d  2 5  m g / m
3
 C e r i a  
N M - 2 1 2 ,  m u l t i f o c a l  m a c r o p h a g e  a g g r e g a t e s  w i t h  p a r t i c l e s  
w e r e  o b s e r v e d  i n  t h e  m e d i a s t i n a l  a s  w e l l  a s  i n  t h e  t r a c h e o -
b r o n c h i a l  l y m p h  n o d e s  ( s e e  F i g .  5 c ) .  A  l y m p h o - r e t i c u l o c e l -
l u l a r  h y p e r p l a s i a  w a s  p r e s e n t  i n  b o t h  l y m p h  n o d e s ,  m o s t l y  
s e e n  i n  a n i m a l s  i n  t h e  g r o u p  o f  2 5  m g / m
3
.  T h e  h y p e r p l a s i a  
o f  t h e  m e d i a s t i n a l  l y m p h  n o d e s  w a s  c o r r e l a t e d  w i t h  t h e i r  
c o r r e s p o n d i n g  m a c r o s c o p i c  e n l a r g e m e n t  a f t e r  e x p o s u r e  t o  
2 5  m g / m
3
 C e r i a  N M - 2 1 2 .  3 4  d a y s  a f t e r  t h e  e n d  o f  e x p o -
s u r e ,  t h e  n u m b e r  o f  a n i m a l s  w i t h  m a c r o p h a g e  a g g r e g a t e s  
( i n c i d e n c e  a n d  g r a d i n g )  a n d  w i t h  h y p e r p l a s i a  i n  b o t h  l y m p h  
n o d e s  w a s  h i g h e r  c o m p a r e d  t o  t h e  a n i m a l s  e x a m i n e d  2  d a y s  
a f t e r  t h e  e n d  o f  t h e  e x p o s u r e .  N e a r l y  a l l  o t h e r  ﬁ n d i n g s  w e r e  
s t i l l  p r e s e n t  3 4  d a y s  a f t e r  t h e  e n d  o f  t h e  e x p o s u r e .
U p p e r  r e s p i r a t o r y  t r a c t
F i v e  d a y s  o f  e x p o s u r e
A f t e r  5  d a y s  o f  e x p o s u r e  t o  2 5  m g / m
3
 C e r i a  N M - 2 1 1  a n d  
N M - 2 1 2 ,  e x t r a c e l l u l a r ,  a m b e r - l i k e  c o l o r e d  p a r t i c l e s  w i t h  
d i a m e t e r s  u p  t o  1 . 5  μ m  w e r e  f o u n d  i n  t h e  l a m i n a  p r o p r i a  
m u c o s a e  o f  t h e  d o r s a l  a r e a  o f  t h e  l a r y n x  ( l e v e l  I I I ) .  A t  
a e r o s o l  c o n c e n t r a t i o n s  o f  2 5  m g / m
3
 C e r i a  N M - 2 1 1  a n d  
N M - 2 1 2 ,  r e s e m b l i n g  a m b e r - l i k e  c o l o r e d  p a r t i c l e s  w e r e  
d e t e c t e d  w i t h i n  t h e  s u b e p i t h e l i a l  t i s s u e  i n  t h e  c a r i n a  o f  t h e  
t r a c h e a .  2 1  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e ,  ﬁ n d i n g s  i n  t h e  
l a r y n x  w e r e  o n l y  o b s e r v e d  f o r  a n i m a l s  e x p o s e d  t o  C e r i a  
N M - 2 1 2 ,  w h e r e a s  p a r t i c l e s  i n  t h e  c a r i n a  ( t r a c h e a )  w e r e  s t i l l  
p r e s e n t  i n  a n i m a l s  e x p o s e d  t o  C e r i a  N M - 2 1 1  a n d  N M - 2 1 2 .
F o u r  w e e k s  o f  e x p o s u r e
T w o  d a y s  a f t e r  t h e  e n d  o f  t h e  e x p o s u r e  t o  5  a n d  2 5  m g /
m
3
 C e r i a  N M - 2 1 2 ,  a m b e r - l i k e  c o l o r e d  p a r t i c l e s  o c c u r r e d  
s i m i l a r l y  i n  t h e  d o r s a l  a r e a  o f  t h e  l a r y n x  ( l e v e l  I I I ) .  A n i -
m a l s  e x p o s e d  t o  2 5  m g / m
3
 s h o w e d  p a r t i c l e s  i n  t h e  c a r i n a  
o f  t h e  t r a c h e a .  A t  a e r o s o l  c o n c e n t r a t i o n s  o f  2 5  m g / m
3
 C e r i a  
N M - 2 1 2 ,  s i n g l e  a m b e r - l i k e  c o l o r e d  p a r t i c l e s  w e r e  ﬁ r s t l y  
f o u n d  i n  t h e  n a s a l - a s s o c i a t e d  l y m p h o i d  t i s s u e  ( N A L T ) ,  
i n s i d e  s i n g l e  m a c r o p h a g e s  o r  e x t r a c e l l u l a r l y .  T h e s e  ﬁ n d -
i n g s  w e r e  s t i l l  p r e s e n t  3 4  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e .
T a r g e t  c o n c .  ( m g / m
3
) 5  d a y s  o f  e x p o s u r e  t o  C e r i a  N M - 2 1 2 5  d a y s  o f  e x p o s u r e  t o  
C e r i a  N M - 2 1 1
4  w e e k s  o f  e x p o s u r e  t o  C e r i a  
N M - 2 1 2
T i m e  p o i n t  1
a
T i m e  p o i n t  2
b
T i m e  p o i n t  
1
a
T i m e  p o i n t  
2
b
T i m e  p o i n t  1
a
T i m e  p o i n t  2
b
0 . 5 5 2 5 0 . 5 5 2 5 0 . 5 2 5 0 . 5 2 5 0 . 5 5 2 5 0 . 5 5 2 5
H y p e r p l a s i a ,  l y m p h o - r e t i c u l o c e l l u l a r – – 4 1 1 2 – 1 1 1 – 1 7 – 1 6
 G r a d e  1 4 1 1 2 1 1
 G r a d e  2 1 1 2 1 1 3 4
 G r a d e  3 2 1
N u m b e r  o f  e x a m i n e d  o r g a n s  p e r  t e s t  g r o u p :  n  =  1 0  ( 4  w e e k s  o f  e x p o s u r e ) ;  n  =  5  ( 5  d a y s  o f  e x p o s u r e )
G r a d e  1 :  m i n i m a l ,  g r a d e  2 :  s l i g h t ,  g r a d e  3 :  m o d e r a t e ,  g r a d e  4 :  s e v e r e ,  g r a d e  5 :  e x t r e m e ;  w h e n e v e r  a  g r a d i n g  w a s  n o t  u s e d ,  t h e  m i c r o s c o p i c  ﬁ n d -
i n g  w a s  i n d i c a t e d  t o  b e  p r e s e n t
a
 T i m e  p o i n t  1 :  a f t e r  t h e  e n d  o f  e x p o s u r e  ( 5  d a y s  o f  e x p o s u r e )  a n d  2  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e  ( 4  w e e k s  o f  e x p o s u r e )
b
 T i m e  p o i n t  2 :  2 1  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e  ( 5  d a y s  o f  e x p o s u r e )  a n d  3 4  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e  ( 4  w e e k s  o f  e x p o s u r e )
T a b l e  4   c o n t i n u e d
5 0
P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
A r c h  T o x i c o l  
1  3
E x t r a p u l m o n a r y  o r g a n s
F i v e  d a y s  o f  e x p o s u r e
E x t r a p u l m o n a r y  o r g a n s  o f  a n i m a l s  e x p o s e d  f o r  5  d a y s  t o  
C e r i a  N M - 2 1 1  a n d  N M - 2 1 2  w e r e  n o t  e x a m i n e d .
F o u r  w e e k s  o f  e x p o s u r e
H i s t o l o g i c a l  e x a m i n a t i o n  o f  e x t r a p u l m o n a r y  o r g a n s ,  e . g . ,  
l i v e r ,  s p l e e n ,  a n d  k i d n e y s ,  d i d  n o t  s h o w  a n y  s u b s t a n c e -
r e l a t e d  m o r p h o l o g i c a l  c h a n g e s  i n  a n i m a l s  e x p o s e d  t o  0 . 5 ,  
5 ,  a n d  2 5  m g / m
3
 C e r i a  N M - 2 1 2  i n  t h e  s h o r t - t e r m  s t u d y  
w i t h  4  w e e k s  o f  e x p o s u r e  ( d a t a  n o t  s h o w n ) .
O r g a n  b u r d e n  a n a l y s i s
I n  t h e  s h o r t - t e r m  s t u d i e s  w i t h  5  d a y s  a n d  4  w e e k s  o f  e x p o -
s u r e ,  C e r i a  b u r d e n  o f  l u n g ,  l y m p h  n o d e s ,  a n d  p a r t l y  l i v e r  i s  
s u m m a r i z e d  i n  T a b l e s  S 6 – S 8 .  T h e  t i m e  c o u r s e  o f  l u n g  a n d  
l y m p h  n o d e  b u r d e n s  i s  p r e s e n t e d  i n  F i g .  6 .
F i v e  d a y s  o f  e x p o s u r e
E x p o s u r e  t o  0 . 5  m g / m
3
 C e r i a  N M - 2 1 2  r e s u l t e d  i n  a  l u n g  
b u r d e n  o f  0 . 0 1 1  m g / l u n g ,  d i r e c t l y  a f t e r  5  d a y s  o f  e x p o -
s u r e  a n d  d e c r e a s e d  t o  0 . 0 0 6  m g / l u n g  2 1  d a y s  a f t e r  t h e  
e n d  o f  t h e  e x p o s u r e ,  w h e r e a s  e x p o s u r e  t o  5  a n d  2 5  m g /
m
3
 y i e l d e d  h i g h e r  l u n g  b u r d e n s  ( 0 . 1  a n d  0 . 5 3  m g / l u n g s ,  
r e s p e c t i v e l y )  w i t h  o n l y  l i t t l e  d e c r e a s e  ( 0 . 0 8 8  a n d  0 . 4  m g /
l u n g ,  r e s p e c t i v e l y )  w i t h i n  2 1  d a y s  a f t e r  t h e  e n d  o f  t h e  
e x p o s u r e .
L u n g  b u r d e n s  o f  C e r i a  N M - 2 1 1  w e r e  a r o u n d  t w o f o l d  
l o w e r  c o m p a r e d  t o  t h o s e  o f  C e r i a  N M - 2 1 2  ( s e e  T a b l e  S 6 ) .  
C e r i u m  c o n t e n t  i n  t h e  l u n g - a s s o c i a t e d  l y m p h  n o d e s  a t  
a e r o s o l  c o n c e n t r a t i o n s  o f  2 5  m g / m
3
 i n c r e a s e d  f r o m  1 . 7  t o  
5  μ g  f o r  C e r i a  N M - 2 1 2  a n d  f r o m  1 . 4  μ g  t o  3  μ g  f o r  C e r i a  
N M - 2 1 1  i n  t h e  s h o r t - t e r m  s t u d y  w i t h  5  d a y s  o f  e x p o s u r e  
( s e e  T a b l e  S 7 ) .
F o u r  w e e k s  o f  e x p o s u r e
T h e  t i m e  c o u r s e  o f  t h e  l u n g  b u r d e n s  i s  p r e s e n t e d  i n  F i g .  6  
( f o r  d e t a i l e d  v a l u e s ,  s e e  T a b l e  S 6 ) .  I n h a l a t i o n  e x p o s u r e  o f  
0 . 5 ,  5 ,  o r  2 5  m g / m
3
 C e r i a  N M - 2 1 2  r e s u l t e d  i n  m e a n  l u n g  
b u r d e n s  o f  0 . 0 4 ,  0 . 5 2 ,  o r  2 . 6 2  m g  1  d a y  a f t e r  t h e  e n d  o f  
e x p o s u r e .  2  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e ,  h i g h e r  l u n g  b u r -
d e n s  o f  t h e  l e f t  l u n g s  w e r e  m e a s u r e d  a n d  t h e s e  d a t a  w e r e  
d i s r e g a r d e d  f o r  h a l f - t i m e  c a l c u l a t i o n s .  A p p l y i n g  t h e  f o l -
l o w i n g  e q u a t i o n ,  r e t e n t i o n  h a l f - t i m e s  o f  C e r i a  i n  t h e  l u n g s  
w e r e  c a l c u l a t e d  a s




w h e r e  N ( t )  w a s  t h e  l u n g  b u r d e n  a t  t i m e  p o i n t  t ,  N
0
 w a s  t h e  
l u n g  b u r d e n  s h o r t l y  a f t e r  l a s t  e x p o s u r e ,  t  a s  d a y s  a f t e r  l a s t  
e x p o s u r e .
A t  a e r o s o l  c o n c e n t r a t i o n s  o f  0 . 5  m g / m
3
 C e r i a  N M - 2 1 2 ,  a  
r e t e n t i o n  h a l f - t i m e  o f  4 0  d a y s  w a s  d e t e r m i n e d .  H i g h e r  a e r -
o s o l  c o n c e n t r a t i o n s  o f  2 5  m g / m
3
 C e r i a  N M - 2 1 2  r e s u l t e d ,  
h o w e v e r ,  i n  a  m u c h  l o n g e r  h a l f - t i m e  a b o v e  2 0 0  d a y s .
T h e  C e r i u m  b u r d e n  i n  t h e  l u n g - a s s o c i a t e d  l y m p h  n o d e s  
( t r a c h e o b r o n c h i a l  a n d  m e d i a s t i n a l  l y m p h  n o d e s )  w a s  1 0  μ g  
3  d a y s  a f t e r  t h e  e n d  o f  t h e  e x p o s u r e  t o  2 5  m g / m
3
 C e r i a  
N M - 2 1 2  a n d  i n c r e a s e d  t o  3 5 0  μ g  1 2 9  d a y s  a f t e r  t h e  e n d  o f  
e x p o s u r e  ( s e e  T a b l e  S 7 ) .
A f t e r  t h e  e x p o s u r e  t o  2 5  m g / m
3
 C e r i a  N M - 2 1 2 ,  C e r i u m  
w a s  a l s o  d e t e c t e d  i n  t h e  l i v e r  ( 1 . 5 6  a n d  1 . 9 3  μ g )  3  a n d  
6 5  d a y s  a f t e r  t h e  e n d  o f  t h e  e x p o s u r e ,  r e s p e c t i v e l y  ( s e e  
T a b l e  S 8 ) .
D i s c u s s i o n
O b j e c t i v e s  o f  t h i s  b o d y  o f  w o r k  w e r e  t o  d e t e r m i n e  l u n g  
d e p o s i t i o n  a n d  c l e a r a n c e  k i n e t i c s  a s  w e l l  a s  t h e  i n h a l a -
t i o n  t o x i c i t y  o f  t w o  n a n o - C e r i a  ( N M - 2 1 1  a n d  N M - 2 1 2 )  
i n  s h o r t - t e r m  s t u d i e s  w i t h  5  d a y s  a n d  4  w e e k s  o f  i n h a l a -
t i o n  e x p o s u r e .  T h e  r e s u l t s  s h o u l d  s e r v e  a s  b a s i s  f o r  s e l e c t -
i n g  a p p r o p r i a t e  e x p o s u r e  c o n c e n t r a t i o n s  f o r  a  s u b s e q u e n t  
l o n g - t e r m  i n h a l a t i o n  s t u d y .  T h e  f o l l o w i n g  s e c t i o n s  f o c u s  o n  
a  d i s c u s s i o n  o f  ( 1 )  d e p o s i t i o n  a n d  c l e a r a n c e ,  ( 2 )  l o c a l  a n d  
s y s t e m i c  e f f e c t s ,  ( 3 )  c o m p a r i s o n  o f  t h e  t w o  C e r i a  N M - 2 1 1  
a n d  N M - 2 1 2 ,  a n d  ( 4 )  c o m p a r i s o n  o f  5  d a y s  a n d  4  w e e k s  o f  
e x p o s u r e .
D e p o s i t i o n  a n d  c l e a r a n c e
F o u r  w e e k s  o f  e x p o s u r e  t o  0 . 5  m g / m
3
 C e r i a  N M - 2 1 2  
r e s u l t e d  i n  a  l u n g  b u r d e n  o f  4 1  μ g / l u n g ;  t h e  p o s t - e x p o s u r e  
r e t e n t i o n  h a l f - t i m e  w a s  4 0  d a y s .  T h i s  i s  i n  t h e  r a n g e  o f  
p h y s i o l o g i c a l  r e t e n t i o n  h a l f - t i m e s  o f  p o o r l y  s o l u b l e  p a r t i -
c l e s  b e t w e e n  6 0  a n d  7 0  d a y s  ( O b e r d o r s t e r  2 0 0 2 ) .  A  h i g h e r  
a e r o s o l  c o n c e n t r a t i o n  o f  2 5  m g / m
3
 e l i c i t e d  a  l u n g  b u r d e n  
o f  2 , 6 2 0  μ g / l u n g  r e s u l t i n g  i n  a  r e t a r d e d  r e t e n t i o n  h a l f - t i m e  
a b o v e  2 0 0  d a y s .  A t  t h e  m i d  c o n c e n t r a t i o n  o f  5  m g / m
3
,  t h e  
l u n g  b u r d e n s  a t  t h r e e  t i m e  p o i n t s  i n d i c a t e d  a  r e t a r d e d  r e t e n -
t i o n  h a l f - t i m e  a s  t h e  l u n g  b u r d e n  ( 5 0 0  μ g / l u n g )  s t a y e d  a t  
a  c o n s t a n t  l e v e l  d u r i n g  4  w e e k s  o f  p o s t - e x p o s u r e .  A  p r o -
l o n g e d  l u n g  c l e a r a n c e  o f  t h e  s a m e  C e r i a  N M - 2 1 2  w a s  a l s o  
o b s e r v e d  i n  a  r a t  i n s t i l l a t i o n  s t u d y  w i t h  n e u t r o n - a c t i v a t e d  
1 4 1
C e r i a  N M - 2 1 2  a t  a n  i n s t i l l e d  d o s e  o f  1  m g / k g  b o d y  
w e i g h t ,  c o r r e s p o n d i n g  t o  2 0 0 – 3 0 0  μ g / l u n g  ( M o l i n a  e t  a l .  
2 0 1 4 ) .  D u r i n g  2 8  d a y s  p o s t - e x p o s u r e ,  o n l y  1 2  %  o f  t h e  
1 4 1
C e r i u m  i n  t h e  l u n g  h a s  b e e n  c l e a r e d .
P u l m o n a r y  i n ﬂ a m m a t i o n  w a s  o n l y  o b s e r v e d  a t  c o n c e n -
t r a t i o n s  o f  5  a n d  2 5  m g / m
3
,  w h i c h  a l s o  c a u s e d  s i g n i ﬁ c a n t  
5 1
P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
 A r c h  T o x i c o l
1  3
5 2
P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
A r c h  T o x i c o l  
1  3
r e t a r d a t i o n  o f  p u l m o n a r y  c l e a r a n c e .  C o n c e r n i n g  t h e  t h r e s h -
o l d  f o r  o v e r l o a d  c o n d i t i o n s ,  m a s s  l u n g  b u r d e n  o f  4 1  μ g ,  
a c h i e v e d  a t  0 . 5  m g / m
3
,  w a s  w e l l  b e l o w  t h e  o v e r l o a d  
t h r e s h o l d  p r o p o s e d  b y  M o r r o w ,  w h i l e  t h e  l u n g  b u r d e n  o f  
2 , 6 2 0  μ g ,  a c h i e v e d  a t  2 5  m g / m
3
,  w a s  a b o v e  i t  ( M o r r o w  
1 9 8 8 ) .  A t  2 5  m g / m
3
;  a  s t r o n g  p u l m o n a r y  i n ﬂ a m m a t i o n  w a s  
a p p a r e n t .  T h e  m i d  c o n c e n t r a t i o n  o f  5  m g / m
3
 C e r i a  N M - 2 1 2  
e l i c i t e d  p u l m o n a r y  i n ﬂ a m m a t i o n  a t  a  c o n s t a n t  l u n g  b u r d e n  
o f  a r o u n d  5 2 0  μ g ,  w h i c h  i s  s l i g h t l y  b e l o w  o r  a t  t h e  b o r d e r  
o f  t h e  o v e r l o a d  t h r e s h o l d .
M o r r o w  a s s u m e d  o v e r l o a d  c o n d i t i o n s  w h e n  p a r t i c l e  
v o l u m e  e x c e e d s  6 0  μ m
3
/ a l v e o l a r  m a c r o p h a g e  ( M o r r o w  
1 9 8 8 ) .  O b e r d o e r s t e r  e t  a l .  ( 1 9 9 4 a )  s u g g e s t e d  r e t a i n e d  s u r -
f a c e  a r e a  a s  a p p r o p r i a t e  m e t r i c s  f o r  c o r r e l a t i n g  o v e r l o a d  
w i t h  r e t a r d e d  c l e a r a n c e ,  p a r t i c u l a r l y  i f  n a n o p a r t i c l e s  a r e  
i n v o l v e d .  T r a n  e t  a l .  ( 2 0 0 0 )  p r o p o s e d  o v e r l o a d  t h r e s h -
o l d  v a l u e s  o f  0 . 0 2 – 0 . 0 3  m
2
/ g  l u n g .  I n  t h e  c u r r e n t  s t u d y ,  
4  w e e k s  o f  e x p o s u r e  t o  a n  a e r o s o l  c o n c e n t r a t i o n  o f  2 5  m g /
m
3
 c a u s e d  a  p a r t i c l e  s u r f a c e  b u r d e n  o f  0 . 0 7  m
2
/ l u n g  a n d  
5  m g / m
3
 r e s u l t e d  i n  0 . 0 1 4  m
2
 s u r f a c e  b u r d e n  p e r  l u n g  ( s e e  
F i g .  7 ;  T a b l e  S 9 ) .  T h i s  i s  s l i g h t l y  b e l o w  t h e  s u r f a c e  b u r -
d e n  t h r e s h o l d  p r o p o s e d  b y  T r a n  e t  a l .  a n d  c a u s e d  a l r e a d y  
i n ﬂ a m m a t i o n  a n d  r e t a r d e d  c l e a r a n c e  i n  t h e  l u n g .  T h e r e f o r e ,  
i t  c a n  b e  a s s u m e d  t h a t  a  t h r e s h o l d ,  h o w e v e r ,  i s  h i g h l y  m a t e -
r i a l - d e p e n d e n t  a n d  m a y  n o t  b e  b a s e d  o n  o n e  o r  t w o  p a r t i c l e  
t y p e s  a l o n e .  T h e  t h r e s h o l d s  p u b l i s h e d  p r e v i o u s l y  m a y  n e e d  
a d a p t a t i o n s  f o r  t h e  s p e c i ﬁ c  t y p e  o f  n a n o m a t e r i a l  i n  o r d e r  t o  
a d d r e s s  i t s  t o x i c o l o g i c a l  p r o p e r t i e s .
L u n g  b u r d e n s  a f t e r  5  d a y s  o f  e x p o s u r e  w e r e  a b o u t  o n e -
f o u r t h  o f  t h o s e  a f t e r  4  w e e k s  o f  e x p o s u r e  r e ﬂ e c t i n g  a  l i n e a r  
k i n e t i c s .  T h i s  i s  t h e  c o n s e q u e n c e  o f  a  l i n e a r  d e p o s i t i o n  a n d  
a  s l o w  c l e a r a n c e .  I n  t h e  l o n g  t e r m ,  h o w e v e r ,  t h e  k i n e t i c s  
w i l l  n o t  b e  l i n e a r  d u e  t o  c l e a r a n c e .
I n  t h e  l u n g - a s s o c i a t e d  l y m p h  n o d e s ,  3 5 0  μ g  C e r i a  w a s  
f o u n d  1 2 9  d a y s  a f t e r  t h e  e x p o s u r e  t o  2 5  m g / m
3
 f o r  4  w e e k s .  
T h e  l u n g  b u r d e n  d e c r e a s e s  f r o m  2 , 6 2 0  t o  1 , 8 0 0  μ g  i n  t h e  
s a m e  t i m e  p e r i o d .  T h e  l y m p h a t i c  c l e a r a n c e  o f  C e r i a  w a s  
a r o u n d  1 3  %  o f  t h e  i n i t i a l  r e t a i n e d  b u r d e n  a f t e r  t h e  e n d  o f  
t h e  e x p o s u r e .  L y m p h a t i c  c l e a r a n c e s  o f  1 – 5  %  w e r e  p r e v i -
o u s l y  r e p o r t e d  f o r  m i c r o s c a l e  p a r t i c l e s  b u t  w e r e  a l s o  s h o w n  
t o  b e  h i g h e r  f o r  n a n o s c a l e  p a r t i c l e s  ( K r e y l i n g  a n d  S c h e u c h  
2 0 0 0 ;  K r e y l i n g  e t  a l .  1 9 8 6 ;  O b e r d o r s t e r  e t  a l .  1 9 9 4 b ) .  
M o s t  o f  t h e  C e r i a  n a n o p a r t i c l e s  w e r e  p r e s u m a b l y  c l e a r e d  
b y  m u c o c i l i a r y  c l e a r a n c e  a n d  s u b s e q u e n t  f e c a l  e x c r e t i o n ,  
w h i c h  w a s  n o t  e v a l u a t e d  i n  t h i s  w o r k .
A  v e r y  l o w  c o n t e n t  o f  C e r i a  w a s  d e t e c t e d  i n  t h e  l i v e r  i n  
t h e  p r e s e n t e d  i n h a l a t i o n  s t u d y  w i t h  4  w e e k s  o f  e x p o s u r e  
t o  2 5  m g / m
3
 C e r i a  N M - 2 1 2 .  C o n s i s t e n t  w i t h  o u r  ﬁ n d i n g s ,  
a c c u m u l a t i o n  o f  C e r i a  N M - 2 1 2  i n  e x t r a p u l m o n a r y  t i s s u e  
a n d  a s s o c i a t e d  t o x i c i t y  a p p e a r e d  t o  b e  l o w  a s  r e p o r t e d  i n  
a  r a t  s t u d y  u s i n g  i n t r a v e n o u s  i n j e c t i o n  o f  n e u t r o n - a c t i v a t e d  
1 4 1
C e r  N M - 2 1 2  ( M o l i n a  e t  a l .  2 0 1 4 ) .  M o r e o v e r ,  d i s s o l u -
t i o n  o f  C e r i a  w i t h i n  a l v e o l a r  m a c r o p h a g e s  o r  o t h e r  e x t r a -
c e l l u l a r  ﬂ u i d s ,  a n d  s u b s e q u e n t  a b s o r p t i o n / b i o a v a i l a b i l i t y  
F i g .  6   B i o k i n e t i c s  o f  l u n g  ( a – c )  a n d  l y m p h  n o d e  b u r d e n s  ( c )  i n  t h e  
s h o r t - t e r m  s t u d y  w i t h  4  w e e k s  o f  e x p o s u r e .  L u n g  b u r d e n  a f t e r  e x p o -
s u r e  t o  0 . 5  m g / m
3
 ( a ) ,  5  m g / m
3
 ( b ) ,  a n d  2 5  m g / m
3
 ( c )  C e r i a  N M - 2 1 2  
a n d  b u r d e n  o f  l u n g - a s s o c i a t e d  l y m p h  n o d e s  a f t e r  e x p o s u r e  t o  2 5  m g /
m
3
 C e r i a  N M - 2 1 2  ( c ,  g r e e n )  a f t e r  4  w e e k s  o f  e x p o s u r e  a n d  d u r i n g  
1 2 9  d a y s  p o s t - e x p o s u r e
F i g .  5   a  M i c r o s c o p i c  a p p e a r a n c e  o f  l u n g s  ( a – d )  i n  t h e  s h o r t - t e r m  
s t u d y  w i t h  4  w e e k s  o f  e x p o s u r e .  a  C o n t r o l ,  l u n g ;  b  2  d a y s  a f t e r  t h e  
e n d  o f  e x p o s u r e  t o  2 5  m g / m
3
 C e r i a  N M - 2 1 2 :  l u n g ,  a l v e o l a r  h i s t i o c y -
t o s i s  w i t h  p a r t i c l e s ;  c ,  d  3 4  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e  t o  2 5  m g /
m
3
 C e r i a  N M - 2 1 2 :  l u n g ,  g r a n u l o m a t o u s  i n ﬂ a m m a t i o n .  b  M i c r o s c o p i c  
a p p e a r a n c e  o f  l u n g s  ( e ,  f )  i n  t h e  s h o r t - t e r m  s t u d y  w i t h  4  w e e k s  o f  
e x p o s u r e ;  e  c o n t r o l ,  B A L T ;  f  3 4  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e  t o  
2 5  m g / m
3
 C e r i a  N M - 2 1 2 :  B A L T  m a c r o p h a g e  a g g r e g a t e s  w i t h  p a r -
t i c l e s .  c  M i c r o s c o p i c  a p p e a r a n c e  o f  l u n g - a s s o c i a t e d  l y m p h  n o d e s  
( g ,  h )  i n  t h e  s h o r t - t e r m  s t u d y  w i t h  4  w e e k s  o f  e x p o s u r e ;  g  c o n t r o l ,  
l y m p h  n o d e ;  h  3 4  d a y s  a f t e r  t h e  e n d  o f  e x p o s u r e  t o  2 5  m g / m
3
 C e r i a  
N M - 2 1 2 :  t r a c h e o b r o n c h i a l  l y m p h  n o d e ,  m a c r o p h a g e  a g g r e g a t i o n  
w i t h  p a r t i c l e s
◂
5 3
P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
 A r c h  T o x i c o l
1  3
o f  i o n i c  C e r i u m  i n t o  t h e  b l o o d  a n d  t r a n s p o r t  t o  e x t r a p u l -
m o n a r y  o r g a n s ,  m a y  o c c u r  ( O b e r d ö r s t e r  e t  a l .  2 0 0 5 ) .  T h e  
e x p l o r a t i o n  i n  s i m u l a n t  ﬂ u i d s  i n d i c a t e d  s t r u c t u r a l  c h a n g e s  
m e d i a t e d  b y  m a r g i n a l  s o l u b i l i t y  i n  ( a c i d i c )  P S F ,  b u t  n o t  i n  
( n e u t r a l )  P B S  ( s e e  T a b l e  1 ) .  H e n c e ,  t h e r e  i s  o n l y  a  m i n o r ,  i f  
a n y ,  c o n t r i b u t i o n  o f  i o n i c  C e r i u m .
L o c a l  e f f e c t s
L o c a l  p u l m o n a r y  e f f e c t s  a f t e r  i n h a l a t i o n  o f  n a n o - C e r i a  
w e r e  c o n s i s t e n t  a f t e r  5  d a y s  a n d  4  w e e k s  o f  e x p o s u r e .  T h e  
r e p o r t e d  p u l m o n a r y  i n ﬂ a m m a t i o n  w a s  a s s e s s e d  b y  t h e  
c h a n g e s  i n  B A L F  p a r a m e t e r s  ( e . g . ,  n e u t r o p h i l s )  a n d  h i s -
t o p a t h o l o g i c a l  ﬁ n d i n g s  ( a l v e o l a r  h i s t i o c y t o s i s  a n d  g r a n u -
l o m a t o u s  i n ﬂ a m m a t i o n ) .
I n  B A L F ,  p r o i n ﬂ a m m a t o r y  c y t o k i n e s  a r e  a l s o  i n d i -
c a t o r s  o f  a n  i n ﬂ a m m a t o r y  p r o c e s s  i n  t h e  l u n g  ( H e n d e r -
s o n  1 9 8 4 ) .  I n c r e a s e d  a c t i v i t i e s  o f  t h e  e n z y m e s  A L P  a n d  
N A G  i n d i c a t e d  t h e  p r o l i f e r a t i o n  o f  p n e u m o c y t e  t y p e  I I  
c e l l s  a n d  a c t i v a t i o n  o f  m a c r o p h a g e s ,  r e s p e c t i v e l y  ( H e n -
d e r s o n  2 0 0 5 ;  C a p e l l i  1 9 9 7 ) .  C o n s i s t e n t l y ,  t h e  c h e m o k i n e  
M C P - 1  r e l e a s e d  b y  m a c r o p h a g e s  w a s  c o n c e n t r a t i o n - r e l a t e d  
i n c r e a s e d  i n d i c a t i n g  a  r e c r u i t m e n t  o f  b l o o d  m o n o c y t e s  
i n t o  t h e  a l v e o l a r  c o m p a r t m e n t .  T h e  p r o - i n ﬂ a m m a t o r y  a n d  
n e u t r o p h i l - a t t r a c t a n t  c h e m o k i n e  C I N C - 1  w e r e  i n c r e a s e d  i n  
p a r a l l e l  b u t  d i d  n o t  e x c e e d  M C P - 1 .  B o t h  p a r a m e t e r s  w e r e  
a s s e s s e d  a s  p r e d i c t i v e  m a r k e r s  f o r  e a r l y  p u l m o n a r y  i n ﬂ a m -
m a t i o n  a n d  m a c r o p h a g e  r e c r u i t m e n t  i n t o  t h e  l u n g s  i n  p r e -
v i o u s  i n h a l a t i o n  s t u d i e s  t e s t i n g  1 4  d i f f e r e n t  n a n o m a t e r i a l s  
( L a n d s i e d e l  e t  a l .  2 0 1 4 ) .  H o w e v e r ,  M C P - 1  w a s  t h e  o n l y  
c e l l  m e d i a t o r ,  w h i c h  c o u l d  b e  c o r r e l a t e d  w i t h  t h e  p r o g r e s -
s i o n  o f  a l v e o l a r  h i s t i o c y t o s i s  i n  h i s t o p a t h o l o g y .  C o n s i s t -
e n t l y  t o  a s c e n d i n g  g r a d i n g s  a n d  i n c i d e n c e s  i n  h i s t o p a t h o l -
o g y  a f t e r  4  w e e k s  e x p o s u r e ,  M C P - 1  l e v e l s  w e r e  h i g h e r  
i n c r e a s e d  a f t e r  4  w e e k s  t h a n  5  d a y s  o f  e x p o s u r e .  T h e  o t h e r  
c e l l  m e d i a t o r s  w e r e  n o t  a b l e  t o  p r e d i c t  o r  i n d i c a t e  a n y  o f  
t h e  o b s e r v e d  m o r p h o l o g i c a l  c h a n g e s .  T h e  c y t o k i n e  M - C S F  
i s  a  m a r k e r  f o r  t h e  d i f f e r e n t i a t i o n  o f  m o n o c y t e s  i n t o  h i s t i o -
c y t e s .  P r o d u c e d  b y  m a c r o p h a g e s ,  i t  m a y  b e  r e s p o n s i b l e  f o r  
i n c r e a s e s  i n  m a c r o p h a g e  n u m b e r s  ( L a n d s i e d e l  e t  a l .  2 0 1 4 ) ,  
b u t  w a s  n o t  i n c r e a s e d  o v e r a l l .  O s t e o p o n t i n  i s  k n o w n  t o  b e  
i n v o l v e d  i n  p u l m o n a r y  g r a n u l o m a  d e v e l o p m e n t  i n  r o d e n t s  
( C h i b a  e t  a l .  2 0 0 0 ) ,  b u t  w a s  n o t  i n c r e a s e d  i n  o u r  s t u d i e s ,  
a l t h o u g h  a  g r a n u l o m a t o u s  i n ﬂ a m m a t i o n  w a s  o b s e r v e d .
I n  B A L F ,  m a c r o p h a g e s  c o u n t s  w e r e  n o t  e l e v a t e d  s i g -
n i ﬁ c a n t l y .  H o w e v e r ,  i n c r e a s e  i n  a l v e o l a r  m a c r o p h a g e  
n u m b e r ,  d i f f e r e n t  s t a g e s  o f  ( r e c r u i t e d ,  a c t i v a t e d ,  h i g h l y  
p a r t i c l e  l o a d e d ,  d e s t r o y e d )  m a c r o p h a g e s ,  a n d  g r a n u l o m a -
t o u s  i n ﬂ a m m a t i o n  w a s  a p p a r e n t  i n  h i s t o p a t h o l o g y .  T h i s  
d i s c r e p a n c y  b e t w e e n  m a c r o p h a g e  n u m b e r s  i n  B A L F  a n d  
h i s t o p a t h o l o g y  d u r i n g  a n  i n ﬂ a m m a t o r y  s t a t e  i n  t h e  l u n g s  
w a s  a l r e a d y  r e c o g n i z e d  i n  d i f f e r e n t  o t h e r  i n h a l a t i o n  s t u d -
i e s  ( P o r t e r  e t  a l .  2 0 0 2 ,  2 0 0 7 ) .  M o s t  p r o b a b l y ,  t h e  l u n g  
m a c r o p h a g e s  w e r e  n o t  d e t a c h e d  a n d  w a s h e d  o u t  u s i n g  
t h e  l a v a g e  t e c h n i q u e  w i t h  o n l y  t w o  w a s h e s  i n  o u r  s t u d i e s  
( H e n d e r s o n  2 0 0 5 ) .  O t h e r  s t u d i e s  w i t h  C e r i a  r e p o r t e d  h i g h e r  
m a c r o p h a g e  c o u n t s  i n  B A L F  u s i n g  t h e  s a m e  o r  a  h i g h e r  
n u m b e r  o f  w a s h e s  ( G o s e n s  e t  a l .  2 0 1 3 ;  M a  e t  a l .  2 0 1 1 ) .  
T h e  B A L  m e t h o d  u s e d  i n  t h e  h e r e - p r e s e n t e d  s t u d i e s  i s  
h i g h l y  s t a n d a r d i z e d  a n d  y i e l d s  h i g h l y  r e p r o d u c i b l e  r e s u l t s  
c o m p a r e d  t o  m o r e  r i g o r o u s  l a v a g e  t e c h n i q u e s  b u t  i s  o b v i -
o u s l y  n o t  c a p a b l e  o f  d e t a c h i n g  m o r e  s e s s i l e  m a c r o p h a g e s  
o f  t h e  l u n g .  H e n c e ,  n e u t r o p h i l  c o u n t s  i n  B A L F  w e r e  u s e d  
a s  s e n s i t i v e  p a r a m e t e r  t o  i n d i c a t e  a n  i n ﬂ a m m a t o r y  r e s p o n s e  
( H e n d e r s o n  2 0 0 5 ;  H e n d e r s o n  e t  a l .  1 9 7 9 a ,  b ) .
F i g .  7   D o s e – r e s p o n s e  c u r v e s  u s i n g  d i f f e r e n t  d o s e  m e t r i c s  a f t e r  
5  d a y s  o f  e x p o s u r e  t o  0 . 5  a n d  2 5  m g / m
3
 C e r i a  N M - 2 1 1  a n d  0 . 5 ,  5 ,  
a n d  2 5  m g / m
3
 C e r i a  N M - 2 1 2 ;  a  m a s s ,  b  s u r f a c e ,  c  v o l u m e
5 4
P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
A r c h  T o x i c o l  
1  3
I n  p a t h o l o g y ,  l u n g  w e i g h t s  w e r e  i n c r e a s e d  i n  t h e  s t u d i e s  
w i t h  5  d a y s  ( 2 5  m g / m
3
 C e r i a  N M - 2 1 1 )  a n d  4  w e e k s  ( 5  a n d  
2 5  m g / m
3
 C e r i a  N M - 2 1 2 )  o f  e x p o s u r e .  B y  l i g h t  m i c r o s -
c o p y ,  C e r i a  p a r t i c l e s  w e r e  p r i m a r i l y  s e e n  e x t r a c e l l u l a r l y  
a n d  i n t r a - a l v e o l a r  o r  e n g u l f e d  b y  a l v e o l a r  m a c r o p h a g e s .  
D i f f e r e n t  t o  o b s e r v a t i o n s  a f t e r  i n h a l a t i o n  t o  o t h e r  n a n o p a r -
t i c l e s  s u c h  a s  T i t a n i a ,  C e r i a  w a s  n o t  d e t e c t e d  w i t h i n  a l v e o -
l a r  e p i t h e l i a l  c e l l s  i n  t h e  c u r r e n t  s t u d y  ( W a r h e i t  a n d  H a r t -
s k y  1 9 9 3 ) .  T h i s  s u p p o r t s  t h e  h y p o t h e s i s  t h a t  m a c r o p h a g e  
a c t i v a t i o n  a n d  i m m o b i l i z a t i o n  t o g e t h e r  w i t h  c y t o k i n e  a n d  
ﬁ b r o g e n i c  e f f e c t s  m a y  b e  t h e  m o d e  o f  a c t i o n  f o r  m i c r o -
s c a l e  C e r i a  i n h a l a t i o n  t o x i c i t y  [ E n v i r o n m e n t a l  P r o t e c t i o n  
A g e n c y  ( E P A )  2 0 0 9 ] .  F u r t h e r m o r e ,  a p o p t o s i s  o f  a l v e o l a r  
m a c r o p h a g e s ,  t h e i r  s t i m u l a t i o n  ( p r o - i n ﬂ a m m a t o r y  c y t o k i n e  
a n d  R O S  r e l e a s e ) ,  a n d  s w i t c h  f r o m  t h e  i n ﬂ a m m a t o r y  M 1  t o  
a  ﬁ b r o t i c  M 2  t y p e  w a s  s h o w n  b y  t h e  i n t e r a c t i o n  o f  n a n o -
C e r i a  w i t h  t h e s e  c e l l s  a f t e r  a n  i n t r a t r a c h e a l  i n s t i l l a t i o n  
s t u d y  w i t h  r a t s  ( M a  e t  a l .  2 0 1 1 ) .
A t  t h e  l o w e s t  c o n c e n t r a t i o n  o f  0 . 5  m g / m
3
 i n  t h e  p r e s e n t  
s t u d i e s ,  t h e  h i s t o p a t h o l o g i c a l  ﬁ n d i n g s  a l v e o l a r  h i s t i o c y t o s i s  
a n d  p a r t i c l e s ,  e i t h e r  f r e e  o r  w i t h i n  m a c r o p h a g e s ,  r e ﬂ e c t  a n  
e x p e c t e d  p h y s i o l o g i c a l  r e s p o n s e  ( B r a i n  e t  a l .  1 9 7 6 ) .  H o w -
e v e r ,  a f t e r  4  w e e k s  o f  e x p o s u r e ,  t h e  a l v e o l a r  h i s t i o c y t o s i s  
h a d  p r o g r e s s e d  t o  a  m u l t i f o c a l  g r a n u l o m a t o u s  i n ﬂ a m m a t i o n  
a t  5  m g / m
3
 a n d  a t  2 5  m g / m
3
 w i t h i n  4  w e e k s  a f t e r  t h e  e n d  o f  
e x p o s u r e .  T h e  c o m b i n a t i o n  o f  m o d e r a t e  a l v e o l a r  h i s t i o c y -
t o s i s  w i t h  p a r t i c l e s  a n d  t h e  p r e s e n c e  o f  e o s i n o p h i l i c  m a t e -
r i a l ,  p o t e n t i a l l y  p r e c u r s o r s  o f  g r a n u l o m a t o u s  i n ﬂ a m m a t i o n ,  
a r e  t h u s  c o n s i d e r e d  t o  b e  a d v e r s e .  G r a n u l o m a t o u s  i n ﬂ a m -
m a t i o n ,  m u l t i f o c a l  m i c r o g r a n u l o m a s ,  o r  g r a n u l o m a s  d u e  t o  
i n h a l a t i o n  o f  n a n o - C e r i a  h a v e  p r e v i o u s l y  b e e n  r e p o r t e d  i n  
a  n u m b e r  o f  a n i m a l  s t u d i e s  ( S r i n i v a s  e t  a l .  2 0 1 1 ;  C h o  e t  a l .  
2 0 1 0 ;  S n i p e s  1 9 8 9 ;  A a l a p a t i  e t  a l .  2 0 1 4 ) .  G r a n u l o m a t o u s  
i n ﬂ a m m a t i o n  r e p r e s e n t s  o n e  t y p e  o f  c h r o n i c  i n ﬂ a m m a t i o n  
w h i c h  i s  c h a r a c t e r i z e d  b y  i n ﬂ a m m a t o r y  l e s i o n s  w i t h  l a r g e  
n u m b e r s  o f  m a c r o p h a g e s  f o r m i n g  i n t e r l a c i n g  p a l i s a d e s ,  
l y m p h o c y t e s ,  a n d  p l a s m a  c e l l s  ( R e n n e  e t  a l .  2 0 0 9 ) .  O t h e r  
c e l l s  o f  t h e  m o n o n u c l e a r  p h a g o c y t e  s y s t e m  ( e p i t h e l i o i d  
a n d  m u l t i n u c l e a t e d  c e l l s )  a l s o  c o n t r i b u t e  t o  m a i n t a i n  t h e  
i n ﬂ a m m a t o r y  p r o c e s s .  H o w e v e r ,  i n  t h e  p r e s e n t  s t u d i e s ,  l a t e r  
s t a g e s  o f  g r a n u l o m a  f o r m a t i o n ,  t r a n s f o r m a t i o n  o f  m a c -
r o p h a g e s  t o  e p i t h e l i o i d ,  o r  g i a n t  c e l l s  w e r e  n o t  o b s e r v e d .  
H o w e v e r ,  g r a n u l o m a t o u s  i n ﬂ a m m a t i o n  c a n  l e a d  t o  t i s s u e  
d a m a g e  a n d  ﬁ b r o s i s  a t  l a t e r  s t a g e s  a s  o b s e r v e d  b y  M a  e t  a l .  
4  w e e k s  a f t e r  a  s i n g l e  i n t r a t r a c h e a l  i n s t i l l a t i o n  o f  7  m g / k g  
n a n o - C e r i a  i n  r a t s  ( M a  e t  a l .  2 0 1 4 ) .
C o n c e r n i n g  t h e  t w o  d i f f e r e n t  m e t h o d s  ( B A L  a n d  h i s t o -
p a t h o l o g y )  i n  t h e  s t u d y  w i t h  4  w e e k s  o f  e x p o s u r e ,  B A L F  
p a r a m e t e r s  s h o w e d  a  r e g r e s s i o n  d u r i n g  t h e  p o s t - e x p o s u r e  
p e r i o d .  H i s t o p a t h o l o g i c a l  ﬁ n d i n g s ,  i n  c o n t r a s t ,  p r o g r e s s e d  
a f t e r  t h e  e n d  o f  t h e  e x p o s u r e  a t  c o n c e n t r a t i o n s  o f  5  m g / m
3
 
C e r i a  a n d  a b o v e .  A  r e g r e s s i o n  o f  t h e  B A L F  p a r a m e t e r  ( e . g . ,  
n e u t r o p h i l s )  a n d  a  c e r t a i n  p r o g r e s s i o n  o f  h i s t o p a t h o l o g i c a l  
ﬁ n d i n g s  d u r i n g  t h e  p o s t - e x p o s u r e  w e r e  a l r e a d y  r e c o g n i z e d  
i n  p r e v i o u s  w o r k s  w i t h  C e r i a  ( G o s e n s  e t  a l .  2 0 1 3 ;  S r i n i -
v a s  e t  a l .  2 0 1 1 ) .  I t  w a s  c o n c l u d e d  t h a t  d u r i n g  a  s u s t a i n e d  
i n ﬂ a m m a t i o n  i n  t h e  l u n g s ,  p a r a m e t e r s  i n  B A L F  d o  n o t  r e p -
r e s e n t  t h e  c u r r e n t  i n ﬂ a m m a t o r y  s t a t e  a n d  d a m a g e  i n  t h e  
l u n g s .
L y m p h a t i c  c l e a r a n c e  o f  i n h a l e d  C e r i a  v i a  t h e  l y m p h a t i c  
v e s s e l s  f r o m  t h e  p u l m o n a r y  r e g i o n  t o  t h e  l u n g - a s s o c i a t e d  
l y m p h  n o d e s  w a s  d e m o n s t r a t e d  b y  h i s t o l o g i c a l  e v a l u a t i o n s  
a n d  c o n ﬁ r m e d  b y  m e a s u r e d  C e r i u m  l y m p h  n o d e  b u r d e n s .  
A c c u m u l a t i o n  o f  f r e e  p a r t i c l e s  o r  p a r t i c l e s  w i t h i n  m a c -
r o p h a g e  a g g r e g a t e s  w a s  d e t e c t e d  i n  t h e  B A L T  o r  m e d i a s t i -
n a l  a n d  t r a c h e o b r o n c h i a l  l y m p h  n o d e s .  I n c r e a s i n g  C e r i u m  
c l e a r a n c e  i n t o  t h e  l u n g - a s s o c i a t e d  l y m p h  n o d e s  w a s  c o r -
r e l a t e d  w i t h  a n  i n c r e a s e  i n  g r a d i n g  a n d  s e v e r i t y  o f  m a c -
r o p h a g e  a g g r e g a t e s  d u r i n g  t h e  p o s t - e x p o s u r e  p e r i o d  ( s e e  
p a t h o l o g i c a l  s c o r e ,  T a b l e  4 ) .  M o d e r a t e  m a c r o p h a g e  a g g r e -
g a t e s  w i t h  p a r t i c l e s  i n  t h e  l u n g - a s s o c i a t e d  l y m p h  n o d e s ,  
c o m b i n e d  w i t h  l y m p h o - r e t i c u l o c e l l u l a r  h y p e r p l a s i a ,  w e r e  
c o n s i d e r e d  t o  b e  a d v e r s e .  I t  i s  m o r e  l i k e l y  t h a t  t h e  p a r t i c l e s  
r e a c h e d  t h e  a s s o c i a t e d  l y m p h  n o d e s  b y  p h a g o c y t i z i n g  m a c -
r o p h a g e s  t h a n  b y  e n t e r i n g  t h e  i n t e r s t i t i u m .
A e r o s o l  c o n c e n t r a t i o n s  o f  5  a n d  2 5  m g / m
3
 c a u s e d  
i n ﬂ a m m a t o r y  e f f e c t s  i n  t h e  l u n g ,  w h i c h  c a n  b e  c o n s i d e r e d  
a d v e r s e .  A t  0 . 5  m g / m
3
,  s l i g h t  e f f e c t s  w e r e  s t i l l  d e t e c t e d  b y  
B A L F  a f t e r  5  d a y s  o f  e x p o s u r e  b u t  n o t  b y  h i s t o p a t h o l o g y  o r  
a f t e r  4  w e e k s  o f  e x p o s u r e .  B A L F  p a r a m e t e r s  p r o v e d  t o  b e  
m o r e  s e n s i t i v e  t o  s h o r t - t e r m  e f f e c t s  b u t  l e s s  p r e d i c t i v e  f o r  
t h e  p r o g r e s s i o n  o f  t h e s e  e f f e c t s .
T h e  o b s e r v a t i o n s  o f  t h e  c u r r e n t  s t u d y  r e s e m b l e  t h e  ﬁ n d -
i n g s  o f  p r e v i o u s l y  p u b l i s h e d  i n h a l a t i o n  ( a n d  i n s t i l l a t i o n )  
s t u d i e s  w i t h  d i f f e r e n t  C e r i a  ( G o s e n s  e t  a l .  2 0 1 3 ;  M a  e t  a l .  
2 0 1 1 ;  D e m o k r i t o u  e t  a l .  2 0 1 2 ;  A a l a p a t i  e t  a l .  2 0 1 4 ) .  I n  
a n  2 8 - d a y  i n h a l a t i o n  s t u d y  w i t h  t h e  C e r i a  N M - 2 1 2 ,  G o s -
e n s  e t  a l .  ( 2 0 1 3 )  o b s e r v e d  p u l m o n a r y  e f f e c t s  a t  a n  a e r o -
s o l  c o n c e n t r a t i o n  e q u i v a l e n t  t o  2 . 5  m g / m
3
.  T h e s e  e f f e c t s  
w e r e  l e s s  p r o n o u n c e d  c o m p a r e d  t o  t h e  c u r r e n t  s t u d y .  T h e  
d o s e - e q u i v a l e n t  c o n c e n t r a t i o n  o f  2 . 5  m g / m
3
 w a s  a c h i e v e d  
b y  t h e  e x p o s u r e  o f  t h e  a n i m a l s  t o  5 0  m g / m
3
 f o r  d i f f e r e n t  
d a i l y  e x p o s u r e  d u r a t i o n s ,  w h e r e a s  t h e  s t u d i e s  r e p o r t e d  
h e r e  e x p o s e d  a n i m a l s  t o  a c t u a l  0 . 5 ,  5 ,  a n d  2 5  m g / m
3
 f o r  
6  h / d a y .  T h e  d i f f e r e n c e  i n  d a i l y  e x p o s u r e  t i m e s  a n d  d o s e  
r a t e  m a y  a c c o u n t  f o r  t h e  d i f f e r e n c e s  i n  t h e  s e v e r i t y  o f  t h e  
e f f e c t s .  A a l a p a t i  e t  a l .  ( 2 0 1 4 )  o b s e r v e d  p u l m o n a r y  i n ﬂ a m -
m a t i o n ,  n e c r o s i s ,  ﬁ b r o s i s ,  a n d  g r a n u l o m a s  i n  t h e  l u n g  o f  
m i c e  e x p o s e d  t o  2  m g / m
3
 n a n o - C e r i a  f o r  1 4  a n d  2 8  d a y s  
r e s u l t i n g  i n  a  b u r d e n  o f  1 , 2 0 0  m g / g  l u n g  a f t e r  e x p o s u r e  f o r  
2 8  d a y s .  R a t s  e x p o s e d  f o r  4  w e e k s  i n  t h e  s t u d y  r e p o r t e d  
h e r e  i n h a l e d  1 2 . 5 - f o l d  h i g h e r  a e r o s o l  c o n c e n t r a t i o n s ,  w h i c h  
y i e l d e d  a  l u n g  b u r d e n  o f  a r o u n d  3 , 0 0 0  μ g / l u n g  ( e q u i v a -
l e n t  t o  2 , 7 3 0  μ g / g  l u n g )  a n d  r e s u l t e d  i n  l e s s  m o r p h o l o g i c a l  
c h a n g e s .  T h e  r e s u l t s  o f  t h e  2  m g / m
3
 C e r i a  i n h a l a t i o n  s t u d y  
t o  m i c e  l e a v e  o p e n  q u e s t i o n s  w h i c h  n e e d  t o  b e  d i s c u s s e d .
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P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
 A r c h  T o x i c o l
1  3
S y s t e m i c  e f f e c t s
S u b s t a n c e - r e l a t e d  a d v e r s e  e f f e c t s  a f t e r  i n h a l a t i o n  e x p o -
s u r e  t o  t w o  C e r i a  i n  t h e  s h o r t - t e r m  s t u d i e s  w e r e  l i m i t e d  
t o  t h e  l u n g .  P o t e n t i a l  s y s t e m i c  g e n o t o x i c i t y  w a s  a s s e s s e d  
b y  m i c r o n u c l e i  t e s t  ( M N T ) .  T h e  M N T  i s  a  f r e q u e n t l y  u s e d  
g e n o t o x i c i t y  t e s t  o n  n a n o m a t e r i a l s  ( O e s c h  a n d  L a n d s -
i e d e l  2 0 1 2 ) .  T h i s  i n  v i v o  a s s a y  i s  a b l e  t o  d e m o n s t r a t e  t h e  
p o t e n t i a l  i n t e r a c t i o n  o f  n a n o m a t e r i a l s  w i t h  c h r o m o s o m e s  
o r  m i t o t i c  a p p a r a t u s  o f  r e p l i c a t i n g  e r y t h r o b l a s t s  a s  w e l l  
a s  t h e i r  i n ﬂ u e n c e  o n  e r y t h r o p o i e s i s  i n  t h e  b o n e  m a r r o w  
( L e B a r o n  e t  a l .  2 0 1 3 ) .  N o  g e n o t o x i c  p o t e n t i a l  a f t e r  i n h a -
l a t i o n  o f  C e r i a  N M - 2 1 1  o r  N M - 2 1 2  w a s  o b s e r v e d  i n  b o t h  
s h o r t - t e r m  s t u d i e s .  C e r i u m  b o n e  m a r r o w  c o n t e n t  w a s  n o t  
d e t e r m i n e d  i n  o u r  i n h a l a t i o n  s t u d i e s ,  b u t  a  t i s s u e  c o n c e n t r a -
t i o n  o f  6 . 6 1  n g / g  b o n e  m a r r o w  w a s  r e p o r t e d  7  d a y s  a f t e r  
i n t r a t r a c h e a l  i n s t i l l a t i o n  o f  1  m g / k g  o f  n e u t r o n - a c t i v a t e d  
C e r i a  N M - 2 1 2  ( M o l i n a  e t  a l .  2 0 1 4 ) .  C e r i a  i n h a l a t i o n  e x p o -
s u r e  h a s  b e e n  r e p o r t e d  t o  r e s u l t  i n  a  w i d e  r a n g e  o f  s y s t e m i c  
r e s p o n s e s  r a n g i n g  f r o m  n o  e f f e c t s  t o  s e v e r e  e f f e c t s  i n  b l o o d  
o r  e x t r a p u l m o n a r y  o r g a n s ,  s u c h  a s  l i v e r  o r  k i d n e y s  ( A a l a -
p a t i  e t  a l .  2 0 1 4 ;  G o s e n s  e t  a l .  2 0 1 3 ;  S r i n i v a s  e t  a l .  2 0 1 1 ) .  
I n  t h e  s t u d y  r e p o r t e d  h e r e ,  5  d a y s  o f  e x p o s u r e  t o  2 5  m g / m
3
 
( r e t a i n e d  l u n g  b u r d e n  o f  0 . 5 3  m g )  r e s u l t e d  i n  h i g h e r  a b s o -
l u t e  a n d  r e l a t i v e  n e u t r o p h i l  c e l l  c o u n t s  i n  t h e  b l o o d ,  w i t h -
o u t  a n  i n c r e a s e  i n  t o t a l  c e l l  c o u n t s .  T h i s  s l i g h t  n e u t r o p h i l i a  
w a s  d e t e c t e d  d i r e c t l y  a f t e r  t h e  e n d  o f  e x p o s u r e  a n d  w a s  n o  
l o n g e r  p r e s e n t  a f t e r  3  w e e k s  o f  p o s t - e x p o s u r e .  C o n s i d e r -
i n g  t h e  p r o n o u n c e d  i n ﬂ a m m a t i o n  i n  t h e  l u n g  a t  2 5  m g / m
3
,  
t h e  n e u t r o p h i l i a  i n  b l o o d  w a s  c o n s i d e r e d  t o  b e  s e c o n d a r y  
t o  t h e  l o c a l  e f f e c t s  ( s y s t e m i c  a c u t e - p h a s e  r e s p o n s e ) .  T h e  
i n ﬂ a m m a t o r y  r e s p o n s e  i n  t h e  l u n g  b a s e d  o n  t h e  i n c r e a s e  
i n  n e u t r o p h i l  c o u n t s  i n  B A L F  w a s  a l s o  l o w e r  a f t e r  4  w e e k s  
c o m p a r e d  t o  5  d a y s  o f  e x p o s u r e .  A n d  n o  a l t e r e d  b l o o d  
p a r a m e t e r s  c o u l d  b e  d e t e c t e d  a f t e r  4  w e e k s  o f  i n h a l a t i o n  
e x p o s u r e .  F u r t h e r m o r e ,  a  w h o l e  p a n e l  o f  e x t r a p u l m o n a r y  
o r g a n s  a n d  t i s s u e s  w a s  e x a m i n e d  h i s t o l o g i c a l l y  a s  r e q u i r e d  
b y  O E C D  t e s t  g u i d e l i n e  4 1 2 .  V e r y  l o w  C e r i u m  c o n t e n t s  
w e r e  d e t e c t e d  i n  t h e  l i v e r  a t  t w o  t i m e  p o i n t s  a f t e r  4  w e e k s  
o f  i n h a l a t i o n  e x p o s u r e  t o  2 5  m g / m
3
 C e r i a  N M - 2 1 2  ( w h i c h  
i s  a  g e n e r a l  ﬁ n d i n g  f o r  i n h a l e d  n a n o p a r t i c l e s )  w i t h o u t  a n y  
r e l a t e d  m o r p h o l o g i c a l  a b n o r m a l i t i e s .  N o n e  o f  t h e  o t h e r  
e x t r a p u l m o n a r y  o r g a n s  s h o w e d  a n y  m o r p h o l o g i c a l  a b n o r -
m a l i t i e s .  T h e  a b s e n c e  o f  s y s t e m i c  e f f e c t s  i s  c o n s i s t e n t  w i t h  
t h e  v e r y  l o w  e x t r a p u l m o n a r y  t i s s u e  C e r i a  c o n c e n t r a t i o n s  
i n  t h i s  a n d  o t h e r  s t u d i e s  ( G o s e n s  e t  a l .  2 0 1 3 ;  G e r a e t s  e t  a l .  
2 0 1 2 ;  M o l i n a  e t  a l .  2 0 1 4 ) .  A f t e r  i n s t i l l a t i o n  o f  1  m g / k g  
b o d y  w e i g h t  n e u t r o n - a c t i v a t e d  
1 4 1
C e r  N M - 2 1 2 ,  o n l y  0 . 3  %  
o f  t h e  a d m i n i s t e r e d  d o s e  w a s  f o u n d  i n  t h e  l i v e r  a f t e r  2 8  d a y s  
p o s t - i n s t i l l a t i o n  ( M o l i n a  e t  a l .  2 0 1 4 ) .  H o w e v e r ,  a f t e r  a  s i n -
g l e  i n t r a v e n o u s  ( i . v . )  a d m i n i s t r a t i o n  o f  3 0  n m  n a n o - C e r i a  
( 8 7  m g / k g  b o d y  w e i g h t )  i n t o  r a t s ,  o x i d a t i v e  s t r e s s  w a s  s e e n  
i n  l i v e r  a n d  s p l e e n  a n d  g r a n u l o m a s  w e r e  o b s e r v e d  i n  t h e  
l i v e r  ( Y o k e l  e t  a l .  2 0 1 2 ) .  T h e  C e r i a - i n d u c e d  a d v e r s e  e f f e c t s  
w e r e  e x p l a i n e d  b y  m e c h a n i c a l  i r r i t a t i o n  o r  i t s  c h e m i c a l  
( c a t a l y t i c )  a c t i v i t y  ( Y o k e l  e t  a l .  2 0 1 2 ) .  T h e  h i g h  C e r i u m  
c o n c e n t r a t i o n s  i n  t h e  l i v e r  a f t e r  i . v .  a d m i n i s t r a t i o n  w e r e  
f a r  b e y o n d  t h e  c o n c e n t r a t i o n s  a c h i e v a b l e  b y  o r a l ,  d e r m a l ,  
o r  i n h a l a t i o n  e x p o s u r e .  I n  c o n t r a s t ,  s e v e r e  s y s t e m i c  ﬁ n d -
i n g s  w e r e  r e p o r t e d  i n  m i c e  a f t e r  2 8 - d a y  i n h a l a t i o n  e x p o -
s u r e  t o  2  m g / m
3
 n a n o - C e r i a  p l u s  2 8  d a y s  o f  p o s t - e x p o s u r e  
( l u n g  b u r d e n  o f  5 0 0  m g / g  t i s s u e ) .  T h e  ﬁ n d i n g s  c o m p r i s e d  
n e c r o s i s  i n  k i d n e y s ,  h e p a t o c y t o m e g a l y ,  a n d  c y t o p l a s m a t i c  
v a c u o l i z a t i o n  i n  t h e  h e a r t  ( A a l a p a t i  e t  a l .  2 0 1 4 ) ,  w h i c h  w a s  
c l a i m e d  t o  b e  a s s o c i a t e d  w i t h  m o d e r a t e  a c c u m u l a t i o n  o f  
C e r i u m  i n  e x t r a p u l m o n a r y  o r g a n s .  H o w e v e r ,  e v e n  i . v .  i n j e c -
t i o n  o f  h i g h  d o s e s  o f  C e r i a  d i d  n o t  l e a d  t o  s i m i l a r  c h a n g e s  
i n  r a t  k i d n e y  a n d  h e a r t  ( Y o k e l  e t  a l .  2 0 1 2 ) .
C o m p a r i s o n  o f  N M - 2 1 1  w i t h  N M - 2 1 2
T h e  e f f e c t s  o f  t w o  d i f f e r e n t  C e r i a  ( N M - 2 1 1  a n d  N M - 2 1 2 )  
w e r e  c o m p a r e d  a f t e r  5  d a y s  o f  i n h a l a t i o n  e x p o s u r e .  C e r i a  
N M - 2 1 1  a n d  N M - 2 1 2  h a v e  i d e n t i c a l  c o m p o s i t i o n ,  a g g l o m -
e r a t i o n  s t a t e ,  c r y s t a l l i n i t y ,  a n d  i n s o l u b i l i t y .  C o m p a r e d  t o  
C e r i a  N M - 2 1 2 ,  N M - 2 1 1  h a s  c o n s i d e r a b l y  s m a l l e r  p r i m a r y  
p a r t i c l e s ,  l a r g e r  s p e c i ﬁ c  s u r f a c e ,  s i g n i ﬁ c a n t l y  f e w e r  o r g a n i c  
c o n t a m i n a t i o n s  o n  t h e  s u r f a c e ,  a n d  r e d u c e d  p h o t o c a t a l y t i c  
a c t i v i t y .  D e s p i t e  t h e s e  d i f f e r e n c e s ,  C e r i a  N M - 2 1 1  a n d  
N M - 2 1 2  s h a r e  t h e  s a m e  t e n d e n c y  t o  r e c r y s t a l l i z e  i n  a c i d i c  
P S F ,  w h i c h  s i m u l a t e s  t h e  l y s o s o m e  o f  m a c r o p h a g e s .  T h e s e  
p r o p e r t i e s  a r e  c o m p a r a b l e  t o  e a c h  o t h e r ,  b u t  s i g n i ﬁ c a n t l y  
d i f f e r e n t  f r o m  o t h e r  m e t a l  o x i d e  n a n o m a t e r i a l s  a n d  s e e m  
t o  b e  p r i m a r i l y  s u b s t a n c e - r e l a t e d  t h e m s e l v e s .  C o m p a r e d  
t o  C e r i a  N M - 2 1 2 ,  C e r i a  N M - 2 1 1  e l i c i t e d  h i g h e r  i n c r e a s e s  
i n  l y m p h o c y t e s ,  c e l l  m e d i a t o r s  ( e . g . ,  M C P - 1 ) ,  a n d  n e u t r o -
p h i l s  i n  B A L F  a t  2 5  m g / m
3
 w i t h  a  s l o w e r  r e c o v e r y  d u r i n g  
t h e  p o s t - e x p o s u r e  p e r i o d .  M o r e o v e r ,  s i g n i ﬁ c a n t  i n c r e a s e  
i n  l u n g  w e i g h t s  w a s  n o t e d  i n  a n i m a l s  e x p o s e d  t o  2 5  m g /
m
3
 C e r i a  N M - 2 1 1 ,  b u t  n o t  N M - 2 1 2 .  W h e n  b i o l o g i c a l  
e f f e c t s  ( e . g . ,  i n ﬂ a m m a t i o n )  o f  t w o  p a r t i c l e s  a r e  c o m p a r e d ,  
t h e  l u n g  b u r d e n  m a y  b e  m o r e  a p p r o p r i a t e l y  e x p r e s s e d  a s  
p a r t i c l e  v o l u m e ,  p a r t i c l e  s u r f a c e  a r e a  ( O b e r d o r s t e r  e t  a l .  
1 9 9 4 b ) .  M o r r o w  ﬁ r s t  i n t r o d u c e d  v o l u m e  a s  d o s e  m e t r i c  f o r  
o v e r l o a d  ( M o r r o w  1 9 8 8 ) .  P a u l u h n  m o d i ﬁ e d  t h e  o v e r l o a d  
h y p o t h e s i s  b y  i n t r o d u c i n g  a g g l o m e r a t e  d e n s i t y  ( i n s t e a d  o f  
p h y s i c a l  d e n s i t y )  i n t o  t h e  c a l c u l a t i o n  o f  v o l u m e t r i c  l o a d i n g  
( P a u l u h n  2 0 1 1 ) .  T h e  e f f e c t i v e  p a r t i c l e  d e n s i t y  i s  n e e d e d  t o  
c a l c u l a t e  t h e  p a r t i c l e  v o l u m e .  I n  a  g u i d a n c e  d o c u m e n t  p u b -
l i s h e d  b y  W e b b  ( 2 0 0 1 ) ,  v a r i o u s  d e ﬁ n i t i o n s  o f  t h e  p o w d e r  
v o l u m e s  a r e  g i v e n  ( e . g . ,  a p p a r e n t  d e n s i t y  a n d  t a p p i n g  d e n -
s i t y ) .  I n  t h e  c u r r e n t  s t u d y ,  a n  a g g l o m e r a t e  d e n s i t y  o f  2  g /
c m
3
 f o r  N M - 2 1 2  a n d  0 . 6  g / c m
3
 f o r  N M - 2 1 1  w a s  s e l e c t e d .  
T h e  d e n s i t i e s  w e r e  e x t r a c t e d  b y  i n t e g r a t i n g  t h e  p o r o s i t y  
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P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
A r c h  T o x i c o l  
1  3
b e l o w  1  μ m  ( f r o m  H g  i n t r u s i o n  p o r o s i m e t r y )  a n d  t h e n  
d e r i v e d  e m p i r i c a l l y  b y  a p p r o a c h i n g  M P P D  m o d e l  c a l c u l a -
t i o n s  t o g e t h e r  w i t h  m e a s u r e d  m a s s  l u n g  b u r d e n .  A c c o r d -
i n g  t o  o u r  c a l c u l a t i o n ,  v o l u m e t r i c  l u n g  o v e r l o a d  c a n  o n l y  
b e  a s s u m e d  a f t e r  4  w e e k s  e x p o s u r e  t o  2 5  m g / m
3
.  I m p a i r e d  
l u n g  c l e a r a n c e — w h i c h  i s  o n e  o f  t h e  c o n s e q u e n c e s  o f  l u n g  
o v e r l o a d  c o n d i t i o n s — w a s ,  h o w e v e r ,  a l r e a d y  o b s e r v e d  a f t e r  
i n h a l a t i o n  o f  5  m g / m
3
 C e r i a .
I t  i s  n o t  f u l l y  u n d e r s t o o d  w h i c h  c h a r a c t e r i s t i c s  o f  n a n o -
C e r i a  l e a d  t o  t h e  e f f e c t s  o b s e r v e d  i n  p r e v i o u s  a n d  c u r r e n t  
s t u d i e s  [ E n v i r o n m e n t a l  P r o t e c t i o n  A g e n c y  ( E P A )  2 0 0 9 ] .  
A s s e s s i n g  t h e  i m m u n e  t o x i c i t y  o f  a n o t h e r  m e m b e r  o f  t h e  
g r o u p  o f  p o o r l y  s o l u b l e  p a r t i c l e  n a m e l y  T i t a n i a  a f t e r  i n s t i l -
l a t i o n  i n  r a t s ,  l o w e r  p h a g o c y t i c  a b i l i t y  a n d  d i s r u p t i o n  o f  
p u l m o n a r y  a l v e o l a r  m a c r o p h a g e  f u n c t i o n  w e r e  c o r r e l a t e d  
w i t h  s u r f a c e  r e a c t i v i t y  a n d  s i z e  o f  s u r f a c e  a r e a  ( L i u  e t  a l .  
2 0 1 0 ) .  A  n u m b e r  o f  s t u d i e s  o v e r  t h e  p a s t  1 5  y e a r s  s u g g e s t e d  
t h a t  t h e  s m a l l e r  t h e  p a r t i c l e  s i z e  ( t h e  g r e a t e r  t h e  s u r f a c e  
a r e a  d o s e ) ,  t h e  g r e a t e r  t h e  i n d u c e d  i n ﬂ a m m a t o r y  r e s p o n s e  
( O b e r d o r s t e r  e t  a l .  1 9 9 4 a ;  C u l l e n  e t  a l .  2 0 0 0 ;  S a g e r  a n d  
C a s t r a n o v a  2 0 0 9 ;  S a g e r  e t  a l .  2 0 0 8 ) .  F u r t h e r m o r e ,  s u r f a c e  
a r e a  o f  r e t a i n e d  p a r t i c l e s  s e e m s  t o  c o r r e l a t e  w i t h  a c u t e  
i n ﬂ a m m a t o r y  r e a c t i o n s  a f t e r  i n h a l a t i o n .  T h e  c o r r e l a t i o n  o f  
l u n g  b u r d e n ,  e x p r e s s e d  a s  m a s s ,  v o l u m e ,  a n d  s u r f a c e  a r e a ,  
a n d  n e u t r o p h i l  ( P M N )  c o u n t s  i n  B A L F  a s  p a r a m e t e r  f o r  
b i o l o g i c a l  e f f e c t s  i s  p r e s e n t e d  i n  F i g .  7  ( T a b l e  S 9 ) .
I n  t h e  p r e s e n t  s t u d y  w i t h  5  d a y s  o f  e x p o s u r e ,  t h e  l a r g e r  
s p e c i ﬁ c  s u r f a c e  a r e a  o f  C e r i a  N M - 2 1 1  s e e m s  t o  c o n t r i b -
u t e  t o  t h e  h i g h e r  b i o l o g i c a l  a c t i v i t y  a s  c o m p a r e d  t o  C e r i a  
N M - 2 1 2 .  S u r f a c e  a r e a  n o r m a l i z e d  t h e  d o s e  r e s p o n s e  o f  t h e  
t w o  C e r i a  m a t e r i a l s .  T h i s  r e s u l t  i s  c o n s i s t e n t  w i t h  o t h e r  
s t u d i e s ,  w h i c h  u s e d  s u r f a c e  a r e a  a s  d o s e  m e t r i c  t o  q u a n t i f y  
t h e  t o x i c i t y  o f  t h e  P S P s  T i t a n i a  a n d  b a r i u m  s u l f a t e  ( T r a n  
e t  a l .  2 0 0 0 ;  O b e r d o r s t e r  e t  a l .  1 9 9 4 a ,  b ) .
C o m p a r i s o n  o f  5  d a y s  a n d  4  w e e k s  o f  e x p o s u r e
R a t s  w e r e  e x p o s e d  t o  C e r i a  N M - 2 1 2  f o r  5  d a y s  a n d  
4  w e e k s .  E x p o s u r e  t o  2 5  m g / m
3
 f o r  5  d a y s  r e s u l t e d  i n  t h e  
s a m e  l u n g  b u r d e n  a s  4  w e e k s  o f  e x p o s u r e  t o  5  m g / m
3
.  I n  
c o n s i d e r a t i o n  o f  t h e  s a m e  l u n g  b u r d e n s ,  t h e  d o s e  r a t e s  
a r e  1 0 6  μ g  ( 5  d a y s  o f  e x p o s u r e  t o  2 5  m g / m
3
)  a n d  2 6  μ g /
d a y  ( 4  w e e k s  o f  e x p o s u r e  t o  5  m g / m
3
)  ( s e e  T a b l e  5 ) .  O n e  
s h o u l d  n o t e  t h a t  t h e  c a l c u l a t e d  d o s e  r a t e s  s t i l l  i n c l u d e  t h e  
c l e a r a n c e  a n d ,  t h e r e f o r e ,  r e ﬂ e c t  r a t h e r  t h e  r e t a i n e d  t h a n  t h e  
d e p o s i t e d  C e r i a  c o n c e n t r a t i o n  i n  t h e  l u n g .
T h e  d o s e  r a t e  o f  p a r t i c l e s  s e e m s  t o  i n ﬂ u e n c e  t h e  a c u t e  
i n ﬂ a m m a t o r y  r e a c t i o n  i n  t h e  l u n g  ( B a i s c h  e t  a l .  2 0 1 4 ) .  
D e s p i t e  t h e  s a m e  l u n g  b u r d e n s  b u t  d i f f e r e n t  d o s e  r a t e s ,  a  
s t r o n g e r  n e u t r o p h i l  r e s p o n s e  i n  B A L F  w a s  o b s e r v e d  a f t e r  
t h e  s h o r t e r  e x p o s u r e  t i m e  ( F i g s .  8 ,  9 ) .  T h e  d e c a y  i n  n e u -
t r o p h i l  n u m b e r s  a f t e r  4  w e e k s  w a s  b y  f a r  s l o w e r  t h a n  a f t e r  
5  d a y s ,  s u g g e s t i n g  t h a t  i n ﬂ a m m a t i o n  d e v e l o p i n g  a t  l o w e r  
d o s e  r a t e  i s  l o n g e r  l a s t i n g  a n d  m o r e  p e r s i s t e n t .  M o r e o v e r ,  
B A L F  e f f e c t s  a l m o s t  c o m p l e t e l y  r e g r e s s e d  a f t e r  t h e  e n d  o f  
t h e  5  d a y s  e x p o s u r e  t o  5  m g / m
3
 e v e n  t h o u g h  t h e  l u n g  b u r -
d e n  w a s  o n l y  c l e a r e d  b y  a b o u t  1 0  %  ( F i g .  9 ) .
H e n c e ,  t h e  d o s e  r a t e  r a t h e r  t h a n  t h e  l u n g  b u r d e n  s e e m s  
t o  d r i v e  t h e  n e u t r o p h i l  c o u n t  i n  B A L F  ( F i g .  9 ;  T a b l e  5 ) .
N e u t r o p h i l s  a r e  o n e  o f  t h e  ﬁ r s t  c e l l  t y p e s  r e c r u i t e d  b y  
i n ﬂ a m m a t o r y  s i g n a l s  e v o k e d  b y  d e p o s i t e d  p a r t i c l e s  i n  t h e  
l u n g ,  w i t h  p e a k  n u m b e r s  w i t h i n  4 8  h  ( A l b e r  e t  a l .  2 0 1 2 ) .  
N e u t r o p h i l s  i n  B A L F  a r e  a  s e n s i t i v e  m e a s u r e  o f  t h i s  i n i t i a l  
p h a s e .  W i t h  s u s t a i n e d  i n ﬂ a m m a t o r y  c o n d i t i o n s ,  n e u t r o p h i l  
r e c r u i t m e n t  u n d e r g o e s  a  c e r t a i n  p h y s i o l o g i c a l  a d a p t a t i o n  
i n  t h e  b o d y .  T h e  n u m b e r  o f  n e u t r o p h i l s  o b s e r v e d  i n  B A L F  
w a s  d e c r e a s i n g  a n d  s u p p l e m e n t e d  b y  m o n o n u c l e a r  c e l l s ,  
e s p e c i a l l y  m a c r o p h a g e s  t h a t  w e r e  v i s i b l e  i n  h i s t o p a t h o l -
o g y  b u t  n o t  i n  B A L F .  T h e  s u s t a i n e d  p r e s e n c e  o f  p a r t i c l e s  
i n  t h e  l u n g  c a n  d r i v e  m a c r o p h a g e s  t o  f o r m  g r a n u l o m a t o u s  
l e s i o n s .  A l t h o u g h  a  s m a l l  d o s e  r a t e  o v e r  a  l o n g  e x p o s u r e  
t i m e  a c h i e v e d  t h e  s a m e  l u n g  b u r d e n  a s  a  h i g h  d o s e  r a t e  
o v e r  a  s h o r t  t i m e  p e r i o d ,  t h e  e f f e c t s  o b s e r v e d  m a y  b e  m o r e  
s e v e r e  d u e  t o  c o n s i s t e n t  i r r i t a t i o n  o f  t h e  t i s s u e  b y  s m a l l  
d o s e  r a t e s  o f  f r e s h  m a t e r i a l s .  A p p a r e n t l y ,  t h e  i n i t i a l  n e u t r o -
p h i l  r e a c t i o n  i s  d i r e c t e d  b y  t h e  d o s e  r a t e  w h i l e  t h e  p r o g r e s -
s i o n  o f  t h e  i n ﬂ a m m a t i o n  i n  t h e  l u n g  i s  a l s o  d r i v e n  b y  t h e  
c o n t i n u i n g  p r e s e n c e  o f  p a r t i c l e s  i n  t h e  l u n g .
C o n c l u s i o n
I n h a l e d  n a n o - C e r i a  w a s  d e p o s i t e d  i n  t h e  l u n g .  T h e  p a r -
t i c l e s  w e r e  c l e a r e d  f r o m  t h e  l u n g  w i t h  a  r e t e n t i o n  h a l f -
t i m e  o f  4 0  d a y s  a t  a  c o n c e n t r a t i o n  o f  0 . 5  m g / m
3
;  h i g h e r  
a e r o s o l  c o n c e n t r a t i o n s  i m p a i r e d  t h i s  c l e a r a n c e .  A  s m a l l e r  
T a b l e  5   D o s e  r a t e  o f  C e r i a  
N M - 2 1 2
a
 L u n g  b u r d e n  v a l u e s  a f t e r  
5  d a y s  o f  e x p o s u r e  ( 5  d a y s  
e x p o s u r e )  a n d  2  d a y s  a f t e r  
t h e  e n d  o f  e x p o s u r e  ( 4  w e e k s  
e x p o s u r e )
S t u d y T e s t  s u b s t a n c e C o n c e n t r a t i o n  ( m g / m
3
) L u n g  b u r d e n
a
 ( μ g ) D o s e  r a t e  ( μ g / d a y )
5  d a y s  ( 5  e x p o s u r e s ) C e r i a  N M - 2 1 2 0 . 5 1 1 2 . 2
5 1 0 0 2 0
2 5 5 3 0 1 0 6
4  w e e k s  ( 2 0  e x p o s u r e s ) C e r i a  N M - 2 1 2 0 . 5 4 1 2 . 0 5
5 5 2 0 2 6
2 5 2 , 6 2 0 1 3 1
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P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
 A r c h  T o x i c o l
1  3
f r a c t i o n  o f  t h e  p a r t i c l e s  w a s  t r a n s f e r r e d  t o  t h e  l u n g - a s s o -
c i a t e d  l y m p h  n o d e s .  T h e  i n i t i a l  i n ﬂ a m m a t o r y  r e a c t i o n  
w a s  o b s e r v e d  b y  a n  i n c r e a s e  i n  n e u t r o p h i l s  w h i c h  c o r r e -
l a t e d  w i t h  d o s e  r a t e  r a t h e r  t h a n  a b s o l u t e  l u n g  b u r d e n .  W i t h  
t i m e ,  t h e  n e u t r o p h i l  n u m b e r  d e c r e a s e d .  T h e  d e c r e a s e  w a s  
o b s e r v e d  a f t e r  t h e  e x p o s u r e  e n d e d  b u t  a l s o  w i t h  s u s t a i n e d  
e x p o s u r e  ( l o n g e r  t h a n  5  d a y s  i n  t h e  c u r r e n t  s t u d i e s ) .  I n  t h e  
l a t e r  p h a s e  ( a f t e r  4  w e e k s  o f  e x p o s u r e ) ,  t h e  i n ﬂ a m m a t o r y  
r e a c t i o n  w a s  d o m i n a t e d  b y  m o n o n u c l e a r  c e l l s ,  e s p e c i a l l y  
m a c r o p h a g e s .  T h e  i n ﬂ a m m a t o r y  r e s p o n s e  w a s  d r i v e n  b y  
t h e  s u r f a c e  o f  t h e  p a r t i c l e s  p r e s e n t e d  t o  t h e  l u n g ,  a s  t h i s  w a s  
t h e  d o s e  m e t r i c s  w i t h  t h e  b e s t  c o r r e l a t i o n  o f  t h e  t w o  C e r i a  
m a t e r i a l s .  A n  a e r o s o l  c o n c e n t r a t i o n  o f  0 . 5  m g / m
3
 d i d  n o t  
c a u s e  i n ﬂ a m m a t o r y  r e s p o n s e s  i n  t h e  l u n g .  5  m g / m
3
 w a s  t h e  
l o w e s t  a e r o s o l  c o n c e n t r a t i o n  a t  w h i c h  t h e  e a r l y  a s  w e l l  a s  
t h e  l a t e r  i n ﬂ a m m a t o r y  r e s p o n s e  w a s  o b s e r v e d ,  e v e n  t h o u g h  
l u n g  b u r d e n s  w e r e  d i f f e r e n t  a t  t h e  o n s e t  o f  t h e  t w o  p h a s e s .  
T h e  p r o g r e s s i o n  o f  t h e  l a t e r  i n ﬂ a m m a t o r y  r e a c t i o n  t o w a r d  a  
g r a n u l o m a t o u s  t y p e  d e p e n d e d  o n  t h e  d u r a t i o n  a n d  a m o u n t  
o f  t h e  p a r t i c l e  ( s u r f a c e )  b u r d e n  i n  t h e  l u n g  ( F i g .  1 0 ) .  T h u s ,  
t h e  p o t e n c y  o f  a n  i n h a l e d  p a r t i c l e  t o  i n d u c e  i n ﬂ a m m a t o r y  
r e s p o n s e s  i n  t h e  l u n g  c o u l d  b e  a s s e s s e d  b y  t h e  a e r o s o l  c o n -
c e n t r a t i o n  c a u s i n g  t h e  i n i t i a l  n e u t r o p h i l  r e s p o n s e ,  w h e r e a s  
t h e  l a t e r  g r a n u l o m a t o u s  p h a s e  c o u l d  o n l y  b e  d e t e c t e d  b y  
h i s t o p a t h o l o g y .  T h e  f u r t h e r  p r o g r e s s i o n  o f  t h e  b i o l o g i c a l  
r e s p o n s e  w a s  d e t e r m i n e d  b y  t h e  c o n t i n u i n g  p r e s e n c e  o f  t h e  
p a r t i c l e s  i n  t h e  l u n g .  U l t i m a t e l y ,  t h e  f u r t h e r  p r o g r e s s i o n  o f  
t h e  b i o l o g i c a l  r e s p o n s e s  n e e d s  t o  b e  s t u d i e d  b y  t h e  l o n g -
t e r m  i n h a l a t i o n  s t u d y  a s s e s s i n g  t h e  e f f e c t s  a s  w e l l  a s  t h e  
t i m e  c o u r s e  o f  t h e  l u n g  b u r d e n s .  T h e  r e s u l t s  o f  t h e  s h o r t -
t e r m  s t u d i e s  p r e s e n t e d  h e r e  w e r e  u s e d  t o  s e t  t h e  a e r o s o l  
c o n c e n t r a t i o n s  o f  t h e  l o n g - t e r m  s t u d y  w i t h  C e r i a  w h i c h  i s  
c u r r e n t l y  b e i n g  p e r f o r m e d .  F o u r  a e r o s o l  c o n c e n t r a t i o n s  a r e  
b e i n g  t e s t e d ,  0 . 1 ,  0 . 3 ,  1 ,  a n d  3  m g / m
3
,  e x p e c t e d  t o  r e s u l t  
i n  n o  i n ﬂ a m m a t i o n  a n d  n o  o v e r l o a d  ( t w o  c o n c e n t r a t i o n s ) ,  
F i g .  8   I n ﬂ a m m a t o r y  p o t e n c y  o f  t h e  s h o r t - t e r m  s t u d i e s  w i t h  5  d a y s  
a n d  4  w e e k s  o f  e x p o s u r e  o v e r  p o s t - e x p o s u r e  p e r i o d :  a b s o l u t e  n e u t r o -
p h i l  c o u n t s  i n  B A L F  i n  t h e  s h o r t - t e r m  s t u d i e s :  3  a n d  2 4  d a y s  a f t e r  e n d  
o f  e x p o s u r e  t o  2 5  m g / m
3
 C e r i a  N M - 2 1 1  ( o r a n g e  5 - d a y  e x p o s u r e )  a n d  
N M - 2 1 2  ( l i g h t  b l u e  5 - d a y  e x p o s u r e )  o r  o n e  a n d  3 5  d a y s  a f t e r  t h e  e n d  
o f  e x p o s u r e  t o  2 5  m g / m
3
 N M - 2 1 2  ( d a r k  b l u e  4 - w e e k  e x p o s u r e )
F i g .  9   N e u t r o p h i l  c o u n t s  i n  B A L F  c o r r e l a t e d  w i t h  d e p o s i t e d  p a r t i c l e  
p e r  s u r f a c e  l u n g  a f t e r  5 - d a y  a n d  4 - w e e k  e x p o s u r e  u s i n g  t h e  a e r o s o l  
c o n c e n t r a t i o n s  o f  0 . 5 ,  5 ,  a n d  2 5  m g / m
3
 C e O
2
 N M - 2 1 2  f o r  e a c h  p o i n t
F i g .  1 0   S u m m a r y  o f  r e s u l t s  
a f t e r  5  d a y s  a n d  4  w e e k s  o f  
e x p o s u r e  t o  C e r i a
5  d a y 4  w e e k
4  w e e k
+  4  w e e k
l o n g - t e r m
P M N
d o m i n a t e d
A M
g r a n u l o -
m a t o u s
?
d o s e - r a t e
l u n g
b u r d e n
c l e a r a n c e
d e p o s i t i o n
I N F L A M M A T I O N
A M
a e r o s o l
c o n c .  
>  0 . 5  m g / m ³
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P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
A r c h  T o x i c o l  
1  3
i n ﬂ a m m a t i o n  w i t h o u t  o v e r l o a d ,  a n d  i n ﬂ a m m a t i o n  a n d  
o v e r l o a d ,  r e s p e c t i v e l y .
A c k n o w l e d g m e n t s  T h e  a u t h o r s  w i s h  t o  t h a n k  t h e  i n h a l a t i o n  t e a m  
a n d  p a t h o l o g y  t e a m  o f  B A S F  f o r  t h e i r  e x c e l l e n t  t e c h n i c a l  a s s i s t a n c e  
i n  p e r f o r m i n g  t h e  i n h a l a t i o n  s t u d y ,  t h e  c l i n i c a l ,  a n d  h i s t o p a t h o l o g i -
c a l  e x a m i n a t i o n s .  T h e  s t u d y  w i t h  5  d a y s  o f  e x p o s u r e  ( N M - 2 1 2 )  w a s  
f u n d e d  v i a  t h e  E u r o p e a n  C o m m i s s i o n ’ s  7 t h  F r a m e w o r k  P r o g r a m m e  
p r o j e c t  N a n o M I L E  ( C o n t r a c t  N o .  N M P 4 - L A - 2 0 1 3 - 3 1 0 4 5 1 ) .  T h e  r e s t  
o f  t h e  w o r k  w a s  s p o n s o r e d  b y  B A S F  S E .
C o n f l i c t  o f  i n t e r e s t  B A S F  S E  i s  a  c o m p a n y  p r o d u c i n g  a n d  m a r k e t -
i n g  n a n o m a t e r i a l s .
O p e n  A c c e s s  T h i s  a r t i c l e  i s  d i s t r i b u t e d  u n d e r  t h e  t e r m s  o f  t h e  C r e a -
t i v e  C o m m o n s  A t t r i b u t i o n  L i c e n s e  w h i c h  p e r m i t s  a n y  u s e ,  d i s t r i b u -
t i o n ,  a n d  r e p r o d u c t i o n  i n  a n y  m e d i u m ,  p r o v i d e d  t h e  o r i g i n a l  a u t h o r ( s )  
a n d  t h e  s o u r c e  a r e  c r e d i t e d .
R e f e r e n c e s
A a l a p a t i  S ,  G a n a p a t h y  S ,  M a n a p u r a m  S ,  A n u m o l u  G ,  P r a k y a  B M  
( 2 0 1 4 )  T o x i c i t y  a n d  b i o - a c c u m u l a t i o n  o f  i n h a l e d  c e r i u m  o x i d e  
n a n o p a r t i c l e s  i n  C D 1  m i c e .  N a n o t o x i c o l o g y  8 : 7 8 6 – 7 9 8
A l b e r  A ,  H o w i e  S E M ,  W a l l a c e  W A H ,  H i r a n i  N  ( 2 0 1 2 )  T h e  r o l e  
o f  m a c r o p h a g e s  i n  h e a l i n g  t h e  w o u n d e d  l u n g .  I n t  J  E x p  P a t h o l  
9 3 : 2 4 3 – 2 5 1
A n j i l v e l  S ,  A s g h a r i a n  B  ( 1 9 9 5 )  A  m u l t i p l e - p a t h  m o d e l  o f  p a r t i c l e  d e p -
o s i t i o n  i n  t h e  r a t  l u n g .  F u n d a m  A p p l  T o x i c o l  2 8 : 4 1 – 5 0
B a i s c h  B L ,  C o r s o n  N M ,  W a d e - M e r c e r  P ,  G e l e i n  R ,  K e n n e l l  A J ,  
O b e r d o r s t e r  G ,  E l d e r  A  ( 2 0 1 4 )  E q u i v a l e n t  t i t a n i u m  d i o x i d e  
n a n o p a r t i c l e  d e p o s i t i o n  b y  i n t r a t r a c h e a l  i n s t i l l a t i o n  a n d  w h o l e  
b o d y  i n h a l a t i o n :  t h e  e f f e c t  o f  d o s e  r a t e  o n  a c u t e  r e s p i r a t o r y  t r a c t  
i n ﬂ a m m a t i o n .  P a r t  F i b r e  T o x i c o l  1 1 : 5
B e c k e r  H ,  H e r z b e r g  F ,  S c h u l t e  A ,  K o l o s s a - G e h r i n g  M  ( 2 0 1 1 )  T h e  
c a r c i n o g e n i c  p o t e n t i a l  o f  n a n o m a t e r i a l s ,  t h e i r  r e l e a s e  f r o m  p r o d -
u c t s  a n d  o p t i o n s  f o r  r e g u l a t i n g  t h e m .  I n t  J  H y g  E n v i r o n  H e a l t h  
2 1 4 : 2 3 1 – 2 3 8
B r a i n  J D ,  K n u d s o n  D E ,  S o r o k i n  S P ,  D a v i s  M A  ( 1 9 7 6 )  P u l m o n a r y  
d i s t r i b u t i o n  o f  p a r t i c l e s  g i v e n  b y  i n t r a t r a c h e a l  i n s t i l l a t i o n  o r  b y  
a e r o s o l  i n h a l a t i o n .  E n v i r o n  R e s  1 1 : 1 3 – 3 3
C a p e l l i  A  ( 1 9 9 7 )  L u n g  a l k a l i n e  p h o s p h a t a s e  a s  a  m a r k e r  o f  ﬁ b r o -
s i s  i n  c h r o n i c  i n t e r s t i t i a l  d i s o r d e r s .  A m  J  R e s p i r  C r i t  C a r e  M e d  
1 5 5 ( 1 ) : 2 4 9 – 2 5 3
C a r g n e l l o  M ,  D o a n - N g u y e n  V,  G o r d o n  T ,  D i a z  R ,  S t a c h  E ,  G o r t e  R ,  
F o r n a s i e r o  P ,  M u r r a y  C  ( 2 0 1 3 )  C o n t r o l  o f  m e t a l  n a n o c r y s t a l  s i z e  
r e v e a l s  m e t a l - s u p p o r t  i n t e r f a c e  r o l e  f o r  c e r i a  c a t a l y s t s .  S c i e n c e  
3 4 1 ( 6 1 4 7 ) : 7 7 1 – 7 7 3
C a s s e e  F R ,  v a n  B a l e n  E C ,  S i n g h  C ,  G r e e n  D ,  M u i j s e r  H ,  W e i n s t e i n  J ,  
D r e h e r  K  ( 2 0 1 1 )  E x p o s u r e ,  h e a l t h  a n d  e c o l o g i c a l  e f f e c t s  r e v i e w  
o f  e n g i n e e r e d  n a n o s c a l e  c e r i u m  a n d  c e r i u m  o x i d e  a s s o c i a t e d  w i t h  
i t s  u s e  a s  a  f u e l  a d d i t i v e .  C r i t  R e v  T o x i c o l  4 1 : 2 1 3 – 2 2 9
C h i b a  S ,  R a s h i d  M M ,  O k a m o t o  H ,  S h i r a i w a  H ,  K o n  S ,  M a e d a  M ,  
M u r a k a m i  M ,  I n o b e  M ,  K i t a b a t a k e  A ,  C h a m b e r s  A F ,  U e d e  T  
( 2 0 0 0 )  T h e  r o l e  o f  o s t e o p o n t i n  i n  t h e  d e v e l o p m e n t  o f  g r a n u l o m a -
t o u s  l e s i o n s  i n  l u n g .  M i c r o b i o l  I m m u n o l  4 4 : 3 1 9 – 3 3 2
C h o  W S ,  D u f ﬁ n  R ,  P o l a n d  C A ,  H o w i e  S E M ,  M a c N e e  W ,  B r a d l e y  
M ,  M e g s o n  I L ,  D o n a l d s o n  K  ( 2 0 1 0 )  M e t a l  o x i d e  n a n o p a r t i c l e s  
i n d u c e  u n i q u e  i n ﬂ a m m a t o r y  f o o t p r i n t s  i n  t h e  l u n g :  i m p o r t a n t  
i m p l i c a t i o n s  f o r  n a n o p a r t i c l e  t e s t i n g .  E n v i r o n  H e a l t h  P e r s p e c t  
1 1 8 : 1 6 9 9 – 1 7 0 6
C u l l e n  R T ,  T r a n  C L ,  B u c h a n a n  D ,  D a v i s  J M C ,  S e a r l  A ,  J o n e s  A D ,  
D o n a l d s o n  K  ( 2 0 0 0 )  I n h a l a t i o n  o f  p o o r l y  s o l u b l e  p a r t i c l e s .  I .  
D i f f e r e n c e s  i n  i n ﬂ a m m a t o r y  r e s p o n s e  a n d  c l e a r a n c e  d u r i n g  e x p o -
s u r e .  I n h a l  T o x i c o l  1 2 : 1 0 8 9 – 1 1 1 1
D e m o k r i t o u  P ,  G a s s  S ,  P y r g i o t a k i s  G ,  C o h e n  J M ,  G o l d s m i t h  W ,  
M c K i n n e y  W ,  F r a z e r  D ,  M a  J ,  S c h w e g l e r - B e r r y  D ,  B r a i n  J ,  C a s -
t r a n o v a  V  ( 2 0 1 2 )  A n  i n  v i v o  a n d  i n  v i t r o  t o x i c o l o g i c a l  c h a r a c t e r i -
s a t i o n  o f  r e a l i s t i c  n a n o s c a l e  C e O 2  i n h a l a t i o n  e x p o s u r e s .  N a n o -
t o x i c o l o g y  7 : 1 3 3 8 – 1 3 5 0
D u d e w i c z  E J ,  R a m b e r g  J S ,  C h e n  H J  ( 1 9 7 5 )  N e w  t a b l e s  f o r  m u l t i p l e  
c o m p a r i s o n s  w i t h  a  c o n t r o l  ( u n k n o w n  v a r i a n c e s ) .  B i o m e t r i s c h e  
Z e i t s c h r i f t  1 7 : 1 3 – 2 6
D u n n e t t  C W  ( 1 9 5 5 )  A  M u l t i p l e  c o m p a r i s o n  p r o c e d u r e  f o r  c o m p a r i n g  
s e v e r a l  t r e a t m e n t s  w i t h  a  c o n t r o l .  J  A m  S t a t  A s s o c  5 0 : 1 0 9 6 – 1 1 2 1
E C H A  ( 2 0 1 2 )  G u i d a n c e  o n  i n f o r m a t i o n  r e q u i r e m e n t s  a n d  c h e m i -
c a l  s a f e t y  a s s e s s m e n t :  a p p e n d i x  R 7 - 1  r e c o m m e n d a t i o n s  f o r  
n a n o m a t e r i a l s  a p p l i c a b l e  t o  c h a p t e r  R 7 a — e n d p o i n t  s p e c i ﬁ c  
g u i d a n c e .  E u r p e a n  C h e m i c a l  A g e n c y .  h t t p : / / e c h a . e u r o p a . e u /
d o c u m e n t s / 1 0 1 6 2 / 1 3 6 3 2 / a p p e n d i x _ r 7 a _ n a n o m a t e r i a l s _ e n . p d f
E n v i r o n m e n t a l  P r o t e c t i o n  A g e n c y  ( E P A )  ( 2 0 0 9 )  T o x i c o l o g i c a l  r e v i e w  
o f  c e r i u m  o x i d e  a n d  c e r i u m  c o m p o u n d s ,  R e p o r t ,  E P A / 6 3 5 / R -
0 8 / 0 0 2 F .  E n v i r o n m e n t a l  P r o t e c t i o n  A g e n c y ,  W a s h i n g t o n ,  D C .  
h t t p : / / w w w . e p a . g o v / i r i s / t o x r e v i e w s / 1 0 1 8 t r . p d f , E P A / 6 3 5 / R - 0 8 / 0 0 2 F
E u r o p e a n  C o m m i s s i o n  ( 2 0 1 3 )  C l a s s i ﬁ c a t i o n ,  l a b e l i n g  a n d  p a c k a g i n g  o f  
n a n o m a t e r i a l s  i n  R E A C H  a n d  C L P  ( D o c .  C A / 9 0 / 2 0 0 9  R e v 2 ) .  E u r o -
p e a n  C o m m i s s i o n ,  B r u s s e l s ,  R e p o r t .  h t t p : / / e c . e u r o p a . e u / e n t e r p r i s e /
s e c t o r s / c h e m i c a l s / ﬁ l e s / r e a c h / n a n o s _ i n _ r e a c h _ a n d _ c l p _ e n . p d f
E u r o p e a n  C o m m i s s i o n  ( 2 0 1 4 )  S c i e n c e  a n d  p o l i c y  r e p o r t  b y  t h e  j o i n t  
r e s e a r c h  c e n t r e ,  t h e  E u r o p e a n  C o m m i s s i o n ,  J R C 8 9 8 2 5 ,  E U R  
2 6 6 4 9  E N .  P u b l i c a t i o n s  o f ﬁ c e  o f  t h e  E u r o p e a n  u n i o n ,  L u x e m -
b o u r g .  d o i : 1 0 . 2 7 8 8 / 8 0 2 0 3
F e d e r a l  M i n i s t r y  f o r  t h e  E n v i r o n m e n t  ( 2 0 1 2 )  N C B a N S  L a n g -
z e i t f o r s c h u n g s p r o j e k t  z u r  S i c h e r h e i t  v o n  N a n o m a t e r i a l -
i e n  g e s t a r t e t ,  p r e s s  r e l e a s e  n o .  0 6 6 / 1 2 .  F e d e r a l  M i n i s t r y  
f o r  t h e  E n v i r o n m e n t ,  B e r l i n .  h t t p : / / w w w . b m u b . b u n d . d e / p r
e s s e / p r e s s e m i t t e i l u n g e n / p m / a r t i k e l / l a n g z e i t f o r s c h u n g s p r o j
e k t - z u r - s i c h e r h e i t - v o n - n a n o m a t e r i a l i e n - g e s t a r t e t - 1 /
G a m e r  A O ,  L e i b o l d  E ,  v a n  R a v e n z w a a y  B  ( 2 0 0 6 )  T h e  i n  v i t r o  a b s o r p -
t i o n  o f  m i c r o ﬁ n e  z i n c  o x i d e  a n d  t i t a n i u m  d i o x i d e  t h r o u g h  p o r c i n e  
s k i n .  T o x i c o l  I n  V i t r o  2 0 : 3 0 1 – 3 0 7
G e r a e t s  L ,  O o m e n  A G ,  S c h r o e t e r  J D ,  C o l e m a n  VA ,  C a s s e e  F R  ( 2 0 1 2 )  
T i s s u e  d i s t r i b u t i o n  o f  i n h a l e d  m i c r o -  a n d  n a n o - s i z e d  c e r i u m  
o x i d e  p a r t i c l e s  i n  r a t s :  r e s u l t s  f r o m  a  2 8 - d a y  e x p o s u r e  s t u d y .  T o x -
i c o l  S c i  1 2 7 : 4 6 3 – 4 7 3
G o s e n s  I ,  M a t h i j s s e n  L ,  B o k k e r s  B ,  M u i j s e r  H ,  C a s s e e  F R  ( 2 0 1 3 )  
C o m p a r a t i v e  h a z a r d  i d e n t i ﬁ c a t i o n  o f  n a n o -  a n d  m i c r o - s i z e d  
c e r i u m  o x i d e  p a r t i c l e s  b a s e d  o n  2 8 - d a y  i n h a l a t i o n  s t u d i e s  i n  r a t s .  
N a n o t o x i c o l o g y  8 ( 6 ) : 6 4 3 – 6 5 3
G r e i m  H ,  Z i e g l e r - S k y l a k a k i s  K  ( 2 0 0 7 )  R i s k  a s s e s s m e n t  f o r  b i o p e r s i s -
t e n t  g r a n u l a r  p a r t i c l e s .  I n h a l  T o x i c o l  1 9 ( S u p p l  1 ) : 1 9 9 – 2 0 4
H e  X ,  Z h a n g  H ,  M a  Y,  B a i  W ,  Z h a n g  Z ,  L u  K ,  D i n g  Y Y,  Z h a o  Y L ,  
C h a i  Z  ( 2 0 1 0 )  L u n g  d e p o s i t i o n  a n d  e x t r a p u l m o n a r y  t r a n s l o c a t i o n  
o f  n a n o - c e r i a  a f t e r  i n t r a t r a c h e a l  i n s t i l l a t i o n .  N a n o t e c h n o l o g y  2 1  
( 2 8 ) : 2 8 5 1 0 3
H e i n r i c h  U ,  F u h s t  R ,  R i t t i n g h a u s e n  S ,  C r e u t z e n b e r g  O ,  B e l l m a n n  B ,  
K o c h  M ,  L e v s e n  K  ( 1 9 9 5 )  C h r o n i c  i n h a l a t i o n  e x p o s u r e  o f  W i s t a r  
r a t s  a n d  t w o  d i f f e r e n t  s t r a i n s  o f  m i c e  t o  d i e s e l  e n g i n e  e x h a u s t ,  
c a r b o n  b l a c k ,  a n d  t i t a n i u m  d i o x i d e .  I n h a l  T o x i c o l  7 : 5 3 3 – 5 5 6
H e n d e r s o n  R  ( 1 9 8 4 )  U s e  o f  b r o n c h o a l v e o l a r  l a v a g e  t o  d e t e c t  l u n g  
d a m a g e .  E n v i r o n  H e a l t h  P e r s p e c t  5 6 : 1 1 5 – 1 2 9
H e n d e r s o n  R  ( 2 0 0 5 )  U s e  o f  b r o n c h o a l v e o l a r  l a v a g e  t o  d e t e c t  r e s -
p i r a t o r y  t r a c t  t o x i c i t y  o f  i n h a l e d  m a t e r i a l .  E x p  T o x i c o l  P a t h o l  
5 7 : 1 5 5 – 1 5 9
H e n d e r s o n  R ,  R e b a r  A ,  P i c k r e l l  J A ,  N e w t o n  G J  ( 1 9 7 9 a )  E a r l y  d a m a g e  
i n d i c a t o r s  i n  t h e  l u n g .  3 .  B i o c h e m i c a l  a n d  c y t o l o g i c a l  r e s p o n s e  o f  
t h e  l u n g  t o  i n h a l e d  m e t a l - s a l t s .  T o x i c o l  A p p l  P h a r m a c o l  5 0 : 1 2 3 – 1 3 6
H e n d e r s o n  R ,  R e b a r  A H ,  D e n i c o l a  D B  ( 1 9 7 9 b )  E a r l y  d a m a g e  i n d i -
c a t o r s  i n  t h e  l u n g s .  4 .  B i o c h e m i c a l  a n d  c y t o l o g i c  r e s p o n s e  o f  
5 9
P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
 A r c h  T o x i c o l
1  3
t h e  l u n g  t o  l a v a g e  w i t h  m e t a l - s a l t s .  T o x i c o l  A p p l  P h a r m a c o l  
5 1 : 1 2 9 – 1 3 5
H e r m a n s  J J  ( 1 9 6 3 )  D e n s i t y  g r a d i e n t  c e n t r i f u g a t i o n  o f  a  m i x t u r e  o f  
p o l y m e r s  d i f f e r i n g  i n  m o l e c u l a r  w e i g h t  a n d  s p e c i ﬁ c  v o l u m e .  J  
P o l y m  S c i  P a r t  C  1 : 1 7 9 – 8 6 .  I S S N :  0 0 2 2 - 3 8 3 2
H u s s a i n  S M ,  B r a y d i c h - S t o l l e  L ,  S c h r a n d  A M ,  M u r d o c k  R C ,  Y u  K O ,  
M a t t i e  D M ,  S c h l a g e r  J J ,  T e r r o n e s  M  ( 2 0 0 9 )  T o x i c i t y  e v a l u a t i o n  
f o r  s a f e  u s e  o f  n a n o m a t e r i a l s :  r e c e n t  a c h i e v e m e n t s  a n d  t e c h n i c a l  
c h a l l e n g e s .  A d v  M a t e r  2 1 : 1 – 1 1
I L S I  R i s k  S c i e n c e  I n s t i t u t e  W o r k s h o p  P a r t i c i p a n t s  ( 2 0 0 0 )  T h e  r e l e -
v a n c e  o f  t h e  r a t  l u n g  r e s p o n s e  t o  p a r t i c l e  o v e r l o a d  f o r  h u m a n  r i s k  
a s s e s s m e n t :  a  w o r k s h o p  c o n s e n s u s  r e p o r t .  I n h a l  T o x i c o l  1 2 : 1 – 1 7
K i t t e l  B ,  R u e h l - F e h l e r t  C ,  M o r a w i e t z  G ,  K l a p w i j k  J ,  E l w e l l  M R ,  
L e n z  B ,  O ’ S u l l i v a n  M G ,  R o t h  D R ,  W a d s w o r t h  P F  ( 2 0 0 4 )  R e v i s e d  
g u i d e s  f o r  o r g a n  s a m p l i n g  a n d  t r i m m i n g  i n  r a t s  a n d  m i c e — p a r t  
2 — a  j o i n t  p u b l i c a t i o n  o f  t h e  R I T A  a n d  N A C A D  g r o u p s .  E x p  
T o x i c o l  P a t h o l  5 5 : 4 1 3 – 4 3 1
K r e y l i n g  W ,  S c h e u c h  G  ( 2 0 0 0 )  C l e a r a n c e  o f  p a r t i c l e s  d e p o s i t e d  i n  t h e  
l u n g s .  I n :  G e h r  P ,  H e y d e r  J  ( e d s )  P a r t i c l e  l u n g  i n t e r a c t i o n s ,   c h a p  
7 .  C R C  P r e s s ,  p p  3 2 3 – 3 7 6
K r e y l i n g  W G ,  F e r r o n  G A ,  H a i d e r  B  ( 1 9 8 6 )  M e t a b o l i c - f a t e  o f  i n h a l e d  
c o  a e r o s o l s  i n  b e a g l e  d o g s .  H e a l t h  P h y s  5 1 : 7 7 3 – 7 9 5
K u h l b u s c h  T A ,  A s b a c h  C ,  F i s s a n  H ,  G ö h l e r  D ,  S t i n t z  M  ( 2 0 1 1 )  N a n o -
p a r t i c l e  e x p o s u r e  a t  n a n o t e c h n o l o g y  w o r k p l a c e s :  a  r e v i e w .  P a r t  
F i b r e  T o x i c o l  8 ( 1 ) : 2 2
L a n d s i e d e l  R ,  F a b i a n  E ,  M a - H o c k  L ,  W o h l l e b e n  W ,  W i e n c h  K ,  O e s c h  
F ,  v a n  R a v e n z w a a y  B  ( 2 0 1 2 )  T o x i c o - / b i o k i n e t i c s  o f  n a n o m a t e r i -
a l s .  A r c h  T o x i c o l  8 6 : 1 0 2 1 – 1 0 6 0
L a n d s i e d e l  R ,  M a - H o c k  L ,  H o f m a n n  T ,  W i e m a n n  M ,  S t r a u s s  V,  T r e u -
m a n n  S ,  W o h l l e b e n  W ,  G r o e t e r s  S ,  W i e n c h  K ,  v a n  R a v e n z w a a y  B  
( 2 0 1 4 )  A p p l i c a t i o n  o f  s h o r t - t e r m  i n h a l a t i o n  s t u d i e s  t o  a s s e s s  t h e  
i n h a l a t i o n  t o x i c i t y  o f  n a n o m a t e r i a l s .  P a r t  F i b r e  T o x i c o l  1 1 : 1 6
L e B a r o n  M J ,  S c h i s l e r  M R ,  T o r o u s  D K ,  D e r t i n g e r  S D ,  G o l l a p u d i  
B B  ( 2 0 1 3 )  I n ﬂ u e n c e  o f  c o u n t i n g  m e t h o d o l o g y  o n  e r y t h r o c y t e  
r a t i o s  i n  t h e  m o u s e  m i c r o n u c l e u s  t e s t .  E n v i r o n  M o l  M u t a g e n  
5 4 : 2 2 2 – 2 2 8
L e e  K P ,  T r o c h i m o w i c z  H J ,  R e i n h a r d t  C F  ( 1 9 8 5 )  P u l m o n a r y  r e s p o n s e  
o f  r a t s  e x p o s e d  t o  t i t a n i u m  d i o x i d e  ( T i O 2 )  b y  i n h a l a t i o n  f o r  t w o  
y e a r s .  T o x i c o l  A p p l  P h a r m a c o l  7 9 : 1 7 9 – 1 9 2
L i u  R ,  Z h a n g  X Y,  P u  Y P ,  Y i n  L H ,  L i  Y H ,  Z h a n g  X Q ,  L i a n g  G Y,  L i  
X B ,  Z h a n g  J  ( 2 0 1 0 )  S m a l l - s i z e d  t i t a n i u m  d i o x i d e  n a n o p a r t i c l e s  
m e d i a t e  i m m u n e  t o x i c i t y  i n  r a t  p u l m o n a r y  a l v e o l a r  m a c r o p h a g e s  
i n  v i v o .  J  N a n o s c i  N a n o t e c h n o l  1 0 : 5 1 6 1 – 5 1 6 9
M a  J Y,  Z h a o  H ,  M e r c e r  R R ,  B a r g e r  M ,  R a o  M ,  M e i g h a n  T ,  S c h w e -
g l e r - B e r r y  D ,  C a s t r a n o v a  V,  M a  J K  ( 2 0 1 1 )  C e r i u m  o x i d e  n a n -
o p a r t i c l e - i n d u c e d  p u l m o n a r y  i n ﬂ a m m a t i o n  a n d  a l v e o l a r  m a c -
r o p h a g e  f u n c t i o n a l  c h a n g e  i n  r a t s .  N a n o t o x i c o l o g y  5 ( 3 ) : 3 1 2 – 3 2 5
M a  J ,  Y o u n g  S ,  M e r c e r  R ,  B a r g e r  M ,  S c h w e g l e r - B e r r y  D ,  M a  J K ,  
C a s t r a n o v a  V  ( 2 0 1 4 )  I n t e r a c t i v e  e f f e c t s  o f  c e r i u m  o x i d e  a n d  d i e -
s e l  e x h a u s t  n a n o p a r t i c l e s  i n  i n d u c i n g  p u l m o n a r y  ﬁ b r o s i s .  T o x i c o l  
A p p l  P h a r m a c o l
M a - H o c k  L ,  G a m e r  A O ,  L a n d s i e d e l  R ,  L e i b o l d  E ,  F r e c h e n  T ,  S e n s  
B ,  L i n s e n b u e h l e r  M ,  v a n  R a v e n z w a a y  B  ( 2 0 0 7 )  G e n e r a t i o n  a n d  
c h a r a c t e r i z a t i o n  o f  t e s t  a t m o s p h e r e s  w i t h  n a n o m a t e r i a l s .  I n h a l  
T o x i c o l  1 9 : 8 3 3 – 8 4 8
M a - H o c k  L ,  B u r k h a r d  S ,  S t r a u s s  V,  G a m e r  A O ,  W i e n c h  K ,  v a n  
R a v e n z w a a y  B ,  L a n d s i e d e l  R  ( 2 0 0 9 )  D e v e l o p m e n t  o f  a  s h o r t -
t e r m  i n h a l a t i o n  t e s t  i n  t h e  r a t  u s i n g  n a n o - t i t a n i u m  d i o x i d e  a s  a  
m o d e l  s u b s t a n c e .  I n h a l  T o x i c o l  2 1 : 1 0 2 – 1 1 8
M o l i n a  R M ,  K o n d u r u  N ,  J i m e n e z  R ,  W o h l l e b e n  W ,  B r a i n  J D  ( 2 0 1 4 )  
B i o a v a i l a b i l i t y ,  d i s t r i b u t i o n  a n d  c l e a r a n c e  o f  t r a c h e a l l y  i n s t i l l e d ,  
g a v a g e d  o r  i n j e c t e d  c e r i u m  d i o x i d e  n a n o p a r t i c l e s  a n d  i o n i c  
c e r i u m .  N a n o  E n v i r o n  S c i  ( s u b m i t t e d )
M o r r o w  P E  ( 1 9 8 8 )  P o s s i b l e  m e c h a n i s m s  t o  e x p l a i n  d u s t  o v e r l o a d i n g  
o f  t h e  l u n g s .  F u n d a m  A p p l  T o x i c o l  1 0 : 3 6 9 – 3 8 4
N a l a b o t u  S K ,  K o l l i  M B ,  T r i e s t  W E ,  M a  J Y,  M a n n e  N D P K ,  K a t t a  A ,  
A d d a g a r l a  H S ,  R i c e  K M ,  B l o u g h  E R  ( 2 0 1 1 )  I n t r a t r a c h e a l  i n s t i l -
l a t i o n  o f  c e r i u m  o x i d e  n a n o p a r t i c l e s  i n d u c e s  h e p a t i c  t o x i c i t y  i n  
m a l e  S p r a g u e – D a w l e y  r a t s .  I n t  J  N a n o m e d  6 : 2 3 2 7 – 2 3 3 5
N i k u l a  K J ,  S n i p e s  M B ,  B a r r  E B ,  G r i f ﬁ t h  W C ,  H e n d e r s o n  R F ,  M a u d -
e r l y  J L  ( 1 9 9 5 )  C o m p a r a t i v e  p u l m o n a r y  t o x i c i t i e s  a n d  c a r c i n o -
g e n i c i t i e s  o f  c h r o n i c a l l y  i n h a l e d  d i e s e l  e x h a u s t  a n d  c a r b o n  b l a c k  
i n  F 3 4 4  r a t s .  F u n d a m  A p p l  T o x i c o l  2 5 : 8 0 – 9 4
O b e r d o r s t e r  G  ( 2 0 0 2 )  T o x i c o k i n e t i c s  a n d  e f f e c t s  o f  ﬁ b r o u s  a n d  n o n ﬁ -
b r o u s  p a r t i c l e s .  I n h a l  T o x i c o l  1 4 : 2 9 – 5 6
O b e r d o r s t e r  G ,  F e r i n  J ,  L e h n e r t  B E  ( 1 9 9 4 a )  C o r r e l a t i o n  b e t w e e n  p a r -
t i c l e  s i z e ,  i n  v i v o  p a r t i c l e  p e r s i s t e n c e ,  a n d  l u n g  i n j u r y .  E n v i r o n  
H e a l t h  P e r s p e c t  1 0 2 ( S u p p l .  5 ) : 1 7 3 – 1 7 9
O b e r d o r s t e r  G ,  F e r i n  J ,  S o d e r h o l m  S C ,  G e l e i n  R ,  C o x  C ,  B a g g s  R ,  
M o r r o w  P E  ( 1 9 9 4 b )  I n c r e a s e d  p u l m o n a r y  t o x i c i t y  o f  i n h a l e d  
u l t r a ﬁ n e  p a r t i c l e s :  d u e  t o  l u n g  o v e r l o a d  a l o n e ?  A n n  O c c u p  H y g  
3 8 : 2 9 5 – 3 0 2
O b e r d ö r s t e r  G ,  O b e r d ö r s t e r  E ,  O b e r d ö r s t e r  J  ( 2 0 0 5 )  N a n o t o x i c o l o g y :  
a n  e m e r g i n g  d i s c i p l i n e  e v o l v i n g  f r o m  s t u d i e s  o f  u l t r a ﬁ n e  p a r t i -
c l e s .  E n v i r o n  H e a l t h  P e r s p e c t  1 1 3 : 8 2 3 – 8 3 9
O e s c h  F ,  L a n d s i e d e l  R  ( 2 0 1 2 )  G e n o t o x i c i t y  i n v e s t i g a t i o n s  o n  n a n o -
m a t e r i a l s .  A r c h  T o x i c o l  8 6 : 9 8 5 – 9 9 4
O r g a n i s a t i o n  f o r  E c o n o m i c  C o o p e r a t i o n  a n d  D e v e l o p m e n t  ( O E C D )  
( 1 9 9 8 )  O E C D  p r i n c i p l e s  o n  g o o d  l a b o r a t o r y  p r a c t i c e  ( a s  r e v i s e d  
i n  1 9 9 7 ) .  E N V / M C / C H E M ( 9 8 ) 1 7 .  O r g a n i s a t i o n  f o r  E c o n o m i c  
C o o p e r a t i o n  a n d  D e v e l o p m e n t ,  P a r i s
O E C D  ( 2 0 0 9 a )  T e s t  n o .  4 5 3 :  c o m b i n e d  c h r o n i c  t o x i c i t y / c a r c i n o g e n i c -
i t y  s t u d i e s ,  O E C D  g u i d e l i n e s  f o r  t h e  t e s t i n g  o f  c h e m i c a l s ,  s e c t  4 .  
O E C D  P u b l i s h i n g .  d o i : 1 0 . 1 7 8 7 / 9 7 8 9 2 6 4 0 7 1 2 2 3 - e n
O r g a n i z a t i o n  f o r  E c o n o m i c  C o o p e r a t i o n  a n d  D e v e l o p m e n t  ( O E C D )  
( 2 0 0 9 b )  T e s t  N o .  4 1 2 :  S u b a c u t e  i n h a l a t i o n  t o x i c i t y :  2 8 - d a y  s t u d y ,  
O E C D  G u i d e l i n e s  f o r  t h e  t e s t i n g  o f  c h e m i c a l s ,  s e c t  4 ,  O E C D  
P u b l i s h i n g .  d o i : 1 0 . 1 7 8 7 / 9 7 8 9 2 6 4 0 7 0 7 8 3 - e n
O E C D  ( 2 0 1 0 )  L i s t  o f  m a n u f a c t u r e d  n a n o m a t e r i a l s  a n d  l i s t  o f  e n d -
p o i n t s  f o r  p h a s e  o n e  o f  t h e  O E C D  t e s t i n g  p r o g r a m m e .  S e r i e s  o n  
t h e  s a f e t y  o f  m a n u f a c t u r e d  n a n o m a t e r i a l s ,  e n v i r o n m e n t  d i r e c t o -
r a t e  O E C D ,  P a r i s ,  R e p o r t  E N V / J M / M O N O ( 2 0 1 0 ) 4 6 .  h t t p : / / w w w
. o e c d . o r g / o f ﬁ c i a l d o c u m e n t s / p u b l i c d i s p l a y d o c u m e n t p d f / ? c o t e = e n
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P a u l u h n  J  ( 2 0 1 1 )  P o o r l y  s o l u b l e  p a r t i c u l a t e s :  s e a r c h i n g  f o r  a  u n i f y i n g  
d e n o m i n a t o r  o f  n a n o p a r t i c l e s  a n d  ﬁ n e  p a r t i c l e s  f o r  D N E L  e s t i m a -
t i o n .  T o x i c o l o g y  2 7 9 : 1 7 6 – 1 8 8
P ﬂ u c k e r  F ,  W e n d e l  V,  H o h e n b e r g  H ,  G a r t n e r  E ,  W i l l  T ,  P f e i f f e r  S ,  
W e p f  R ,  G e r s - B a r l a g  H  ( 2 0 0 1 )  T h e  h u m a n  s t r a t u m  c o r n e u m  
l a y e r :  a n  e f f e c t i v e  b a r r i e r  a g a i n s t  d e r m a l  u p t a k e  o f  d i f f e r e n t  
f o r m s  o f  t o p i c a l l y  a p p l i e d  m i c r o n i s e d  t i t a n i u m  d i o x i d e .  S k i n  
P h a r m a c o l  A p p l  S k i n  P h y s i o l  1 4 : 9 2 – 9 7
P o r t e r  D W ,  Y e  J ,  M a  J ,  B a r g e r  M ,  R o b i n s o n  VA ,  R a m s e y  D ,  M c L a u -
r i n  J ,  K h a n  A ,  L a n d s i t t e l  D ,  T e a s s  A ,  C a s t r a n o v a  V  ( 2 0 0 2 )  T i m e  
c o u r s e  o f  p u l m o n a r y  r e s p o n s e  o f  r a t s  t o  i n h a l a t i o n  o f  c r y s t a l l i n e  
s i l i c a :  N F - k a p p a  B  a c t i v a t i o n ,  i n ﬂ a m m a t i o n ,  c y t o k i n e  p r o d u c t i o n ,  
a n d  d a m a g e .  I n h a l  T o x i c o l  1 4 : 3 4 9 – 3 6 7
P R O S P E c T :  E c o t o x i c o l o g y  T e s t  P r o t o c o l s  f o r  R e p r e s e n t a -
t i v e  N a n o m a t e r i a l s  i n  S u p p o r t  o f  t h e  O E C D S p o n s o r s h i p  
P r o g r a m m e  ( 2 0 1 0 )  T o x i c o l o g i c a l  r e v i e w  o f  n a n o  c e r i u m  
o x i d e .  h t t p : / / w w w . n a n o t e c h i a . o r g / s i t e s / d e f a u l t / ﬁ l e s / ﬁ l e s /
P R O S P E C T _ N a n o - C e O 2 _ L i t e r a t u r e _ R e v i e w . p d f
P o r t e r  D W ,  H u b b s  A F ,  B a r o n  P A ,  M i l l e c c h i a  L L ,  W o l f a r t h  M G ,  B a t -
t e l l i  L A ,  S c h w e g l e r - B e r r y  D E ,  B e i g h l e y  C M ,  A n d r e w  M E ,  C a s -
t r a n o v a  V  ( 2 0 0 7 )  P u l m o n a r y  t o x i c i t y  o f  E x p a n c e l  m i c r o s p h e r e s  
i n  t h e  r a t .  T o x i c o l  P a t h o l  3 5 : 7 0 2 – 7 1 4
R e n n e  R ,  B r i x  A ,  H a r k e m a  J ,  H e r b e r t  R ,  K i t t e l  B ,  L e w i s  D ,  M a r c h  
T ,  N a g a n o  K ,  P i n o  M ,  R i t t i n g h a u s e n  S ,  R o s e n b r u c h  M ,  T e l l i e r  
P ,  W o h r m a n n  T  ( 2 0 0 9 )  P r o l i f e r a t i v e  a n d  n o n p r o l i f e r a t i v e  l e s i o n s  
o f  t h e  r a t  a n d  m o u s e  r e s p i r a t o r y  t r a c t .  T o x i c o l  P a t h o l  3 7 : 5 S – 7 3 S
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P a p e r  1 :  T i m e  c o u r s e  o f  l u n g  r e t e n t i o n  a n d  t o x i c i t y  o f  i n h a l e d  p a r t i c l e s :  
s h o r t - t e r m  e x p o s u r e  t o  n a n o - C e r i a
A r c h  T o x i c o l  
1  3
R u e h l - F e h l e r t  C ,  K i t t e l  B ,  M o r a w i e t z  G ,  D e s l e x  P ,  K e e n a n  C ,  M a h r t  
C R ,  N o l t e  T ,  R o b i n s o n  M ,  S t u a r t  B P ,  D e s c h l  U  ( 2 0 0 3 )  R e v i s e d  
g u i d e s  f o r  o r g a n  s a m p l i n g  a n d  t r i m m i n g  i n  r a t s  a n d  m i c e — p a r t  
1 — a  j o i n t  p u b l i c a t i o n  o f  t h e  R I T A  a n d  N A C A D  g r o u p s .  E x p  
T o x i c o l  P a t h o l  5 5 : 9 1 – 1 0 6
S a g e r  T M ,  C a s t r a n o v a  V  ( 2 0 0 9 )  S u r f a c e  a r e a  o f  p a r t i c l e  a d m i n i s t e r e d  
v e r s u s  m a s s  i n  d e t e r m i n i n g  t h e  p u l m o n a r y  t o x i c i t y  o f  u l t r a ﬁ n e  
a n d  ﬁ n e  c a r b o n  b l a c k :  c o m p a r i s o n  t o  u l t r a ﬁ n e  t i t a n i u m  d i o x i d e .  
P a r t  F i b r e  T o x i c o l  6 : 1 5
S a g e r  T M ,  K o m m i n e n i  C ,  C a s t r a n o v a  V  ( 2 0 0 8 )  P u l m o n a r y  r e s p o n s e  
t o  i n t r a t r a c h e a l  i n s t i l l a t i o n  o f  u l t r a ﬁ n e  v e r s u s  ﬁ n e  t i t a n i u m  d i o x -
i d e :  r o l e  o f  p a r t i c l e  s u r f a c e  a r e a .  P a r t  F i b r e  T o x i c o l  5 : 1 7
S n i p e s  M B  ( 1 9 8 9 )  L o n g - t e r m  r e t e n t i o n  a n d  c l e a r a n c e  o f  p a r t i c l e s  
i n h a l e d  b y  m a m m a l i a n - s p e c i e s .  C r i t  R e v  T o x i c o l  2 0 : 1 7 5 – 2 1 1
S r i n i v a s  A ,  R a o  P J ,  S e l v a m  G ,  M u r t h y  P B ,  R e d d y  P N  ( 2 0 1 1 )  A c u t e  
i n h a l a t i o n  t o x i c i t y  o f  c e r i u m  o x i d e  n a n o p a r t i c l e s  i n  r a t s .  T o x i c o l  
L e t t  2 0 5 : 1 0 5 – 1 1 5
T e u n e n b r o e k  T ,  D i j k z e u l  A ,  H o e h e n e r  K  ( 2 0 1 3 )  N A N o R E G - A  
c o m m o n  E u r o p e a n  a p p r o a c h  t o  t h e  r e g u l a t o r y  t e s t i n g  o f  n a n o -
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i m a g e s / N A N O R E G _ P r e s s R e l e a s e _ ﬁ n a l . p d f
T r a n  C L ,  B u c h a n a n  D ,  C u l l e n  R T ,  S e a r l  A ,  J o n e s  A D ,  D o n a l d s o n  K  
( 2 0 0 0 )  I n h a l a t i o n  o f  p o o r l y  s o l u b l e  p a r t i c l e s .  I I .  I n ﬂ u e n c e  o f  p a r -
t i c l e  s u r f a c e  a r e a  o n  i n ﬂ a m m a t i o n  a n d  c l e a r a n c e .  I n h a l  T o x i c o l  
1 2 : 1 1 1 3 – 1 1 2 6
W a r h e i t  D B ,  H a r t s k y  M A  ( 1 9 9 3 )  R o l e  o f  a l v e o l a r  m a c r o p h a g e  c h e m -
o t a x i s  a n d  p h a g o c y t o s i s  i n  p u l m o n a r y  c l e a r a n c e  r e s p o n s e s  t o  
i n h a l e d  p a r t i c l e s :  c o m p a r i s o n s  a m o n g  r o d e n t  s p e c i e s .  M i c r o s c  
R e s  T e c h  2 6 : 4 1 2 – 4 2 2
W e b b  P A  ( 2 0 0 1 )  Vo l u m e  a n d  d e n s i t y  d e t e r m i n a t i o n s  f o r  p a r t i c l e  t e c h -
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H ,  H i n r i c h s e n  B ,  H i r t h  S ,  L a n d s i e d e l  R  ( 2 0 1 3 )  N a n o s p e c i ﬁ c  
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B a c k g r o u n d : N a n o p a r t i c u l a t e b a r i u m s u l f a t e h a s p o t e n t i a l n o v e l a p p l i c a t i o n s a n d w i d e u s e i n t h e p o l y m e r a n d
p a i n t i n d u s t r i e s . A s h o r t - t e r m i n h a l a t i o n s t u d y o n b a r i u m s u l f a t e n a n o p a r t i c l e s ( B a S O
4
N P s ) w a s p r e v i o u s l y p u b l i s h e d
[ P a r t F i b r e T o x i c o l 1 1 : 1 6 , 2 0 1 4 ] . W e p e r f o r m e d c o m p r e h e n s i v e b i o k i n e t i c s t u d i e s o f
1 3 1
B a S O
4
N P s a d m i n i s t e r e d v i a
d i f f e r e n t r o u t e s a n d o f a c u t e a n d s u b c h r o n i c p u l m o n a r y r e s p o n s e s t o i n s t i l l e d o r i n h a l e d B a S O
4
i n r a t s .
M e t h o d s : W e c o m p a r e d t h e t i s s u e d i s t r i b u t i o n o f
1 3 1
B a o v e r 2 8 d a y s a f t e r i n t r a t r a c h e a l ( I T ) i n s t i l l a t i o n , a n d o v e r 7
d a y s a f t e r g a v a g e a n d i n t r a v e n o u s ( I V ) i n j e c t i o n o f
1 3 1
B a S O
4
. R a t s w e r e e x p o s e d t o 5 0 m g / m
3
B a S O
4
a e r o s o l f o r 4 o r
1 3 w e e k s ( 6 h / d a y , 5 c o n s e c u t i v e d a y s / w e e k ) , a n d t h e n g r o s s a n d h i s t o p a t h o l o g i c , b l o o d a n d b r o n c h o a l v e o l a r
l a v a g e ( B A L ) f l u i d a n a l y s e s w e r e p e r f o r m e d . B A L f l u i d f r o m i n s t i l l e d r a t s w a s a l s o a n a l y z e d .
R e s u l t s : I n h a l e d B a S O
4
N P s s h o w e d n o t o x i c i t y a f t e r 4 - w e e k e x p o s u r e , b u t a s l i g h t n e u t r o p h i l i n c r e a s e i n B A L a f t e r
1 3 - w e e k e x p o s u r e w a s o b s e r v e d . L u n g b u r d e n o f i n h a l e d B a S O
4
N P s a f t e r 4 - w e e k e x p o s u r e ( 0 . 8 4 ± 0 . 1 8 m g / l u n g )
d e c r e a s e d b y 9 5 % o v e r 3 4 d a y s . I n s t i l l e d B a S O
4
N P s c a u s e d d o s e - d e p e n d e n t i n f l a m m a t o r y r e s p o n s e s i n t h e l u n g s .
I n s t i l l e d B a S O
4
N P s ( 0 . 2 8 m g / l u n g ) w a s c l e a r e d w i t h a h a l f - l i f e o f ≈ 9 . 6 d a y s . T r a n s l o c a t e d
1 3 1
B a f r o m t h e l u n g s
w a s p r e d o m i n a n t l y f o u n d i n t h e b o n e ( 2 9 % ) . O n l y 0 . 1 5 % o f g a v a g e d d o s e w a s d e t e c t e d i n a l l o r g a n s a t 7 d a y s .
I V - i n j e c t e d
1 3 1
B a S O
4
N P s w e r e p r e d o m i n a n t l y l o c a l i z e d i n t h e l i v e r , s p l e e n , l u n g s a n d b o n e a t 2 h o u r s , b u t r e d i s t r i b u t e d
f r o m t h e l i v e r t o b o n e o v e r t i m e . F e c a l e x c r e t i o n w a s t h e d o m i n a n t e l i m i n a t i o n p a t h w a y f o r a l l t h r e e r o u t e s o f e x p o s u r e .
C o n c l u s i o n s : P u l m o n a r y e x p o s u r e t o i n s t i l l e d B a S O
4
N P s c a u s e d d o s e - d e p e n d e n t l u n g i n j u r y a n d i n f l a m m a t i o n .
F o u r - w e e k a n d 1 3 - w e e k i n h a l a t i o n e x p o s u r e s t o a h i g h c o n c e n t r a t i o n ( 5 0 m g / m
3
) o f B a S O
4
N P s e l i c i t e d m i n i m a l
p u l m o n a r y r e s p o n s e a n d n o s y s t e m i c e f f e c t s . I n s t i l l e d a n d i n h a l e d B a S O
4
N P s w e r e c l e a r e d q u i c k l y y e t r e s u l t e d i n
h i g h e r t i s s u e r e t e n t i o n t h a n w h e n i n g e s t e d . P a r t i c l e d i s s o l u t i o n i s a l i k e l y m e c h a n i s m . I n j e c t e d B a S O
4
N P s l o c a l i z e d i n
t h e r e t i c u l o e n d o t h e l i a l o r g a n s a n d r e d i s t r i b u t e d t o t h e b o n e o v e r t i m e . B a S O
4
N P e x h i b i t e d l o w e r t o x i c i t y a n d
b i o p e r s i s t e n c e i n t h e l u n g s c o m p a r e d t o o t h e r p o o r l y s o l u b l e N P s s u c h a s C e O
2
a n d T i O
2
.
K e y w o r d s : L u n g a b s o r p t i o n , B i o a v a i l a b i l i t y , P a r t i c o k i n e t i c s , P a r t i c l e d i s s o l u t i o n , T r a n s l o c a t i o n , I n h a l a t i o n
B a c k g r o u n d
B a r i u m s u l f a t e n a n o p a r t i c l e s ( B a S O
4
N P s ) a r e u s e d
a s f i l l e r s i n c o a t i n g s ( e . g . i n m o t o r v e h i c l e s ) d u e t o t h e i r
m e c h a n i c a l , o p t i c a l a n d c h e m i c a l p r o p e r t i e s . R e c e n t l y ,
B a S O
4
N P s h a v e a l s o b e e n u s e d i n o r t h o p e d i c m e d i c i n e ,
d i a g n o s t i c i m a g i n g a n d o t h e r a p p l i c a t i o n s [ 1 - 5 ] . I t h a s
b e e n r e p o r t e d t h a t p e l l e t h a n e , a p o l y u r e t h a n e e l a s t o m e r ,
w h e n i n c o r p o r a t e d w i t h B a S O
4
N P s e x h i b i t e d a n t i m i -
c r o b i a l p r o p e r t i e s i n v i t r o [ 6 ] . E x p o s u r e t o a e r o s o l i z e d
B a S O
4
N P s m a y o c c u r d u r i n g t h e i r p r o d u c t i o n , s h i p p i n g ,
h a n d l i n g , i n c o r p o r a t i o n i n t o f i n a l p r o d u c t s , a n d t h e u s e
a n d d i s p o s a l o f t h o s e p r o d u c t s . C h r o n i c e x p o s u r e t o
h i g h l e v e l s o f m i c r o n - s c a l e B a S O
4
s u l f a t e m a y i n d u c e
p n e u m o c o n i o s i s ( b a r i t o s i s ) i n m i n e r s [ 7 - 9 ] .
B a r i u m s u l f a t e i s c o n s i d e r e d a m e m b e r o f t h e p o o r l y
s o l u b l e p a r t i c l e s ( P S P ) o r p o o r l y s o l u b l e l o w t o x i c i t y
( P S L T ) p a r t i c l e g r o u p s , a s a r e c e r i u m d i o x i d e ( C e O
2
)
a n d t i t a n i u m d i o x i d e ( T i O
2
) [ 1 0 - 1 2 ] . T h e s e b i o d u r a b l e
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2
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C a r l - B o s c h - S t r a ß e 3 8 , L u d w i g s h a f e n 6 7 0 5 6 , G e r m a n y
1
D e p a r t m e n t o f E n v i r o n m e n t a l H e a l t h , M o l e c u l a r a n d I n t e g r a t i v e
P h y s i o l o g i c a l S c i e n c e s P r o g r a m , H a r v a r d S c h o o l o f P u b l i c H e a l t h , 6 6 5
H u n t i n g t o n A v e n u e , B o s t o n , M A 0 2 1 1 5 , U S A
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P a p e r  2 :  B i o k i n e t i c s  a n d  e f f e c t s  o f  b a r i u m  s u l f a t e  n a n o p a r t i c l e s
n a n o m a t e r i a l s a r e u s u a l l y p o o r l y a b s o r b e d a f t e r o r a l a n d
i n h a l a t i o n e x p o s u r e [ 1 3 - 1 5 ] . P a r t i c o k i n e t i c s o f n a n o -
p a r t i c l e s a r e i n f l u e n c e d b y p a r t i c l e s i z e a n d r o u t e o f
e x p o s u r e [ 1 6 ] . P o o r l y s o l u b l e p a r t i c l e s m a y a l s o d i f f e r i n
c l e a r a n c e a n d b i o l o g i c a l e f f e c t s c o m p a r e d t o s o l u b l e p a r -
t i c l e s [ 1 2 , 1 7 - 1 9 ] . I t i s n o t e s t a b l i s h e d w h e t h e r t h e b i o k i -
n e t i c s o f i n h a l e d B a S O
4
N P s a r e s i m i l a r t o o t h e r P S L T
N P s . T h e r e f o r e , i t i s o f i n t e r e s t w h e t h e r t h e b i o k i n e t i c s
o f i n h a l e d B a S O
4
N P s a r e d i f f e r e n t f r o m o t h e r P S L T N P s .
P r e v i o u s s t u d i e s h a v e d e s c r i b e d t h e l u n g c l e a r a n c e o f
i n t r a t r a c h e a l l y i n s t i l l e d m i c r o n - s i z e d r a d i o a c t i v e B a S O
4
a n d s h o w e d t h a t t h e p a r t i c l e s i z e i n f l u e n c e s l u n g c l e a r a n c e
o f B a [ 2 0 , 2 1 ] . A s u b c h r o n i c i n h a l a t i o n s t u d y i n r a t s
s h o w e d a n e u t r o p h i l i n c r e a s e i n b r o n c h o a l v e o l a r l a v a g e
( B A L ) w i t h m i c r o n - s c a l e T i O
2
b u t n o t w i t h B a S O
4
a t
c o m p a r a b l e o v e r l o a d l u n g b u r d e n s ( ~ 1 0 m g B a ) [ 1 2 , 1 7 ] .
T h e d i f f e r e n c e w a s a t t r i b u t e d t o t h e l o w e r s u r f a c e a r e a o f
B a S O
4
t h a n T i O
2
. T o x i c i t y o f n a n o p a r t i c l e s i s i n f l u e n c e d
b y p a r t i c l e p h y s i c o c h e m i c a l p r o p e r t i e s [ 1 6 , 2 2 - 2 4 ] . T h e
b i o l o g i c a l r e s p o n s e s t o s m a l l p a r t i c l e s d i f f e r f r o m b i g g e r
p a r t i c l e s o f t h e s a m e c o m p o s i t i o n [ 2 5 , 2 6 ] . F u r t h e r m o r e , a
s h o r t - t e r m i n h a l a t i o n s t u d y o n B a S O
4
N P s h a s b e e n r e -
p o r t e d r e c e n t l y [ 2 7 , 2 8 ] . R a t s w e r e e x p o s e d ( n o s e - o n l y ) t o
5 0 m g / m
3
B a S O
4
( N M - 2 2 0 ) f o r 6 h o u r s / d a y f o r 5 d a y s . I t
w a s f o u n d t h a t t h e l u n g b u r d e n o f B a S O
4
a t t h e e n d o f e x -
p o s u r e w a s 1 . 1 m g / l u n g w h i c h d e c r e a s e d t o 0 . 2 4 m g / l u n g
w i t h i n 2 1 d a y s . T h i s s h o r t - t e r m e x p o s u r e t o B a S O
4
d i d
n o t e l i c i t s i g n i f i c a n t p u l m o n a r y o r s y s t e m i c r e s p o n s e s
c o n s i s t e n t w i t h p r e v i o u s r e p o r t s i n v a r i o u s i n v i t r o a n d
i n v i v o t e s t s y s t e m s [ 2 6 ] . T h e m e c h a n i s m s u n d e r l y i n g t h e
l o w e r t o x i c i t y a n d r a p i d l u n g c l e a r a n c e o f B a S O
4
N P s a r e
n o t f u l l y u n d e r s t o o d . F o r e x a m p l e , m o r e r e s e a r c h i s
n e e d e d t o q u a n t i f y t h e c o m p o n e n t s o f c l e a r a n c e a t t r i -
b u t a b l e t o i n t a c t p a r t i c l e s v e r s u s p a r t i c l e d i s s o l u t i o n a n d
c l e a r a n c e o f b a r i u m i o n s . T h u s , t h e r e i s c o n t i n u i n g i n t e -
r e s t i n t h e b i o k i n e t i c s a n d e f f e c t s o f B a S O
4
N P s , e s p e c i a l l y
a f t e r p u l m o n a r y e x p o s u r e . A t w o - y e a r i n h a l a t i o n s t u d y o f
B a S O
4
a n d C e O
2
h a s b e e n i n i t i a t e d i n c o l l a b o r a t i o n b e t -
w e e n t h e G e r m a n F e d e r a l M i n i s t r y f o r t h e E n v i r o n m e n t
G e r m a n g o v e r n m e n t a n d B A S F ( L u d w i g s h a f e n , G e r m a n y ) .
T h e p r o j e c t i s w i t h i n t h e O r g a n i z a t i o n f o r E c o n o m i c
C o o p e r a t i o n a n d D e v e l o p m e n t ( O E C D ) s p o n s o r s h i p p r o -
g r a m a n d t h e E u r o p e a n U n i o n P r o j e c t N A N o R E G
( a E u r o p e a n a p p r o a c h t o t h e r e g u l a t o r y t e s t i n g o f m a n u -
f a c t u r e d n a n o m a t e r i a l s ) .
T h e d a t a p r e s e n t e d h e r e w e r e u s e d i n d e s i g n i n g t h i s
l o n g - t e r m i n h a l a t i o n s t u d y . O u r o b j e c t i v e w a s t o c h a -
r a c t e r i z e t h e p u l m o n a r y a n d s y s t e m i c e f f e c t s o f i n h a l e d
B a S O
4
N P s a f t e r s h o r t - t e r m a n d s u b c h r o n i c e x p o s u r e . I n
a d d i t i o n , w e r e p o r t h e r e a c o m p r e h e n s i v e s t u d y o n t h e
b i o k i n e t i c s o f
1 3 1
B a a f t e r i n t r a t r a c h e a l i n s t i l l a t i o n ( I T ) ,
i n t r a v e n o u s i n j e c t i o n ( I V ) a n d g a v a g e a d m i n i s t r a t i o n o f
r a d i o l a b e l e d
1 3 1
B a S O
4
N P s . T h e s e s t u d i e s a r e i m p o r t a n t
i n a s s e s s m e n t o f r i s k s f r o m e x p o s u r e t o B a S O
4
N P s .
R e s u l t s
P h y s i c o c h e m i c a l c h a r a c t e r i z a t i o n o f N M - 2 2 0 a n d t h e
r e p r o d u c e d b a t c h o f B a S O
4
n a n o p a r t i c l e s
B a r i u m s u l f a t e N P s ( N M - 2 2 0 ) u s e d i n a l l I T i n s t i l l a t i o n ,
g a v a g e a n d I V i n j e c t i o n s t u d i e s w e r e o b t a i n e d f r o m B A S F
S E ( L u d w i g s h a f e n , G e r m a n y ) . T h i s s a m p l e w a s a r e f e r e n c e
m a t e r i a l f o r t h e N a n o m a t e r i a l T e s t i n g S p o n s o r s h i p P r o -
g r a m o f t h e O E C D . T h e c h a r a c t e r i z a t i o n o f t h i s o r i g i n a l
b a t c h w a s p u b l i s h e d r e c e n t l y [ 2 9 ] . S i n c e t h e c h r o n i c i n h a l -
a t i o n s t u d y r e q u i r e s l a r g e a m o u n t s ( > 1 0 0 k g ) , B a S O
4
N P s
w e r e r e p r o d u c e d a t a d i f f e r e n t p r o d u c t i o n p l a n t u s i n g t h e
s a m e s y n t h e s i s p r o t o c o l . T h i s r e p r o d u c e d b a t c h w a s c h a -
r a c t e r i z e d b y t h e s a m e m e t h o d s a n d w a s u s e d f o r t h e
4 - w e e k a n d 1 3 - w e e k i n h a l a t i o n s t u d i e s . A l l p h y s i c o -
c h e m i c a l e n d p o i n t s a r e s u m m a r i z e d i n A d d i t i o n a l f i l e 1 :
T a b l e S 1 ( o n l i n e S u p p o r t i n g I n f o r m a t i o n ) , w h i c h i n c l u d e s
t h e p r e v i o u s l y p u b l i s h e d c h a r a c t e r i z a t i o n o f N M - 2 2 0 f o r
c o m p a r i s o n [ 2 9 ] . T r a n s m i s s i o n a n d s c a n n i n g e l e c t r o n
m i c r o g r a p h s s h o w t h a t B a S O
4
N P s i n b o t h b a t c h e s w e r e
n o n s p h e r i c a l g l o b u l a r w i t h n o f i b e r , r o d o r p l a t e l e t i m -
p u r i t i e s . T h e p r i m a r y p a r t i c l e s i z e w a s 2 5 n m f o r b o t h
b a t c h e s ( F i g u r e 1 A a n d 1 B ) . T h e N P s f o r m l a r g e r s p h e r i c a l
a g g l o m e r a t e s ( 2 – 1 5 μ m d i a m e t e r ) i n t h e a s - p r o d u c e d
p o w d e r ( A d d i t i o n a l f i l e 1 : T a b l e S 1 ) . T h i s a g g l o m e r a t e
s t r u c t u r e w a s c o n f i r m e d b y p o r o s i m e t r y w h i c h s h o w e d
d o m i n a n t p o r e s i z e s o f 3 0 n m a n d 5 μ m f o r b o t h b a t c h e s
( A d d i t i o n a l f i l e 1 : F i g u r e S 1 A ) . X - r a y d i f f r a c t i o n ( X R D )
a n a l y s i s s h o w e d t h a t t h e p a r t i c l e m i n e r a l o g y w a s o r t h o -
r h o m b i c b a r i t e ( A d d i t i o n a l f i l e 1 : F i g u r e S 1 B ) f o r b o t h
b a t c h e s . P h o t o c a t a l y t i c a c t i v i t y o f b o t h b a t c h e s w a s e x -
t r e m e l y l o w a s s h o w n b y t h e a b s e n c e o f m e t h y l e n e b l u e
d e g r a d a t i o n ( A d d i t i o n a l f i l e 1 : F i g u r e S 2 ) .
T h e s h a p e , p a r t i c l e s i z e d i s t r i b u t i o n , p r i m a r y p a r t i c l e
d i a m e t e r , s t a t e o f a g g l o m e r a t i o n ( p o w d e r ) , c r y s t a l l i n e
p h a s e , s p e c i f i c s u r f a c e a r e a , s u r f a c e c h a r g e , p h o t o c a t a l y t i c
a c t i v i t y , a n d d i s p e r s a b i l i t y i n w a t e r a n d i n D u l b e c c o ’ s
m o d i f i e d E a g l e / f e t a l c a l f s e r u m ( D M E M / F C S ) m e d i a w e r e
s i m i l a r i n b o t h b a t c h e s . A n a l y s e s b y s e v e r a l m e t h o d s ( E M ,
m i n i m a l p o r e s i z e , s p e c i f i c s u r f a c e a r e a ) i n d i c a t e t h a t t h e
t w o b a t c h e s h a v e s i m i l a r p r i m a r y p a r t i c l e s i z e s . T h e p r o -
p e r t i e s t h a t w e r e d e t e r m i n e d b y s u r f a c e c h e m i s t r y s u c h a s
d i s p e r s a b i l i t y , c h a r g e / z e t a p o t e n t i a l a n d p h o t o c a t a l y t i c r e -
a c t i v i t y w e r e a l s o s i m i l a r ( A d d i t i o n a l f i l e 1 : F i g u r e S 2 ) .
H o w e v e r , s i g n i f i c a n t d i f f e r e n c e s w e r e o b s e r v e d i n c r y s -
t a l l i t e s i z e ( 3 6 n m f o r N M - 2 2 0 v s . 2 3 n m f o r r e p r o d u c e d
b a t c h ) . T h e r e p r o d u c e d m a t e r i a l a l s o h a d a n i n t e r -
m e d i a t e p o r e s i z e o f 2 0 0 n m ( a g g l o m e r a t e s t r u c t u r e )
w h i c h w a s a b s e n t i n t h e o r i g i n a l N M - 2 2 0 m a t e r i a l . X P S
a n a l y s e s s h o w e d s i g n i f i c a n t l y l e s s c a r b o n a t o m s e x p o s e d
o n t h e s u r f a c e o f t h e r e p r o d u c e d m a t e r i a l ( 2 v s . 1 7 % ) .
A d d i t i o n a l l y , e l e m e n t a l a n a l y s i s b y n e u t r o n a c t i v a t i o n
s h o w e d t h a t t h e N M - 2 2 0 b a t c h h a d 5 9 9 μ g B a / m g
m a t e r i a l ( 5 9 . 9 w t % ) , a s e x p e c t e d f o r r e l a t i v e l y p u r e
B a S O
4
( T a b l e 1 ) .
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P a p e r  2 :  B i o k i n e t i c s  a n d  e f f e c t s  o f  b a r i u m  s u l f a t e  n a n o p a r t i c l e s
I n p h y s i o l o g i c a l s i m u l a n t f l u i d s , B a S O
4
N P s ( N M - 2 2 0 )
d i s s o l v e d o n l y s l i g h t l y a t p H 1 ( 1 % d i s s o l u t i o n i n 0 . 1 N
H C l ) a l t h o u g h i t s p a r t i c l e s h a p e s c h a n g e d ( A d d i t i o n a l
f i l e 1 : T a b l e S 1 , F i g u r e 1 E ) [ 2 9 ] . V e r y l o w ( 0 . 1 % ) d i s s o -
l u t i o n w a s o b s e r v e d i n p h o s p h a t e b u f f e r e d s a l i n e ( P B S )
o r p h a g o l y s o s o m a l s i m u l a n t f l u i d ( P S F , p H 4 . 5 ) a f t e r
2 8 d a y s i n c u b a t i o n ( A d d i t i o n a l f i l e 1 : T a b l e S 1 ) . N o m o r -
p h o l o g i c c h a n g e s w e r e s e e n i n P B S ( F i g u r e 1 C ) . H o w -
e v e r , t h e n o n - s p h e r i c a l B a S O
4
N P s l o s t t h e i r s t r u c t u r a l
f e a t u r e s w i t h l o w e s t r a d i u s o f c u r v a t u r e a n d r e c r y s t a l -
l i z e d t o s p h e r i c a l s t r u c t u r e s i n P S F ( F i g u r e 1 D ) [ 3 0 ] . I t
w a s c o n f i r m e d b y s e l e c t e d a r e a e l e c t r o n d i f f r a c t i o n t h a t
t h e c r y s t a l l i n i t y w a s r e t a i n e d ( d a t a n o t s h o w n ) . B a S O
4
N P s r e m a i n e d i n a l o w a g g l o m e r a t i o n s t a t e a n d r e t a i n e d a
s i g n i f i c a n t d i s p e r s e d f r a c t i o n ( 8 0 % ) o f ≤ 1 μ m d i a m e t e r i n
a l l s i m u l a n t b u f f e r c o n d i t i o n s . T h e z e t a p o t e n t i a l r a n g e d
f r o m − 2 0 m V t o − 3 2 m V .
T h e a g g l o m e r a t e s i z e o f B a S O
4
N P s i n d e i o n i z e d w a t e r
s u s p e n s i o n e m p l o y e d i n I T i n s t i l l a t i o n ( 0 . 6 7 m g / m l ) ,
g a v a g e ( 1 0 m g / m l ) a n d I V i n j e c t i o n ( 1 m g / m l ) w a s a s -
s e s s e d u s i n g d y n a m i c l i g h t s c a t t e r i n g ( D L S ) . W e f o u n d
t h a t B a S O
4
N P a g g l o m e r a t e s i z e w a s i n f l u e n c e d b y p a r -
t i c l e c o n c e n t r a t i o n ( T a b l e 2 ) : t h e h i g h e r t h e c o n c e n -
t r a t i o n , t h e l a r g e r t h e h y d r o d y n a m i c d i a m e t e r . F o r t h e
i n h a l a t i o n s t u d i e s , t h e p a r t i c l e c o n c e n t r a t i o n s a n d s i z e
F i g u r e 1 S t r u c t u r a l c h a r a c t e r i z a t i o n b y r e p r e s e n t a t i v e S E M s c a n s o f a s - p r o d u c e d B a S O
4
n a n o m a t e r i a l a n d a f t e r i n c u b a t i o n f o r t e s t i n g
o f p e r s i s t e n c e . ( A ) r e p r o d u c e d b a t c h , a s - p r o d u c e d p o w d e r ; ( B ) N M - 2 2 0 b a t c h , a s - p r o d u c e d p o w d e r ; ( C ) p e l l e t o f N M - 2 2 0 a f t e r 2 8 d i n c u b a t i o n i n
P B S ; ( D ) p e l l e t o f N M - 2 2 0 a f t e r 2 8 d i n c u b a t i o n i n P S F ; ( E ) p e l l e t o f N M - 2 2 0 a f t e r 1 d i n c u b a t i o n i n 0 . 1 N H C l .
T a b l e 1 N e u t r o n a c t i v a t i o n a n a l y s i s o f B a S O
4
N M - 2 2 0
E l e m e n t C o n c e n t r a t i o n ( μ g / g )
B a 5 9 9 , 0 0 0 ± 3 3 , 0 0 0
S r 9 , 8 2 0 ± 5 7 0
N a 3 , 0 2 2 ± 6 9
Z n 3 1 . 1 ± 2
M n 0 . 4 1 ± 0 . 2 1
C o 0 . 1 6 4 ± 0 . 0 3 8
A u 0 . 0 4 ± 0 . 0 0 3
S c 0 . 0 2 0 6 ± 0 . 0 0 5 5
D a t a a r e m e a n ± s t a n d a r d d e v i a t i o n .
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P a p e r  2 :  B i o k i n e t i c s  a n d  e f f e c t s  o f  b a r i u m  s u l f a t e  n a n o p a r t i c l e s
d i s t r i b u t i o n s a r e s u m m a r i z e d i n T a b l e 3 . T h e t a r g e t c o n -
c e n t r a t i o n o f 5 0 m g / m
3
w a s a c h i e v e d a n d m a i n t a i n e d
t h r o u g h o u t t h e i n h a l a t i o n e x p o s u r e s . P a r t i c l e s i z e d i s t r i -
b u t i o n o f a e r o s o l i z e d B a S O
4
N P s w a s i n t h e r e s p i r a b l e
r a n g e f o r r a t s .
P u l m o n a r y r e s p o n s e s t o i n s t i l l e d o r i n h a l e d B a S O
4
n a n o p a r t i c l e s
T o d e t e r m i n e w h e t h e r B a S O
4
N P s e l i c i t t o x i c o r i n f l a m -
m a t o r y r e s p o n s e i n r a t s a n d t o i d e n t i f y a s u i t a b l e d o s e
f o r t h e I T b i o k i n e t i c s t u d i e s , g r o u p s o f s i x r a t s w e r e
I T - i n s t i l l e d w i t h B a S O
4
N P s u s p e n s i o n ( N M - 2 2 0 ) a t 0 , 1 ,
2 , a n d 5 m g / k g b o d y w e i g h t . W e f o u n d t h a t B a S O
4
N P s
c a u s e d a n a c u t e d o s e - d e p e n d e n t i n f l a m m a t o r y r e s p o n s e
e v i d e n c e d b y s i g n i f i c a n t i n c r e a s e s i n B A L p a r a m e t e r s
( T a b l e 4 ) . N e u t r o p h i l s , m y e l o p e r o x i d a s e ( M P O ) a n d l a c -
t a t e d e h y d r o g e n a s e ( L D H ) l e v e l s i n b r o n c h o a l v e o l a r
l a v a g e ( B A L ) w e r e e l e v a t e d 2 4 h o u r s p o s t - i n s t i l l a t i o n . W e
a l s o f o u n d t h a t 2 a n d 5 m g / k g d o s e s c a u s e d p u l m o n a r y
h e m o r r h a g e a n d e d e m a a s i n d i c a t e d b y i n c r e a s e d B A L
h a e m o g l o b i n a n d a l b u m i n l e v e l s . B a s e d o n t h e s e d a t a ,
w e c o n c l u d e d t h a t 1 m g / k g w a s t h e m a x i m u m s a f e d o s e
f o r t h e I T b i o k i n e t i c s t u d y , s i n c e i n j u r y a n d i n f l a m m a t i o n
w e r e m i n i m a l , y e t i t w a s s u f f i c i e n t f o r g a m m a d e t e c t i o n
o f
1 3 1
B a i n t h e l u n g s a n d o t h e r t i s s u e s o v e r a p e r i o d o f
2 8 d a y s .
T o a s s e s s p u l m o n a r y r e s p o n s e s o f r a t s a f t e r s h o r t - t e r m
a n d s u b c h r o n i c i n h a l a t i o n o f B a S O
4
N P s , B A L a n a l y s i s
w a s p e r f o r m e d o n e d a y ( 4 - a n d 1 3 - w e e k g r o u p s ) a n d 3 5
d a y s ( 4 - w e e k g r o u p ) a f t e r t h e e n d o f e a c h e x p o s u r e p r o -
t o c o l . R e s u l t s f o r a l l B A L p a r a m e t e r s a r e p r e s e n t e d i n
T a b l e 5 . A f t e r 4 w e e k s o f e x p o s u r e , n e u t r o p h i l s w e r e
s i g n i f i c a n t l y i n c r e a s e d c o m p a r e d t o c o n c u r r e n t c o n t r o l s
( f i l t e r e d a i r - e x p o s e d ) o n e d a y a f t e r t h e e n d o f e x p o s u r e .
H o w e v e r , t h e s e v a l u e s w e r e w i t h i n t h e h i s t o r i c a l c o n t r o l
r a n g e i n o u r p r e v i o u s s t u d i e s . R a t s e x p o s e d f o r 1 3 w e e k s
s h o w e d s i g n i f i c a n t i n c r e a s e s i n B A L t o t a l c e l l s a n d n e u t r o -
p h i l s c o m p a r e d t o c o n t r o l . T h e s e n e u t r o p h i l c o u n t s w e r e
s i g n i f i c a n t l y l o w e r t h a n t h o s e s e e n i n i n s t i l l e d r a t s ( T a b l e 4 ,
A d d i t i o n a l f i l e 1 : F i g u r e S 3 ) . C y t o k i n e l e v e l s o f m o n o c y t e
c h e m o a t t r a c t a n t p r o t e i n - 1 ( M C P - 1 ) a n d c y t o k i n e - i n d u c e d
n e u t r o p h i l c h e m o a t t r a c t a n t - 1 ( C I N C - 1 ) w e r e e l e v a t e d i n
b o t h e x p o s u r e g r o u p s ( T a b l e 5 ) . T h e l o n g e r 1 3 - w e e k
e x p o s u r e t o B a S O
4
N P s i n d u c e d h i g h e r l e v e l s o f t h e c y t o -
k i n e M C P - 1 c o m p a r e d t o t h e 4 - w e e k e x p o s u r e . A l l B A L
p a r a m e t e r s e l e v a t e d a t 1 d a y p o s t - e x p o s u r e r e t u r n e d t o
c o n t r o l l e v e l s i n t h e 4 - w e e k e x p o s u r e g r o u p a t 3 5 d a y s .
N o m o r p h o l o g i c a l c h a n g e s w e r e d e t e c t e d b y h i s t o p a t h -
o l o g y i n t h e l u n g s ( A d d i t i o n a l f i l e 1 : F i g u r e S 4 ) a n d e x t r a -
p u l m o n a r y o r g a n s . O t h e r p a r a m e t e r s s u c h a s b o d y
w e i g h t s , m i c r o n u c l e u s t e s t o f e r y t h r o c y t e s i n p e r i p h e r a l
b l o o d , s h o w e d n o s i g n i f i c a n t c h a n g e . R a t s e x p o s e d f o r 1 3
w e e k s s h o w e d s i g n i f i c a n t l y h i g h e r g a m m a g l u t a m y l t r a n s -
f e r a s e ( G G T ) a n d a l k a l i n e p h o s p h a t a s e ( A L P ) l e v e l s t h a n
t h e i r c o r r e s p o n d i n g c o n t r o l s ( T a b l e 5 ) .
I n v i v o c l e a r a n c e a n d t r a n s l o c a t i o n o f
1 3 1
B a S O
4
n a n o p a r t i c l e s a f t e r I T i n s t i l l a t i o n i n r a t s
T h e c l e a r a n c e o f
1 3 1
B a S O
4
N P s f r o m t h e l u n g s p o s t -
i n s t i l l a t i o n i s s h o w n i n F i g u r e 2 A . A p p r o x i m a t e l y 4 7 % o f
t h e t o t a l d o s e w a s c l e a r e d f r o m t h e l u n g s b y d a y 7 a n d
8 4 % b y d a y 2 8 . A l i n e a r r e g r e s s i o n o n t h e n a t u r a l l o g a -
r i t h m o f t h e l u n g
1 3 1
B a S O
4
l e v e l s ( % d o s e ) o v e r t i m e w a s
p e r f o r m e d ( y = e
- 0 . 0 0 3 0 1 1 x
, R
2
= 0 . 9 6 , p = < 0 . 0 0 0 1 ) . T h e e s -
t i m a t e d c l e a r a n c e h a l f - l i f e w a s 9 . 6 d a y s . E x t r a p u l m o n a r y
t r a n s l o c a t i o n o f
1 3 1
B a i s s h o w n i n F i g u r e 2 B . A s i g n i f i c a n t
f r a c t i o n o f
1 3 1
B a r a d i o a c t i v i t y w a s f o u n d i n t h e b o n e s
( 2 9 % o f d o s e ) a n d l o w e r f r a c t i o n s i n a l l o t h e r t i s s u e s c o m -
b i n e d ( 7 % ) . T h e r e s t o f t h e
1 3 1
B a w a s e x c r e t e d m o s t l y i n
t h e f e c e s ( 3 0 % ) a n d t o a l e s s e r e x t e n t i n t h e u r i n e ( 3 . 9 % )
( F i g u r e 3 ) . T h e c o m p l e t e d i s t r i b u t i o n d a t a o f
1 3 1
B a a f t e r
i n s t i l l a t i o n o f
1 3 1
B a S O
4
a r e s u m m a r i z e d i n A d d i t i o n a l
f i l e 1 : T a b l e S 2 .
F a t e o f
1 3 1
B a S O
4
n a n o p a r t i c l e s a f t e r o r a l a d m i n i s t r a t i o n
i n r a t s
T h e t i s s u e d i s t r i b u t i o n o f
1 3 1
B a a c t i v i t y f o l l o w i n g o r a l
a d m i n i s t r a t i o n i s s u m m a r i z e d i n F i g u r e 4 a n d l i s t e d i n
A d d i t i o n a l f i l e 1 : T a b l e S 3 . N e a r l y 1 0 0 % o f t h e a d m i n i s -
t e r e d d o s e w a s m e a s u r e d i n t h e s t o m a c h a t 5 m i n u t e s
p o s t - g a v a g e ( F i g u r e 4 A ) . A t 7 d a y s , v e r y l o w p e r c e n t a g e s
o f t h e t o t a l d o s e w e r e d e t e c t e d i n b l o o d , b o n e a n d b o n e
m a r r o w ( < 0 . 1 % ) ( F i g u r e 4 B ) . G a v a g e d
1 3 1
B a S O
4
N P s w e r e
m o s t l y c l e a r e d f r o m t h e G I t r a c t a n d e l i m i n a t e d i n t h e
T a b l e 2 D y n a m i c l i g h t s c a t t e r i n g a n a l y s i s o f B a S O
4
N M - 2 2 0 s u s p e n s i o n s




( n m ) P d I ζ ( m V )
0 . 6 6 1 4 4 ± 4 0 . 2 0 ± 0 . 0 3 − 1 8 . 5
1 1 5 4 ± 2 1 0 . 2 4 ± 0 . 0 7 − 1 8 . 7
1 0 3 5 4 ± 3 0 . 4 6 ± 0 . 0 3 − 1 6 . 5
D a t a a r e m e a n ± s t a n d a r d d e v i a t i o n , n = 3 .
d
H
, h y d r o d y n a m i c d i a m e t e r , P d I , p o l y d i s p e r s i t y i n d e x , ζ , z e t a p o t e n t i a l .
T a b l e 3 A e r o s o l c o n c e n t r a t i o n s a n d p a r t i c l e s i z e d i s t r i b u t i o n s o f B a S O
4
N M - 2 2 0
D u r a t i o n o f
e x p o s u r e
T a r g e t e d
c o n c e n t r a t i o n s ( m g / m
3
)
M e a s u r e d
c o n c e n t r a t i o n s ( m g / m
3
)
M M A D
( μ m ) / G S D m e a n
P a r t i c l e c o u n t
c o n c e n t r a t i o n ( p a r t i c l e / c m
3
)
P a r t i c l e c o u n t
m e d i a n d i a m e t e r ( n m )
4 w e e k s 5 0 4 6 . 2 ± 5 . 9 2 . 3 / 2 . 0 9 2 7 5 2 3 2 6
1 3 w e e k s 5 0 5 0 . 1 ± 5 . 6 1 . 9 / 2 . 1 7 7 9 9 2 3 0 4
K o n d u r u e t a l . P a r t i c l e a n d F i b r e T o x i c o l o g y 2 0 1 4 , 1 1 : 5 5 P a g e 4 o f 1 5
h t t p : / / w w w . p a r t i c l e a n d f i b r e t o x i c o l o g y . c o m / c o n t e n t / 1 1 / 1 / 5 5
6 6
P a p e r  2 :  B i o k i n e t i c s  a n d  e f f e c t s  o f  b a r i u m  s u l f a t e  n a n o p a r t i c l e s
f e c e s ( F i g u r e 5 A ) . O n l y 0 . 0 2 % w a s e x c r e t e d i n t h e u r i n e
( F i g u r e 5 B ) .
T i s s u e d i s t r i b u t i o n o f
1 3 1
B a S O
4
n a n o p a r t i c l e s a f t e r
i n t r a v e n o u s i n j e c t i o n i n r a t s
A t 2 h o u r s a f t e r i n t r a v e n o u s i n j e c t i o n o f
1 3 1
B a S O
4
N P s ,
t h e b l o o d l e v e l s o f
1 3 1
B a w e r e l e s s t h a n 0 . 5 % o f t h e
a d m i n i s t e r e d d o s e ( F i g u r e 6 ) . T h e c o m p l e t e d i s t r i b u t i o n
d a t a a t v a r i o u s t i m e p o i n t p o s t - i n j e c t i o n a r e s u m m a r i z e d
i n A d d i t i o n a l f i l e 1 : T a b l e S 4 . T h e t i s s u e d i s t r i b u t i o n w a s
t y p i c a l o f c i r c u l a t i n g p a r t i c l e s t h a t a r e t a k e n u p i n o r g a n s
c o m p r i s i n g t h e m o n o n u c l e a r p h a g o c y t e s y s t e m w i t h a c -
c e s s t o t h e c i r c u l a t i o n [ 3 1 ] . N o t a b l y ,
1 3 1
B a S O
4
N P s w e r e
p r e d o m i n a n t l y l o c a l i z e d i n t h e l i v e r , s p l e e n , b o n e a n d
T a b l e 4 B r o n c h o a l v e o l a r l a v a g e a n a l y s i s a t 1 d a y a f t e r i n t r a t r a c h e a l i n s t i l l a t i o n o f B a S O
4
N P s
D o s e C o n t r o l 1 m g / k g 2 m g / k g 5 m g / k g
B a S O
4
l u n g b u r d e n ( m g ) 0 0 . 2 8 ± 0 . 0 0 4 0 . 5 6 ± 0 . 0 0 4 1 . 4 ± 0 . 0 0 4
T o t a l C e l l s ( m i l l i o n ) 8 . 3 1 ± 1 . 0 1 1 2 . 5 9 ± 1 . 7 1 1 4 . 2 6 ± 0 . 7 4 * 1 6 . 7 6 ± 1 . 1 5 *
M a c r o p h a g e ( m i l l i o n ) 8 . 3 1 ± 1 . 0 1 1 2 . 2 8 ± 1 . 6 2 1 1 . 4 1 ± 0 . 6 7 1 0 . 3 1 ± 1 . 4 0
N e u t r o p h i l s ( m i l l i o n 0 . 0 0 1 ± 0 . 0 0 0 . 2 9 ± 0 . 1 0 2 . 8 5 ± 0 . 2 9 * 6 . 4 5 ± 1 . 0 9 *
L D H ( m U / m l ) 3 8 . 1 0 ± 0 . 3 0 5 7 . 2 3 ± 4 . 9 8 1 7 1 . 5 2 ± 3 3 . 0 5 1 6 7 . 6 8 ± 1 8 . 5 3 *
M P O ( m U / m l ) 0 . 9 4 ± 0 . 0 7 0 . 8 0 ± 0 . 2 1 2 6 . 4 8 ± 8 . 5 0 3 4 . 9 5 ± 8 . 8 2
A l b u m i n ( μ g / m l ) 3 . 2 8 ± 1 . 3 9 6 . 1 2 ± 0 . 3 8 * 1 1 . 8 8 ± 1 . 2 0 * 1 4 . 5 3 ± 1 . 1 2 *
H e m o g l o b i n ( μ g ) 9 . 4 4 ± 1 . 3 9 1 6 . 5 6 ± 0 . 8 9 * 2 4 . 7 9 ± 2 . 7 8 * 3 7 . 2 4 ± 2 . 6 4 *
D a t a a r e m e a n ± S E , n = 4 - 5 / g r o u p .
* p < 0 . 0 5 , B a S O
4
v e r s u s 0 m g / k g ( C o n t r o l , e q u i v a l e n t v o l u m e o f d i s t i l l e d w a t e r ) .
T a b l e 5 B r o n c h o a l v e o l a r l a v a g e a n a l y s i s a t 1 o r 3 5 d a y s a f t e r i n h a l a t i o n e x p o s u r e t o B a S O
4
N P s
4 - w e e k e x p o s u r e 1 3 - w e e k e x p o s u r e
C o n t r o l B a S O
4
C o n t r o l B a S O
4
B a S O
4
l u n g b u r d e n ( m g ) 0 . 8 4 ± 0 . 1 8 1 . 7 3 ± 0 . 8 5
T o t a l c e l l s ( m i l l i o n )
1 d a y 0 . 6 4 9 ± 0 . 2 0 0 . 5 6 2 ± 0 . 1 2 0 . 6 1 0 ± 0 . 2 0 0 . 8 3 6 ± 0 . 1 5 *
3 5 d a y s 0 . 5 8 0 ± 0 . 1 1 0 . 4 5 4 ± 0 . 1 2 N D N D
N e u t r o p h i l s ( m i l l i o n )
1 d a y 0 . 0 0 7 ± 0 . 0 0 3 0 . 0 2 1 ± 0 . 0 1 0 * 0 . 0 1 6 ± 0 . 0 0 6 0 . 2 0 4 ± 0 . 1 7 5 *
3 5 d a y s 0 . 0 1 9 ± 0 . 0 0 8 0 . 0 3 2 ± 0 . 0 2 4 N D N D
T o t a l p r o t e i n ( m g / L )
1 d a y 6 0 ± 4 7 7 ± 1 3 * 5 2 ± 1 0 6 4 ± 1 3
3 5 d a y s 8 1 ± 2 3 5 9 ± 1 3 N D N D
G G T ( n k a t / L )
1 d a y 3 7 ± 1 7 4 0 ± 1 0 4 1 ± 7 6 4 ± 1 3 *
3 5 d a y s 4 2 ± 1 2 3 7 ± 1 2 N D N D
A L P ( μ k a t / L )
1 d a y 0 . 8 3 ± 0 . 1 6 0 . 8 3 ± 0 . 2 0 0 . 5 1 ± 0 . 1 0 0 . 8 7 ± 0 . 2 1 *
3 5 d a y s 0 . 7 0 ± 0 . 0 9 0 . 7 0 ± 0 . 1 2 N D N D
M C P - 1 ( p g / m l )
1 d a y 1 4 . 0 ± 0 . 0 5 4 . 7 ± 1 4 . 3 * 2 4 . 2 ± 8 . 4 1 7 6 . 7 ± 1 2 6 . 1 *
#
3 5 d a y s 1 7 . 3 ± 2 . 6 1 4 . 7 ± 1 . 7 N D N D
C I N C - 1 / I L - 8 ( p g / m l )
1 d a y 1 0 4 . 2 ± 2 6 . 7 1 5 8 . 7 ± 2 2 . 4 * 9 3 . 7 ± 1 8 . 7 2 2 3 . 8 ± 1 2 5 . 7 *
3 5 d a y s 1 5 8 . 8 ± 3 8 . 1 1 6 7 . 6 ± 4 1 . 1 N D N D
D a t a a r e m e a n ± S D , n = 5 / g r o u p . C o n t r o l r a t s w e r e e x p o s e d t o f i l t e r e d a i r .
N D , n o t d e t e r m i n e d .
* p ≤ 0 . 0 5 , B a S O
4
- e x p o s e d v s . c o n t r o l ;
#
p ≤ 0 . 0 5 , 1 3 - w e e k v s . 4 - w e e k e x p o s u r e .
N e u t r o p h i l s c o u n t s w e r e s i g n i f i c a n t l y m u c h l o w e r c o m p a r e d t o d a t a f r o m r a t s i n s t i l l e d w i t h 1 . 4 m g B a S O
4
( 5 m g / k g B a S O
4
) ( T a b l e 4 ) .
K o n d u r u e t a l . P a r t i c l e a n d F i b r e T o x i c o l o g y 2 0 1 4 , 1 1 : 5 5 P a g e 5 o f 1 5
h t t p : / / w w w . p a r t i c l e a n d f i b r e t o x i c o l o g y . c o m / c o n t e n t / 1 1 / 1 / 5 5
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P a p e r  2 :  B i o k i n e t i c s  a n d  e f f e c t s  o f  b a r i u m  s u l f a t e  n a n o p a r t i c l e s
b o n e m a r r o w . I n t e r e s t i n g l y , a s i g n i f i c a n t f r a c t i o n w a s a l s o
m e a s u r e d i n t h e l u n g s . T h i s m a y r e p r e s e n t t h e l a r g e r
a g g l o m e r a t e s t h a t m a y b e l o d g e d w i t h i n p u l m o n a r y c a p i l -
l a r i e s . O v e r t h e p e r i o d o f 7 d a y s a f t e r I V a d m i n i s t r a t i o n ,
1 3 1
B a i n t h e l i v e r s i g n i f i c a n t l y d e c r e a s e d a n d r e d i s t r i b u t e d
i n t o l u n g s , b o n e , a n d b o n e m a r r o w ( F i g u r e 6 ) .
1 3 1
B a
a c t i v i t y i n t h e l u n g s a l s o s i g n i f i c a n t l y d e c r e a s e d o v e r t i m e
( F i g u r e 6 ) . B y d a y 7 , a s i g n i f i c a n t f r a c t i o n o f
1 3 1
B a r a -
d i o a c t i v i t y w a s f o u n d i n t h e b o n e s ( 4 6 % ) . T h e c u m u l a -
t i v e f e c a l a n d u r i n a r y e x c r e t i o n s o f
1 3 1
B a a r e s h o w n i n
A d d i t i o n a l f i l e 1 : F i g u r e S 5 . T h e c u m u l a t i v e f e c a l e x c r e t i o n
w a s 1 7 % w h i l e o n l y 4 % o f t h e t o t a l i n j e c t e d d o s e w a s
e x c r e t e d i n t h e u r i n e o v e r a p e r i o d o f 7 d a y s ( A d d i t i o n a l
f i l e 1 : F i g u r e S 5 B ) .
B a r i u m t i s s u e c o n c e n t r a t i o n - i n f l u e n c e o f r o u t e o f
e x p o s u r e
W e e x a m i n e d h o w t h e r o u t e o f e x p o s u r e a f f e c t s t i s s u e
b a r i u m c o n c e n t r a t i o n s a f t e r d o s i n g w i t h
1 3 1
B a S O
4
N P s .
U s i n g t h e m e a s u r e d s p e c i f i c a c t i v i t y o f
1 3 1
B a S O
4
N P s a n d
e a c h t i s s u e
1 3 1
B a c o n c e n t r a t i o n , w e e s t i m a t e d B a c o n c e n -
t r a t i o n i n n g B a / g t i s s u e . T h e B a c o n c e n t r a t i o n s a t 7 d a y s
p o s t - d o s i n g a r e s h o w n i n T a b l e 6 . T h e s e d a t a d e m o n s t r a t e
t h a t I T i n s t i l l a t i o n r e s u l t e d i n s i g n i f i c a n t l y h i g h e r t i s s u e
c o n c e n t r a t i o n s t h a n g a v a g e , e s p e c i a l l y i n t h e b o n e . B a r i u m
t i s s u e l e v e l s r a n g e d f r o m v e r y l o w t o n o t d e t e c t a b l e p o s t -
g a v a g e d e s p i t e d o s i n g t h e a n i m a l s w i t h a h i g h e r m a s s d o s e
( 1 v . 5 m g / k g ) . A s e x p e c t e d , I V i n j e c t i o n r e s u l t e d i n h i g h e r
B a c o n c e n t r a t i o n s i n m o s t t i s s u e s c o m p a r e d t o I T a n d
g a v a g e a d m i n i s t r a t i o n .
L u n g a n d l y m p h n o d e b a r i u m a n a l y s i s a f t e r i n h a l a t i o n
e x p o s u r e t o B a S O
4
n a n o p a r t i c l e s
T h e a m o u n t s o f B a S O
4
i n t h e l u n g s a n d l y m p h n o d e s
w e r e e s t i m a t e d b y m e a s u r i n g B a w i t h I C P - M S . I n h a l a t i o n
F i g u r e 2 C l e a r a n c e a n d t r a n s l o c a t i o n o f
1 3 1
B a S O
4
N P s f o l l o w i n g I T i n s t i l l a t i o n . ( A ) L u n g c l e a r a n c e o f
1 3 1
B a S O
4
o v e r t i m e . T h e c l e a r a n c e h a l f
l i f e w a s a p p r o x i m a t e l y 9 . 6 d a y s . B y 2 8 d a y s , 8 4 % o f d o s e h a s b e e n c l e a r e d f r o m t h e l u n g s . ( B ) T r a n s l o c a t e d
1 3 1
B a f r o m t h e l u n g s g r a d u a l l y a c c u m u l a t e d
i n o t h e r o r g a n s . B y 2 8 d a y s , 2 9 % o f t h e i n s t i l l e d
1 3 1
B a d o s e w a s r e t a i n e d i n t h e b o n e a n d 7 % i n a l l t h e o t h e r o r g a n s . D a t a a r e m e a n ± s t a n d a r d e r r o r o f
t h e m e a n , n = 5 p e r g r o u p .
F i g u r e 3 C u m u l a t i v e f e c a l a n d u r i n a r y e x c r e t i o n o f
1 3 1
B a
f o l l o w i n g I T i n s t i l l a t i o n . E l i m i n a t i o n o f
1 3 1
B a w a s m a i n l y v i a t h e
f e c e s . B y 2 8 d a y s p o s t - d o s i n g , 3 0 % o f t h e i n s t i l l e d d o s e w a s e x c r e t e d i n
t h e f e c e s ( A ) a n d o n l y 4 . 4 % i n t h e u r i n e ( B ) . D a t a a r e m e a n ± s t a n d a r d
e r r o r o f t h e m e a n , n = 5 p e r g r o u p .
K o n d u r u e t a l . P a r t i c l e a n d F i b r e T o x i c o l o g y 2 0 1 4 , 1 1 : 5 5 P a g e 6 o f 1 5
h t t p : / / w w w . p a r t i c l e a n d f i b r e t o x i c o l o g y . c o m / c o n t e n t / 1 1 / 1 / 5 5
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P a p e r  2 :  B i o k i n e t i c s  a n d  e f f e c t s  o f  b a r i u m  s u l f a t e  n a n o p a r t i c l e s
e x p o s u r e t o 5 0 m g / m
3
r e s u l t e d i n a n e q u i v a l e n t B a S O
4
l u n g b u r d e n o f 0 . 8 4 ± 0 . 1 8 m g a t 1 d a y a f t e r t h e e n d o f
a 4 - w e e k e x p o s u r e . L u n g B a S O
4
b u r d e n d e c r e a s e d b y
9 5 % ( 0 . 8 4 ± 0 . 1 8 t o 0 . 0 4 m g ) o n d a y 1 v e r s u s d a y 3 5
a f t e r e x p o s u r e . A f t e r 1 3 w e e k s o f e x p o s u r e , t h e l u n g ,
t r a c h e o b r o n c h i a l a n d m e d i a s t i n a l l y m p h n o d e b u r d e n s
w e r e 1 . 7 3 ± 0 . 8 5 m g , 5 . 9 2 ± 6 . 5 2 μ g , 2 . 7 2 ± 3 . 3 8 μ g B a S O
4
,
r e s p e c t i v e l y .
D i s c u s s i o n
O u r s t u d i e s e x a m i n e d t h e e f f e c t s o f s h o r t - t e r m ( 4 - w e e k )
a n d s u b c h r o n i c ( 1 3 - w e e k ) i n h a l a t i o n e x p o s u r e a n d a s i n -
g l e I T i n s t i l l a t i o n o f B a S O
4
N P s i n r a t s . W e a l s o p e r -
f o r m e d c o m p r e h e n s i v e b i o k i n e t i c s t u d i e s o f
1 4 1
B a w h e n
1 4 1
B a S O
4
N P s w e r e a d m i n i s t e r e d i n r a t s v i a d i f f e r e n t
r o u t e s . F o u r w e e k s o f i n h a l a t i o n o f 5 0 m g / m
3
B a S O
4
r e -
s u l t e d i n n o p u l m o n a r y t o x i c i t y b y 3 5 d a y s p o s t - e x p o s u r e .
B A L p a r a m e t e r s w e r e c o m p a r a b l e t o c o n t r o l v a l u e s a f t e r
t h e p o s t - e x p o s u r e p e r i o d . D e l a y e d o n s e t o f a d v e r s e e f f e c t s
b e y o n d t h i s p o s t - e x p o s u r e p e r i o d i s u n k n o w n . H i s t o -
p a t h o l o g i c e x a m i n a t i o n p e r f o r m e d i n 4 - w e e k e x p o s e d a n i -
m a l s s h o w e d n o m o r p h o l o g i c a l c h a n g e s i n l u n g s a n d
e x t r a p u l m o n a r y o r g a n s ( e . g . b r a i n , h e a r t , l i v e r , s p l e e n ,
k i d n e y s ) . T h e s e r e s u l t s a r e c o n s i s t e n t w i t h o u r p r e v i o u s
s h o r t - t e r m i n h a l a t i o n s t u d y t h a t t e s t e d a v a r i e t y o f n a n o -
m a t e r i a l s i n c l u d i n g B a S O
4
N P s [ 2 7 ] . A 1 3 - w e e k e x p o s u r e
e l i c i t e d a s l i g h t i n f l a m m a t o r y r e s p o n s e i n r a t l u n g s . T h e
l o n g - t e r m e f f e c t s o f i n h a l a t i o n e x p o s u r e t o B a S O
4
N P s a r e
b e i n g e v a l u a t e d i n a n o n g o i n g t w o - y e a r s t u d y . O u r i n s t i l -
l a t i o n d a t a s h o w e d a m o d e r a t e d o s e - d e p e n d e n t i n f l a m m a -
t o r y r e s p o n s e t o B a S O
4
N P s a t 2 4 h o u r s . L u n g b u r d e n s a t
1 d a y a f t e r 4 o r 1 3 w e e k s o f i n h a l a t i o n e x p o s u r e w e r e
0 . 8 4 ± 0 . 1 8 a n d 1 . 7 3 ± 0 . 8 5 m g B a S O
4
/ l u n g , r e s p e c t i v e l y .
A t t h e 5 m g / k g i n s t i l l e d d o s e ( 1 . 4 m g B a S O
4
l u n g b u r d e n )
t h e n e u t r o p h i l r e s p o n s e w a s s i g n i f i c a n t l y h i g h e r t h a n a t
2 4 h o u r s a f t e r t h e l a s t i n h a l a t i o n e x p o s u r e . T h e d i f f e r e n c e
i n n e u t r o p h i l r e s p o n s e m a y b e d u e t o t h e d i f f e r e n c e s i n
d o s e r a t e , p a r t i c l e d i s t r i b u t i o n , p a r t i c l e c l e a r a n c e , a g g l o m -
e r a t e s u r f a c e p r o p e r t i e s a n d g e n d e r b e t w e e n t h e t w o
s t u d i e s . T h a t t h e t w o e x p o s u r e m e t h o d s y i e l d d i f f e r e n t r e -
s p o n s e s i s a l s o c o n s i s t e n t w i t h p r e v i o u s r e p o r t s [ 3 2 , 3 3 ] . A
F i g u r e 4 T i s s u e d i s t r i b u t i o n o f
1 3 1
B a f o l l o w i n g g a v a g e . A . I m m e d i a t e l y p o s t - g a v a g e , 1 0 0 % o f d o s e w a s r e c o v e r e d i n t h e s t o m a c h . B . A t 7 d a y s
p o s t - g a v a g e ,
1 3 1
B a w a s n e g l i g i b l e i n a l l t i s s u e s . V e r y l o w p e r c e n t a g e s o f t h e d o s e w e r e d e t e c t e d i n b o n e a n d b o n e m a r r o w . D a t a a r e m e a n ± s t a n d a r d
e r r o r o f t h e m e a n , n = 5 p e r g r o u p .
F i g u r e 5 C u m u l a t i v e f e c a l a n d u r i n a r y e x c r e t i o n o f
1 3 1
B a
p o s t - g a v a g e . A . E l i m i n a t i o n o f
1 3 1
B a w a s n e a r l y 1 0 0 % v i a t h e f e c e s .
B . B y 7 d a y s p o s t - g a v a g e , o n l y 0 . 0 2 % o f t h e a d m i n i s t e r e d d o s e w a s
e x c r e t e d i n t h e u r i n e . D a t a a r e m e a n ± s t a n d a r d e r r o r o f t h e m e a n ,
n = 5 p e r g r o u p .
K o n d u r u e t a l . P a r t i c l e a n d F i b r e T o x i c o l o g y 2 0 1 4 , 1 1 : 5 5 P a g e 7 o f 1 5
h t t p : / / w w w . p a r t i c l e a n d f i b r e t o x i c o l o g y . c o m / c o n t e n t / 1 1 / 1 / 5 5
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P a p e r  2 :  B i o k i n e t i c s  a n d  e f f e c t s  o f  b a r i u m  s u l f a t e  n a n o p a r t i c l e s
F i g u r e 6 T i s s u e d i s t r i b u t i o n o f
1 3 1
B a p o s t - I V i n j e c t i o n . T w o h o u r s p o s t - i n j e c t i o n , 5 8 % o f t h e i n j e c t e d d o s e w a s r e c o v e r e d i n t h e l i v e r a n d l o w e r
p e r c e n t a g e s i n t h e s p l e e n , b o n e , b o n e m a r r o w a n d t h e l u n g s . O v e r t i m e ,
1 3 1
B a l e v e l s i n t h e l i v e r a n d l u n g s d e c r e a s e d w i t h a c c o m p a n y i n g i n c r e a s e s i n
b o n e a n d b o n e m a r r o w . D a t a a r e m e a n ± s t a n d a r d e r r o r o f t h e m e a n , n = 5 p e r g r o u p . * P < 0 . 0 5 , d e c r e a s e o v e r t i m e ,
#
P < 0 . 0 5 , i n c r e a s e o v e r t i m e ,
M A N O V A ) .
T a b l e 6 C o m p a r i s o n o f t i s s u e b a r i u m c o n c e n t r a t i o n s a t 7 d a y s a f t e r d o s i n g
R o u t e ( d o s e ) I T I n s t i l l a t i o n ( 1 m g / k g ) G a v a g e ( 5 m g / k g ) I V I n j e c t i o n ( 1 m g / k g )
n g / g ± S E n g / g ± S E n g / g ± S E
L u n g s 6 9 0 7 4 . 5 ± 4 9 9 3 . 8 < 0 . 0 1 9 8 4 7 . 5 ± 9 8 3 . 8
B o n e 2 2 7 1 . 9 ± 1 2 4 . 6 * 0 . 0 7 9 ± 0 . 0 1 4 3 7 8 8 . 5 ± 1 5 6 . 6
#
B o n e m a r r o w 1 0 1 8 . 3 ± 7 1 . 4 * 0 . 1 3 ± 0 . 1 2 1 6 4 1 . 3 ± 6 2 . 2
#
C e c u m 1 1 9 . 3 ± 2 3 . 8 < 0 . 0 1 6 1 . 2 ± 4 . 2
#
T B L N 1 1 3 . 1 ± 1 6 . 3 < 0 . 0 1 6 4 . 8 ± 1 4 . 1
L a r g e I n t e s t i n e 1 0 6 . 6 ± 3 1 . 2 < 0 . 0 1 7 2 . 8 ± 6 . 1
#
S m a l l I n t e s t i n e 4 3 . 2 ± 6 . 7 < 0 . 0 1 2 8 . 5 ± 2 . 3
S p l e e n 3 7 . 5 ± 1 . 5 < 0 . 0 1 3 2 5 6 . 4 ± 3 9 1 . 2
#
S t o m a c h 3 0 . 3 ± 1 8 . 6 * 0 . 0 1 6 ± 0 . 0 1 6 4 6 . 3 ± 1 0 . 1
K i d n e y s 7 . 8 ± 2 . 7 < 0 . 0 1 1 4 0 . 8 ± 1 2 . 9
#
P l a s m a 3 . 6 ± 1 . 2 < 0 . 0 1 0 . 1 ± 0 . 1
H e a r t 3 . 6 ± 1 . 2 < 0 . 0 1 7 7 . 5 ± 1 0 . 8
#
B r a i n 3 . 5 ± 0 . 8 < 0 . 0 1 1 8 . 6 ± 4 . 5
#
R B C 3 . 1 ± 0 . 5 < 0 . 0 1 < 0 . 0 1
S k e l e t a l M u s c l e 3 . 0 ± 0 . 8 < 0 . 0 1 8 . 3 ± 0 . 5
#
L i v e r 2 . 5 ± 0 . 5 < 0 . 0 1 1 7 6 0 . 0 ± 2 2 1 . 9
#
S k i n 2 . 5 ± 1 . 0 < 0 . 0 1 2 . 5 ± 0 . 8
T e s t e s 0 . 7 ± 0 . 7 < 0 . 0 1 3 . 3 ± 3 . 3
D a t a a r e m e a n ± S E , n = 5 / g r o u p .
* P < 0 . 0 5 , I T i n s t i l l a t i o n h i g h e r t h a n g a v a g e . A l l o t h e r t i s s u e s p o s t - g a v a g e w e r e l o w e r t h a n d e t e c t i o n l i m i t ~ 0 . 0 1 n g / g B a r i u m .
#
P < 0 . 0 5 , I V i n j e c t i o n h i g h e r t h a n I T i n s t i l l a t i o n .
T B L N , t r a c h e o b r o n c h i a l l y m p h n o d e s .
K o n d u r u e t a l . P a r t i c l e a n d F i b r e T o x i c o l o g y 2 0 1 4 , 1 1 : 5 5 P a g e 8 o f 1 5
h t t p : / / w w w . p a r t i c l e a n d f i b r e t o x i c o l o g y . c o m / c o n t e n t / 1 1 / 1 / 5 5
7 0
P a p e r  2 :  B i o k i n e t i c s  a n d  e f f e c t s  o f  b a r i u m  s u l f a t e  n a n o p a r t i c l e s
s t u d y b y B a i s c h e t a l . r e p o r t e d a h i g h e r i n f l a m m a t o r y
r e s p o n s e t o a s i m i l a r d e p o s i t e d d o s e o f T i O
2
N P s w h e n
d e l i v e r e d v i a I T i n s t i l l a t i o n r a t h e r t h a n w h o l e b o d y i n h a l a -
t i o n [ 3 2 ] . I t i s c l e a r t h a t a l t h o u g h I T i n s t i l l a t i o n i s a r e l i -
a b l e m e t h o d f o r a d m i n i s t e r i n g a p r e c i s e d o s e t o t h e l u n g s ,
i t d o e s n o t m o d e l i n h a l a t i o n e x p o s u r e . P a r t i c l e d i s t r i -
b u t i o n a n d d o s e r a t e a r e d i f f e r e n t b e t w e e n t h e s e t w o
e x p o s u r e m e t h o d s . H o w e v e r , I T i n s t i l l a t i o n i s u s e f u l i n
b i o k i n e t i c s t u d i e s t h a t r e q u i r e p r e c i s e d o s i n g a n d t i m i n g
e s p e c i a l l y f o r r a d i o a c t i v e m a t e r i a l s s u c h a s
1 3 1
B a S O
4
N P s .
O u r u s e o f r a d i o l a b e l l e d N P s p r o v i d e d a v e r y s e n s i t i v e
m e t h o d t h a t m e a s u r e d o n l y
1 3 1
B a f r o m t h e n a n o p a r t i c l e s
a n d e x c l u d e d b a c k g r o u n d B a f r o m o t h e r s o u r c e s , s u c h a s
f o o d a n d w a t e r . T h e s e n s i t i v i t y o f
1 3 1
B a d e t e c t i o n a l s o
a v o i d e d t h e u s e o f h i g h B a S O
4
d o s e s w h i l e a l l o w i n g u s t o
m e a s u r e v e r y l o w l e v e l s i n t i s s u e s .
P u l m o n a r y c l e a r a n c e k i n e t i c s p o s t - i n h a l a t i o n w a s s i m i -
l a r t o t h e p r e v i o u s 5 - d a y i n h a l a t i o n s t u d y [ 2 8 ] . W e
o b s e r v e d a 9 5 % c l e a r a n c e o f B a f r o m t h e l u n g s i n
3 4 d a y s . T h i s i s c o n s i s t e n t w i t h t h e p r e v i o u s l y o b s e r v e d
7 7 % c l e a r a n c e o v e r 2 1 d a y s [ 2 8 ] . T h e l u n g b u r d e n o f
B a S O
4
a f t e r 1 3 - w e e k e x p o s u r e t o a h i g h c o n c e n t r a t i o n
o f B a S O
4
w a s a l s o s i m i l a r t o t h o s e o f r a t s e x p o s e d
t o l o w e r c o n c e n t r a t i o n s o f T i O
2
a n d C e O
2
[ 2 8 , 3 4 ] . T h i s
s h o w s t h a t c l e a r a n c e o f B a S O
4
i s m u c h f a s t e r t h a n t h e s e
o t h e r t w o n a n o m a t e r i a l s . B u t t h e s i m i l a r l u n g b u r d e n s
f r o m e x p o s u r e t o T i O
2
a n d C e O
2
r e s u l t e d i n g r e a t e r i n -
f l a m m a t o r y r e s p o n s e s [ 1 0 , 2 8 ] . O u r d a t a s u g g e s t t h a t t h e
l o w t o x i c i t y o f i n h a l e d B a S O
4
i s i n h e r e n t t o t h e n a n o m a -
t e r i a l a s w e l l a s i t s r e l a t i v e l y f a s t e r c l e a r a n c e .
T h e b i o k i n e t i c d a t a b a s e d o n r a d i o a c t i v e
1 3 1
B a S O
4
s h o w e d a f a s t c l e a r a n c e o f
1 3 1
B a f r o m t h e l u n g s . W e o b -
s e r v e d t h a t 5 0 % o f t h e i n i t i a l d o s e w a s c l e a r e d f r o m t h e
l u n g s a f t e r 9 . 6 d a y s . B y 2 8 d a y s o n l y 1 6 % o f t h e i n i t i a l
d o s e w a s r e t a i n e d i n t h e l u n g s . T h i s c l e a r a n c e r a t e a l s o
r o u g h l y c o r r e l a t e d w i t h t h a t o b t a i n e d f r o m o u r i n -
h a l a t i o n e x p e r i m e n t . B a s e d o n a l i n e a r r e g r e s s i o n o n t h e
n a t u r a l l o g a r i t h m o f l u n g
1 3 1
B a l e v e l s ( % o f i n s t i l l e d d o s e )
o v e r t i m e , t h e e x t r a p o l a t e d c l e a r a n c e o f i n s t i l l e d
1 3 1
B a S O
4
d o s e a t 3 5 d a y s i s 9 2 % . T h e l u n g b u r d e n p o s t - i n s t i l l a t i o n
w a s 0 . 2 8 ± 0 . 0 0 4 w h i c h w a s l o w e r t h a n l u n g b u r d e n a f t e r
4 - w e e k i n h a l a t i o n ( 0 . 8 4 ± 0 . 1 8 m g B a S O
4
) . D e s p i t e t h i s
d i f f e r e n c e i n i n i t i a l l u n g b u r d e n , t h e c l e a r a n c e r a t e o f
B a S O
4
N P s w a s n o t d i f f e r e n t b e t w e e n t h e t w o e x p o s u r e
m e t h o d s .
T h e l u n g c l e a r a n c e o f B a S O
4
N P s w a s s i m i l a r t o t h a t
s h o w n f o r m i c r o n - s i z e d r a d i o l a b e l e d B a S O
4
w h e r e 1 7 %
o f r a d i o l a b e l e d b a r i u m r e m a i n e d a t 2 2 d a y s p o s t -
i n s t i l l a t i o n i n r a t l u n g s [ 2 0 , 2 1 ] . T h e f a t e o f t h e 1 6 % o f
1 3 1
B a r e m a i n i n g i n t h e l u n g s a t t h e e n d o f o u r o b s e r v a -
t i o n n e e d s l o n g e r - t e r m s t u d i e s . S i n c e l u n g e p i t h e l i a l i n -
j u r y m a y a l t e r t h e f a t e o f i n s t i l l e d N P s , w e c h o s e a d o s e
t h a t w o u l d n o t c a u s e s i g n i f i c a n t i n j u r y t h a t m i g h t a f f e c t
t h e o u t c o m e o f o u r I T b i o k i n e t i c s t u d y . O u r d a t a
s u g g e s t t h a t
1 3 1
B a f r o m i n s t i l l e d
1 3 1
B a S O
4
N P s w a s
c l e a r e d f r o m t h e e n t i r e a n i m a l m a i n l y v i a t h e g a s t r o -
i n t e s t i n a l r o u t e . T h e e x c r e t e d f r a c t i o n i n t h e f e c e s m i g h t
i n c l u d e c o n t r i b u t i o n s f r o m b o t h t h e m u c o c i l i a r y a n d
b i l i a r y c l e a r a n c e p a t h w a y s . A l t h o u g h l u n g c l e a r a n c e o f
1 3 1
B a S O
4
N P s i s r e l a t i v e l y f a s t a n d o n l y 1 6 % o f t h e a d m i -
n i s t e r e d d o s e r e m a i n e d 4 w e e k s p o s t - i n s t i l l a t i o n , a s u b -
s t a n t i a l f r a c t i o n ( 3 7 % ) w a s r e t a i n e d e l s e w h e r e i n t h e b o d y .
T h e t i s s u e d i s t r i b u t i o n o f
1 3 1
B a f o l l o w i n g I T i n s t i l l a t i o n
s h o w e d a s i g n i f i c a n t t r a n s l o c a t i o n t o b o n e , c o n s i s t e n t w i t h
o t h e r h e a v y e a r t h a l k a l i n e m e t a l s l i k e c a l c i u m a n d s t r o n -
t i u m [ 3 5 ] a s w e l l a s t o t h e t h o r a c i c l y m p h n o d e s . W h e t h e r
t h e
1 3 1
B a m e a s u r e d i n t h e s e e x t r a p u l m o n a r y o r g a n s w a s
1 3 1
B a S O
4
N P s o r i o n i c
1 3 1
B a c o u l d n o t b e a s c e r t a i n e d i n
t h i s s t u d y . A p r e v i o u s s t u d y s h o w e d t h a t I T - i n s t i l l e d i o n i c
b a r i u m c l e a r e d m u c h m o r e r a p i d l y t h a n B a S O
4
p a r t i c l e s
[ 3 6 ] . W e h a v e a l s o d e m o n s t r a t e d t h a t i o n i c c e r i u m w a s
m o r e t o x i c a n d w a s c l e a r e d m o r e r a p i d l y t h a n C e O
2
N P s [ 3 7 ] .
T h e c l e a r a n c e o f i n h a l e d B a S O
4
N P s w a s f a s t a s e v i -
d e n c e d b y t h e d e c r e a s e i n B a S O
4
l u n g b u r d e n o v e r t i m e .
O n l y 5 % o f r e t a i n e d B a S O
4
i n t h e l u n g s ( 4 - w e e k - e x p o s u r e )
r e m a i n e d 3 5 d a y s a f t e r t h e e n d o f e x p o s u r e . T h e r e l a t i v e l y
h i g h b i o a v a i l a b i l i t y o f i n h a l e d o r i n s t i l l e d B a S O
4
d o e s n o t
c o r r e l a t e w i t h i t s v e r y l o w d i s s o l u t i o n r a t e i n p h a g o l y s o -
s o m a l s i m u l a n t f l u i d , a p r o p o s e d m o d e l o f m a c r o p h a g e
d i s s o l u t i o n / c l e a r a n c e o f p a r t i c l e s [ 3 0 ] . T h i s s t r o n g l y s u g -
g e s t s t h a t P S F d o e s n o t f u l l y s i m u l a t e t h e c o m p l e x k i n e t i c
p r o c e s s e s o f l u n g t r a n s p o r t a n d c l e a r a n c e , e s p e c i a l l y t h e
m e c h a n i s m o f p a r t i c l e d i s s o l u t i o n w i t h i n m a c r o p h a g e p h a -
g o l y s o s o m e s . O u r c e l l - f r e e i n v i t r o d i s s o l u t i o n s t u d i e s
s h o w e d v e r y l o w d i s s o l u t i o n i n P S F e v e n a f t e r 2 8 d a y s .
H o w e v e r , w e o b s e r v e d t h a t t h e n o n - s p h e r i c a l B a S O
4
N P s
l o s t t h e i r f e a t u r e o f l o w e s t r a d i u s o f c u r v a t u r e a n d
l a t e r r e c r y s t a l l i z e d o v e r t h i s p e r i o d . I n t e r e s t i n g l y , i t h a s
b e e n s h o w n t h a t t h e N P s u r f a c e c h a r g e a n d i n t e r a c t i v e
p r o p e r t i e s m a y v a r y w i t h t h e l o c a l r a d i u s o f c u r v a t u r e
[ 3 8 ] . T h e r e g i o n s o f t h e p a r t i c l e s u r f a c e w i t h d i f f e r e n t
c u r v a t u r e b e c o m e c h a r g e d a t d i f f e r i n g p H v a l u e s o f t h e
s u r r o u n d i n g s o l u t i o n [ 3 8 ] . P r e v i o u s s t u d i e s s h o w e d t h a t
n o n - s p h e r i c a l n a n o m a t e r i a l m a y e x h i b i t d i f f e r e n t t o x i c i t y
f r o m t h a t o f s p h e r i c a l l y s h a p e d n a n o m a t e r i a l o f t h e s a m e
c o m p o s i t i o n d u e t o t h e v a r y i n g l o c a l c h a r g e d e n s i t y [ 3 9 ] .
L i k e w i s e , q u a r t z a n d v i t r e o u s s i l i c a N P s , w i t h i r r e g u l a r s u r -
f a c e s a n d s h a r p e d g e s w e r e m o r e t o x i c t h a n s p h e r i c a l s i l i c a
[ 4 0 ] . T h e s i g n i f i c a n c e o f t h e n o t e d s t r u c t u r a l c h a n g e s o f
B a S O
4
N P s i n v i t r o r e m a i n s t o b e s t u d i e d i n t h e p h a g o l y -
s o s o m a l c o m p a r t m e n t o f l u n g m a c r o p h a g e s . H o w t h e s e
s t r u c t u r a l c h a n g e s r e l a t e t o c y t o t o x i c i t y i s l i k e w i s e y e t t o
b e d e t e r m i n e d .
W h o l e - b o d y e x p o s u r e o f r a t s t o N P a e r o s o l s r e s u l t s i n
n o t o n l y p u l m o n a r y d e p o s i t i o n b u t a l s o i n i n g e s t i o n o f
N P s d u e t o t h e g r o o m i n g b e h a v i o r o f r a t s . T h i s i n g e s t i o n
c a n c o m p l i c a t e t h e p a t t e r n o f b i o a v a i l a b i l i t y f r o m w h o l e -
K o n d u r u e t a l . P a r t i c l e a n d F i b r e T o x i c o l o g y 2 0 1 4 , 1 1 : 5 5 P a g e 9 o f 1 5
h t t p : / / w w w . p a r t i c l e a n d f i b r e t o x i c o l o g y . c o m / c o n t e n t / 1 1 / 1 / 5 5
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P a p e r  2 :  B i o k i n e t i c s  a n d  e f f e c t s  o f  b a r i u m  s u l f a t e  n a n o p a r t i c l e s
b o d y i n h a l a t i o n e x p o s u r e s . H o w e v e r , f o r a n i m a l w e l f a r e
c o n s i d e r a t i o n s , w h o l e - b o d y i s m o r e c o n v e n i e n t t h a n n o s e -
o n l y e x p o s u r e f o r l o n g - t e r m i n h a l a t i o n s t u d i e s . F o r s o m e
a p p l i c a t i o n s o f B a S O
4
, t h e g a s t r o i n t e s t i n a l t r a c t i s a l s o a
c o m m o n r o u t e f o r h u m a n e x p o s u r e s . T h u s , w e i n v e s t i -
g a t e d t h e f a t e o f o r a l l y a d m i n i s t e r e d
1 3 1
B a S O
4
N P s . S i n c e
t h e G I t r a n s i t t i m e i s g e n e r a l l y l e s s t h a n o n e d a y , i t i s l e s s
l i k e l y f o r n a n o p a r t i c l e s t o r e m a i n i n t h e G I t r a c t f o r a
p r o l o n g e d p e r i o d o f t i m e . E v e n p a r t i c l e s a d h e r e n t t o o r
i n g e s t e d b y c o l u m n a r e p i t h e l i a l c e l l s a r e e l i m i n a t e d r a p i d l y
s i n c e t h e e p i t h e l i u m s l o u g h s o f f a n d r e g e n e r a t e s c o n -
s t a n t l y . O u r d a t a s h o w e d t h a t 8 8 % o f t h e d o s e w a s e l i m i -
n a t e d i n t h e f e c e s w i t h i n 2 4 h o u r s , a n d a l m o s t 1 0 0 %
b y 7 d a y s p o s t - g a v a g e . S i n c e v e r y l o w r a d i o a c t i v i t y w a s d e -
t e c t e d i n o t h e r o r g a n s , w e c o n c l u d e t h a t n e i t h e r
1 3 1
B a S O
4
N P s n o r
1 3 1
B a i o n s s i g n i f i c a n t l y c r o s s e d t h e i n t e s t i n a l
b a r r i e r . T h i s l o w o r a l b i o a v a i l a b i l i t y c o r r e l a t e s w i t h o u r o b -
s e r v a t i o n o f v e r y l o w d i s s o l u t i o n o f B a S O
4
N P s i n s i m u l a t e d
g a s t r i c a n d i n t e s t i n a l f l u i d ( A d d i t i o n a l f i l e 1 : T a b l e S 1 ) .
T h i s i n d i c a t e s t h a t t h e r e i s n e g l i g i b l e c o n t r i b u t i o n f r o m f u r
d e p o s i t i o n a n d i n g e s t i o n d u r i n g i n h a l a t i o n e x p o s u r e . I t a l s o
m e a n s t h a t b a r i u m d e t e c t e d i n e x t r a p u l m o n a r y o r g a n s a f t e r
i n h a l a t i o n t r a n s l o c a t e s f r o m t h e l u n g s t o t h e b l o o d .
A s w e a n d o t h e r s h a v e s h o w n , a s m a l l f r a c t i o n o f
i n h a l e d n a n o p a r t i c l e s m a y t r a n s l o c a t e i n t o t h e s y s t e m i c
c i r c u l a t i o n [ 4 1 ] . A l t h o u g h o u r s t u d y f o c u s e d o n n o r m a l
l u n g s , w h e n t h e y a r e c o m p r o m i s e d b y i n j u r y o r i n f l a m -
m a t i o n i n c r e a s e d r a t e s o f N P t r a n s l o c a t i o n m a y o c c u r .
T h e r e f o r e , w e e v a l u a t e d t h e b i o k i n e t i c s a n d t i s s u e d i s -
t r i b u t i o n o f i n t r a v e n o u s l y i n j e c t e d
1 3 1
B a S O
4
N P s t o e l u -
c i d a t e t h e i r f a t e i n t h e c i r c u l a t i o n . W h e n w e s a c r i f i c e d
a n i m a l s a t 2 h o u r s p o s t - I V i n j e c t i o n o f
1 3 1
B a S O
4
N P s ,
w e f o u n d v e r y l o w r a d i o a c t i v i t y i n t h e b l o o d . S i n c e t h e
f i r s t t i m e p o i n t w e e x a m i n e d w a s a t 2 h o u r s , w e c o u l d
n o t d e t e r m i n e t h e v a s c u l a r c l e a r a n c e r a t e . P r e v i o u s l y ,
w e h a v e s h o w n t h a t c l e a r a n c e h a l f - l i v e s o f c i r c u l a t i n g
p a r t i c l e s a r e o n t h e o r d e r o f m i n u t e s e v e n f o r n a n o p a r t i -
c u l a t e s s u c h a s g o l d c o l l o i d [ 3 1 ] . I n i t i a l l y , a s i g n i f i c a n t
h e p a t i c a c c u m u l a t i o n o f
1 3 1
B a w a s o b s e r v e d b u t l i v e r r e -
t e n t i o n w a s d e c r e a s e d b y 7 d a y s . T h i s l i k e l y r e f l e c t s
r a p i d i n g e s t i o n o f
1 3 1
B a S O
4
N P s b y t h e a b u n d a n t h e -
p a t i c m a c r o p h a g e s ( K u p f f e r c e l l s ) a n d p o s s i b l y s u b s e -
q u e n t d i s s o l u t i o n f o l l o w e d b y r e l e a s e o f b a r i u m i o n s
i n t o t h e b l o o d . T h e d e c r e a s e w a s a c c o m p a n i e d b y i n -
c r e a s i n g a c c u m u l a t i o n i n b o n e s i m i l a r t o t h a t o b s e r v e d
f o l l o w i n g I T i n s t i l l a t i o n . D e s p i t e t h e s i g n i f i c a n t u p t a k e
o f B a i n t h e b o n e , n o e v i d e n c e o f g e n o t o x i c i t y i n t h e
b o n e m a r r o w w a s n o t e d . W e f o u n d n o m i c r o n u c l e u s
f o r m a t i o n i n p e r i p h e r i a l b l o o d c e l l s t h a t o r i g i n a t e f r o m
h e m a t o p o i e s i s i n t h e b o n e m a r r o w .
C o n c l u s i o n s
O u r d a t a s h o w t h a t i n h a l e d B a S O
4
N P s e l i c i t e d m i n i m a l
p u l m o n a r y r e s p o n s e a n d n o s y s t e m i c e f f e c t s . E q u i v a l e n t
l u n g b u r d e n s o f C e O
2
a n d T i O
2
e l i c i t m o r e p u l m o n a r y
r e s p o n s e t h a n B a S O
4
[ 2 8 ] . T h i s d i f f e r e n c e m i g h t b e d u e
t o i t s l o w e r i n h e r e n t t o x i c i t y a n d a l s o t o i t s f a s t e r l u n g
c l e a r a n c e . T h e m e c h a n i s m o f t h i s f a s t e r c l e a r a n c e n e e d s
f u r t h e r i n v e s t i g a t i o n . T h e r e i s n o d i r e c t c o r r e l a t i o n b e t -
w e e n a b i o t i c i n v i t r o d i s s o l u t i o n o f B a S O
4
i n s e v e r a l
c e l l - f r e e b i o l o g i c a l s i m u l a t i o n f l u i d s a n d a c t u a l i n v i v o
b i o p e r s i s t e n c e a n d b i o a v a i l a b i l i t y o f b a r i u m f r o m B a S O
4
N P s . O u r d a t a s u g g e s t t h a t c e l l - f r e e i n v i t r o a s s a y s e i t h e r
l a c k c r u c i a l c o n s t i t u e n t s o r d o n o t a d e q u a t e l y s i m u l a t e
t h e p r o c e s s e s t h a t f a c i l i t a t e p a r t i c l e d i s s o l u t i o n a n d i n -
c r e a s e b i o a v a i l a b i l i t y . T h e B a i n B a S O
4
f r o m t h e l u n g s
t r a n s l o c a t e s t o m a n y t i s s u e s , e s p e c i a l l y t h e b o n e s . T h e
c o m p a r i s o n o f p u l m o n a r y v e r s u s i n g e s t i o n r o u t e s o f e x -
p o s u r e p r o v i d e s a q u a n t i t a t i v e m e a s u r e o f r e l a t i v e d o s e s
t o a v a r i e t y o f n o n - p u l m o n a r y t i s s u e s . F r o m o u r d a t a , i t
i s e v i d e n t t h a t t h e b i o a v a i l a b i l i t y o f B a f r o m i n g e s t i o n o f
B a S O
4
N P s i s v e r y l o w a n d t h a t n o s i g n i f i c a n t c o n t r i b u -
t i o n f r o m i n g e s t i o n s h o u l d o c c u r d u r i n g w h o l e - b o d y i n -
h a l a t i o n s t u d i e s i n r a t s .
O u r s t u d y u n d e r s c o r e s t h e h i g h B a b i o a v a i l a b i l i t y a n d
c l e a r a n c e o f B a S O
4
N P s d e p o s i t e d i n t h e l u n g s . U n l i k e
C e O
2
a n d T i O
2
, B a S O
4
N P s a r e r e t a i n e d t o a l e s s e r e x -
t e n t i n t h e l u n g s a f t e r i n h a l a t i o n . E v e n a t l u n g b u r d e n s
s i m i l a r t o C e O
2
a n d T i O
2
, B a S O
4
N P s c a u s e l o w e r p u l -
m o n a r y t o x i c i t y . B a r i u m s u l f a t e e x h i b i t s l o w e r t o x i c i t y
a n d b i o p e r s i s t e n c e i n t h e l u n g s c o m p a r e d t o p o o r l y
s o l u b l e C e O
2
a n d T i O
2
.
M e t h o d s
P h y s i c o c h e m i c a l c h a r a c t e r i z a t i o n o f B a S O
4
n a n o p a r t i c l e s
B a S O
4
N P s ( N M - 2 2 0 ) u s e d f o r I T i n s t i l l a t i o n s t u d i e s w e r e
o b t a i n e d f r o m B A S F S E ( L u d w i g s h a f e n , G e r m a n y ) . I t w a s a
r e f e r e n c e m a t e r i a l f o r t h e N a n o m a t e r i a l T e s t i n g S p o n -
s o r s h i p P r o g r a m o f t h e O r g a n i z a t i o n f o r E c o n o m i c C o -
o p e r a t i o n a n d D e v e l o p m e n t ( O E C D ) . T h e c h a r a c t e r i z a t i o n
o f t h e o r i g i n a l b a t c h d i s t r i b u t e d a s “ N M - 2 2 0 ” w a s p u b -
l i s h e d r e c e n t l y [ 2 9 ] . T h e r e p r o d u c e d B a S O
4
u s e d i n i n h a -
l a t i o n s t u d i e s w a s c h a r a c t e r i z e d b y t h e s a m e m e t h o d s ( S e e
S u p p o r t i n g I n f o r m a t i o n ) .
A n i m a l s f o r i n t r a t r a c h e a l i n s t i l l a t i o n , g a v a g e a n d
i n t r a v e n o u s i n j e c t i o n s t u d i e s
T h e p r o t o c o l s u s e d i n t h i s s t u d y w e r e a p p r o v e d b y
t h e H a r v a r d M e d i c a l A r e a A n i m a l C a r e a n d U s e C o m -
m i t t e e . M a l e W i s t a r r a t s ( 8 w e e k s o l d ) w e r e o b t a i n e d
f r o m C h a r l e s R i v e r L a b o r a t o r i e s ( W i l m i n g t o n , M A ) a n d
w e r e h o u s e d i n s t a n d a r d m i c r o i s o l a t o r c a g e s u n d e r c o n -
t r o l l e d c o n d i t i o n s o f t e m p e r a t u r e , h u m i d i t y , a n d l i g h t a t
t h e H a r v a r d C e n t e r f o r C o m p a r a t i v e M e d i c i n e . T h e y
w e r e f e d c o m m e r c i a l c h o w ( P i c o L a b R o d e n t D i e t 5 0 5 3 ,
F r a m i n g h a m , M A ) a n d r e v e r s e - o s m o s i s p u r i f i e d w a t e r
w a s p r o v i d e d a d l i b i t u m . T h e a n i m a l s w e r e a c c l i m a t i z e d
i n t h e f a c i l i t y f o r 7 d a y s b e f o r e t h e s t a r t o f e x p e r i m e n t s .
K o n d u r u e t a l . P a r t i c l e a n d F i b r e T o x i c o l o g y 2 0 1 4 , 1 1 : 5 5 P a g e 1 0 o f 1 5
h t t p : / / w w w . p a r t i c l e a n d f i b r e t o x i c o l o g y . c o m / c o n t e n t / 1 1 / 1 / 5 5
7 2
P a p e r  2 :  B i o k i n e t i c s  a n d  e f f e c t s  o f  b a r i u m  s u l f a t e  n a n o p a r t i c l e s
P r e p a r a t i o n o f B a S O
4
s u s p e n s i o n f o r a n i m a l d o s i n g
S u s p e n s i o n s o f B a S O
4
N P s w e r e p r e p a r e d a t a p p r o p r i a t e
c o n c e n t r a t i o n s i n s t e r i l e p o l y e t h y l e n e t u b e s . T h e c r i t i c a l
d i s p e r s i o n s o n i c a t i o n e n e r g y ( D S E
c r
) r e q u i r e d t o a c h i e v e
t h e l o w e s t r e p o r t e d p a r t i c l e a g g l o m e r a t i o n w a s u s e d a s
p r e v i o u s l y r e p o r t e d [ 4 2 ] . S u s p e n s i o n s i n s a m p l e t u b e s
w e r e s o n i c a t e d w i t h a B r a n s o n S o n i f i e r S - 4 5 0 A ( B r a n s o n
U l t r a s o n i c s , D a n b u r y , C T ) f i t t e d w i t h a c u p s o n i c a t o r
a t 2 4 2 J / m l , t h e c r i t i c a l d i s p e r s i v e e n e r g y s h o w n t o
m a x i m a l l y d i s p e r s e t h e s e p a r t i c l e s i n w a t e r [ 4 2 ] w h i l e
i m m e r s e d i n r u n n i n g c o l d w a t e r t o m i n i m i z e h e a t i n g o f t h e
p a r t i c l e s . T h e h y d r o d y n a m i c d i a m e t e r ( d
H
) , p o l y d i s p e r s i t y
i n d e x ( P d I ) , a n d z e t a p o t e n t i a l ( ζ ) o f e a c h s u s p e n s i o n w e r e
m e a s u r e d b y d y n a m i c l i g h t s c a t t e r i n g u s i n g a Z e t a s i z e r
N a n o - Z S ( M a l v e r n I n s t r u m e n t s , W o r c e s t e r s h i r e , U K ) .
P u l m o n a r y r e s p o n s e s t o i n t r a t r a c h e a l l y i n s t i l l e d B a S O
4
n a n o p a r t i c l e s – B r o n c h o a l v e o l a r l a v a g e a n d a n a l y s e s
T h i s e x p e r i m e n t w a s p e r f o r m e d t o d e t e r m i n e a p a r t i c l e
d o s e f o r p u l m o n a r y p a r t i c l e i n s t i l l a t i o n t h a t d o e s n o t c a u s e
s i g n i f i c a n t i n j u r y o r i n f l a m m a t i o n . T w e n t y r a t s ( m e a n w t ±
s t a n d a r d d e v i a t i o n , 2 8 0 ± 1 5 g ) w e r e I T - i n s t i l l e d w i t h
B a S O
4
s u s p e n s i o n a t 1 , 2 a n d 5 m g / k g d o s e ( 5 r a t s p e r
d o s e ) t o d e t e r m i n e t h e a c u t e p u l m o n a r y e f f e c t s o f B a S O
4
p a r t i c l e s . T h e n a n o p a r t i c l e c o n c e n t r a t i o n s w e r e 0 . 6 7 , 1 . 3 3 ,
a n d 3 . 3 3 m g / m l f o r t h e 1 , 2 , a n d 5 m g / k g d o s e , r e s p e c -
t i v e l y . R a t s i n s t i l l e d w i t h a n e q u i v a l e n t v o l u m e o f s t e r i l e
d i s t i l l e d w a t e r s e r v e d a s c o n t r o l s . T h e v o l u m e d o s e w a s
1 . 5 m l / k g . T h e p a r t i c l e s u s p e n s i o n s w e r e d e l i v e r e d t o
t h e l u n g s t h r o u g h t h e t r a c h e a , a s d e s c r i b e d e a r l i e r [ 4 3 ] .
T w e n t y - f o u r h o u r s l a t e r , t h e r a t s w e r e a n e s t h e t i z e d a n d
e u t h a n i z e d v i a e x s a n g u i n a t i o n . T h e t r a c h e a w a s e x p o s e d
a n d c a n n u l a t e d . T h e l u n g s w e r e t h e n l a v a g e d 1 2 t i m e s
w i t h 3 m L o f C a - a n d M g - f r e e 0 . 9 % s t e r i l e P B S . T h e c e l l s
o f a l l w a s h e s w e r e s e p a r a t e d f r o m t h e s u p e r n a t a n t b y c e n -
t r i f u g a t i o n ( 3 5 0 × g a t 4 ° C f o r 1 0 m i n ) . T o t a l c e l l c o u n t
a n d h e m o g l o b i n m e a s u r e m e n t s w e r e m a d e f r o m t h e c e l l
p e l l e t s . A f t e r s m e a r i n g a n d s t a i n i n g t h e c e l l s , a d i f f e r e n t i a l
c e l l c o u n t w a s p e r f o r m e d . T h e s u p e r n a t a n t o f t h e t w o f i r s t
w a s h e s w a s c l a r i f i e d v i a c e n t r i f u g a t i o n ( 1 4 , 5 0 0 × g a t 4 ° C
f o r 3 0 m i n ) , a n d u s e d f o r s p e c t r o p h o t o m e t r i c a s s a y s f o r
l a c t a t e d e h y d r o g e n a s e ( L D H ) , m y e l o p e r o x i d a s e ( M P O )
a n d a l b u m i n .
N e u t r o n a c t i v a t i o n o f B a S O
4
n a n o p a r t i c l e s f o r
p h a r m a c o k i n e t i c s t u d i e s
B a r i u m s u l f a t e N M - 2 2 0 p a r t i c l e s w e r e n e u t r o n a c t i v a t e d
a t t h e M I T N u c l e a r R e a c t o r L a b o r a t o r y ( C a m b r i d g e , M A )
w i t h a t h e r m a l n e u t r o n f l u x o f 5 × 1 0
1 3
n / c m
2
s f o r 2 4
h o u r s . T h e p r o c e s s g e n e r a t e d
1 3 1
B a , w h i c h d e c a y s w i t h a
h a l f l i f e o f 1 0 . 5 d a y s a n d e m i t s m u l t i p l e g a m m a r a y s w i t h
v a r y i n g e n e r g i e s . T h e s p e c i f i c a c t i v i t y w a s 2 . 6 μ C i
1 3 1
B a
p e r m g B a S O
4
N P s .
P h a r m a c o k i n e t i c s o f t r a c h e a l l y - i n s t i l l e d , g a v a g e d o r
i n t r a v e n o u s l y - i n j e c t e d
1 3 1
B a S O
4
n a n o p a r t i c l e s
F i f t y r a t s ( m e a n w t ± s t a n d a r d d e v i a t i o n , 2 7 0 ± 1 2 g ) w e r e
u s e d f o r t h i s s t u d y . N e u t r o n - a c t i v a t e d
1 3 1
B a S O
4
N P s w e r e
s u s p e n d e d i n s t e r i l e d i s t i l l e d w a t e r a t 0 . 6 7 m g / m l f o r i n t r a -
t r a c h e a l i n s t i l l a t i o n ( I T ) , 1 0 m g / m l f o r g a v a g e , a n d 1 m g / m l
f o r i n t r a v e n o u s ( I V ) i n j e c t i o n . T h e m a s s a n d v o l u m e d o s e s
w e r e 1 ) I T - 1 m g / k g ( 1 . 5 m l / k g ) , 2 ) g a v a g e - 5 m g / k g
( 0 . 5 m l / k g ) , a n d 3 ) I V - 1 m g / k g ( 1 m l / k g ) . T h e p a r t i c l e
s u s p e n s i o n s w e r e d i s p e r s e d a s d e s c r i b e d e a r l i e r . A l i q u o t s
o f e a c h s u s p e n s i o n w e r e m e a s u r e d i n a W I Z A R D g a m m a
c o u n t e r ( P e r k i n E l m e r , I n c . , W a l t h a m , M A ) t o e s t i m a t e
e a c h r a t ’ s
1 3 1
B a d o s e . G a m m a e n e r g i e s a t 2 0 0 – 2 7 0 K e V
w e r e u t i l i z e d f o r
1 3 1
B a q u a n t i t a t i o n . E a c h r a t w a s a n e s t h e -
t i z e d w i t h i s o f l u r a n e ( P i r a m a l H e a l t h c a r e , B e t h l e h e m , P A )
d u r i n g p a r t i c l e a d m i n i s t r a t i o n . A f t e r d o s i n g , e a c h r a t w a s
p l a c e d i n a m e t a b o l i c c a g e w i t h f o o d a n d w a t e r a d l i b i t u m .
T w e n t y - f o u r - h o u r s a m p l e s o f u r i n e a n d f e c e s w e r e c o l -
l e c t e d a t 0 – 1 , 2 – 3 , 6 – 7 , 9 – 1 0 , 1 3 – 1 4 , 2 0 – 2 1 , a n d 2 7 – 2 8
d a y s a f t e r d o s i n g .
T h e
1 3 1
B a S O
4
N P s u s p e n s i o n w a s d e l i v e r e d t o t h e l u n g s
t h r o u g h t h e t r a c h e a a s d e s c r i b e d e a r l i e r . F o r g a v a g e ,
1 3 1
B a S O
4
N P s w e r e d e l i v e r e d i n t o t h e s t o m a c h v i a t h e
e s o p h a g u s . I V i n j e c t i o n w a s d o n e u s i n g t h e p e n i l e v e i n i n
s i m i l a r l y a n e s t h e t i z e d a n i m a l s . F i v e r a t s f r o m t h e I T g r o u p
w e r e h u m a n e l y k i l l e d a t e a c h t i m e p o i n t : 5 m i n u t e s a n d 2 ,
7 , 1 4 a n d 2 8 d a y s p o s t - d o s i n g . A n a l y s i s o f r a t s a t 5 m i n u t e s
p o s t - i n s t i l l a t i o n w a s p e r f o r m e d t o g e t a n a c c u r a t e m e a s u r e
o f t h e i n i t i a l d e p o s i t e d d o s e . E q u a l n u m b e r s o f r a t s ( 5 p e r
t i m e p o i n t ) w e r e a n a l y z e d a t 5 m i n u t e s a n d 7 d a y s p o s t -
g a v a g e , a n d a t 2 h o u r s , 2 d a y s , a n d 7 d a y s p o s t - I V i n j e c -
t i o n . A t e a c h t i m e p o i n t , r a t s w e r e a n e s t h e t i z e d a n d b l o o d
c o l l e c t e d f r o m t h e a b d o m i n a l a o r t a . P l a s m a a n d r e d b l o o d
c e l l s w e r e s e p a r a t e d b y c e n t r i f u g a t i o n . T h e l u n g s , b r a i n ,
h e a r t , s p l e e n , k i d n e y s , g a s t r o i n t e s t i n a l t r a c t , l i v e r , t e s t e s ,
a n d s a m p l e s o f s k e l e t a l m u s c l e , b o n e m a r r o w , s k i n , a n d
f e m o r a l b o n e w e r e c o l l e c t e d a n d p l a c e d i n p r e - w e i g h e d
t u b e s . S a m p l e w e i g h t w a s r e c o r d e d a n d r a d i o a c t i v i t y
( 2 0 0 – 2 7 0 K e V ) w a s m e a s u r e d i n a W I Z A R D g a m m a c o u n -
t e r ( P e r k i n E l m e r , I n c . , W a l t h a m , M A ) . D i s i n t e g r a t i o n s p e r
m i n u t e w e r e c a l c u l a t e d f r o m t h e c o u n t s p e r m i n u t e a n d
t h e c o u n t e r e f f i c i e n c y . T h e l i m i t o f d e t e c t i o n f o r
1 3 1
B a w a s
0 . 0 5 n C i . A l l r a d i o a c t i v i t y d a t a w e r e a d j u s t e d f o r p h y s i c a l
d e c a y o v e r t h e e n t i r e o b s e r v a t i o n p e r i o d . D a t a w e r e
e x p r e s s e d a s μ C i / g a n d a s a p e r c e n t a g e o f t h e a d m i n i s t e r e d
d o s e r e t a i n e d i n e a c h o r g a n . T o t a l r a d i o a c t i v i t y i n o r g a n s
a n d t i s s u e s n o t m e a s u r e d i n t h e i r e n t i r e t y w a s c o m p u t e d
u s i n g t h e f o l l o w i n g e s t i m a t e s o f t i s s u e p e r c e n t a g e o f t o t a l
b o d y w e i g h t : s k e l e t a l m u s c l e , 4 0 % ; b o n e m a r r o w , 3 . 2 % ;
p e r i p h e r a l b l o o d , 7 % ; s k i n , 1 9 % ; a n d b o n e , 6 % [ 4 4 , 4 5 ] .
A n i m a l s f o r i n h a l a t i o n s t u d i e s
P r o t o c o l s f o r t h e i n h a l a t i o n s t u d i e s w e r e a p p r o v e d b y t h e
l o c a l a u t h o r i z i n g a g e n c y i n L a n d e s u n t e r s u c h u n g s a m t
K o n d u r u e t a l . P a r t i c l e a n d F i b r e T o x i c o l o g y 2 0 1 4 , 1 1 : 5 5 P a g e 1 1 o f 1 5
h t t p : / / w w w . p a r t i c l e a n d f i b r e t o x i c o l o g y . c o m / c o n t e n t / 1 1 / 1 / 5 5
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P a p e r  2 :  B i o k i n e t i c s  a n d  e f f e c t s  o f  b a r i u m  s u l f a t e  n a n o p a r t i c l e s
K o b l e n z , G e r m a n y . A n i m a l s w e r e h o u s e d i n a n A A A L A C -
a c c r e d i t e d f a c i l i t y i n a c c o r d a n c e w i t h t h e G e r m a n A n i m a l
W e l f a r e A c t a n d t h e e f f e c t i v e E u r o p e a n C o u n c i l D i r e c t i v e .
F e m a l e W i s t a r H a n r a t s w e r e o b t a i n e d a t 5 o r 7 w e e k s o f
a g e f r o m C h a r l e s R i v e r L a b o r a t o r i e s ( S u l z f e l d , G e r m a n y ) .
T h e a n i m a l s w e r e m a i n t a i n e d i n g r o u p s o f u p t o 5 a n i m a l s
i n a p o l y s u l f o n c a g e ( H - T e m p [ P S U ] , T E C N I P L A S T ,
G e r m a n y ) w i t h a f l o o r a r e a o f a b o u t 2 0 6 5 c m
2
w i t h a c c e s s
t o w o o d e n g n a w i n g b l o c k s , G L P c e r t i f i e d d i e t ( K l i b a
l a b o r a t o r y d i e t , P r o v i m i K l i b a S A , K a i s e r a u g s t , B a s e l
S w i t z e r l a n d ) a n d w a t e r a d l i b i t u m . A n i m a l r o o m s w e r e
k e p t u n d e r c o n t r o l l e d c o n d i t i o n s ( 2 0 - 2 4 ° C t e m p e r a -
t u r e , 3 0 - 7 0 % r e l a t i v e h u m i d i t y , 1 5 a i r c h a n g e s p e r h o u r ,
1 2 - h o u r l i g h t / d a r k c y c l e ) . T o a d a p t t o t h e e x p o s u r e c o n -
d i t i o n s , t h e a n i m a l s w e r e a c c l i m a t i z e d t o e x p o s u r e c o n -
d i t i o n s o v e r t w o d a y s ( 3 a n d 6 h o u r s , r e s p e c t i v e l y ) . U p t o
t w o a n i m a l s p e r w i r e c a g e t y p e D K I I I ( B E C K E R & C o . ,
C a s t r o p - R a u x e l , G e r m a n y ) w e r e e x p o s e d i n t h e w h o l e -
b o d y e x p o s u r e c h a m b e r .
S t u d y d e s i g n - i n h a l a t i o n e x p o s u r e f o r f o u r a n d t h i r t e e n
w e e k s
T h i r t y f e m a l e r a t s ( i n g r o u p s o f f i v e ) w e r e w h o l e - b o d y e x -
p o s e d t o 5 0 m g / m
3
B a S O
4
N P s f o r 6 h o u r s p e r d a y o n f i v e
c o n s e c u t i v e d a y s f o r 4 w e e k s ( 1 5 r a t s ) . A n o t h e r c o h o r t o f
1 5 r a t s w a s e x p o s e d f o r 1 3 w e e k s . B o d y w e i g h t s w e r e r e -
c o r d e d b e f o r e a n d e v e r y w e e k t h r o u g h o u t t h e d u r a t i o n o f
t h e e x p e r i m e n t s . A f t e r 4 w e e k s o f e x p o s u r e , o n e g r o u p
w a s e x a m i n e d a n d a n o t h e r a f t e r a p o s t - e x p o s u r e p e r i o d o f
3 5 d a y s . T h e s h o r t - t e r m i n h a l a t i o n s t u d y w i t h 4 w e e k s o f
e x p o s u r e w a s p e r f o r m e d a c c o r d i n g t o t h e O E C D P r i n c i -
p l e s o f G o o d L a b o r a t o r y P r a c t i c e ( G L P ) [ 4 6 ] , a c c o r d i n g t o
O E C D G u i d e l i n e s f o r T e s t i n g o f C h e m i c a l s , S e c t i o n 4 :
H e a l t h E f f e c t s , N o . 4 1 2 [ 4 7 ] . T h i s s t u d y p r o v i d e s i n f o r m a -
t i o n o n b i o k i n e t i c s a n d e f f e c t s o f B a S O
4
N P s r e q u i r e d f o r
t h e d e s i g n o f t h e l o n g - t e r m i n h a l a t i o n s t u d y . B a r i u m
b u r d e n i n l u n g s w a s m e a s u r e d a t t h r e e t i m e p o i n t s t o d e -
t e r m i n e t h e r e t e n t i o n h a l f - l i f e . B A L a n a l y s i s a n d h i s t o -
p a t h o l o g y o f t h e l u n g s w e r e p e r f o r m e d . I n a d d i t i o n ,
s y s t e m i c e f f e c t s w e r e i n v e s t i g a t e d w i t h h i s t o p a t h o l o g y o f
e x t r a p u l m o n a r y o r g a n s , e x a m i n a t i o n o f b l o o d a n d s y s t e m i c
g e n o t o x i c i t y b y m i c r o n u c l e u s t e s t ( M N T ) . B a s e d o n t h e
r e s u l t o f t h e s h o r t - t e r m s t u d y w i t h 4 w e e k s o f e x p o s u r e ,
t h e l o n g - t e r m s t u d y w a s s t a r t e d a t t h e s a m e c o n c e n t r a t i o n
o f 5 0 m g / m
3
B a S O
4
. T h e l o n g - t e r m i n h a l a t i o n s t u d y i s
p e r f o r m e d a c c o r d i n g t o O E C D G u i d e l i n e s f o r T e s t i n g o f
C h e m i c a l s , S e c t i o n 4 : H e a l t h E f f e c t s , N o . 4 5 3 [ 4 8 ] .
I n h a l a t i o n s y s t e m
T h e a n i m a l s w e r e e x p o s e d w h i l e i n w i r e c a g e s t h a t w e r e
l o c a t e d i n a s t a i n l e s s - s t e e l w h o l e - b o d y i n h a l a t i o n c h a m b e r
( V = 2 . 8 m
3
o r V = 1 . 4 m
3
) . T h e a e r o s o l s w e r e p a s s e d i n t o
t h e i n h a l a t i o n c h a m b e r s w i t h t h e s u p p l y a i r a n d w e r e r e -
m o v e d b y a n e x h a u s t a i r s y s t e m w i t h 2 0 a i r c h a n g e s p e r
h o u r . F o r t h e c o n t r o l a n i m a l s , t h e e x h a u s t a i r s y s t e m w a s
a d j u s t e d i n s u c h a w a y t h a t t h e a m o u n t o f e x h a u s t a i r w a s
l o w e r t h a n t h e f i l t e r e d c l e a n , s u p p l y a i r ( p o s i t i v e p r e s s u r e )
t o e n s u r e t h a t n o l a b o r a t o r y r o o m a i r r e a c h e s t h e c o n t r o l
a n i m a l s . F o r t h e B a S O
4
- e x p o s e d r a t s , t h e a m o u n t o f
e x h a u s t a i r w a s h i g h e r t h a n t h e s u p p l y a i r ( n e g a t i v e p r e s -
s u r e ) t o p r e v e n t c o n t a m i n a t i o n o f t h e l a b o r a t o r y a s a r e -
s u l t o f p o t e n t i a l l e a k a g e s f r o m t h e i n h a l a t i o n c h a m b e r s .
A e r o s o l g e n e r a t i o n a n d m o n i t o r i n g
B a S O
4
a e r o s o l s w e r e p r o d u c e d b y d r y d i s p e r s i o n o f p o w -
d e r p e l l e t s w i t h a b r u s h d u s t g e n e r a t o r u s i n g c o m p r e s s e d
a i r a t 1 . 5 m
3
/ h ( d e v e l o p e d b y t h e T e c h n i c a l U n i v e r s i t y o f
K a r l s r u h e i n c o o p e r a t i o n w i t h B A S F , G e r m a n y ) . T h e d u s t
a e r o s o l w a s d i l u t e d b y c o n d i t i o n e d a i r p a s s e d i n t o t h e
w h o l e - b o d y i n h a l a t i o n c h a m b e r s . T h e c o n t r o l g r o u p w a s
e x p o s e d t o c o n d i t i o n e d c l e a n a i r . T h e d e s i r e d c o n c e n -
t r a t i o n s w e r e a c h i e v e d b y v a r y i n g t h e f e e d i n g s p e e d o f t h e
p o w d e r p e l l e t o r b y v a r y i n g t h e r o t a t i o n s p e e d o f t h e
b r u s h . B a s e d o n a c o m p r e h e n s i v e t e c h n i c a l t r i a l , a t m o s -
p h e r i c c o n c e n t r a t i o n s w i t h i n t h e c h a m b e r s w e r e f o u n d t o
b e h o m o g e n o u s ( T a b l e 3 ) . N e v e r t h e l e s s , e x p o s u r e c a g e s
w e r e r o t a t e d w i t h i n e a c h c h a m b e r d a i l y f o r t h e 4 - w e e k ,
a n d w e e k l y f o r t h e 1 3 - w e e k g r o u p .
G e n e r a t e d a e r o s o l s w e r e c o n t i n u o u s l y m o n i t o r e d b y
s c a t t e r e d l i g h t p h o t o m e t e r s ( V i s G u a r d , S i g r i s t ) . P a r t i c l e
c o n c e n t r a t i o n s i n t h e i n h a l a t i o n c h a m b e r s w e r e a n a l y z e d
b y g r a v i m e t r i c m e a s u r e m e n t o f a i r f i l t e r s a m p l e s . P a r t i c l e
s i z e d i s t r i b u t i o n w a s d e t e r m i n e d g r a v i m e t r i c a l l y b y c a s -
c a d e i m p a c t o r a n a l y s i s u s i n g e i g h t s t a g e s M a r p l e P e r s o n a l
C a s c a d e I m p a c t o r ( S i e r r a - A n d e r s o n , U S A ) . I n a d d i t i o n , a
l i g h t - s c a t t e r i n g a e r o s o l s p e c t r o m e t e r ( W E L A S 2 0 0 0 , P a l a s ,
K a r l s r u h e , G e r m a n y ) w a s u s e d t o m e a s u r e p a r t i c l e s i z e s
f r o m 0 . 2 4 t o 1 0 μ m . T o m e a s u r e p a r t i c l e s i n t h e s u b -
m i c r o m e t e r r a n g e , a s c a n n i n g m o b i l i t y p a r t i c l e s i z e r
( S M P S 5 . 4 0 0 , G r i m m A e r o s o l t e c h n i k , A i n r i n g , G e r m a n y )
w a s u s e d . T h e s a m p l i n g p r o c e d u r e s a n d m e a s u r e m e n t s t o
c h a r a c t e r i z e t h e g e n e r a t e d a e r o s o l s w e r e p r e v i o u s l y d e -
s c r i b e d [ 4 9 ] .
P u l m o n a r y r e s p o n s e s t o i n h a l e d B a S O
4
n a n o p a r t i c l e s - B r o n c h o a l v e l o a r l a v a g e a n d a n a l y s i s
F i v e a n i m a l s p e r g r o u p w e r e e x a m i n e d . A f t e r e u t h a n a s i a ,
t h e l u n g s w e r e l a v a g e d t w i c e i n s i t u w i t h 2 2 m L / k g b o d y
w e i g h t ( 4 t o 5 m l ) o f n o r m a l s a l i n e . T h e r e c o v e r e d v o -
l u m e r a n g e d f r o m 8 t o 1 0 m l p e r a n i m a l . A l i q u o t s o f
B A L w e r e u s e d f o r d e t e r m i n a t i o n s o f t o t a l p r o t e i n c o n -
c e n t r a t i o n , t o t a l c e l l c o u n t , d i f f e r e n t i a l c e l l c o u n t a n d
e n z y m e a c t i v i t i e s . I n t h e 4 w e e k - e x p o s u r e g r o u p a n d i t s
c o n t r o l , B A L a n a l y s i s w a s p e r f o r m e d t w i c e ( 1 a n d 3 5
d a y s a f t e r t h e e n d o f e x p o s u r e ) b u t o n l y a t 1 d a y p o s t -
e x p o s u r e i n t h e 1 3 - w e e k e x p o s u r e g r o u p . L a v a g e d l u n g
t i s s u e a n d a l i q u o t s o f t h e B A L f l u i d ( 1 m l ) w e r e s t o r e d
a t − 8 0 ° C a n d u s e d f o r d e t e r m i n a t i o n o f b a r i u m c o n t e n t .
K o n d u r u e t a l . P a r t i c l e a n d F i b r e T o x i c o l o g y 2 0 1 4 , 1 1 : 5 5 P a g e 1 2 o f 1 5
h t t p : / / w w w . p a r t i c l e a n d f i b r e t o x i c o l o g y . c o m / c o n t e n t / 1 1 / 1 / 5 5
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P a p e r  2 :  B i o k i n e t i c s  a n d  e f f e c t s  o f  b a r i u m  s u l f a t e  n a n o p a r t i c l e s
T o t a l B A L c e l l c o u n t s w e r e d e t e r m i n e d w i t h a n A d v i a 1 2 0
( S i e m e n s D i a g n o s t i c s , F e r n w a l d , G e r m a n y ) h e m a t o l o g y
a n a l y z e r . D i f f e r e n t i a l c e l l c o u n t s w e r e m a d e o n W r i g h t -
s t a i n e d c y t o c e n t r i f u g e s l i d e p r e p a r a t i o n s . U s i n g a H i t a c h i
9 1 7 ( R o c h e D i a g n o s t i c s , M a n n h e i m , G e r m a n y ) r e a c t i o n
r a t e a n a l y z e r , l e v e l s o f B A L t o t a l p r o t e i n a n d a c t i v i t i e s o f
l a c t a t e d e h y d r o g e n a s e ( L D H ) , a l k a l i n e p h o s p h a t a s e ( A L P ) ,
γ - g l u t a m y l t r a n s f e r a s e ( G G T ) a n d N - a c e t y l - β - g l u c o s a m i -
n i d a s e ( N A G ) w e r e m e a s u r e d . I n f l a m m a t o r y c y t o k i n e s
( M C P - 1 , I L - 8 / C I N C - 1 , M - C S F , o s t e o p o n t i n ) i n B A L
w e r e m e a s u r e d u s i n g E L I S A t e s t k i t s a s d e s c r i b e d p r e -
v i o u s l y [ 5 0 ] .
T i s s u e a n a l y s i s o f b a r i u m c o n t e n t
B a l e v e l s w e r e m e a s u r e d i n t h e l u n g s a n d l u n g - a s s o c i a t e d
l y m p h n o d e s o f e x p o s e d a n i m a l s a n d c o n t r o l s . T h e
l a v a g e d l u n g s a n d a l i q u o t s o f B A L o f f i v e a n i m a l s p e r
g r o u p w e r e u s e d . B a r i u m c o n t e n t i n t h e 4 w e e k - e x p o s u r e
g r o u p l u n g s w a s m e a s u r e d t h r e e t i m e s ( 1 , 2 a n d 3 5 d a y s
a f t e r t h e e n d o f e x p o s u r e ) b u t o n l y o n c e ( 1 d a y p o s t -
e x p o s u r e ) i n t h e 1 3 - w e e k e x p o s u r e g r o u p . E a c h t i s s u e
s a m p l e w a s d r i e d a n d s u l f u r i c a c i d w a s a d d e d . T h e s a m p l e
w a s t h e n a s h e d a n d a c i d w a s v a p o r i z e d a t 5 0 0 ° C f o r 1 5
m i n . S u l f u r i c a n d n i t r i c a c i d w e r e a d d e d t o t h e r e s i d u e .
T h e n a m i x t u r e o f n i t r i c a c i d , s u l f u r i c a c i d a n d p e r c h l o r i c
a c i d ( 2 : 1 : 1 v / v / v ) w a s a d d e d a n d t h e s o l u t i o n w a s h e a t e d
t o o x i d i z e o r g a n i c m a t t e r . A f t e r e v a p o r a t i o n , t h e r e s i d u e
w a s d i s s o l v e d i n c o n c e n t r a t e d s u l f u r i c a c i d . T h e r e s u l t i n g
s o l u t i o n w a s a n a l y z e d f o r
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B a c o n t e n t b y i n d u c t i v e l y
c o u p l e d p l a s m a m a s s s p e c t r o m e t r y ( I C P - M S ) u s i n g
A g i l e n t 7 5 0 0 C ( A g i l e n t , F r a n k f u r t , G e r m a n y ) . T h e l i m i t o f
d e t e c t i o n f o r B a i s 0 . 3 μ g p e r t i s s u e s a m p l e .
N e c r o p s y a n d h i s t o p a t h o l o g y
A f t e r 4 w e e k s o f e x p o s u r e , n e c r o p s y a n d h i s t o p a t h o l o g y
w e r e p e r f o r m e d o n s e l e c t e d r a t s a t 1 d a y a n d 3 4 d a y s a f t e r
t h e e n d o f e x p o s u r e . G r o s s a n d h i s t o p a t h o l o g i c a l e x a -
m i n a t i o n o f t h e l u n g s a n d e x t r a p u l m o n a r y o r g a n s w e r e
p e r f o r m e d o n t e n r a t s p e r g r o u p . T h e a n i m a l s w e r e e u t h a -
n i z e d b y c u t t i n g t h e a b d o m i n a l a o r t a a n d v e n a c a v a u n d e r
s o d i u m p e n t o b a r b i t a l a n e s t h e s i a . A c c o r d i n g t o O E C D n o .
4 1 2 , t h e f o l l o w i n g o r g a n s w e r e w e i g h e d : a d r e n a l g l a n d s ,
b r a i n , h e a r t , o v a r i e s , u t e r u s w i t h c e r v i x , k i d n e y , l i v e r , l u n g s ,
s p l e e n , t h y m u s , t h y r o i d g l a n d s . T h e l u n g s w e r e I T - i n s t i l l e d
w i t h n e u t r a l b u f f e r e d 1 0 % f o r m a l i n a t 3 0 c m w a t e r p r e s -
s u r e . A l l o t h e r o r g a n s w e r e f i x e d i n t h e s a m e f i x a t i v e . T h e
o r g a n s a n d t i s s u e s w e r e t r i m m e d , p a r a f f i n e m b e d d e d a n d
s e c t i o n e d a c c o r d i n g t o R I T A t r i m m i n g g u i d e s f o r i n h a -
l a t i o n s t u d i e s [ 5 1 - 5 3 ] . P a r a f f i n s e c t i o n s w e r e s t a i n e d w i t h
h e m a t o x y l i n a n d e o s i n . E x t r a p u l m o n a r y o r g a n s a n d t h e r e -
s p i r a t o r y t r a c t , c o m p r i s e d o f t h e n a s a l c a v i t y ( f o u r l e v e l s ) ,
l a r y n x ( t h r e e l e v e l s ) , t r a c h e a ( t r a n s v e r s e a n d l o n g i t u d i n a l
w i t h c a r i n a ) , l u n g s ( f i v e l o b e s ) , a n d m e d i a s t i n a l a n d
t r a c h e o b r o n c h i a l l y m p h n o d e s , w e r e e x a m i n e d b y l i g h t
m i c r o s c o p y .
S t a t i s t i c a l a n a l y s e s
P h a r m a c o k i n e t i c a n d s i n g l e i n s t i l l a t i o n s t u d i e s
A l l B A L p a r a m e t e r s a n d t i s s u e
1 3 1
B a d i s t r i b u t i o n d a t a
w e r e a n a l y z e d u s i n g m u l t i v a r i a t e a n a l y s i s o f v a r i a n c e
( M A N O V A ) f o l l o w e d b y B o n f e r r o n i ( D u n n ) p o s t h o c t e s t s
u s i n g S A S S t a t i s t i c a l A n a l y s i s s o f t w a r e ( S A S I n s t i t u t e ,
C a r y , N C ) . L u n g c l e a r a n c e d a t a w e r e a n a l y z e d b y l i n e a r
r e g r e s s i o n o f t h e n a t u r a l l o g a r i t h m o f t h e l u n g
1 3 1
B a S O
4
l e v e l s ( % d o s e ) o v e r t i m e u s i n g R P r o g r a m v . 3 . 1 . 0 ( T h e R
F o u n d a t i o n f o r S t a t i s t i c a l C o m p u t i n g , V i e n n a , A u s t r i a ) .
I n h a l a t i o n s t u d i e s
B o d y w e i g h t d i f f e r e n c e s w e r e c o m p a r e d b e t w e e n
B a S O
4
- e x p o s e d a n d c o n t r o l g r o u p s u s i n g D u n n e t t ’ s t e s t .
B r o n c h o a l v e o l a r l a v a g e c y t o l o g y , e n z y m e a n d c e l l m e -
d i a t o r d a t a w e r e a n a l y z e d b y n o n - p a r a m e t r i c o n e - w a y
a n a l y s i s o f v a r i a n c e u s i n g t h e K r u s k a l - W a l l i s t e s t ( t w o -
s i d e d ) . I f t h e r e s u l t i n g p v a l u e w a s e q u a l o r l e s s t h a n
0 . 0 5 , a p a i r - w i s e c o m p a r i s o n o f e a c h t e s t g r o u p w i t h t h e
c o n t r o l g r o u p w a s p e r f o r m e d u s i n g t h e W i l c o x o n t e s t
o r t h e M a n n – W h i t n e y U - t e s t . C o m p a r i s o n o f o r g a n
w e i g h t s w a s p e r f o r m e d b y n o n p a r a m e t r i c o n e - w a y a n a -
l y s i s u s i n g t h e t w o - s i d e d K r u s k a l – W a l l i s t e s t , f o l l o w e d
b y a t w o - s i d e d W i l c o x o n t e s t f o r t h e h y p o t h e s i s o f e q u a l
m e d i a n s .
A d d i t i o n a l f i l e
A d d i t i o n a l f i l e 1 : O n l i n e S u p p o r t i n g I n f o r m a t i o n . T a b l e S 1 .
P h y s i c o c h e m i c a l c h a r a c t e r i z a t i o n o f B a S O
4
n a n o p a r t i c l e s . T a b l e S 2 .
D i s t r i b u t i o n o f r e c o v e r e d
1 3 1
B a p o s t - i n t r a t r a c h e a l i n s t i l l a t i o n o f
1 3 1
B a S O
4
n a n o p a r t i c l e s . T a b l e S 3 . D i s t r i b u t i o n o f r e c o v e r e d
1 3 1
B a p o s t - g a v a g e o f
1 3 1
B a S O
4
n a n o p a r t i c l e s . T a b l e S 4 . D i s t r i b u t i o n o f r e c o v e r e d
1 3 1
B a
p o s t - i n t r a v e n o u s i n j e c t i o n o f
1 3 1
B a S O
4
n a n o p a r t i c l e s . F i g u r e S 1 . S t r u c t u r e
o f B a S O
4
N M - 2 2 0 . A ) P o r e s i z e d i s t r i b u t i o n b y H g i n t r u s i o n . B ) C r y s t a l l i n i t y
b y X R D ( b l a c k l i n e ) , w i t h a s s i g n m e n t o f p e a k s t o r e f e r e n c e s p e c t r u m o f
b u l k B a S O
4
o r t h o r o m b i c ( r e d ) . T h e r e w e r e n o u n e x p e c t e d p e a k s .
F i g u r e S 2 . P h o t o c a t a l y t i c r e a c t i v i t y o f A ) N M - 2 2 0 b a t c h , B ) r e p r o d u c e d
b a t c h : s h o w n a r e U V – v i s a b s o r p t i o n s p e c t r a a t 0 , 2 , 6 a n d 2 2 h i n c u b a t i o n
o f M e t h y l e n e B l u e w i t h B a S O
4
, i r r a d i a t e d w i t h 1 m W / c m
2
U V ( 3 5 0 n m ) a s
s p e c i f i e d i n D I N 5 2 9 8 0 : 2 0 0 8 – 1 0 , a d a p t e d f o r d i s p e r s e d s u r f a c e s [ 1 ] . T h e
b l u e c u r v e s a r e s p e c t r a o f s a m p l e s k e p t i n t h e d a r k , t h e r e d - y e l l o w c u r v e s
a r e s p e c t r a o f i r r a d i a t e d s a m p l e s . T h e e v a l u a t i o n i s c o m p a t i b l e w i t h z e r o
d e g r a d a t i o n o f t h e d y e . F i g u r e S 3 . T o t a l l a v a g e d n e u t r o p h i l s a t 1 d a y
p o s t - i n s t i l l a t i o n ( A ) o r a f t e r t h e e n d o f 4 a n d 1 3 w e e k s i n h a l a t i o n
e x p o s u r e o f B a S O
4
N P s ( B ) . T h e x - a x i s r e p r e s e n t s t h e l u n g b u r d e n o f b a r i u m
a t t h e e n d o f 4 - w e e k ( 0 . 8 m g ) o r 1 3 - w e e k i n h a l a t i o n e x p o s u r e ( 1 . 7 m g ) ( B ) .
T h e n e u t r o p h i l c o u n t s w e r e s i g n i f i c a n t l y h i g h e r i n i n s t i l l e d ( A ) t h a n
a e r o s o l - e x p o s e d r a t s ( B ) . F i g u r e S 4 . M i c r o s c o p i c a p p e a r a n c e o f l u n g s a f t e r 4
w e e k s o f i n h a l a t i o n e x p o s u r e . L u n g s e c t i o n o f c o n t r o l a n i m a l ( A ) a n d a n i m a l
e x p o s e d t o 5 0 m g / m
3
B a S O
4
( B ) . F i g u r e S 5 . C u m u l a t i v e f e c a l a n d u r i n a r y
e x c r e t i o n o f
1 3 1
B a p o s t - I V i n j e c t i o n . E l i m i n a t i o n o f
1 3 1
B a w a s 1 7 % v i a t h e
f e c e s ( A ) a n d o n l y 4 . 4 % o f d o s e v i a t h e u r i n e ( B ) .
A b b r e v i a t i o n s
A L P : A l k a l i n e p h o s p h a t a s e ; B A L : B r o n c h o a l v e o l a r l a v a g e ; B A L F : B r o n c h o a l v e o l a r
l a v a g e f l u i d ; C I N C : C y t o k i n e - i n d u c e d n e u t r o p h i l c h e m o a t t r a c t a n t ; D L S : D y n a m i c
K o n d u r u e t a l . P a r t i c l e a n d F i b r e T o x i c o l o g y 2 0 1 4 , 1 1 : 5 5 P a g e 1 3 o f 1 5
h t t p : / / w w w . p a r t i c l e a n d f i b r e t o x i c o l o g y . c o m / c o n t e n t / 1 1 / 1 / 5 5
7 5
P a p e r  2 :  B i o k i n e t i c s  a n d  e f f e c t s  o f  b a r i u m  s u l f a t e  n a n o p a r t i c l e s
l i g h t s c a t t e r i n g ; F a S S I F : F a s t e d s t a t e s i m u l a t e d i n t e s t i n a l f l u i d ; G G T : γ - G l u t a m y l -
t r a n s p e p t i d a s e ; G S D : G e o m e t r i c s t a n d a r d d e v i a t i o n ; I C P - M S : I n d u c t i v e l y c o u p l e d
p l a s m a m a s s s p e c t r o m e t r y ; I L : I n t e r l e u k i n ; L D H : L a c t a t e d e h y d r o g e n a s e ;
M - C S F : M a c r o p h a g e c o l o n y s t i m u l a t i n g f a c t o r ; M C P : M o n o c y t e c h e m o a t t r a c t a n t
p r o t e i n ; M M A D : M a s s m e d i a n a e r o d y n a m i c d i a m e t e r ; M P O : M y e l o p e r o x i d a s e ;
N A G : N - A c e t y l - β - g l u c o s a m i n i d a s e ; N M : N a n o m a t e r i a l ; O P N : O s t e o p o n t i n ;
P B S : P h o s p h a t e b u f f e r e d s a l i n e ; P M N : P o l y m o r p h o n u c l e a r ; P S F : P h a g o l y s o s o m a l
s i m u l a n t f l u i d ; P S L T : P o o r l y s o l u b l e l o w t o x i c i t y ; S E M : S c a n n i n g e l e c t r o n
m i c r o s c o p y ; S M P S : S c a n n i n g m o b i l i t y p a r t i c l e s i z e r ; T E M : T r a n s m i s s i o n e l e c t r o n
m i c r o s c o p y ; T G A : T h e r m o g r a v i m e t r i c a n a l y s i s .
C o m p e t i n g i n t e r e s t s
J K , L M , S G , R L a n d W W a r e e m p l o y e e s o f B A S F S E , a c o m p a n y t h a t p r o d u c e s
a n d m a r k e t s n a n o m a t e r i a l s . N V K w a s a B A S F f e l l o w f o r t h e d u r a t i o n o f t h e
s t u d y . A l l o t h e r a u t h o r s d e c l a r e t h a t t h e y h a v e n o c o m p e t i n g i n t e r e s t s .
A u t h o r s ’ c o n t r i b u t i o n s
R L , R M M a n d J D B d e s i g n e d t h e p r o j e c t a n d e v a l u a t e d t h e e x p e r i m e n t a l
r e s u l t s . R M M , N V K , T C D a n d J D B c a r r i e d o u t t h e b i o k i n e t i c s t u d i e s w i t h
r a d i o a c t i v e b a r i u m s u l f a t e a n d p u l m o n a r y t o x i c i t y e x p e r i m e n t s a f t e r
i n t r a t r a c h e a l i n s t i l l a t i o n . J K , L M , S G , R L a n d W W p e r f o r m e d t h e i n h a l a t i o n
t o x i c i t y s t u d i e s a n d p h y s i c o - c h e m i c a l c h a r a c t e r i z a t i o n s o f b a r i u m s u l f a t e
n a n o p a r t i c l e s . N V K a n d J K d r a f t e d t h e m a n u s c r i p t . A l l a u t h o r s r e a d , r e v i s e d
a n d a p p r o v e d t h e m a n u s c r i p t .
A c k n o w l e d g m e n t
T h i s s t u d y w a s f u n d e d b y B A S F S E ( L u d w i g s h a f e n , G e r m a n y ) a n d b y t h e
N a t i o n a l I n s t i t u t e o f E n v i r o n m e n t a l H e a l t h S c i e n c e s ( E S 0 0 0 0 0 2 ) . N a g a r j u n
K o n d u r u w a s s u p p o r t e d w i t h a B A S F F e l l o w s h i p . W e t h a n k T h o m a s B o r k f o r
t e c h n i c a l a s s i s t a n c e w i t h n e u t r o n a c t i v a t i o n , t h e i n h a l a t i o n a n d p a t h o l o g y
t e a m o f B A S F f o r t h e i r t e c h n i c a l s u p p o r t , C h r i s t a W a t s o n f o r t e c h n i c a l h e l p
w i t h D L S a n a l y s i s a n d M e l i s s a C u r r a n f o r h e r e d i t o r i a l a s s i s t a n c e .
R e c e i v e d : 7 A u g u s t 2 0 1 4 A c c e p t e d : 4 O c t o b e r 2 0 1 4
R e f e r e n c e s
1 . G i l l a n i R , E r c a n R , Q i a o A , W e b s t e r T J : N a n o f u n c t i o n a l i z e d z i r c o n i a a n d
b a r i u m s u l f a t e p a r t i c l e s a s b o n e c e m e n t a d d i t i v e s . I n t J N a n o m e d 2 0 1 0 ,
5 : 1 – 1 1 .
2 . G o m o l l A H , F i t z W , S c o t t R D , T h o r n h i l l T S , B e l l a r e A : N a n o p a r t i c u l a t e f i l l e r s
i m p r o v e t h e m e c h a n i c a l s t r e n g t h o f b o n e c e m e n t . A c t a O r t h o p 2 0 0 8 ,
7 9 : 4 2 1 – 4 2 7 .
3 . M o h n D , Z e h n d e r M , I m f e l d T , S t a r k W J : R a d i o - o p a q u e n a n o s i z e d
b i o a c t i v e g l a s s f o r p o t e n t i a l r o o t c a n a l a p p l i c a t i o n : e v a l u a t i o n o f
r a d i o p a c i t y , b i o a c t i v i t y a n d a l k a l i n e c a p a c i t y . I n t E n d o d J 2 0 1 0 ,
4 3 : 2 1 0 – 2 1 7 .
4 . N o r e e n R , P i n e a u R , C h i e n C C , C e s t e l l i - G u i d i M , H w u Y , M a r c e l l i A , M o e n n e r
M , P e t i b o i s C : F u n c t i o n a l h i s t o l o g y o f g l i o m a v a s c u l a t u r e b y F T I R
i m a g i n g . A n a l B i o a n a l C h e m 2 0 1 1 , 4 0 1 : 7 9 5 – 8 0 1 .
5 . V i l l a l o b o s - H e r n a n d e z J R , M u l l e r - G o y m a n n C C : N o v e l n a n o p a r t i c u l a t e c a r r i e r
s y s t e m b a s e d o n c a r n a u b a w a x a n d d e c y l o l e a t e f o r t h e d i s p e r s i o n o f
i n o r g a n i c s u n s c r e e n s i n a q u e o u s m e d i a . E u r J P h a r m B i o p h a r m 2 0 0 5 ,
6 0 : 1 1 3 – 1 2 2 .
6 . A n i n w e n e G E 2 n d , S t o u t D , Y a n g Z , W e b s t e r T J : N a n o - B a S O
4
: a n o v e l
a n t i m i c r o b i a l a d d i t i v e t o p e l l e t h a n e . I n t J N a n o m e d 2 0 1 3 ,
8 : 1 1 9 7 – 1 2 0 5 .
7 . D o i g A T : B a r i t o s i s : a b e n i g n p n e u m o c o n i o s i s . T h o r a x 1 9 7 6 , 3 1 : 3 0 – 3 9 .
8 . D o s i o s T , K a r y d a s A G : B a r i t o s i s o f t h e m e d i a s t i n a l l y m p h n o d e s . A n n
T h o r a c S u r g 2 0 0 3 , 7 6 : 2 9 7 .
9 . L e v i - V a l e n s i P , D r i f M , D a t A , H a d j a d j G : A p r o p o s o f 5 7 c a s e s o f p u l m o n a r y
b a r i t o s i s . ( R e s u l t s o f a s y s t e m a t i c i n v e s t i g a t i o n i n a b a r y t a f a c t o r y ) .
J F r M e d C h i r T h o r a c 1 9 6 6 , 2 0 : 4 4 3 – 4 5 5 .
1 0 . M a y n a r d A D , K u e m p e l E D : A i r b o r n e n a n o s t r u c t u r e d p a r t i c l e s a n d
o c c u p a t i o n a l h e a l t h . J N a n o p a r t R e s 2 0 0 5 , 7 : 5 8 7 – 6 1 4 .
1 1 . O b e r d o r s t e r G : T o x i c o k i n e t i c s a n d e f f e c t s o f f i b r o u s a n d n o n f i b r o u s
p a r t i c l e s . I n h a l T o x i c o l 2 0 0 2 , 1 4 : 2 9 – 5 6 .
1 2 . T r a n C L , B u c h a n a n D , C u l l e n R T , S e a r l A , J o n e s A D , D o n a l d s o n K : I n h a l a t i o n
o f p o o r l y s o l u b l e p a r t i c l e s . I I . I n f l u e n c e o f p a r t i c l e s u r f a c e a r e a o n
i n f l a m m a t i o n a n d c l e a r a n c e . I n h a l T o x i c o l 2 0 0 0 , 1 2 : 1 1 1 3 – 1 1 2 6 .
1 3 . H e X , Z h a n g H , M a Y , B a i W , Z h a n g Z , L u K , D i n g Y , Z h a o Y , C h a i Z : L u n g
d e p o s i t i o n a n d e x t r a p u l m o n a r y t r a n s l o c a t i o n o f n a n o - c e r i a a f t e r
i n t r a t r a c h e a l i n s t i l l a t i o n . N a n o t e c h n o l o g y 2 0 1 0 , 2 1 : 2 8 5 1 0 3 .
1 4 . P a r k E - J , P a r k Y - K , P a r k K : A c u t e t o x i c i t y a n d t i s s u e d i s t r i b u t i o n o f c e r i u m
o x i d e n a n o p a r t i c l e s b y a s i n g l e o r a l a d m i n i s t r a t i o n i n r a t s . T o x i c o l R e s
2 0 0 9 , 2 5 : 7 9 – 8 4 .
1 5 . S h i H , M a g a y e R , C a s t r a n o v a V , Z h a o J : T i t a n i u m d i o x i d e n a n o p a r t i c l e s :
a r e v i e w o f c u r r e n t t o x i c o l o g i c a l d a t a . P a r t F i b r e T o x i c o l 2 0 1 3 , 1 0 : 1 5 .
1 6 . B u z e a C , P a c h e c o I I , R o b b i e K : N a n o m a t e r i a l s a n d n a n o p a r t i c l e s : s o u r c e s
a n d t o x i c i t y . B i o i n t e r p h a s e s 2 0 0 7 , 2 : M R 1 7 – M R 7 1 .
1 7 . C u l l e n R T , T r a n C L , B u c h a n a n D , D a v i s J M , S e a r l A , J o n e s A D , D o n a l d s o n K :
I n h a l a t i o n o f p o o r l y s o l u b l e p a r t i c l e s . I . D i f f e r e n c e s i n i n f l a m m a t o r y
r e s p o n s e a n d c l e a r a n c e d u r i n g e x p o s u r e . I n h a l T o x i c o l 2 0 0 0 , 1 2 : 1 0 8 9 – 1 1 1 1 .
1 8 . D h a w a n A , S h a r m a V , P a r m a r D : N a n o m a t e r i a l s : A c h a l l e n g e f o r
t o x i c o l o g i s t s . N a n o t o x i c o l o g y 2 0 0 8 , 3 : 1 – 9 .
1 9 . K o n d u r u N V , M u r d a u g h K M , S o t i r i o u G A , D o n a g h e y T C , D e m o k r i t o u P , B r a i n
J D , M o l i n a R M : B i o a v a i l a b i l i t y , d i s t r i b u t i o n a n d c l e a r a n c e o f t r a c h e a l l y - i n s t i l l e d
a n d g a v a g e d u n c o a t e d o r s i l i c a - c o a t e d z i n c o x i d e n a n o p a r t i c l e s . P a r t F i b r e
T o x i c o l 2 0 1 4 , 1 1 : 4 4 .
2 0 . C e m b e r H , H a t c h T F , W a t s o n J A , G r u c c i T : P u l m o n a r y e f f e c t s f r o m
r a d i o a c t i v e b a r i u m s u l f a t e d u s t . A M A A r c h I n d H e a l t h 1 9 5 5 , 1 2 : 6 2 8 – 6 3 4 .
2 1 . C e m b e r H , H a t c h T F , W a t s o n J A , G r u c c i T , B e l l P : T h e e l i m i n a t i o n o f
r a d i o a c t i v e b a r i u m s u l f a t e p a r t i c l e s f r o m t h e l u n g . A M A A r c h I n d H e a l t h
1 9 5 6 , 1 3 : 1 7 0 – 1 7 6 .
2 2 . R e i j n d e r s L : T h e r e l e a s e o f T i O
2
a n d S i O
2
n a n o p a r t i c l e s f r o m
n a n o c o m p o s i t e s . P o l y m D e g r a d S t a b 2 0 0 9 , 9 4 : 8 7 3 – 8 7 6 .
2 3 . S o n g G , W a n g Q , W a n g Y , L v G , L i C , Z o u R , C h e n Z , Q i n Z , H u o K , H u R ,




@ m S i O
2
c o r e - s h e l l n a n o c o m p o s i t e s : c o m b i n i n g p h o t o t h e r m a l - a n d c h e m o t h e r a p i e s
w i t h i n f r a r e d t h e r m a l i m a g i n g f o r c a n c e r t r e a t m e n t . A d F u n c M a t 2 0 1 3 ,
2 3 : 4 2 8 1 – 4 2 9 2 .
2 4 . S t e c A A , H u l l T R : T o x i c C o m b u s t i o n o f P r o d u c t s f r o m F i r e R e t a r d e d N a n o c o m p o s i t e
P o l y m e r s . E d i n b u r g h , U K : P r o c e e d i n g s o f t h e 5 t h I n t e r n a t i o n a l S e m i n a r o n F i r e
a n d E x p l o s i o n H a z a r d s ; 2 0 0 7 . 2 3 – 2 7 A p r i l 2 0 0 7 , E d i n b u r g h , U K .
2 5 . J o h n s t o n H , P o j a n a G , Z u i n S , J a c o b s e n N R , M o l l e r P , L o f t S , S e m m l e r - B e h n k e
M , M c G u i n e s s C , B a l h a r r y D , M a r c o m i n i A , W a l l i n H , K r e y l i n g W , D o n a l d s o n K ,
T r a n L , S t o n e V : E n g i n e e r e d n a n o m a t e r i a l r i s k . L e s s o n s l e a r n t f r o m
c o m p l e t e d n a n o t o x i c o l o g y s t u d i e s : p o t e n t i a l s o l u t i o n s t o c u r r e n t a n d
f u t u r e c h a l l e n g e s . C r i t R e v T o x i c o l 2 0 1 3 , 4 3 : 1 – 2 0 .
2 6 . L a n d s i e d e l R , M a - H o c k L , K r o l l A , H a h n D , S c h n e k e n b u r g e r J , W i e n c h K ,
W o h l l e b e n W : T e s t i n g m e t a l - o x i d e n a n o m a t e r i a l s f o r h u m a n s a f e t y .
A d v M a t e r 2 0 1 0 , 2 2 : 2 6 0 1 – 2 6 2 7 .
2 7 . K l e i n C L , W i e n c h K , W i e m a n n M , M a - H o c k L , V a n R a v e n z w a a y B , L a n d s i e d e l R :
H a z a r d i d e n t i f i c a t i o n o f i n h a l e d n a n o m a t e r i a l s : m a k i n g u s e o f s h o r t - t e r m
i n h a l a t i o n s t u d i e s . A r c h T o x i c o l 2 0 1 2 , 8 6 : 1 1 3 7 – 1 1 5 1 .
2 8 . L a n d s i e d e l R , M a - H o c k L , H o f m a n n T , W i e m a n n M , S t r a u s s V , T r e u m a n n S ,
W o h l l e b e n W , G r o t e r s S , W i e n c h K , v a n R a v e n z w a a y B : A p p l i c a t i o n o f s h o r t - t e r m
i n h a l a t i o n s t u d i e s t o a s s e s s t h e i n h a l a t i o n t o x i c i t y o f n a n o m a t e r i a l s . P a r t F i b r e
T o x i c o l 2 0 1 4 , 1 1 : 1 6 .
2 9 . W o h l l e b e n W , M a - H o c k L , B o y k o V , C o x G , E g e n o l f H , F r e i b e r g e r H , H i n r i c h s e n
B , H i r t h S , L a n d s i e d e l R : N a n o s p e c i f i c g u i d a n c e i n R E A C H : a c o m p a r a t i v e
p h y s i c a l - c h e m i c a l c h a r a c t e r i z a t i o n o f 1 5 m a t e r i a l s w i t h m e t h o d i c a l
c o r r e l a t i o n s . J C e r a m S c i T e c h 2 0 1 3 , 4 : 9 3 – 1 0 4 .
3 0 . S t e f a n i a k A B , G u i l m e t t e R A , D a y G A , H o o v e r M D , B r e y s s e P N , S c r i p s i c k R C :
C h a r a c t e r i z a t i o n o f p h a g o l y s o s o m a l s i m u l a n t f l u i d f o r s t u d y o f b e r y l l i u m
a e r o s o l p a r t i c l e d i s s o l u t i o n . T o x i c o l I n V i t r o 2 0 0 5 , 1 9 : 1 2 3 – 1 3 4 .
3 1 . B r a i n J D , M o l i n a R M , D e C a m p M M , W a r n e r A E : P u l m o n a r y i n t r a v a s c u l a r
m a c r o p h a g e s : t h e i r c o n t r i b u t i o n t o t h e m o n o n u c l e a r p h a g o c y t e s y s t e m
i n 1 3 s p e c i e s . A m J P h y s i o l 1 9 9 9 , 2 7 6 : L 1 4 6 – L 1 5 4 .
3 2 . B a i s c h B L , C o r s o n N M , W a d e - M e r c e r P , G e l e i n R , K e n n e l l A J , O b e r d o r s t e r G ,
E l d e r A : E q u i v a l e n t t i t a n i u m d i o x i d e n a n o p a r t i c l e d e p o s i t i o n b y i n t r a t r a c h e a l
i n s t i l l a t i o n a n d w h o l e b o d y i n h a l a t i o n : t h e e f f e c t o f d o s e r a t e o n a c u t e
r e s p i r a t o r y t r a c t i n f l a m m a t i o n . P a r t F i b r e T o x i c o l 2 0 1 4 , 1 1 : 5 .
3 3 . O s i e r M , O b e r d o r s t e r G : I n t r a t r a c h e a l i n h a l a t i o n v s i n t r a t r a c h e a l i n s t i l l a t i o n :
d i f f e r e n c e s i n p a r t i c l e e f f e c t s . F u n d a m A p p l T o x i c o l 1 9 9 7 , 4 0 : 2 2 0 – 2 2 7 .
3 4 . K e l l e r J , W o h l l e b e n W , M a - H o c k L , S t r a u s s V , G r o t e r s S , K u t t l e r K , W i e n c h K ,
H e r d e n C , O b e r d o r s t e r G , v a n R a v e n z w a a y B , L a n d s i e d e l R : T i m e c o u r s e o f
l u n g r e t e n t i o n a n d t o x i c i t y o f i n h a l e d p a r t i c l e s : s h o r t - t e r m e x p o s u r e t o
n a n o - C e r i a . A r c h T o x i c o l 2 0 1 4 . d o i : 1 0 . 1 0 0 7 / s 0 0 2 0 4 - 0 1 4 - 1 3 4 9 - 9 .
3 5 . M o o r e W J r : C o m p a r a t i v e m e t a b o l i s m o f b a r i u m - 1 3 3 a n d c a l c i u m - 4 5 b y
e m b r y o n i c b o n e g r o w n i n v i t r o . R a d i a t R e s 1 9 6 4 , 2 1 : 3 7 6 – 3 8 2 .
K o n d u r u e t a l . P a r t i c l e a n d F i b r e T o x i c o l o g y 2 0 1 4 , 1 1 : 5 5 P a g e 1 4 o f 1 5
h t t p : / / w w w . p a r t i c l e a n d f i b r e t o x i c o l o g y . c o m / c o n t e n t / 1 1 / 1 / 5 5
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3 6 . C e m b e r H , W a t s o n J A , N o v a k M E : T h e i n f l u e n c e o f r a d i o a c t i v i t y a n d l u n g
b u r d e n o n t h e p u l m o n a r y c l e a r a n c e r a t e o f b a r i u m s u l f a t e . A m I n d H y g
A s s o c J 1 9 6 1 , 2 2 : 2 7 – 3 2 .
3 7 . M o l i n a R M , K o n d u r u N V , J i m e n e z R J , P y r g i o t a k i s G , D e m o k r i t o u P ,
W o h l l e b e n W , B r a i J D : B i o a v a i l a b i l i t y , d i s t r i b u t i o n a n d c l e a r a n c e o f
t r a c h e a l l y i n s t i l l e d , g a v a g e d o r i n j e c t e d c e r i u m d i o x i d e n a n o p a r t i c l e s
a n d i o n i c c e r i u m . P a r t F i b r e T o x i c o l 2 0 1 4 . d o i : 1 0 . 1 0 3 9 / c 4 e n 0 0 0 3 4 j .
3 8 . W a l k e r D A , L e i t s c h E K , N a p R J , S z l e i f e r I , G r z y b o w s k i B A : G e o m e t r i c c u r v a t u r e
c o n t r o l s t h e c h e m i c a l p a t c h i n e s s a n d s e l f - a s s e m b l y o f n a n o p a r t i c l e s .
N a t N a n o t e c h n o l 2 0 1 3 , 8 : 6 7 6 – 6 8 1 .
3 9 . W a n i M Y , H a s h i m M A , N a b i F , M a l i k M A : N a n o t o x i c i t y : d i m e n s i o n a l
a n d m o r p h o l o g i c a l c o n c e r n s . A d v P h y s C h e m 2 0 1 1 , 2 0 1 1 : 1 – 1 5 .
4 0 . G h i a z z a M , P o l i m e n i M , F e n o g l i o I , G a z z a n o E , G h i g o D , F u b i n i B : D o e s
v i t r e o u s s i l i c a c o n t r a d i c t t h e t o x i c i t y o f t h e c r y s t a l l i n e s i l i c a p a r a d i g m ?
C h e m R e s T o x i c o l 2 0 1 0 , 2 3 : 6 2 0 – 6 2 9 .
4 1 . C h o i H S , A s h i t a t e Y , L e e J H , K i m S H , M a t s u i A , I n s i n N , B a w e n d i M G , S e m m l e r -
B e h n k e M , F r a n g i o n i J V , T s u d a A : R a p i d t r a n s l o c a t i o n o f n a n o p a r t i c l e s f r o m
t h e l u n g a i r s p a c e s t o t h e b o d y . N a t B i o t e c h n o l 2 0 1 0 , 2 8 : 1 3 0 0 – 1 3 0 3 .
4 2 . C o h e n J , D e l o i d G , P y r g i o t a k i s G , D e m o k r i t o u P : I n t e r a c t i o n s o f e n g i n e e r e d
n a n o m a t e r i a l s i n p h y s i o l o g i c a l m e d i a a n d i m p l i c a t i o n s f o r i n v i t r o
d o s i m e t r y . N a n o t o x i c o l o g y 2 0 1 3 , 7 : 4 1 7 – 4 3 1 .
4 3 . B r a i n J D , K n u d s o n D E , S o r o k i n S P , D a v i s M A : P u l m o n a r y d i s t r i b u t i o n o f
p a r t i c l e s g i v e n b y i n t r a t r a c h e a l i n s t i l l a t i o n o r b y a e r o s o l i n h a l a t i o n .
E n v i r o n R e s 1 9 7 6 , 1 1 : 1 3 – 3 3 .
4 4 . B r o w n R P , D e l p M D , L i n d s t e d t S L , R h o m b e r g L R , B e l i l e s R P : P h y s i o l o g i c a l
p a r a m e t e r v a l u e s f o r p h y s i o l o g i c a l l y b a s e d p h a r m a c o k i n e t i c m o d e l s .
T o x i c o l I n d H e a l t h 1 9 9 7 , 1 3 : 4 0 7 – 4 8 4 .
4 5 . S c h o e f f n e r D J , W a r r e n D A , M u r a l i d a r a S , B r u c k n e r J V , S i m m o n s J E : O r g a n
w e i g h t s a n d f a t v o l u m e i n r a t s a s a f u n c t i o n o f s t r a i n a n d a g e . J T o x i c o l
E n v i r o n H e a l t h A 1 9 9 9 , 5 6 : 4 4 9 – 4 6 2 .
4 6 . O r g a n i z a t i o n f o r E c o n o m i c C o o p e r a t i o n a n d D e v e l o p m e n t ( O E C D ) : O E C D
P r i n c i p l e s o n G o o d L a b o r a t o r y P r a c t i c e ( a s r e v i s e d i n 1 9 9 7 ) . E N V / M C / C H E M ( 9 8 ) 1 7 ,
G u i d a n c e M a n u a l f o r t h e t e s t i n g o f m a n u f a c t u r e d n a n o m a t e r i a l s . P a r i s : O E C D ;
1 9 9 8 .
4 7 . O r g a n i z a t i o n f o r E c o n o m i c C o o p e r a t i o n a n d D e v e l o p m e n t ( O E C D ) : O E C D
G u i d e l i n e s f o r T e s t i n g o f C h e m i c a l s , S e c t i o n 4 : H e a l t h E f f e c t s , N o . 4 1 2 , " R e p e a t e d
D o s e I n h a l a t i o n T o x i c i t y : 2 8 d a y o r 1 4 d a y S t u d y " , G u i d a n c e M a n u a l f o r t h e
T e s t i n g o f M a n u f a c t u r e d N a n o m a t e r i a l s : O E C D ' s S p o n s o r s h i p P r o g r a m m e .
P a r i s : O E C D ; 2 0 0 9 .
4 8 . O r g a n i z a t i o n f o r E c o n o m i c C o o p e r a t i o n a n d D e v e l o p m e n t ( O E C D ) : O E C D
G u i d e l i n e s f o r t h e T e s t i n g o f C h e m i c a l s , S e c t i o n 4 , T e s t N o . 4 5 3 : C o m b i n e d
C h r o n i c T o x i c i t y / C a r c i n o g e n i c i t y S t u d i e s . P a r i s : O E C D ; 2 0 0 9 .
4 9 . M a - H o c k L , G a m e r A O , L a n d s i e d e l R , L e i b o l d E , F r e c h e n T , S e n s B ,
L i n s e n b u e h l e r M , V a n R a v e n z w a a y B : G e n e r a t i o n a n d c h a r a c t e r i z a t i o n o f
t e s t a t m o s p h e r e s w i t h n a n o m a t e r i a l s . I n h a l T o x i c o l 2 0 0 7 , 1 9 : 8 3 3 – 8 4 8 .
5 0 . M a - H o c k L , B u r k h a r d t S , S t r a u s s V , G a m e r A O , W i e n c h K , V a n R a v e n z w a a y B ,
L a n d s i e d e l R : D e v e l o p m e n t o f a s h o r t - t e r m i n h a l a t i o n t e s t i n t h e r a t u s i n g
n a n o - t i t a n i u m d i o x i d e a s a m o d e l s u b s t a n c e . I n h a l T o x i c o l 2 0 0 9 , 2 1 : 1 0 2 – 1 1 8 .
5 1 . K i t t e l B , R u e h l - F e h l e r t C , M o r a w i e t z G , K l a p w i j k J , E l w e l l M R , L e n z B , O ' S u l l i v a n
M G , R o t h D R , W a d s w o r t h P F : R e v i s e d g u i d e s f o r o r g a n s a m p l i n g a n d
t r i m m i n g i n r a t s a n d m i c e – p a r t 2 . A j o i n t p u b l i c a t i o n o f t h e R I T A a n d
N A C A D g r o u p s . E x p T o x i c o l P a t h o l 2 0 0 4 , 5 5 : 4 1 3 – 4 3 1 .
5 2 . M o r a w i e t z G , R u e h l - F e h l e r t C , K i t t e l B , B u b e A , K e a n e K , H a l m S , H e u s e r A ,
H e l l m a n n J : R e v i s e d g u i d e s f o r o r g a n s a m p l i n g a n d t r i m m i n g i n r a t s a n d
m i c e – p a r t 3 . A j o i n t p u b l i c a t i o n o f t h e R I T A a n d N A C A D g r o u p s .
E x p T o x i c o l P a t h o l 2 0 0 4 , 5 5 : 4 3 3 – 4 4 9 .
5 3 . R u e h l - F e h l e r t C , K i t t e l B , M o r a w i e t z G , D e s l e x P , K e e n a n C , M a h r t C R , N o l t e
T , R o b i n s o n M , S t u a r t B P , D e s c h l U : R e v i s e d g u i d e s f o r o r g a n s a m p l i n g
a n d t r i m m i n g i n r a t s a n d m i c e – p a r t 1 . E x p T o x i c o l P a t h o l 2 0 0 3 , 5 5 : 9 1 – 1 0 6 .
d o i : 1 0 . 1 1 8 6 / s 1 2 9 8 9 - 0 1 4 - 0 0 5 5 - 3
C i t e t h i s a r t i c l e a s : K o n d u r u e t a l . : B i o k i n e t i c s a n d e f f e c t s o f b a r i u m
s u l f a t e n a n o p a r t i c l e s . P a r t i c l e a n d F i b r e T o x i c o l o g y 2 0 1 4 1 1 : 5 5 .
S u b m i t  y o u r  n e x t  m a n u s c r i p t  t o  B i o M e d  C e n t r a l
a n d  t a k e  f u l l  a d v a n t a g e  o f :  
•  C o n v e n i e n t  o n l i n e  s u b m i s s i o n
•  T h o r o u g h  p e e r  r e v i e w
•  N o  s p a c e  c o n s t r a i n t s  o r  c o l o r  ﬁ g u r e  c h a r g e s
•  I m m e d i a t e  p u b l i c a t i o n  o n  a c c e p t a n c e
•  I n c l u s i o n  i n  P u b M e d ,  C A S ,  S c o p u s  a n d  G o o g l e  S c h o l a r
•  R e s e a r c h  w h i c h  i s  f r e e l y  a v a i l a b l e  f o r  r e d i s t r i b u t i o n
S u b m i t  y o u r  m a n u s c r i p t  a t  
w w w . b i o m e d c e n t r a l . c o m / s u b m i t
K o n d u r u e t a l . P a r t i c l e a n d F i b r e T o x i c o l o g y 2 0 1 4 , 1 1 : 5 5 P a g e 1 5 o f 1 5
h t t p : / / w w w . p a r t i c l e a n d f i b r e t o x i c o l o g y . c o m / c o n t e n t / 1 1 / 1 / 5 5
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  Inhalation exposure to cerium dioxide and barium sulfate nanoparticles for  8.
1, 4, 13 and 52 weeks: Additional examinations 
 
The here presented inhalation studies were approved by the local authorizing agency for animal 
experiments (Landesuntersuchungsamt Koblenz, Germany) as referenced by the approval number 
G12-3-028. Animals were housed in an AAALAC-accredited facility in accordance with the German 
Animal Welfare Act and the effective European Council Directive. Female Wistar rats [strain: 
Crl:WI(Han)] were obtained from Charles River Laboratories (Sulzfeld, Germany; for further details see 
paper 1 and 2).  
 
8.1 One and 4 weeks of inhalation exposure to nano-CeO2 and -BaSO4  
 
The following chapter 8.1 complements the paper 1 and 2 concerning (histo-)pathology and 




Table 4 Overview of histopathological examinations  











0.5 / 25 0.5 / 5 / 25 0.5 / 5 / 25 50 
Days after exposure 
Directly after last exposure and 
3 weeks after exposure end 
 
2 days and 4 weeks after 
exposure end 
 




In the studies with 1 and 4 weeks of exposure, necropsy and histopathology were performed after the 
last exposure and after an exposure free period of 3 or 4 weeks, respectively (table 4). Five animals 
per test group were investigated for pathological examination of the respiratory tract. Extrapulmonary 




Inhalation exposure to cerium dioxide and barium sulfate nanoparticles 
for 1, 4, 13 and 52 weeks: Additional examinations
 Materials and methods of the histopathological examination were described in paper 1 and 2. The 
histotechnical processing, examination by light microscopy and assessment of findings after 1 and 4 
weeks of exposure were described in table 5 and 6. All the organs and tissues described in the OECD 
TG No. 412 were trimmed according to the Registry of Industrial Toxicology Animal-data (RITA) 
trimming guides for inhalation studies (Kittel et al. 2004).  
Results and summary 
In the upper and lower respiratory tract, amber-like colored particles were observed freely or within 
macrophages in tissues of the trachea (figure 8-1), nasal cavity (figure 8-2) and larynx (figure 8-3), 
without any inflammatory response or morphological changes in the corresponding tissues after 1 and 
4 weeks of exposure to CeO2 NM-212 (see also paper 1). These findings have already been reported 
earlier: particles within the epithelium or in subepithelial tissue of larynx and nasal cavity were seen 
after a 21 day inhalation study to 9 and 45 mg/m³ TiO2 (MMAD 1.1 µm) and after a 1 week inhalation 
study to 88 mg/m³ nano-TiO2, respectively (Eydner et al. 2012; Ma-Hock et al. 2009). In contrast to our 
studies, slight focal alterations of the epithelium at the base of the epiglottis of the larynx were 
observed together with the particles at aerosol concentrations of 50 mg/m³ nano-TiO2 (Ma-Hock et al. 
2009).  
In addition to the histopathology pictures in the papers, further histopathology pictures of nano-CeO2 
and -BaSO4 exposed animals are presented in figure 8-4 for demonstration of inflammatory changes 
in lung tissue sections and 8-5, respectively. 
Few CeO2- and BaSO4- particle-laden macrophages were also seen in pulmonary blood vessels, in 
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Inhalation exposure to cerium dioxide and barium sulfate nanoparticles 
for 1, 4, 13 and 52 weeks: Additional examinations
  
 
Figure 8-3 Histopathological images of larynx after 4 weeks of exposure: 
                  A Control animal, B Animal exposed to 25 mg/m³ CeO2 (NM-212):  
                  Occurrence of particles (arrows) 
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Inhalation exposure to cerium dioxide and barium sulfate nanoparticles 
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Inhalation exposure to cerium dioxide and barium sulfate nanoparticles 
for 1, 4, 13 and 52 weeks: Additional examinations
 Figure 8-6 Histopathological images of pulmonary blood vessels after 4 weeks of 
                  exposure: A and B Animal exposed to 5 mg/m³ CeO2 (NM-212): Occurrence of 





Inhalation exposure to cerium dioxide and barium sulfate nanoparticles 
for 1, 4, 13 and 52 weeks: Additional examinations
 Figure 8-7 Histopathological images of pulmonary blood vessels after 4 weeks of 
                  exposure: A and B Animal exposed to 25 mg/m³ CeO2 (NM-212): Occurrence of 
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 8.1.2. Immunohistology (cell proliferation, BrdU) 
 
Material and Methods 
Cell proliferation was determined in large/medium bronchi, terminal bronchioli and alveoli (table 7).  
For evaluation of cell proliferation in the lung, rats were subcutaneously implanted with Alzet (Alzet 
Corporation, Palo Alto, CA, USA) osmotic pumps (Model 2ML1) three days prior to necropsy. The 
pumps contained 20 mg/mL 5-bromo-2-deoxyuridine (BrdU, Sigma Chem.), a thymidine structural 
analog, which can be incorporated into DNA as a substitute for thymidine. Implantation was 
subcutaneously to the dorsal region under Isofluran anesthesia (Essex GmbH, Munich, Germany). In 
order to reduce pain during and after the implantation, the animals received a subcutaneous injection 
of an appropriate analgetic compound (Buprenorphine, 0.01 mg/kg body weight) 10 to 30 minutes 
prior to surgery. 
Cell proliferation was determined after immunostaining of dewaxed sections and was performed with a 
mouse anti-BrdU antibody (BioGenex, Hamburg, Germany; see protocol below). The BrdU-staining 
identified cells passed through the S-phase of the cell cycle during the BrdU-labeling period. This 
enabled detection of DNA replication in proliferating cells. Dividing cells in a defined time period and 
area were related to non-dividing cells. At least 1000 cells per compartment and overall 3000 cells per 
lung were counted (see below). For the microscope, 400x and 100x magnification were used for 
counting type 1 cells (alveoli) and cells in the bronchioles, respectively. Numbers of dividing cells were 
expressed as Labeling Index (LI). The percentage of nuclei was counted which underwent replicative 
DNA synthesis (cells located in the S-phase of the cell cycle). 
For the 1 week study, the left and accessory lung lobes of animals were used (one time point only). In 
the 4 week study, the right half lungs (three lobes) were examined in order to reduce the animal 
number per examination method. Two slides of each lung were prepared: one serving as test slides 
and the other as a negative control slide. Jejunum served as positive control for the BrdU stain. 
Immunhistological staining: 
Sections were dewaxed by Xylol (2x 5 min) and rehydrated with descending 100, 96, 70 % alcohol (2 x 
5 min each). Afterwards sections were rinsed in deionized water. For antigen retrieval, samples were 
predigested with 0.05 % protease (2 min at 37° C) and hydrolysed with HCL (4N) for 20 min.  After 
washing with deionized water, 6 % H2O2 was added for 10 min. Samples were washed again and PBS 
buffer were added. To reduce the areas which were moistened by the antibody, the tissue were traced 
with a wax pencil (Pap-pen, BioGenex, USA). Then the primary monoclonal antibody (mouse anti-
BrdU; dilution of 1:1200) was added for 2 h. After rinsing twice with PBS buffer, the secondary 
antibody (BioGenex, USA; link, anti-mouse, biotinilated; dilution of 1:20) were added for 20 min. After 
rinsing again, the HR-Peroxidase/Streptavidin enzyme complex (BioGenex, Germany) for labelling 
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 Staining was developed with diaminobenzidine (DAB; Zytomed Systems GmbH, Germany) and the 
slides were counterstained with Mayer’s hematoxylin (30 sec). For the negative control slides, PBS 
replaced the primary antibody. 
Quantitative assessment: 
Performing quantitative assessment, positively stained cells were identified by red/brown pigment over 
the nuclei. An image analysis system (KS 400, ZEISS, Germany) were used. Type 1 cells (alveoli) and 
cells in the bronchioles were discriminated from mesenchymal cell on the base of their shape and size. 
To facilitate comparability of counted cells, comparable lung compartments were selected for all 
animals. Labeling indices (percentage of nuclei counted undergoing replicative DNA synthesis) were 
determined for the lung compartments, the large/medium sized bronchi, the terminal bronchiole and 
the alveoli (pneumocytes type I cells). In each compartment a minimum of 1 000 cells were counted. 
For the alveoli, a minimum of 15 areas were used to count 1 000 cells. For the large/medium sized 
bronchi and the terminal bronchiole, cell counts were based on a previously defined line of epithelial 
cells including 1 000 cells. 
The Labeling index (LI) in BrdU immunostained sections were calculated as follows: 




After 1 week of exposure to CeO2 NM-212, increased cell proliferation rates were observed in the 
large/medium bronchi (5 and 25 mg/m³), terminal bronchioli (25 mg/m³) and alveoli (> 0.5 mg/m³) 
(table 7). After 4 weeks of exposure, increased cell proliferation rates were comparable as after 1 
week of exposure, besides a higher increase in the terminal bronchioli at 25 mg/m³ after 1 week. Two 
days after 4 weeks of exposure, increased cell proliferation rates were observed in the large/medium 
bronchi, terminal bronchioli and alveoli at aerosol concentrations of 25 mg/m³ CeO2 (NM-212). After 4 
weeks plus 4 weeks post-exposure, cell proliferation rates were concentration-dependent increased in 
all three compartments. Higher proliferation rates of large/medium bronchi and terminal bronchiole 
were recorded after the post-exposure period than after exposure end whereas the proliferation rates 
of the alveoli were comparable for both time points.  
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 8.1.3. Statistical analysis 
 
Clinical pathology parameters (BALF cytology, enzyme data and BALF and serum cell mediator data) 
were analyzed by non-parametric one-way analysis using the Kruskal-Wallis test (two-sided). If the 
resulting p value was equal or less than 0.05, a pair-wise comparison of each test group with the 
control group was performed using the Wilcoxon test or the Mann-Whitney U-test (both two-sided) (p ≤ 
0.05 for statistical significance). Comparison of lung weights among test groups were performed by 
nonparametric one-way analysis using the two-sided Kruskal–Wallis test, followed by a two-sided 
Wilcoxon test for the hypothesis of equal medians in case of p ≤ 0.05. The cell proliferation data was 
analyzed by a pairwise comparison of each dose group with the control group using the Wilcoxon test 




Inhalation exposure to cerium dioxide and barium sulfate nanoparticles 
for 1, 4, 13 and 52 weeks: Additional examinations
  
8.2 Thirteen and 52 weeks of exposure within the long-term inhalation study 
 
A part of the results obtained after 13 weeks of exposure to 50 mg/m³ BaSO4 was already presented 
in paper 2: Konduru, N., Keller, J. et al. "Biokinetics and effects of barium sulfate nanoparticles". All 
other results obtained after inhalation exposure of 13 and 52 weeks to CeO2 and BaSO4 are described 
in this chapter. 
 
8.2.1. Aerosol characterization 
 
The aerosols were generated by brush dust generators (Ma-Hock et al. 2007). The aerosols were 
analysed as described in the Material and Methods of paper 1 and 2. The particle concentrations and 
particle size distributions are summarized in table 8. The target concentrations were met and 
maintained well throughout the studies. Particle size distribution demonstrated that all particles were in 
the respirable range for rats. The particles were largely agglomerated.  
Table 8 Aerosol concentrations and particle size distributions after 52 weeks of 
exposure 
Test material Targeted concentrations [mg/m³] Measured concentrations  





0.1 0.1 ± 0.1 2.3 / 2.4  
CeO2  
NM-212 
0.3 0.3 ± 0.1 1.7 / 2.3 
CeO2  
NM-212 
1 1.0  ± 0.1 1.5 / 2.3 
CeO2  
NM-212 
3 3.0  ± 0.4 1.4 / 2.1 
BaSO4  50 49.9 ± 5.6 2.0 / 2.0 
Presented mean values of >14 measurements (MMAD, GSD); MMAD: mass median aerodynamic 
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8.2.2. Results: Lung and lymph node burdens 
 
Directly after 13 and 52 weeks of exposure, the lavaged lungs, aliquots of lavage fluids and 
tracheobronchial and mediastinal lymph nodes of five animals per group were used to determine lung 
burden (as described in the Material and Methods of paper 2). The amounts of BaSO4 in lungs and 
lymph nodes were estimated by measuring Ba with Inductively coupled plasma optical emission 
spectrometry (ICP-MS) and extrapolating to BaSO4 (assuming that it was still particulate). The same 
method was applied to lung burdens of CeO2. During the exposure period, lung burdens increased 
with longer exposure duration (table 9). Only a slight translocation of the nanoparticles to the 
tracheobronchial and mediastinal lymph nodes was observed (0.5 and 1.9 % of the BaSO4 and CeO2 
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8.2.3. Results: Bronchoalveolar lavage  
 
Bronchoalveolar lavage fluids were assessed for 5 animals per group after 13 (paper 2: nano-BaSO4 
BALF results) and 52 weeks of exposure (table 10). The procedure and analysis of BALF is described 
in paper 1 and 2.  
Exposure to nano-CeO2 
After 13 weeks, exposure to 0.1, 0.3, 1 and 3 mg/m³ CeO2 induced a dose-dependent increase in 
neutrophil cell counts with a statistically significant increase in total cells (table 10). Lymphocytes and 
monocytes were significantly increased only at 3 mg/m³. Macrophage numbers and total cell counts 
were statistically significantly increased also at lower concentrations (0.1 and 0.3 mg/m³). The 
enzymes GGT, LDH and ALP were statistically significantly increased by aerosol concentrations of 1 
mg/m³ and above. Total protein and NAG were increased only at 3 mg/m³. Cell mediators (MCP-1, 
CINC-1 and Osteopontin) were statistically significant increased at 1 mg/m³ and above. 
After 52 weeks of exposure to aerosol concentrations of 0.3 mg/m³ CeO2 and above, neutrophils and 
lymphocytes were more elevated than after 13 weeks, but total cell counts were only increased at 3 
mg/m³. Exposure of 0.1 mg/m³ CeO2 caused no changes in BALF cell numbers. Total protein and the 
enzyme LDH were significantly increased at 1 and 3 mg/m³. ALP and NAG levels were not affected at 
any aerosol concentration whereas GGT were significantly increased at all concentrations. MCP-1 and 
CINC-1 levels were still elevated but to a lower extent compared with 13 weeks of exposure. 
Exposure to nano-BaSO4 
After 13 weeks of 50 mg/m³ nano-BaSO4 exposure, neutrophil and total cell numbers were 
significantly increased (table 10). The enzyme ALP and the cell mediators MCP-1 and CINC-1 were 
elevated as well. 
After 52 weeks of exposure, neutrophil and total cells were even more increased than after 13 weeks. 
Additionally, monocyte and lymphocytes levels were elevated. The levels of ALP were elevated after 
13 weeks of exposure but declined to near control levels after 52 weeks whereas all other enzymes 
were significantly increased. With the exception of MCS-F, all other cell mediators were more elevated 
after 52 weeks of exposure than after 13 weeks. 
Comparison of exposure to nano-CeO2 and -BaSO4 
After 13 weeks of exposure, 3 mg/m3 nano-CeO2 elicited higher increases in (pro-)inflammatory 
parameters (neutrophils, lymphocytes, total cells, MCP-1, NAG) than 50 mg/m³ BaSO4. However, this 
reversed after 52 weeks of exposure where nearly all other parameters (neutrophil, lymphocytes, total 
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8.2.4. Results: Hematology and acute phase proteins in blood 
 
Hematology, clinical chemistry and acute phase proteins were measured in the blood of 5 animals per 
group (see detailed procedure in paper 1).  
In blood, a slight increase of neutrophil counts was observed for CeO2 NM-212 after 1 week (5 days) 
of exposure to 25 mg/m³ (see paper 1). Exposure of 4 weeks to CeO2 NM-212 and BaSO4 elicited no 
increase of neutrophil counts (table 11 and 12).  
Thirteen and 52 weeks of inhalation exposure to nano-CeO2 did not affect hematology and clinical 
chemistry parameters in blood at any tested concentration apart from increased haptoglobin (HAPT) 
and α2-macroglobulin (A2M) levels in serum after 52 weeks of exposure to 3 mg/m³ CeO2 (table 11). A 
dose-dependent increase was observed for A2M after 52 weeks of exposure using the median values 
rather than the means (median values of 10.94 and 11.64 for 1 and 3 mg/m³, respectively). After 13 
weeks, the acute phase protein A2M was only significantly increased at 1 mg/m³, but had returned to 
near control values by 52 weeks. The change was not dose-dependent and regarded as incidental.  
Nano-BaSO4 inhalation exposure showed no changes in hematology and clinical chemistry 
parameters in blood apart from a slight increase in (absolute and relative) neutrophil numbers and a 
not statistically significant elevation in HAPT and A2M levels after 52 weeks of exposure (table 11).  
A summary of neutrophil levels in BALF (x-fold of control) and of neutrophil levels and acute phase 
proteins in blood (x-fold of control) after 4, 13 and 52 weeks of exposure to CeO2 and BaSO4 is 
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Table 12 Neutrophil levels in BAL and neutrophil levels and acute phase proteins in 
blood after 4, 13 and 52 weeks of exposure to CeO2 and BaSO4 
CeO2 (NM-212) 




25 3 3 
Lung burden [mg] 2.6  1.4 2.6  
Neutrophil BAL 
[x-fold of control] 
262** 43** 55** 
Neutrophil blood 
[x-fold of control] 
1.0 2.0 1.0 
Haptoglobin 
[x-fold of control] 
1.0 1.0 2.0* 
A2M 
[x-fold of control] 
1.0 1.0 1.0* 
50 mg/m³ BaSO4 
Study 4 weeks 13 weeks 52 weeks 
Lung burden [mg] 0.8  1.7 10.2  
Neutrophil BAL 
[x-fold of control] 
3.0 14.0* 263.0** 
Neutrophil blood 
[x-fold of control] 
1.0 1.0 2.0* 
Haptoglobin 
[x-fold of control] 
1.0 1.0 2.0* 
A2M 
[x-fold of control] 
1.0** (0.6) 1.0 2.0 
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 Retained particle surface [m²] in the lung 
Figure 8-9 Neutrophil counts in BALF correlated with retained particle surface in the 
                  lung after 1, 4, 13 and 52 weeks of exposure to CeO2 NM-212 using the aerosol 
                  concentrations of 0.5, 5, and 25 mg/m³ (1 and 4 weeks) and 0.1 and 3 mg/m³  
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 9. Discussion  
 
In this body of work, biokinetics and toxicity of inhaled cerium dioxide and barium sulfate nanoparticles 
were examined after 1, 4, 13 and 52 weeks of exposure. The following sections discuss the results on 
biokinetics and effects of nano-CeO2 (9.1) and -BaSO4 (9.2) in the lung and systemic effects of both 
nanoparticles (9.3). 
 
9.1 Biokinetics and effects of CeO2 in the lung 
 
Before starting the inhalation exposure, the tested nano-CeO2 was studied in cell-free in vitro solubility 
assays as reported previously (Molina et al. 2014). In these assays, CeO2 (NM-212) demonstrated a 
very low solubility in fluids simulating different compartments of the body (e.g. below 0.001 wt% in 
phagolysosomal simulant fluid (PSF), 0.02 wt% in 0.1 N HCl) and recrystallized in PSF, a model of 
macrophage dissolution and clearance of particles. However, nano-CeO2 is not completely insoluble 
and is able to release cerium ions (Schwabe et al. 2014; Yokel et al. 2014a; Yokel et al. 2014b). This 
process is highly dependent on the particle size and composition of the surrounding medium. This was 
valid at a pH below 4.6 and even at a pH of 8 in the presence of chelating agents. In the environment, 
the following four steps seem to be involved in chemical transformation of nano-CeO2: dissolution of 
Ce in the (3+) oxidation state, reduction of Ce4+ to Ce3+ in acidic media and release of Ce3+, 
complexation with chelating agents and precipitation on the surface (Kakuwa & Matsumoto 2006, 
Schwabe et al. 2014). These pathways may also play a role in vivo. 
Consistently to the in vitro dissolution assays, inhaled CeO2 showed high biopersistence in the lungs 
and a low bioavailability in the presented inhalation studies. Intratracheal instillation of the same, but 
neutron activated 141CeO2 (dose of around 250 µg per lung) showed prolonged lung retention and a 
slow clearance with an estimated half-time of 140 days (Molina et al. 2014). In our short-term study 
with 1 week (5 days) of exposure, lung burdens were about one-fourth of those after 4 weeks of 
exposure. In the short-term study with 4 weeks of exposure, inhaled CeO2 was deposited in the lungs 
and cleared with a retention half-time of 40 days at aerosol concentrations of 0.5 mg/m³ (lung burden 
of 0.041±0.007 mg/lung decreased to 0.009±0.004 mg 129 days post-exposure). At higher aerosol 
concentrations of 25 mg/m³, the clearance was retarded with a retention half-life above 200 days (lung 
burden of 2.62±0.20 mg/lung decreased to 1.8±0.26 mg 129 days post-exposure). Retardation of 
clearance was already observed at aerosol concentrations of 5 mg/m³ since the lung burdens stayed 
nearly constant during 4 weeks of post-exposure (lung burden of around 0.5 mg/lung). In the long-term 
study, the lung burden of CeO2 after 13 weeks was nearly doubled after 52 weeks of exposure at 
aerosol concentrations of 0.1 and 3 mg/m³. However, no information on time course of lung retention 





 Lymph node burdens after short-term exposure were higher than after long-term exposure. In general, 
lymph node burdens were low (below 14 and 2 % of the initial lung burden after 4 and 13 weeks, 
respectively) indicating that, at least at this lung burden range, it plays no major role for particle 
clearance. 
In the lung, inflammation was associated with retardation of pulmonary clearance in the short-term 
studies. In the long-term study, local inflammation in the lung was observed by increases in BAL 
neutrophils, lymphocytes and monocytes after 13 weeks of exposure. BAL changes (cell counts, 
enzyme activities, total protein and cell mediator levels) after 52 weeks of exposure to 3 mg/m³ CeO2 
were comparable to those after 13 weeks. Minor changes in BAL were observed at lower aerosol 
concentrations of 1 mg/m³. Exposure to 0.3 mg/m³ elicited no BAL changes after 13 weeks and only 
minor changes after 52 weeks (neutrophils, GGT, MCP-1). In animals exposed to lower aerosol 
concentrations rather than in those exposed to higher, BAL lymphocytes were higher increased than 
neutrophils after 52 weeks of exposure indicating a later phase of inflammation.  
The strongest increase in BAL neutrophils indicating pulmonary inflammation was observed after 1 
week of exposure. The increase in BAL neutrophils appeared to be attenuated after 4 and 13 weeks of 
exposure. One week of exposure to 25 mg/m³ CeO2 caused a lung burden of 0.5 mg and elicited a 
330-fold increase of BAL neutrophils whereas a lung burden of 2.6 mg was observed after 4 and 52 
weeks of exposure to 25 and 3 mg/m³ CeO2, respectively. This burden caused 262-fold and 55-fold 
increases in BALF neutrophils, respectively (figure 8-8 and table 13). The dose-rate at 3 mg/m³ for 52 
weeks (10.3 µg/day) is 13 times lower than that of 4 weeks exposure to 25 mg/m³ (131 µg/day). The 
initial pulmonary inflammation after 1 week of exposure correlates with the dose rate rather than with 
the lung burden (see paper 1, conclusion).  
For CeO2, the particle surface area was the dose metrics correlating best with pulmonary inflammation 
based on BAL neutrophils. This was shown by dose-response curves using different dose-metrics 
(surface area, mass, volume) for the two tested CeO2 (NM-211 and NM-212) in the 1 week study (see 
paper 1, figure 7). To compare total lung burden and dose rate, neutrophils in BALF after 1, 4, 13 and 
52 weeks of exposure to CeO2 NM-212 were put into relation to the lung burden or lung burden per 
exposure time (table 13 and figure 8-9). The dose rate was linearly correlated with the observed lung 
effects at all exposure times and aerosol concentrations. The neutrophil response observed in BALF 
was obviously driven by the dose rate of particle surface entering the lung. Dose rate did not obviously 
correlate with other lung response parameters (absolute lung weight) (table 13). The increase of 
absolute lung weights after 1 and 4 weeks of exposure was rather affected by the exposure duration 
than by dose rate. 
After exposure to 5 and 25 mg/m³ CeO2, the initial pulmonary inflammation based on BAL neutrophils 
was supplemented and dominated by mononuclear cells, especially macrophages. In the 4 week 
study, alveolar histiocytosis progressed towards a granulomatous inflammation after 4 weeks plus 4 
weeks post-exposure at aerosol concentrations of 5 and 25 mg/m³. The later inflammatory phase was 





 was clearly driven by the continuous presence of the particles in the lung. Histopathology after 13 and 
52 weeks of exposure was not part of this body of work.  
Despite the differences in the early and later phase of the reaction (neutrophil vs. macrophage; dose-
rate vs dose), the observations made in the short-term studies have relevance for the longer 
exposure. At lung burdens of 2.6 mg after 4 and 52 weeks of exposure and an increasing duration of 
particle presence in the lung, biological responses in the lung (e.g. granulomatous inflammation) may 
show a further progression after 52 weeks. However, the further development of the granulomatous 
inflammation and the occurrence of possible morphological changes will be studied in another project 
within the long-term study. 
Besides pulmonary inflammation, increased epithelial cell proliferation in the lung may be an indicator 
for potential lung tumor formation (ECETOC 2013; ILSI Risk Science Institute Workshop Participants 
2000). For assessment of cell proliferation in paraffin-embedded tissue sections, 5-bromodeoxyuridine 
(BrdU) immunohistochemistry is the method of choice (Muskhelishvili et al. 2003). In our short-term 
studies, statistically significant increased proliferation rates of epithelial cells, especially in the terminal 
bronchioli and alveoli, were shown after 1 and 4 weeks of exposure (table 7). At lung burdens of 
around 0.5 mg after 1 week of exposure, cell proliferation rates of inhaled CeO2 (aerosol concentration 
of 25 mg/m³) were comparable or slightly higher than those of nano-TiO2 (10 mg/m³) although the 
deposited particle surface per lung was 2 times lower for CeO2 (0.014 m²) than for TiO2 (0.028 m²) 
(Ma-Hock et al. 2009). At lung burdens of around 0.5 mg after 4 week of exposure, inhaled CeO2 (5 
mg/m³) elicited a slightly lower proliferation rate than after 1 week of exposure (25 mg/m³). The 
increased response after shorter exposure may be explained by the higher dose-rate after 1 week 
than after 4 weeks of exposure. The age of the animals may have a further impact since younger 
animals may show higher cell turnover rates than older due to ongoing organ development and 
growth. In our short-term studies, epithelial cells of the alveoli and terminal bronchioli proliferated 
stronger than those of the large/medium bronchi, especially in the test groups exposed to CeO2. This 
may be explained by higher particle deposition and particle-cell interaction in these areas since most 
of the particles were found within the alveoli. No other particle induced changes of epithelial cells were 
observed by histopathology. 
Cell proliferation rates can also be influenced by increased cell turnover rates due to tissue growth. 
Further investigations such as evaluation of epithelial cell apoptosis would be necessary to clarify this 
question. Furthermore, comparative data on cell proliferation in the lung after inhalation of 
nanoparticles is limited to a few studies. Statistically significant cell proliferation rates of the 1 and 4 
week study were measured. The biological relevance of this increase remains questionable as cell 
proliferation rates in young, growing animals are rather variable. In this case, the endpoint tumor 
formation after inhalation of nanoparticles can only be revealed by histopathology after 2 years of 
inhalation exposure. Cell proliferation data may be used in the future to establish a test system for 
predicting possible tumour development already after shorter exposure.  
For neoplastic responses in rats after inhalation of PSLT, the mode of action may require particle 





 (ECETOC 2013; ILSI Risk Science Institute Workshop Participants 2000). In our inhalation studies, all 
three processes were observed. Whether the extent and interaction of these processes will lead to 
lung tumour formation or not can only be revealed by histopathology after 2 years of exposure in the 
current long-term inhalation study.  
 
9.2. Biokinetics and effects of BaSO4 in the lung 
 
Barium sulfate nanoparticles were also characterized and tested in cell-free in vitro solubility studies 
(see paper 2). The cell-free in vitro studies showed very low dissolution (0.1 wt%) of nano-BaSO4 in 
PSF. A consistent negligible dissolution in simulated physiological saline fluid was previously observed 
for micron-BaSO4 (Cullen et al. 2000; Cullen et al. 1999). But in the short-term in vivo studies inhaled 
nano-BaSO4 showed an unusual fast short-term clearance which may be explained by higher in vivo 
biosolubility compared to our in vitro cell-free static system since the observed fast lung clearance and 
high systemic bioavailability of inhaled BaSO4 cannot be explained by any known physiological 
process. The available cell-free biological simulation fluids may lack critical constituents of the lung 
which facilitate a more rapid dissolution. Moreover, the cell-free system determined the dissolution in a 
static mode which may not adequately reflect the dynamics of an in vivo system and kinetics of the 
dissolution process (e.g. removal of barium ions from the dissolution compartment resulting in a 
steady state condition). Such limitations of abiotic, static solubility assays to estimate in vivo 
biosolubility have been previously described (ECETOC 2013).  
Differences in biosolubility of particles can affect particle clearance kinetics and overload conditions. In 
our 4 week study, 95 % of BaSO4 initial lung burden was cleared within 35 days post-exposure (a lung 
burden of 0.84 mg/lung 1 day post-exposure decreased to a lung burden of 0.04 mg/lung after 35 days 
post-exposure). The retention half-time of inhaled BaSO4 was calculated with around 7 days (see 
equation used for calculations of CeO2 retention half-times in paper 1). The retention half-time of 
instilled 131BaSO4 (0.28 ± 0.004 mg/lung) was 9.6 days (see paper 2). Pulmonary micron-BaSO4 
clearance was reported to consist of 52 % mucociliary clearance and 48 % transport from the lung via 
blood to extrapulmonary tissues and organs, assuming macrophage involvement and disposal of 
sulfate particles (Spritzer & Watson 1964; IPCS 1990). Dissolution in vivo is a known mechanism for 
particle clearance (ECETOC 2013). Dissolution of BaSO4 in the lungs (e.g. in the phagolysosome of 
macrophages) may contribute to their rapid clearance and translocation to extrapulmonary organs and 
tissues. After instillation, 131BaSO4 was found in faeces (30 % of instilled dose) and bone (29 %). 
Whether the instilled 131Ba measured in the bones was particulate 131BaSO4 or ionic 131Ba could not be 
determined in this study.  
In our inhalation study, lung burdens increased strongly with a longer exposure period (from 1.73 
±0.85 mg after 13 weeks to 10.21 ±2.69 mg after 52 weeks, see table 9). This may indicate a change 





 dependent particle clearance, it may indicate a saturation of the process facilitating the dissolution of 
BaSO4 in the lung or could be a combination of both. 
After inhalation, deposited micron-BaSO4 has been reported to be cleared from the lung and elevated 
barium levels were detected in the bone (Einbrodt et al. 1972; Cuddihy et al. 1974). This clearance 
may also be transferable to BaSO4 nanoparticles. After 10 days (50 hours) of inhalation exposure to 
micron-BaSO4, the barium burden in the lung was 83 µg/g dried tissue whereas the barium burden in 
the femur was 1300 µg/g dried tissue, around 16-fold higher than in the lung (Einbrodt et al. 1972). 
Whether the translocated barium was in an ionic or particulate form was not assessed in this study. 
The majority of inhaled BaSO4 may be retained in the skeleton and to a much lesser extent in the soft 
tissues. Barium translocation to the bone had already been observed to be similar to other heavy earth 
alkaline metals like calcium and strontium (Moore 1964). 
In the periodic table, barium neighbors calcium in the group of alkaline earth metals. The ratio of 
calcium to barium atoms in the body is 1000 to 1 (Straube & Donate 2013). In the bone, calcium is 
embedded in hydroxyapatite crystals. But as barium may mimic calcium in the body, barium ions may 
also be incorporated in the bone matrix, mainly in areas of active bone growth in the distal regions 
(Bligh & Taylor 1963; IPCS 1990; Moore 1964). In an in vitro model for bone metabolism, the 
replacement of calcium by barium seems to be limited to the surface of the hydroxyapatite crystal 
whereas strontium is able to replace calcium also in the interior of the crystal (Stark 1968). Barium 
uptake into the bone seems to be rapid and, 1.5 till 5 times faster than calcium or strontium (Reeves 
1986). Barium incorporation into the bone was reported to be increased in young growing animals and 
reduced in mature animals (Bligh & Taylor 1963). This may help to explain the results of our studies 
since the rats were around 6 weeks old, still developing, at the start of inhalation exposure and will be 
around 2 years old after long-term exposure ends. At this time, it is not known why BaSO4 has such as 
fast clearance after short-term exposure and if there is a (specific, active) process for barium transport 
from the lung to the bone. The half-time of barium in the bone is around 50 days (Machata 1988). 
Saturation of a specific process may also partly explain the decrease of barium clearance out of the 
lung and the corresponding high barium burden in the lung after 52 weeks of exposure. 
Variations in pulmonary barium burden and clearance mechanisms were already observed after 40 
inhalation exposures to 40 mg/m³ micron-BaSO4 (Einbrodt et al. 1972). After the first 14 exposures, 
barium content in the lungs increased but decreased rapidly during the next 4 weeks. It increased 
again during the post-exposure period of 4 weeks. The author stated that barium redistribution from 
extrapulmonary organs via blood to the lung might play a role. Barium translocation to rat femora and 
jaw was also reported. Barium content in the femora peaked after 10 exposures and decreased 
thereafter during further exposures and the post-exposure period.  
To follow up the distribution and clearance mechanism of inhaled BaSO4 in our studies, further 
investigations have to include the analysis of barium content in blood, bone and bone marrow. The 
mechanism of barium deposition in the bone is also unclear. Proposed mechanisms include ionic 
exchange with calcium at actively calcifying surfaces and rapid process of adsorption of colloidal 





 ionic or particle - BaSO4 was rapidly cleared from the lung and translocated to the bone as well as how 
and where it was integrated in the bone. Since barium is mainly excreted in the faeces and to a lesser 
extent in the urine (see paper 2: by 28 days post-dosing, 30% of the 131Ba instilled dose was excreted 
in the faeces and only 4.4% in the urine) (Cember et al. 1961), analysis of faeces and urine of 
exposed animals may also contribute to excretion and clearance mechanisms of inhaled BaSO4 and 
has to be investigated in the ongoing long-term study. 
BaSO4 (nano)particles are used as filler in poly methyl methacrylate (PMMA) bone cements for 
orthopedic reasons (Gillani et al. 2010). BaSO4 particles which are used as radiopaque agent within 
the bone cement seems to promote osteolysis at the bone-implant interface (Wimhurst et al. 2001). 
Increased inflammatory response and pathological bone resorption by enhancing macrophage-
osteoclast differentiation were also reported with BaSO4 containing cement (concentrations of 5 μg/ml 
added to murine monocytes culture with osteoblast-like UMR106 cells) (Lazarus et al. 1994; Sabokbar 
et al. 2000). Therefore, biological effects in bone by translocated BaSO4 after inhalation have to be 
further evaluated in the long-term inhalation study. 
After inhalation and deposition in the lung, nano-PSLT can be taken up by macrophages which then 
can translocate to the lymph nodes (as mentioned in chapter 4.2.1.-4.2.3.). This mechanism has 
generally only a minor contribution to the total lung clearance of particles (Ma-Hock et al. 2009; IARC 
2010; Ravenzwaay et al. 2009). In the present work, after 13 weeks of exposure, barium burden in the 
tracheobronchial and mediastinal lymph nodes was generally low (around 0.5 % of the initial lung 
burden). This is consistent with other inhalation studies with micron-BaSO4 (Einbrodt et al. 1972).  
Other inhaled PSLT nanoparticles, such as nano-TiO2 and -CeO2, were found within macrophages 
and also free in pulmonary blood vessels (figure 8-6 and 8-7) (Eydner et al. 2012). There are two 
possible mechanisms which may underlay this observation: nanoparticles may be phagocytized by 
pulmonary macrophages and translocated within macrophages from the lung tissue into the blood. Or 
free nanoparticles translocated from the lung to the blood vessels and were phagocytized by 
pulmonary intravascular macrophages; these macrophages were, however, reported to be rare in rats 
(Brain et al. 1999; Geiser 2010; Lehnert 1992). It is of interest whether nano-BaSO4 may translocate 
freely or cell-associated (within macrophages) from the lungs to the blood and further into 
extrapulmonary tissues. The mechanistic basis of the observed nanoparticles which were found within 
macrophages and also free in pulmonary blood vessels warrants further investigations. 
In the lung, inhaled BaSO4 elicited vanishing low effects after 4 weeks of exposure to high aerosol 
concentrations. These observations were consistent with the previous short-term inhalation study after 
1 week of exposure (Landsiedel et al. 2014). This may be explained by the low inherent toxicity and 
the remarkable fast clearance of BaSO4 from the lungs.  
With a burden of 0.84 mg/lung, nano-BaSO4 elicited no inflammation and no morphological changes in 
the lung (and extra-pulmonary organs) (see figure 8-5) after short-term exposure of 4 weeks and a 
subsequent post-exposure period of 4 weeks, besides a negligible elevation of some BAL parameters 





 observed at a burden of 1.73 mg/lung after 13 weeks of exposure. This change led to corresponding 
increases of enzyme levels (GGT, ALP) indicating slight pulmonary inflammation. Increased numbers 
of neutrophils (263-fold of concurrent control), lymphocytes and monocytes showed a stronger 
pulmonary inflammation after 52 weeks of exposure (burden of 10 mg/lung). Additional elevation of 
total protein and all enzyme levels and MCP-1 may indicate a strong response to recruit and activate 
monocytes and macrophages into the lung.  
In another study, prolonged exposure to high aerosol concentrations led to high lung burdens and, 
eventually, pulmonary inflammation occurred. In a 118 day-inhalation study, pulmonary response and 
lung retention and clearance were compared for two micron-TiO2 and -BaSO4 tested at 50 mg/m³ and 
75 mg/m³, respectively (Cullen et al. 1999). After 90 days with 64 exposures, micron-BaSO4 elicited a 
burden of around 7.5 mg in the lung and 0.5 mg in the lymph nodes. Neutrophil response in BAL was 
generally low (at background levels), besides a slight peak after 90 days (around 600 000 neutrophils, 
12 % of total cells). These findings are in contrast to our effect data. In the same study, at equal mass 
burdens of the two dusts, micron-TiO2 elicited a pulmonary inflammation based on increased 
neutrophil numbers in BALF (around 28 % of total cells). Differences of the two particles were 
explained by the smaller surface area of micron-BaSO4 (3.13 m²/g) compared to micron-TiO2  
(6.68 m²/g) (Tran et al. 2000).  
The change in inflammatory potential and toxicity after 52 weeks of exposure parallels the increase of 
the test material in the lungs. In the phagolysosomal simulation fluid of our cell free studies, BaSO4 
nanoparticles changed their physico-chemical properties and showed difference in charge at different 
pH and recrystallized later over 28 days of incubation. These altered properties may lead to 
differences in clearance and pulmonary toxicity. 
Overall, BaSO4 nanoparticles are clearly deposited in the lung in our inhalation studies, especially 
after 52 weeks of exposure. On the other hand, the clearance rate is faster after short-term exposure 
than the clearance of other PSLT nanoparticles indicating a yet unknown clearance mechanism of 
BaSO4 particles from the lung or dissolution of BaSO4 particles in vivo (albeit there was no indication 
of this in vitro). The question on which of the two mechanisms are involved is of utmost interest and 
needs to be addressed in future investigations.  
The first case (clearance of undissolved BaSO4 nanoparticles) implies a hitherto unknown particle 
clearance mechanism. Additionally, this would point out the need to re-frame the concept of PSLT 
effects in the lung, since, in the case of the presented results, biopersistence would not correlate with 
high lung retention or lung burdens. 
The latter case (bio-dissolution of BaSO4 nanoparticles) implies that the in vivo biopersistence (or 
rather the non-biopersistence) of a (nano-)particle cannot always be predicted from in vitro dissolution 
(or rather insolubility) in biolological simulation fluids. With the presented results, BaSO4 
(nano)particles may not be considered to be a classical PSLT (albeit indicated to be one by chemical 





 particle effects in the lung (especially after 52 weeks of exposure) but no indication of barium 
intoxication as described in the literature (Bhoelan et al. 2014).  
The actual lung burden is always a function of both: the deposition and the clearance rate. The 
aerosol concentration was quite high for BaSO4 in our studies. Low aerosol concentrations of 
biopersistent particles may result in the same lung burden as high aerosol concentrations of rapidly-
cleared particles: aerosol concentrations of 3 mg/m³ CeO2 and 50 mg/m³ BaSO4 resulted in similar 
lung burdens after 13 weeks of exposure (table 9). The effects of the (nano-)particles in the lung, 
however, depend on the properties of the deposited material, the dose-rate and the toxicity of the 
released ions: aerosol concentrations of 3 mg/m³ CeO2 and 50 mg/m³ BaSO4 resulted in similar lung 
burdens after 13 weeks of exposure, but the effects (based on BALF parameters) differed. Different 
(nano-)particles will span a continuous range of solubilities in the lung without a distinct threshold 
dividing poorly soluble from soluble (nano-)particles. Likewise, most (nano-)particle may not exhibit 
mere particle effects or mere released-ion effects. Hence, BaSO4 (nano-)particles could be regarded 
as not being a classical PSLT or representing the lower toxicity and biopersistence end of PSLT.  
 
9.3. Systemic effects  
 
Systemic toxicity for inhaled PSLT seems to be less relevant since translocation rates to extra-
pulmonary organs are low and very rarely associated with toxic effects (Landsiedel et al. 2012a; 
Moreno-Horn & Gebel 2014). This was also observed in our studies with 1, 4, 13 and 52 weeks of 
exposure to nano-CeO2 and -BaSO4. There were, however, small amounts of particles translocating 
from the lung and slight effects secondary to local pulmonary inflammation. 
In blood, a slight neutrophilia was observed for CeO2 NM-212 after 1 week (5 days) of exposure to 25 
mg/m³ (see paper 1). The neutrophilia in blood was considered to be secondary since a pronounced 
inflammation was found in the lung at these aerosol concentrations. Exposure of 4 and 13 weeks to 
CeO2 NM-212 and BaSO4 elicited no neutrophilia. After 52 weeks of exposure, a slight neutrophilia in 
blood was apparent for 50 mg/m³ BaSO4 (table 11 and 12). Consistent to the 1 week study, the 
neutrophilia in blood after 52 weeks of BaSO4 exposure seems to be rather a concomitant effect of the 
corresponding local inflammation in the lung. 
There is a concern that occupational exposure to nanoparticles can lead to an increased risk in 
cardiovascular diseases (Donaldson et al. 2001). Various inhaled nanoparticles (e.g. carbon black, 
TiO2) seem to be capable to induce an acute phase response in the blood (Halappanavar et al. 2011; 
Saber et al. 2009; Saber et al. 2013). The major acute phase protein of the rat is alpha-2-
macroglobulin which is a proteinase inhibitor in serum. It is able to bind foreign substances or particles 
as humoral defense (Borth 1992). Alpha-2-macroglobulin is further a carrier of growth factors with 
regulatory functions of growth factor activity and is increased in inflammation (Bhattacharjee et al. 
2005). Its expression is furthermore enhanced by Interleukin-6. The second acute phase protein 





 cell turnover (Quaye 2008). Its increase is linked to diseases which exhibit inflammatory causes. 
Haptoglobin is also a novel specific granule protein of neutrophils and its synthesis takes place during 
differentiation of granulocytes (Theilgaard-Monch et al. 2006). After storage, it is released by activated 
neutrophils. Furthermore, haptoglobin is involved in free radical quenching, tissue repair and 
regeneration (Quaye 2008). Increase of haptoglobin levels in plasma were already observed after 
intravenous exposure to 0.8 mg silica nanoparticles (particle diameter of 70 nm) in mice (Higashisaka 
et al. 2011). The alteration of acute phase protein levels in blood may reflect the level of inflammation 
(Donaldson et al. 2001; Halappanavar et al. 2011; Saber et al. 2009; Saber et al. 2013). Activated 
leukocytes migrate to the site of inflammation in the lung. They pass the blood stream and release 
cytokines which are able to trigger acute phase response (Gabay 1999). This acute phase response is 
generated during inflammation over time leading to altered serum levels of acute phase proteins.  
In our inhalation studies, the acute phase proteins haptoglobin and alpha-2-macroglobulin (A2M) (3 
mg/m³ CeO2, 50 mg/m³ BaSO4) were slightly increased in blood after 52 weeks but not after 4 or 13 
weeks of exposure (table 11 and 12). For 50 mg/m³ BaSO4, a late onset of pulmonary inflammation 
occurred after 52 weeks accompanied by a slight increase of neutrophils.  
Four weeks exposure of 25 mg/m³ CeO2 showed a pronounced lung inflammation, but no increase in 
neutrophils and acute phase proteins in blood (table 12). After 52 weeks of exposure to 3 mg/m³, lung 
burdens (of 2.6 mg) were comparable to those after 4 weeks of exposure to 25 mg/m³. Although 
pulmonary inflammation based on increased BALF neutrophils was around 5-times lower after 52 
weeks than after 4 weeks and no neutrophilia in blood was apparent, both acute phase proteins were 
slightly increased even after 52 weeks. Since altered levels of acute-phase proteins reflect the 
presence and intensity of inflammation (Gabay 1999; Davidson 2013), the duration of pulmonary 
inflammation may be also a decisive parameter. The increase in acute phase proteins may be 
explained by the longer lasting pulmonary inflammation after 52 weeks compared to 4 weeks of 
exposure. A good correlation was shown for dose-rate and initial inflammation in the lung (based on 
BALF neutrophils) after short-term exposure. Here, the dose rate seems not to be the driver for the 
increase of the acute phase proteins after 52 weeks. This may indicate a different mechanism.  
Overall, the increase in acute phase proteins in blood seems to be no nanoparticle-specific effect, but 
rather, together with the slight neutrophilia in blood, a concomitant effect of recruitment of neutrophils 
into the lung and of pulmonary inflammation and released mediators.  
After 4 weeks of exposure to 25 mg/m³ CeO2, translocation of CeO2 from the lung to the liver was low 
since liver burdens were below 2 µg at two time points and during 8 weeks of post-exposure (see 
paper 1) unless there was a rapid hepato-biliary excretion of CeO2 from the liver. Cerium in bile was, 
however, not measured. Low translocation of CeO2 deposited in the lung was also confirmed by an 
intratracheal instillation study where less than 1 % of the total instilled 141Ce concentration was found 
in extrapulmonary tissues after 28 days (Molina et al. 2014). Furthermore, no morphological changes 






 10. Conclusion 
 
Differences in toxic potency of various PSLT (nano-)particles were reported earlier (ECETOC 2013; 
ILSI Risk Science Institute Workshop Participants 2000). In this body of work, two different 
nanoparticles were tested in our inhalation studies. 
In the short-term studies, inhaled nano-BaSO4 showed an unusually fast short-term clearance. This 
may be explained by higher in vivo dissolution compared to our cell-free in vitro solubility studies since 
the observed fast lung clearance and high systemic bioavailability of inhaled BaSO4 cannot be 
achieved by any known physiological process unless there may be a specific rapid translocation of 
nano-BaSO4. It is of utmost interest which mechanisms are involved; this needs to be addressed in 
future investigations. In the long-term study, lung burdens increased strongly with longer exposure 
period indicating a change in clearance from short-term to long-term exposure. Long-term exposure to 
high aerosol concentrations of nano-BaSO4 led to high lung burdens and, eventually, pulmonary 
inflammation based on increased BALF parameters. There were no indications of barium-ion toxicity 
and the effects are regarded as being particle effects in the lung. Nano-BaSO4 seems to exhibit 
peculiar characteristics concerning kinetics and effects compared to nano-PSLT. Nano-BaSO4 could 
be regarded as not being a classical PSLT, but rather soluble in vivo albeit indicated to be insoluble by 
its chemical properties. The remarkably low toxicity of inhaled nano-BaSO4 could only partly be 
assigned to its fast lung clearance, but may also be the result of its low inherent toxicity.  
Nano-CeO2, on the other hand, was biopersistent. Low lung burdens were cleared at physiological 
rates whereas higher burdens induced retarded clearance and toxicity already after short-term 
exposure. Comparing the observed effects in our studies with the literature data, CeO2 seems to 
possess a higher toxicity than TiO2 (Ma-Hock et al. 2009; Eydner et al. 2012). It may represent the 
higher toxicity and high biopersistence end of the group of PSLT.  
Comparing the two tested nanoparticles, aerosol concentrations of 3 mg/m³ CeO2 and 50 mg/m³ 
BaSO4 resulted in similar lung burdens after 13 weeks of exposure, but the effects (based on BALF 
parameters) were different; this probably depends on the properties of the deposited material, the 
dose-rate and the toxicity of the released ions. Different (nano-)particles will span a continuous range 
of solubilities in the lung without a distinct threshold dividing poorly soluble from soluble  
(nano-)particles. Likewise, most particle may not exhibit mere particle effects or mere released-ion 
effects.  
The local no observed adverse effect concentrations in the lung (NOAEC) of CeO2 - based on BALF in 
female rats after 13 and 52 weeks of exposure - are 0.3 and 0.1 mg/m³, respectively. The local 
NOAEC of BaSO4 in the lung - based on BALF in female rats after 13 and 52 weeks of exposure – is 
below 50 mg/m³.  
Inhalation exposure to CeO2 and BaSO4 elicited no or only minimal systemic effects after short-term 





The two nanoparticles examined in this body of work differed in their particle kinetics and effects in the 
lung already after one week and up to 52 weeks of exposure. Whether the lung burdens and effects 
observed within the first 52 weeks of exposure will lead to lung tumour formation will be revealed by 
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12.1. Abbrevations 
 
AAALAC, Association for Assessment and Accreditation of Laboratory Animal Care International 
AAN, Average Agglomeration Numbers 
ALP, Alkaline phosphatase 
AUC, Area under the curve 
BALF, Bronchoalveolar lavage fluid 
BALT, Bronchus-associated lymphoid tissue 
BET, Brunauer-Emmet-Teller 
Ceria, Cerium dioxide 
CINC, Cytokine-induced neutrophil chemoattractant 
FaSSIF, Fasted State Simulated Intestinal Fluid 
GGT, γ-Glutamyl-transferase 
GSD, Geometric standard deviation 
ICP-AES, Inductively coupled plasma atomic emission spectrometry 
ICP-MS, Inductively coupled plasma optical emission spectrometry 
IL, interleukin 
LDH, lactate dehydrogenase 
M-CSF, macrophage colony stimulating factor 
MCP, monocyte chemoattractant protein 
MMAD, mass median aerodynamic diameter 
MPPD, multiple-path particle dosimetry model 
NAG, N-acetyl-β-glucosaminidase 
NOAEC, no observed adverse effect concentration 
OPN, osteopontin 
PMN, polymorphnuclear neutrophil 
PSF, phagolysosomal simulant fluid 
PSP, poorly soluble particles with low toxicity 
SAD, selected area electron diffraction 
SEM, scanning electron microscopy 
SIMS, secondary ion mass spectrometry 
SMPS, scanning mobility particle sizer 
STIS, short term inhalation study protocol 
TEM, transmission electron microscopy 
TGA, thermogravimetric analysis 
TiO2, titanium dioxide 
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